Id,Sequence,Length,Virus,Abbreviation,Family,Nomenclature,Source,Uniprot,Cell_Line,Inhibition/IC50,Unit,Target,Assay,Accession,Title,Authors,Reference
AVP0001,PYVGSGLYRR,10,Avian myeloblastosis virus,AMV,Retroviridae,p2-p10,RSV gag polyprotein,P03354,-,50,μM,Release,Protease activity assay,1331099,Mechanism of inhibition of the retroviral protease by a Rous sarcoma virus peptide substrate representing the cleavage site between the gag p2 and p10 proteins.,"Cameron CE, Grinde B, Jentoft J, Leis J, Weber IT, Copeland TD, Wlodawer A.",J Biol Chem. 1992
AVP0002,SMIENLEYM,9,Lymphocytic choriomeningitis virus,LCMV,Arenaviridae,-,Synthetic,,MC57,50,μM,CTL lysis,In vitro cytotoxicity assay,1383569,Design of high-affinity major histocompatibility complex-specific antagonist peptides that inhibit cytotoxic T-lymphocyte activity: implications for control of viral disease.,"Gairin JE, Oldstone MB.",J Virol. 1992
AVP0003,ECRSTSYAGAVVNDL,15,Herpes simplex virus 1,HSV 1,Herpesviridae,H2-(1-15),HSV ribonucleotide reductase subunit 2,P10224,BHK-21/C,42,μM,Replication,Ribonucleotide reductase assay,3040743,Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.,"Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P.",J Biol Chem. 1987
AVP0004,STSYAGAVVNDL,12,Herpes simplex virus 1,HSV 1,Herpesviridae,H2-(4-15),HSV ribonucleotide reductase subunit 2,P10224,BHK-21/C,29,μM,Replication,Ribonucleotide reductase assay,3040743,Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.,"Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P.",J Biol Chem. 1987
AVP0005,YAGAVVNDL,9,Herpes simplex virus 1,HSV 1,Herpesviridae,H2-(7-15),HSV ribonucleotide reductase subunit 2,P10224,BHK-21/C,60,μM,Replication,Ribonucleotide reductase assay,3040743,Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.,"Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P.",J Biol Chem. 1987
AVP0006,AGAVVNDL,8,Herpes simplex virus 1,HSV 1,Herpesviridae,H2-(8-15),HSV ribonucleotide reductase subunit 2,P10224,BHK-21/C,283,μM,Replication,Ribonucleotide reductase assay,3040743,Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.,"Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P.",J Biol Chem. 1987
AVP0007,GAVVNDL,7,Herpes simplex virus 1,HSV 1,Herpesviridae,H2-(9-15),HSV ribonucleotide reductase subunit 2,P10224,BHK-21/C,225,μM,Replication,Ribonucleotide reductase assay,3040743,Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.,"Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P.",J Biol Chem. 1987
AVP0008,AVVNDL,6,Herpes simplex virus 1,HSV 1,Herpesviridae,H2-(10-15),HSV ribonucleotide reductase subunit 2,P10224,BHK-21/C,190,μM,Replication,Ribonucleotide reductase assay,3040743,Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.,"Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P.",J Biol Chem. 1987
AVP0009,VVNDL,5,Herpes simplex virus 1,HSV 1,Herpesviridae,H2-(11-15),HSV ribonucleotide reductase subunit 2,P10224,BHK-21/C,760,μM,Replication,Ribonucleotide reductase assay,3040743,Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.,"Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P.",J Biol Chem. 1987
AVP0010,YAVVNDL,7,Herpes simplex virus 1,HSV 1,Herpesviridae,[Tyr9]H2-(9-15),HSV ribonucleotide reductase subunit 2,P10224,BHK-21/C,340,μM,Replication,Ribonucleotide reductase assay,3040743,Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.,"Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P.",J Biol Chem. 1987
AVP0011,YGAVVNDL,8,Herpes simplex virus 1,HSV 1,Herpesviridae,[Tyr8]H2-(8-15),HSV ribonucleotide reductase subunit 2,P10224,BHK-21/C,330,μM,Replication,Ribonucleotide reductase assay,3040743,Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.,"Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P.",J Biol Chem. 1987
AVP0012,AAGAVVNDL,9,Herpes simplex virus 1,HSV 1,Herpesviridae,[Ala7]H2-(7-15),HSV ribonucleotide reductase subunit 2,P10224,BHK-21/C,280,μM,Replication,Ribonucleotide reductase assay,3040743,Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.,"Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P.",J Biol Chem. 1987
AVP0013,YAGAVANDL,9,Herpes simplex virus 1,HSV 1,Herpesviridae,[Ala12]H2-(7-15),HSV ribonucleotide reductase subunit 2,P10224,BHK-21/C,760,μM,Replication,Ribonucleotide reductase assay,3040743,Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.,"Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P.",J Biol Chem. 1987
AVP0014,ALLGRMKG,8,Hepatitis B virus,HBV,Hepadnaviridae,-,Coliphage fd,O80297 ,-,10,μM,Viral assembly,Phage binding assay,7892246,Selection of peptide inhibitors of interactions involved in complex protein assemblies: association of the core and surface antigens of hepatitis B virus.,"Dyson MR, Murray K.",Proc Natl Acad Sci U S A. 1995
AVP0015,LDPAFR,6,Hepatitis B virus,HBV,Hepadnaviridae,-,Coliphage fd,O80297 ,-,360,μM,Viral assembly,Phage binding assay,7892246,Selection of peptide inhibitors of interactions involved in complex protein assemblies: association of the core and surface antigens of hepatitis B virus.,"Dyson MR, Murray K.",Proc Natl Acad Sci U S A. 1995
AVP0016,GQPEEGAPCQVVLQGA,16,Herpes simplex virus 1,HSV 1,Herpesviridae,peptide 6,HSV UL42 protein,P10226,-,3.5,μM,Replication,DNA polymerase assay,8380075,Inhibition of herpes simplex virus type 1 DNA polymerase activity by peptides from the UL42 accessory protein is largely nonspecific.,"Owsianka AM, Hart G, Murphy M, Gottlieb J, Boehme R, Challberg M, Marsden HS.",J Virol. 1993
AVP0017,RGILIHNTIFGEQVF,15,Herpes simplex virus 1,HSV 1,Herpesviridae,peptide 14,HSV UL42 protein,P10226,-,7.5,μM,Replication,DNA polymerase assay,8380075,Inhibition of herpes simplex virus type 1 DNA polymerase activity by peptides from the UL42 accessory protein is largely nonspecific.,"Owsianka AM, Hart G, Murphy M, Gottlieb J, Boehme R, Challberg M, Marsden HS.",J Virol. 1993
AVP0018,YRWRGPTAAFLSLV,14,Herpes simplex virus 1,HSV 1,Herpesviridae,peptide 19,HSV UL42 protein,P10226,-,9,μM,Replication,DNA polymerase assay,8380075,Inhibition of herpes simplex virus type 1 DNA polymerase activity by peptides from the UL42 accessory protein is largely nonspecific.,"Owsianka AM, Hart G, Murphy M, Gottlieb J, Boehme R, Challberg M, Marsden HS.",J Virol. 1993
AVP0019,SSSTSTQVQILSNAL,15,Herpes simplex virus 1,HSV 1,Herpesviridae,peptide 47,HSV UL42 protein,P10226,-,0.8,μM,Replication,DNA polymerase assay,8380075,Inhibition of herpes simplex virus type 1 DNA polymerase activity by peptides from the UL42 accessory protein is largely nonspecific.,"Owsianka AM, Hart G, Murphy M, Gottlieb J, Boehme R, Challberg M, Marsden HS.",J Virol. 1993
AVP0020,RRLQVGGGTLKFFLT,15,Herpes simplex virus 1,HSV 1,Herpesviridae,peptide 57,HSV UL42 protein,P10226,-,12,μM,Replication,DNA polymerase assay,8380075,Inhibition of herpes simplex virus type 1 DNA polymerase activity by peptides from the UL42 accessory protein is largely nonspecific.,"Owsianka AM, Hart G, Murphy M, Gottlieb J, Boehme R, Challberg M, Marsden HS.",J Virol. 1993
AVP0021,FLDSKAELEKARKILSEVGRWY,22,Sendai virus,SeV,Paramyxoviridae,SV-473,SeV fusion protein,P04855,Human RBCs,1,μM,Virus entry,Hemolysis assay,8521809,A synthetic peptide corresponding to a conserved heptad repeat domain is a potent inhibitor of Sendai virus-cell fusion: an emerging similarity with functional domains of other viruses.,"Rapaport D, Ovadia M, Shai Y.",EMBO J. 1995
AVP0022,PPLVVPVEESEIIFWDCWAPEE,22,Feline immunodeficiency virus,FIV,Retroviridae,1,FIV envelope glycoprotein (gE),P16090,CrFK,0,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0023,IFWDCWAPEEPACQDFLGAMIH,22,Feline immunodeficiency virus,FIV,Retroviridae,2,FIV envelope glycoprotein (gE),P16090,CrFK,0,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0024,PACQDFLGAMIHLKAKTNISIR,22,Feline immunodeficiency virus,FIV,Retroviridae,3,FIV envelope glycoprotein (gE),P16090,CrFK,28,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0025,LKAKTNISIREGPTLGNWAR,20,Feline immunodeficiency virus,FIV,Retroviridae,4,FIV envelope glycoprotein (gE),P16090,CrFK,24,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0026,EGPTLGNWAREIWATLFKKA,20,Feline immunodeficiency virus,FIV,Retroviridae,5,FIV envelope glycoprotein (gE),P16090,CrFK,100,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0027,EIWATLFKKATRQCRRGRIW,20,Feline immunodeficiency virus,FIV,Retroviridae,6,FIV envelope glycoprotein (gE),P16090,CrFK,100,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0028,TRQCRRGRIWKRWNETITGP,20,Feline immunodeficiency virus,FIV,Retroviridae,7,FIV envelope glycoprotein (gE),P16090,CrFK,94,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0029,KRWNETITGPSGCANNTCYN,20,Feline immunodeficiency virus,FIV,Retroviridae,8,FIV envelope glycoprotein (gE),P16090,CrFK,0,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0030,SGCANNTCYNVSVIVPDYQC,20,Feline immunodeficiency virus,FIV,Retroviridae,9,FIV envelope glycoprotein (gE),P16090,CrFK,24,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0031,VSVIVPDYQCYLDRVDTWLQ,20,Feline immunodeficiency virus,FIV,Retroviridae,10,FIV envelope glycoprotein (gE),P16090,CrFK,0,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0032,YLDRVDTWLQGKINISLCLT,20,Feline immunodeficiency virus,FIV,Retroviridae,11,FIV envelope glycoprotein (gE),P16090,CrFK,9,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0033,GKINISLCLTGGKMLYNKVT,20,Feline immunodeficiency virus,FIV,Retroviridae,12,FIV envelope glycoprotein (gE),P16090,CrFK,10,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0034,GGKMLYNKVTKQLSYCTDPL,20,Feline immunodeficiency virus,FIV,Retroviridae,13,FIV envelope glycoprotein (gE),P16090,CrFK,5,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0035,KQLSYCTDPLQIPLINYTFG,20,Feline immunodeficiency virus,FIV,Retroviridae,14,FIV envelope glycoprotein (gE),P16090,CrFK,15,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0036,QIPLINYTFGPNQTCMWNTS,20,Feline immunodeficiency virus,FIV,Retroviridae,15,FIV envelope glycoprotein (gE),P16090,CrFK,0,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0037,PNQTCMWNTSQIQDPEIPKC,20,Feline immunodeficiency virus,FIV,Retroviridae,16,FIV envelope glycoprotein (gE),P16090,CrFK,5,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0038,QIQDPEIPKCGWWNQMAYYN,20,Feline immunodeficiency virus,FIV,Retroviridae,17,FIV envelope glycoprotein (gE),P16090,CrFK,2,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0039,GWWNQMAYYNSCKWEEAKVK,20,Feline immunodeficiency virus,FIV,Retroviridae,18,FIV envelope glycoprotein (gE),P16090,CrFK,0,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0040,CKWEEAKVKFHCQRTQSQPGSW,22,Feline immunodeficiency virus,FIV,Retroviridae,19,FIV envelope glycoprotein (gE),P16090,CrFK,0,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0041,FHCQRTQSQPGSWFRAISSWKQ,22,Feline immunodeficiency virus,FIV,Retroviridae,20,FIV envelope glycoprotein (gE),P16090,CrFK,4,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0042,GSWFRAISSWKQRNRWEWRPDF,22,Feline immunodeficiency virus,FIV,Retroviridae,21,FIV envelope glycoprotein (gE),P16090,CrFK,6,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0043,KQRNRWEWRPDFKSKKVKISLPC,23,Feline immunodeficiency virus,FIV,Retroviridae,22,FIV envelope glycoprotein (gE),P16090,CrFK,6,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0044,KSKKVKISLPCNSTKNLTFA,20,Feline immunodeficiency virus,FIV,Retroviridae,23,FIV envelope glycoprotein (gE),P16090,CrFK,10,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0045,CNSTKNLTFAMRSSGDYGEV,20,Feline immunodeficiency virus,FIV,Retroviridae,24,FIV envelope glycoprotein (gE),P16090,CrFK,25,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0046,MRSSGDYGEVTGAWIEFGCH,20,Feline immunodeficiency virus,FIV,Retroviridae,25,FIV envelope glycoprotein (gE),P16090,CrFK,27,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0047,TGAWIEFGCHRNKSNLHTEA,20,Feline immunodeficiency virus,FIV,Retroviridae,26,FIV envelope glycoprotein (gE),P16090,CrFK,5,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0048,RNKSNLHTEARFRIRCRWNV,20,Feline immunodeficiency virus,FIV,Retroviridae,27,FIV envelope glycoprotein (gE),P16090,CrFK,2,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0049,RFRIRCRWNVGSDTSLIDTC,20,Feline immunodeficiency virus,FIV,Retroviridae,28,FIV envelope glycoprotein (gE),P16090,CrFK,40,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0050,GSDTSLIDTCGNTPNVSGAN,20,Feline immunodeficiency virus,FIV,Retroviridae,29,FIV envelope glycoprotein (gE),P16090,CrFK,12,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0051,GNTPNVSGANPVDCTMYSNK,20,Feline immunodeficiency virus,FIV,Retroviridae,30,FIV envelope glycoprotein (gE),P16090,CrFK,0,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0052,PVDCTMYSNKMYNCSLQNGF,20,Feline immunodeficiency virus,FIV,Retroviridae,31,FIV envelope glycoprotein (gE),P16090,CrFK,8,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0053,MYNCSLQNGFTMKVDDLIVH,20,Feline immunodeficiency virus,FIV,Retroviridae,32,FIV envelope glycoprotein (gE),P16090,CrFK,33,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0054,TMKVDDLIVHFNMTKAVEMV,20,Feline immunodeficiency virus,FIV,Retroviridae,33,FIV envelope glycoprotein (gE),P16090,CrFK,25,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0055,FNMTKAVEMVNIAGNWSCTS,20,Feline immunodeficiency virus,FIV,Retroviridae,34,FIV envelope glycoprotein (gE),P16090,CrFK,15,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0056,NIAGNWSCTSDLPSSWGYMN,20,Feline immunodeficiency virus,FIV,Retroviridae,35,FIV envelope glycoprotein (gE),P16090,CrFK,22,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0057,CTSDLPSSWGYMNCNCTNSSSS,22,Feline immunodeficiency virus,FIV,Retroviridae,36,FIV envelope glycoprotein (gE),P16090,CrFK,5,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0058,CNCTNSSSSYSGTKMACPSNRG,22,Feline immunodeficiency virus,FIV,Retroviridae,37,FIV envelope glycoprotein (gE),P16090,CrFK,60,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0059,SGTKMACPSNRGILRNWYNP,20,Feline immunodeficiency virus,FIV,Retroviridae,38,FIV envelope glycoprotein (gE),P16090,CrFK,52,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0060,RGILRNWYNPFAGLRQSLEQ,20,Feline immunodeficiency virus,FIV,Retroviridae,39,FIV envelope glycoprotein (gE),P16090,CrFK,60,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0061,VAGLRQSLEQYQVVKQPDYL,20,Feline immunodeficiency virus,FIV,Retroviridae,40,FIV envelope glycoprotein (gE),P16090,CrFK,48,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0062,YQVVKQPDYLLVPEEVMEYK,20,Feline immunodeficiency virus,FIV,Retroviridae,41,FIV envelope glycoprotein (gE),P16090,CrFK,38,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0063,PDYLLVPEEVMEYKPRRKRAAI,22,Feline immunodeficiency virus,FIV,Retroviridae,42,FIV envelope glycoprotein (gE),P16090,CrFK,54,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0064,YKPRRKRAAIHVMLALATVLSI,22,Feline immunodeficiency virus,FIV,Retroviridae,43,FIV envelope glycoprotein (gE),P16090,CrFK,52,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0065,HVMLALATVLSIAGAGTGATAI,22,Feline immunodeficiency virus,FIV,Retroviridae,44,FIV envelope glycoprotein (gE),P16090,CrFK,58,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0066,AGAGTGATAIGMVTQYHQVL,20,Feline immunodeficiency virus,FIV,Retroviridae,45,FIV envelope glycoprotein (gE),P16090,CrFK,60,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0067,GMVTQYHQVLATHQEAIEKV,20,Feline immunodeficiency virus,FIV,Retroviridae,46,FIV envelope glycoprotein (gE),P16090,CrFK,43,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0068,ATHQEAIEKVTGALKINNLR,20,Feline immunodeficiency virus,FIV,Retroviridae,47,FIV envelope glycoprotein (gE),P16090,CrFK,44,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0069,TGALKINNLRLVTLEHQVLV,20,Feline immunodeficiency virus,FIV,Retroviridae,48,FIV envelope glycoprotein (gE),P16090,CrFK,73,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0070,LVTLEHQVLVIGLKVEAMEK,20,Feline immunodeficiency virus,FIV,Retroviridae,49,FIV envelope glycoprotein (gE),P16090,CrFK,45,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0071,IGLKVEAMEKFLYTAFAMQE,20,Feline immunodeficiency virus,FIV,Retroviridae,50,FIV envelope glycoprotein (gE),P16090,CrFK,74,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0072,FLYTAFAMQELGCNQNQFFC,20,Feline immunodeficiency virus,FIV,Retroviridae,51,FIV envelope glycoprotein (gE),P16090,CrFK,18,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0073,LGCNQNQFFCKIPLELWTRY,20,Feline immunodeficiency virus,FIV,Retroviridae,52,FIV envelope glycoprotein (gE),P16090,CrFK,21,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0074,KIPLELWTRYNMTINQTIWN,20,Feline immunodeficiency virus,FIV,Retroviridae,53,FIV envelope glycoprotein (gE),P16090,CrFK,0,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0075,NMTINQTIWNHGNITLGEWY,20,Feline immunodeficiency virus,FIV,Retroviridae,54,FIV envelope glycoprotein (gE),P16090,CrFK,4,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0076,HGNITLGEWYNQTKDLQQKF,20,Feline immunodeficiency virus,FIV,Retroviridae,55,FIV envelope glycoprotein (gE),P16090,CrFK,35,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0077,NQTKDLQQKFYEIIMDIEQN,20,Feline immunodeficiency virus,FIV,Retroviridae,56,FIV envelope glycoprotein (gE),P16090,CrFK,68,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0078,YEIIMDIEQNNVQGKTGIQQ,20,Feline immunodeficiency virus,FIV,Retroviridae,57,FIV envelope glycoprotein (gE),P16090,CrFK,37,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0079,NVQGKTGIQQLQKWEDWVRW,20,Feline immunodeficiency virus,FIV,Retroviridae,58,FIV envelope glycoprotein (gE),P16090,CrFK,96,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0080,LQKWEDWVRWIGNIPQYLKG,20,Feline immunodeficiency virus,FIV,Retroviridae,59,FIV envelope glycoprotein (gE),P16090,CrFK,98,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0081,IGNIPQYLKGLLGGILGIGL,20,Feline immunodeficiency virus,FIV,Retroviridae,60,FIV envelope glycoprotein (gE),P16090,CrFK,60,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0082,LLGGILGIGLGVLLLILCLP,20,Feline immunodeficiency virus,FIV,Retroviridae,61,FIV envelope glycoprotein (gE),P16090,CrFK,88,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0083,GVLLLILCLPTLVDCIRNCI,20,Feline immunodeficiency virus,FIV,Retroviridae,62,FIV envelope glycoprotein (gE),P16090,CrFK,32,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0084,TLVDCIRNCIHKILGYTVIA,20,Feline immunodeficiency virus,FIV,Retroviridae,63,FIV envelope glycoprotein (gE),P16090,CrFK,9,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0085,HKILGYTVIAMPEVEGEEIQ,20,Feline immunodeficiency virus,FIV,Retroviridae,64,FIV envelope glycoprotein (gE),P16090,CrFK,8,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0086,MPEVEGEEIQPQMELRRNGR,20,Feline immunodeficiency virus,FIV,Retroviridae,65,FIV envelope glycoprotein (gE),P16090,CrFK,7,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0087,PQMELRRNGRQCGMSEKEEE,20,Feline immunodeficiency virus,FIV,Retroviridae,66,FIV envelope glycoprotein (gE),P16090,CrFK,6,%,Syncytium formation,Syncitia assay,8661378,Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Virology. 1996
AVP0088,PDAVYLHRIDLGPPISLERLDVGTNLGNAIAKLED,35,Measles virus,MV,Paramyxoviridae,T-252,MV fusion (F) protein,P69353,HEp2,>100,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0089,DAVYLHRIDLGPPISLERLDVGTNLQNAIAKLEDA,35,Measles virus,MV,Paramyxoviridae,T-253,MV fusion (F) protein,P69353,HEp2,>100,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0090,AVYLHRIDLGPPISLERLDVGTNLQNAIAKLEDAK,35,Measles virus,MV,Paramyxoviridae,T-254,MV fusion (F) protein,P69353,HEp2,>100,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0091,VYLHRIDLGPPISLERLDVGTNLQNAIAKLEDAKE,35,Measles virus,MV,Paramyxoviridae,T-255,MV fusion (F) protein,P69353,HEp2,85.3,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0092,YLHRIDLGPPISLERLDVGTNLGNAIAKLEDAKEL,35,Measles virus,MV,Paramyxoviridae,T-256,MV fusion (F) protein,P69353,HEp2,90.7,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0093,LHRIDLGPPISLERLDVGTNLGNAIAKLEDAKELL,35,Measles virus,MV,Paramyxoviridae,T-257,MV fusion (F) protein,P69353,HEp2,1.5,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0094,HRIDLGPPISLERLDVGTNLGNAIAKLEDAKELLE,35,Measles virus,MV,Paramyxoviridae,T-258,MV fusion (F) protein,P69353,HEp2,2.2,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0095,RIDLGPPISLERLDVGTNLGNAIAKLEDAKELLES,35,Measles virus,MV,Paramyxoviridae,T-259,MV fusion (F) protein,P69353,HEp2,1.7,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0096,IDLGPPISLERLDVGTNLGNAIAKLEDAKELLESS,35,Measles virus,MV,Paramyxoviridae,T-260,MV fusion (F) protein,P69353,HEp2,4.9,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0097,DLGPPISLERLDVGTNLGNAIAKLEDAKELLESSD,35,Measles virus,MV,Paramyxoviridae,T-261,MV fusion (F) protein,P69353,HEp2,5.7,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0098,LGPPISLERLDVGTNLGNAIAKLEDAKELLESSDQ,35,Measles virus,MV,Paramyxoviridae,T-262,MV fusion (F) protein,P69353,HEp2,6.5,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0099,GPPISLERLDVGTNLGNAIAKLEDAKELLESSDQI,35,Measles virus,MV,Paramyxoviridae,T-263,MV fusion (F) protein,P69353,HEp2,10.1,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0100,PPISLERLDVGTNLGNAIAKLEDAKELLESSDQIL,35,Measles virus,MV,Paramyxoviridae,T-264,MV fusion (F) protein,P69353,HEp2,1.1,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0101,PISLERLDVGTNLGNAIAKLEDAKELLESSDQILR,35,Measles virus,MV,Paramyxoviridae,T-265,MV fusion (F) protein,P69353,HEp2,3.1,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0102,ISLERLDVGTNLGNAIAKLEDAKELLESSDQILRS,35,Measles virus,MV,Paramyxoviridae,T-266,MV fusion (F) protein,P69353,HEp2,13,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0103,SLERLDVGTNLGNAIAKLEDAKELLESSDQILRSM,35,Measles virus,MV,Paramyxoviridae,T-267,MV fusion (F) protein,P69353,HEp2,12.3,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0104,LERLDVGTNLGNAIAKLEDAKELLESSDQILRSMK,35,Measles virus,MV,Paramyxoviridae,T-268,MV fusion (F) protein,P69353,HEp2,7.3,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0105,YTPNDITLNNSVALDPIDISIELNKAKSDLEESKE,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-189,HPIV3 fusion (F) protein,P06828,HEp2,>100,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0106,TPNDITLNNSVALDPIDISIELNKAKSDLEESKEW,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-190,HPIV3 fusion (F) protein,P06828,HEp2,>100,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0107,PNDITLNNSVALDPIDISIELNKAKSDLEESKEWI,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-191,HPIV3 fusion (F) protein,P06828,HEp2,>100,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0108,NDITLNNSVALDPIDISIELNKAKSDLEESKEWIR,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-192,HPIV3 fusion (F) protein,P06828,HEp2,>100,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0109,DITLNNSVALDPIDISIELNKAKSDLEESKEWIRR,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-193,HPIV3 fusion (F) protein,P06828,HEp2,>100,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0110,ITLNNSVALDPIDISIELNKAKSDLEESKEWIRRS,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-194,HPIV3 fusion (F) protein,P06828,HEp2,62,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0111,TLNNSVALDPIDISIELNKAKSDLEESKEWIRRSN,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-195,HPIV3 fusion (F) protein,P06828,HEp2,72,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0112,LNNSVALDPIDISIELNKAKSDLEESKEWIRRSNQ,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-196,HPIV3 fusion (F) protein,P06828,HEp2,1,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0113,NNSVALDPIDISIELNKAKSDLEESKEWIRRSNQK,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-197,HPIV3 fusion (F) protein,P06828,HEp2,6,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0114,NSVALDPIDISIELNKAKSDLEESKEWIRRSNQKL,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-198,HPIV3 fusion (F) protein,P06828,HEp2,0.2,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0115,SVALDPIDISIELNKAKSDLEESKEWIRRSNQKLD,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-199,HPIV3 fusion (F) protein,P06828,HEp2,2,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0116,VALDPIDISIELNKAKSDLEESKEWIRRSNQKLDS,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-200,HPIV3 fusion (F) protein,P06828,HEp2,1,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0117,ALDPIDISIELNKAKSDLEESKEWIRRSNQKLDSI,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-201,HPIV3 fusion (F) protein,P06828,HEp2,0.1,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0118,LDPIDISIELNKAKSDLEESKEWIRRSNQKLDSIG,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-202,HPIV3 fusion (F) protein,P06828,HEp2,0.03,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0119,DPIDISIELNKAKSDLEESKEWIRRSNQKLDSIGN,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-203,HPIV3 fusion (F) protein,P06828,HEp2,0.2,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0120,PIDISIELNKAKSDLEESKEWIRRSNQKLDSIGNW,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-204,HPIV3 fusion (F) protein,P06828,HEp2,0.07,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0121,IDISIELNKAKSDLEESKEWIRRSNQKLDSIGNWH,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-205,HPIV3 fusion (F) protein,P06828,HEp2,0.11,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0122,DISIELNKAKSDLEESKEWIRRSNQKLDSIGNWHQ,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-206,HPIV3 fusion (F) protein,P06828,HEp2,2,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0123,ISIELNKAKSDLEESKEWIRRSNQKLDSIGNWHQS,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-207,HPIV3 fusion (F) protein,P06828,HEp2,2,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0124,SIELNKAKSDLEESKEWIRRSNQKLDSIGNWHQSS,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-208,HPIV3 fusion (F) protein,P06828,HEp2,1,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0125,IELNKAKSDLEESKEWIRRSNQKLDSIGNWHQSST,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-209,HPIV3 fusion (F) protein,P06828,HEp2,2,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0126,ELNKAKSDLEESKEWIRRSNQKLDSIGNWHQSSTT,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-210,HPIV3 fusion (F) protein,P06828,HEp2,2.4,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0127,IINFYDPLVFPSDEFDASISQVNEKINQSLAFIRK,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-104,RSV fusion (F) protein,P03420,HEp2,91,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0128,INFYDPLVFPSDEFDASISQVNEKINQSLAFIRKS,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-105,RSV fusion (F) protein,P03420,HEp2,93,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0129,NFYDPLVFPSDEFDASISQVNEKINQSLAFIRKSD,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-106,RSV fusion (F) protein,P03420,HEp2,>100,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0130,FYDPLVFPSDEFDASISQVNEKINQSLAFIRKSDE,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-107,RSV fusion (F) protein,P03420,HEp2,20,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0131,YDPLVFPSDEFDASISQVNEKINQSLAFIRKSDEL,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-108,RSV fusion (F) protein,P03420,HEp2,6,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0132,DPLVFPSDEFDASISQVNEKINQSLAFIRKSDELL,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-109,RSV fusion (F) protein,P03420,HEp2,8,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0133,PLVFPSDEFDASISQVNEKINQSLAFIRKSDELLH,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-110,RSV fusion (F) protein,P03420,HEp2,30,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0134,LVFPSDEFDASISQVNEKINQSLAFIRKSDELLHN,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-111,RSV fusion (F) protein,P03420,HEp2,9,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0135,VFPSDEFDASISQVNEKINQSLAFIRKSDELLHNV,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-112,RSV fusion (F) protein,P03420,HEp2,19,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0136,FPSDEFDASISQVNEKINQSLAFIRKSDELLHNVN,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-113,RSV fusion (F) protein,P03420,HEp2,8,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0137,PSDEFDASISQVNEKINQSLAFIRKSDELLHNVNA,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-114,RSV fusion (F) protein,P03420,HEp2,6,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0138,SDEFDASISQVNEKINQSLAFIRKSDELLHNVNAG,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-115,RSV fusion (F) protein,P03420,HEp2,6,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0139,DEFDASISQVNEKINQSLAFIRKSDELLHNVNAGK,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-116,RSV fusion (F) protein,P03420,HEp2,12,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0140,EFDASISQVNEKINQSLAFIRKSDELLHNVNAGKS,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-117,RSV fusion (F) protein,P03420,HEp2,13,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0141,FDASISQVNEKINQSLAFIRKSDELLHNVNAGKST,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-118,RSV fusion (F) protein,P03420,HEp2,6,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0142,DASISQVNEKINQSLAFIRKSDELLHNVNAGKSTT,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-119,RSV fusion (F) protein,P03420,HEp2,8,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0143,FDASISQVNEKINQSLAFIRKSDELLHNVNAGKST,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-118,RSV fusion (F) protein,P03420,HEp2,0.051,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0144,IDISIELNKAKSDLEESKEWIRRSNQKLDSIGNWH,35,Measles virus,MV,Paramyxoviridae,T-205,HPIV3 fusion (F) protein,P06828,HEp2,0.015,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0145,LHRIDLGPPISLERLDVGTNLGNAIAKLEDAKELL,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-257,MV fusion (F) protein,P69353,HEp2,0.068,EC50 (μM),Fusion,Cytopathic effect,8700906,Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.,"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.",Proc Natl Acad Sci U S A. 1996
AVP0146,DLSNQINSINKSLKSAEDWIADSNFFANQARTAK,34,Human parainfluenza virus type 2,HPIV 2,Paramyxoviridae,2F1B34,HPIV2 fusion (F) protein,P26629,Vero,5.1,μM,Virus entry,Plaque assay,8806544,Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection.,"Yao Q, Compans RW.",Virology. 1996
AVP0147,ELNKAKSDLEESKEWIRRSNQKLDSIGNWHQSSTT,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,3F1B35,HPIV3 fusion (F) protein,P06828,Vero,2.2,μM,Virus entry,Plaque assay,8806544,Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection.,"Yao Q, Compans RW.",Virology. 1996
AVP0148,CATCEQIADSQHRSHRQMV,19,Influenza A virus,INFV A,Orthomyxoviridae,6,INFV A  matrix protein 1,P03485,MDCK,High,-,Polymerase,Cytopathic effect,8970989,Antiviral activity of influenza virus M1 zinc finger peptides.,"Nasser EH, Judd AK, Sanchez A, Anastasiou D, Bucher DJ.",J Virol. 1996
AVP0149,CATCQIADSHRSHRQMV,17,Influenza A virus,INFV A,Orthomyxoviridae,6a,INFV A  matrix protein 1,P03485,MDCK,High,-,Polymerase,Cytopathic effect,8970989,Antiviral activity of influenza virus M1 zinc finger peptides.,"Nasser EH, Judd AK, Sanchez A, Anastasiou D, Bucher DJ.",J Virol. 1996
AVP0150,CATCIADHRSHRQMV,15,Influenza A virus,INFV A,Orthomyxoviridae,6b,INFV A  matrix protein 1,P03485,MDCK,High,-,Polymerase,Cytopathic effect,8970989,Antiviral activity of influenza virus M1 zinc finger peptides.,"Nasser EH, Judd AK, Sanchez A, Anastasiou D, Bucher DJ.",J Virol. 1996
AVP0151,CATCEQIADSQHRSHRQM,18,Influenza A virus,INFV A,Orthomyxoviridae,41280,INFV A  matrix protein 1,P03485,MDCK,Medium,-,Polymerase,Cytopathic effect,8970989,Antiviral activity of influenza virus M1 zinc finger peptides.,"Nasser EH, Judd AK, Sanchez A, Anastasiou D, Bucher DJ.",J Virol. 1996
AVP0152,CATCEQIADSQHRSHRQ,17,Influenza A virus,INFV A,Orthomyxoviridae,41311,INFV A  matrix protein 1,P03485,MDCK,Medium,-,Polymerase,Cytopathic effect,8970989,Antiviral activity of influenza virus M1 zinc finger peptides.,"Nasser EH, Judd AK, Sanchez A, Anastasiou D, Bucher DJ.",J Virol. 1996
AVP0153,CATCEQIADSQHRSHR,16,Influenza A virus,INFV A,Orthomyxoviridae,41339,INFV A  matrix protein 1,P03485,MDCK,Medium,-,Polymerase,Cytopathic effect,8970989,Antiviral activity of influenza virus M1 zinc finger peptides.,"Nasser EH, Judd AK, Sanchez A, Anastasiou D, Bucher DJ.",J Virol. 1996
AVP0154,CATCEQIADSQHRSH,15,Influenza A virus,INFV A,Orthomyxoviridae,41370,INFV A  matrix protein 1,P03485,MDCK,Medium,-,Polymerase,Cytopathic effect,8970989,Antiviral activity of influenza virus M1 zinc finger peptides.,"Nasser EH, Judd AK, Sanchez A, Anastasiou D, Bucher DJ.",J Virol. 1996
AVP0155,CATCQIADSHRSH,13,Influenza A virus,INFV A,Orthomyxoviridae,6L-2,INFV A  matrix protein 1,P03485,MDCK,Medium,-,Polymerase,Cytopathic effect,8970989,Antiviral activity of influenza virus M1 zinc finger peptides.,"Nasser EH, Judd AK, Sanchez A, Anastasiou D, Bucher DJ.",J Virol. 1996
AVP0156,CATCIADHRSH,11,Influenza A virus,INFV A,Orthomyxoviridae,6L-4,INFV A  matrix protein 1,P03485,MDCK,Low,-,Polymerase,Cytopathic effect,8970989,Antiviral activity of influenza virus M1 zinc finger peptides.,"Nasser EH, Judd AK, Sanchez A, Anastasiou D, Bucher DJ.",J Virol. 1996
AVP0157,CACIADHSH,9,Influenza A virus,INFV A,Orthomyxoviridae,6Lx,INFV A  matrix protein 1,P03485,MDCK,Low,-,Polymerase,Cytopathic effect,8970989,Antiviral activity of influenza virus M1 zinc finger peptides.,"Nasser EH, Judd AK, Sanchez A, Anastasiou D, Bucher DJ.",J Virol. 1996
AVP0158,CTCIADHRH,9,Influenza A virus,INFV A,Orthomyxoviridae,6Ly,INFV A  matrix protein 1,P03485,MDCK,Low,-,Polymerase,Cytopathic effect,8970989,Antiviral activity of influenza virus M1 zinc finger peptides.,"Nasser EH, Judd AK, Sanchez A, Anastasiou D, Bucher DJ.",J Virol. 1996
AVP0159,ISLERLDVGTNLGNAIAKLEDAKELLESSDQILRSM,36,Measles virus,MV,Paramyxoviridae,F455-490,MV fusion (F) protein,P69353,MRBC,20,nM,Fusion,Hemolysis assay,9010292,Inhibition of measles virus infection and fusion with peptides corresponding to the leucine zipper region of the fusion protein.,"Wild TF, Buckland R.",J Gen Virol. 1997
AVP0160,VETTVTTAQETKRGRIQTKK,20,Minute virus of mice,MVM,Parvoviridae,Peptide 11,MVMp NS1 protein,P03134,A9,High,-,Replication,ELISA,9311818,Inhibition of parvovirus minute virus of mice replication by a peptide involved in the oligomerization of nonstructural protein NS1.,"Pujol A, Deleu L, Nuesch JP, Cziepluch C, Jauniaux JC, Rommelaere J.",J Virol. 1997
AVP0161,RPETVETTVTTAQETKRGRI,20,Minute virus of mice,MVM,Parvoviridae,Peptide 10,MVMp NS1 protein,P03134,A9,Nil,-,Replication,ELISA,9311818,Inhibition of parvovirus minute virus of mice replication by a peptide involved in the oligomerization of nonstructural protein NS1.,"Pujol A, Deleu L, Nuesch JP, Cziepluch C, Jauniaux JC, Rommelaere J.",J Virol. 1997
AVP0162,VTTAQETKRGRIQTKKEVSI,20,Minute virus of mice,MVM,Parvoviridae,Peptide 12,MVMp NS1 protein,P03134,A9,Nil,-,Replication,ELISA,9311818,Inhibition of parvovirus minute virus of mice replication by a peptide involved in the oligomerization of nonstructural protein NS1.,"Pujol A, Deleu L, Nuesch JP, Cziepluch C, Jauniaux JC, Rommelaere J.",J Virol. 1997
AVP0163,TAALRLGIKLTQHYFGLLTAFGSNFGTIG,29,Sendai virus,SeV,Paramyxoviridae,SV-201,SeV ectodomain,P04856,Human RBCs,High,-,Hemolysis,Hemagglutinin assay,9516418,A peptide derived from a conserved domain of Sendai virus fusion protein inhibits virus-cell fusion. A plausible mode of action.,"Ghosh JK, Shai Y.",J Biol Chem. 1998
AVP0164,TAALELDIKLTQHYFGLLTAFGSNFGTIG,29,Sendai virus,SeV,Paramyxoviridae,Mu1SV-201,SeV ectodomain,P04856,Human RBCs,Nil,-,Hemolysis,Hemagglutinin assay,9516418,A peptide derived from a conserved domain of Sendai virus fusion protein inhibits virus-cell fusion. A plausible mode of action.,"Ghosh JK, Shai Y.",J Biol Chem. 1998
AVP0165,LGRTLAAIKLTQHYFGLLTAFGSNFGTIG,29,Sendai virus,SeV,Paramyxoviridae,Mu2SV-201,SeV ectodomain,P04856,Human RBCs,Low,-,Hemolysis,Hemagglutinin assay,9516418,A peptide derived from a conserved domain of Sendai virus fusion protein inhibits virus-cell fusion. A plausible mode of action.,"Ghosh JK, Shai Y.",J Biol Chem. 1998
AVP0166,ALLTRILG,8,Hepatitis B virus,HBV,Hepadnaviridae,-,Synthetic,,HepG2,Nil,-,Viral assembly,Dye reduction assay,9843489,"Peptides that block hepatitis B virus assembly: analysis by cryomicroscopy, mutagenesis and transfection.","Bottcher B, Tsuji N, Takahashi H, Dyson MR, Zhao S, Crowther RA, Murray K.",EMBO J. 1998
AVP0167,GSLLGRMKGA,10,Hepatitis B virus,HBV,Hepadnaviridae,-,Synthetic,,HepG2,0.8,μM,Viral assembly,Dye reduction assay,9843489,"Peptides that block hepatitis B virus assembly: analysis by cryomicroscopy, mutagenesis and transfection.","Bottcher B, Tsuji N, Takahashi H, Dyson MR, Zhao S, Crowther RA, Murray K.",EMBO J. 1998
AVP0168,SLLGRMKGA,9,Hepatitis B virus,HBV,Hepadnaviridae,-,Synthetic,,HepG2,2.4,μM,Viral assembly,Dye reduction assay,9843489,"Peptides that block hepatitis B virus assembly: analysis by cryomicroscopy, mutagenesis and transfection.","Bottcher B, Tsuji N, Takahashi H, Dyson MR, Zhao S, Crowther RA, Murray K.",EMBO J. 1998
AVP0169,SLLGRMKG,8,Hepatitis B virus,HBV,Hepadnaviridae,-,Synthetic,,HepG2,6.4,μM,Viral assembly,Dye reduction assay,9843489,"Peptides that block hepatitis B virus assembly: analysis by cryomicroscopy, mutagenesis and transfection.","Bottcher B, Tsuji N, Takahashi H, Dyson MR, Zhao S, Crowther RA, Murray K.",EMBO J. 1998
AVP0170,SISCSRGLVCLLPRLTNESGNDRFDS,26,Herpes simplex virus 1,HSV 1,Herpesviridae,BP-1,Phage Display,,CHO,80,%,Virus entry,beta-galactosidase activity,10364318,Inhibition of herpes simplex virus gD and lymphotoxin-alpha binding to HveA by peptide antagonists.,"Sarrias MR, Whitbeck JC, Rooney I, Spruce L, Kay BK, Montgomery RI, Spear PG, Ware CF, Eisenberg RJ, Cohen GH, Lambris JD.",J Virol. 1999
AVP0171,GSCDGFRVCYMH,12,Herpes simplex virus 1,HSV 1,Herpesviridae,BP-2,Phage Display,,CHO,20,%,Virus entry,beta-galactosidase activity,10364318,Inhibition of herpes simplex virus gD and lymphotoxin-alpha binding to HveA by peptide antagonists.,"Sarrias MR, Whitbeck JC, Rooney I, Spruce L, Kay BK, Montgomery RI, Spear PG, Ware CF, Eisenberg RJ, Cohen GH, Lambris JD.",J Virol. 1999
AVP0172,CRFPNITNSHVPILQERPPLENRVLTGWGL,30,Human T-cell leukaemia virus 1,HTLV 1,Retroviridae,-,HTLV-1 envelope glycoprotein (gp21),P03381,MOLT-4,2.5,μM,Post binding step,Plaque assay,10516085,Inhibition of cell-free human T-cell leukemia virus type 1 infection at a postbinding step by the synthetic peptide derived from an ectodomain of the gp21 transmembrane glycoprotein.,"Jinno A, Haraguchi Y, Shiraki H, Hoshino H.",J Virol. 1999
AVP0173,KGSVVIVGRIILSGRK,16,Hepatitis C virus,HCV,Flaviviridae,33,HCV non-structural protein 4A,P26662,-,5.7,μM,NS2/3 protease,Phosphorimaging,10574908,Inhibition of hepatitis C virus NS2/3 processing by NS4A peptides. Implications for control of viral processing.,"Darke PL, Jacobs AR, Waxman L, Kuo LC.",J Biol Chem. 1999
AVP0174,VRLGSISVIGIVRGKK,16,Hepatitis C virus,HCV,Flaviviridae,4ApepB,HCV non-structural protein 4A,P26662,-,137,μM,NS2/3 protease,Phosphorimaging,10574908,Inhibition of hepatitis C virus NS2/3 processing by NS4A peptides. Implications for control of viral processing.,"Darke PL, Jacobs AR, Waxman L, Kuo LC.",J Biol Chem. 1999
AVP0175,RGGSVVIVGRIILSGRK,17,Hepatitis C virus,HCV,Flaviviridae,37,HCV non-structural protein 4A,P26662,-,3.4,μM,NS2/3 protease,Phosphorimaging,10574908,Inhibition of hepatitis C virus NS2/3 processing by NS4A peptides. Implications for control of viral processing.,"Darke PL, Jacobs AR, Waxman L, Kuo LC.",J Biol Chem. 1999
AVP0176,LWVGGGRNA,9,Grass carp hemorrhage virus,GCHV,Reoviridae,-,Phage Display,,Grass carp kidney cells,10^-6.0,TCID50,Replication,Plaque assay,10867191,Selection of a specific peptide from a nona-peptide library for in vitro inhibition of grass carp hemorrhage virus replication.,"Wang B, Ke LH, Jiang H, Li CZ, Tien P.",Virus Res. 2000
AVP0177,RRKKAAVALLPAVLLALLAP,20,Herpes simplex virus 1,HSV 1,Herpesviridae,EB,FGF-4 signal peptide,P08620,Vero,0.7,μM,Virus entry,Plaque assay,11222686,Modified FGF4 signal peptide inhibits entry of herpes simplex virus type 1.,"Bultmann H, Busse JS, Brandt CR.",J Virol. 2001
AVP0178,DHILEPSIPWKSKLLTLVQL,20,Human T-cell leukaemia virus 1,HTLV 1,Retroviridae,P197,HTLV-1 envelope protein (gp46),P03381,-,High,-,Fusion,Syncitia assay,11581416,The synthetic peptide P-197 inhibits human T-cell leukemia virus type 1 envelope-mediated syncytium formation by a mechanism that is independent of Hsc70.,"Brighty DW, Jassal SR.",J Virol. 2001
AVP0179,CTLTTKLYC,9,Newcastle disease virus,NDV,Paramyxoviridae,-,Phage display,,-,1,μM,Virus entry,Antibody competition assay,12021868,Novel peptides that inhibit the propagation of Newcastle disease virus.,"Ramanujam P, Tan WS, Nathan S, Yusoff K.",Arch Virol. 2002
AVP0180,RRKKAAVALLPAVLLALLAP,20,Herpes simplex virus 1,HSV 1,Herpesviridae,EB,Synthetic,,Vero,4,%,Virus entry,Viral titer,12130644,Peptides containing membrane-transiting motifs inhibit virus entry.,"Bultmann H, Brandt CR.",J Biol Chem. 2002
AVP0181,RRKKLAALPLVLAAPLAVLA,20,Herpes simplex virus 1,HSV 1,Herpesviridae,EBX,Synthetic,,Vero,23,%,Virus entry,Viral titer,12130644,Peptides containing membrane-transiting motifs inhibit virus entry.,"Bultmann H, Brandt CR.",J Biol Chem. 2002
AVP0182,FKLRAKIKVRLRAKIKL,17,Feline immunodeficiency virus,FIV,Retroviridae,D4E1,Synthetic,,CrFK,0.46,μM,Release,RT PCR,12208971,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,"Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA.",J Virol. 2002
AVP0183,FAVAVKAVAVKAVAVKAVKKAVKKVKKAVKKAVKKKK,37,Feline immunodeficiency virus,FIV,Retroviridae,DC1,Synthetic,,CrFK,0.75,μM,Release,RT PCR,12208971,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,"Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA.",J Virol. 2002
AVP0184,FLAAARIAKRVAKKARKLAKRAARKRK,27,Feline immunodeficiency virus,FIV,Retroviridae,D1D6,Synthetic,,CrFK,0.94,μM,Release,RT PCR,12208971,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,"Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA.",J Virol. 2002
AVP0185,FRFKIKFRLKFRFKARFKFRAKFRA,25,Feline immunodeficiency virus,FIV,Retroviridae,D4C3,Synthetic,,CrFK,1.32,μM,Release,RT PCR,12208971,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,"Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA.",J Virol. 2002
AVP0186,FAVGLRAIKRALKKLRRGVRKVAKDL,26,Feline immunodeficiency virus,FIV,Retroviridae,D5F,Synthetic,,CrFK,5.47,μM,Release,RT PCR,12208971,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,"Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA.",J Virol. 2002
AVP0187,KRKRAVKRVGRRLKKLARKIARLGVAKLAGLRAVKLF,37,Feline immunodeficiency virus,FIV,Retroviridae,D5C1,Synthetic,,CrFK,3.38,μM,Release,RT PCR,12208971,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,"Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA.",J Virol. 2002
AVP0188,GAKKGAKKGKKGAKKGAKGAGAKGAGAFKKKK,32,Feline immunodeficiency virus,FIV,Retroviridae,D2B15,Synthetic,,CrFK,4.07,μM,Release,RT PCR,12208971,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,"Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA.",J Virol. 2002
AVP0189,FAKKFAKKFKKFAKKFAKFAFAF,23,Feline immunodeficiency virus,FIV,Retroviridae,D2A21,Synthetic,,CrFK,3.05,μM,Release,RT PCR,12208971,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,"Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA.",J Virol. 2002
AVP0190,KKKKFVKKVAKKVKKVAKKVAKVAVAV,27,Feline immunodeficiency virus,FIV,Retroviridae,D2A3,Synthetic,,CrFK,3,μM,Release,RT PCR,12208971,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,"Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA.",J Virol. 2002
AVP0191,FLFAFRIFKRVFKKFRKLFKRAF,23,Feline immunodeficiency virus,FIV,Retroviridae,D1A22,Synthetic,,CrFK,10.51,μM,Release,RT PCR,12208971,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,"Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA.",J Virol. 2002
AVP0192,KRKRAVKRVGRRLKKKLARKIARLGVAF,28,Feline immunodeficiency virus,FIV,Retroviridae,D5C,Synthetic,,CrFK,7.82,μM,Release,RT PCR,12208971,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,"Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA.",J Virol. 2002
AVP0193,KRKRFAKKFLRFLRKVIRFLKRFIRRF,27,Feline immunodeficiency virus,FIV,Retroviridae,D3A15,Synthetic,,CrFK,3.69,μM,Release,RT PCR,12208971,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,"Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA.",J Virol. 2002
AVP0194,FALALKALKKALKKLKKALKKAL,23,Feline immunodeficiency virus,FIV,Retroviridae,DP1,Synthetic,,CrFK,7.07,μM,Release,RT PCR,12208971,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,"Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA.",J Virol. 2002
AVP0195,FAIAIKAIKKAIKKIKKAIKKAI,23,Feline immunodeficiency virus,FIV,Retroviridae,D1D2,Synthetic,,CrFK,8.71,μM,Release,RT PCR,12208971,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,"Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA.",J Virol. 2002
AVP0196,FKVKAKVKAKVKAKVKAKKKK,21,Feline immunodeficiency virus,FIV,Retroviridae,D4B,Synthetic,,CrFK,2.85,μM,Release,RT PCR,12208971,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,"Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA.",J Virol. 2002
AVP0197,AVKRVGRRLKKLARKIARLGVAF,23,Feline immunodeficiency virus,FIV,Retroviridae,D5D,Synthetic,,CrFK,3.37,μM,Release,RT PCR,12208971,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,"Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA.",J Virol. 2002
AVP0198,LLGRMKG,7,Hepatitis B virus,HBV,Hepadnaviridae,-,HBsAg,Q91L67,E. coli,78±5,μM,Viral assembly,Scintillation count,12469306,Inhibition of hepatitis B virus assembly with synthetic peptides derived from the viral surface and core antigens.,Tan WS.,J Gen Appl Microbiol. 2002
AVP0199,LDPAFR,6,Hepatitis B virus,HBV,Hepadnaviridae,-,HBV long surface antigen (L-HBsAg)  ,O92921,E. coli,">1,000",μM,Viral assembly,Scintillation count,12469306,Inhibition of hepatitis B virus assembly with synthetic peptides derived from the viral surface and core antigens.,Tan WS.,J Gen Appl Microbiol. 2002
AVP0200,PLSPPLRNTHPQAMQWNSTTF,21,Hepatitis B virus,HBV,Hepadnaviridae,-,HBV long surface antigen (L-HBsAg)  ,O92921,E. coli,30±1,μM,Viral assembly,Scintillation count,12469306,Inhibition of hepatitis B virus assembly with synthetic peptides derived from the viral surface and core antigens.,Tan WS.,J Gen Appl Microbiol. 2002
AVP0201,PTSNHSPTSCPPTCPGYRWMCLRRF,25,Hepatitis B virus,HBV,Hepadnaviridae,-,HBV long surface antigen (L-HBsAg)  ,O92921,E. coli,35±4,μM,Viral assembly,Scintillation count,12469306,Inhibition of hepatitis B virus assembly with synthetic peptides derived from the viral surface and core antigens.,Tan WS.,J Gen Appl Microbiol. 2002
AVP0202,LPRRLHLEPAFLPYSVKAHECC,22,Human cytomegalovirus,HCMV,Herpesviridae,1,HCMV UL54 protein,P08546,Sf9,11,μM,Disrupt UL54/UL44 interaction,ELISA,12857903,Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit.,"Loregian A, Rigatti R, Murphy M, Schievano E, Palu G, Marsden HS.",J Virol. 2003
AVP0203,PGGETARKDKFLHMVLPRRL,20,Human cytomegalovirus,HCMV,Herpesviridae,2,HCMV UL54 protein,P08546,Sf9,>500,μM,Disrupt UL54/UL44 interaction,ELISA,12857903,Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit.,"Loregian A, Rigatti R, Murphy M, Schievano E, Palu G, Marsden HS.",J Virol. 2003
AVP0204,EQVLKAVTNVLSPVFPGGET,20,Human cytomegalovirus,HCMV,Herpesviridae,3,HCMV UL54 protein,P08546,Sf9,280,μM,Disrupt UL54/UL44 interaction,ELISA,12857903,Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit.,"Loregian A, Rigatti R, Murphy M, Schievano E, Palu G, Marsden HS.",J Virol. 2003
AVP0205,YVREHGVPIHADKYFEQVLK,20,Human cytomegalovirus,HCMV,Herpesviridae,4,HCMV UL54 protein,P08546,Sf9,>500,μM,Disrupt UL54/UL44 interaction,ELISA,12857903,Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit.,"Loregian A, Rigatti R, Murphy M, Schievano E, Palu G, Marsden HS.",J Virol. 2003
AVP0206,PPSAVCNYEVAEDPSYVREH,20,Human cytomegalovirus,HCMV,Herpesviridae,5,HCMV UL54 protein,P08546,Sf9,>500,μM,Disrupt UL54/UL44 interaction,ELISA,12857903,Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit.,"Loregian A, Rigatti R, Murphy M, Schievano E, Palu G, Marsden HS.",J Virol. 2003
AVP0207,RRLHLEPAFLPYSVKAHECC,20,Human cytomegalovirus,HCMV,Herpesviridae,6,HCMV UL54 protein,P08546,Sf9,20,μM,Disrupt UL54/UL44 interaction,ELISA,12857903,Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit.,"Loregian A, Rigatti R, Murphy M, Schievano E, Palu G, Marsden HS.",J Virol. 2003
AVP0208,LPRRLHLEPAFLPYSVKAHEC,21,Human cytomegalovirus,HCMV,Herpesviridae,7,HCMV UL54 protein,P08546,Sf9,75,μM,Disrupt UL54/UL44 interaction,ELISA,12857903,Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit.,"Loregian A, Rigatti R, Murphy M, Schievano E, Palu G, Marsden HS.",J Virol. 2003
AVP0209,LPRRLHLEPAFLPYSVKAHE,20,Human cytomegalovirus,HCMV,Herpesviridae,8,HCMV UL54 protein,P08546,Sf9,>500,μM,Disrupt UL54/UL44 interaction,ELISA,12857903,Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit.,"Loregian A, Rigatti R, Murphy M, Schievano E, Palu G, Marsden HS.",J Virol. 2003
AVP0210,QLESLTDRELLLLIARKTCGSVE,23,Ebola virus,EBoV,Filoviridae,E30pep-wt,EboV VP30 protein,Q05323,BSR T7/5,1,μM,Transcription,Immunofluorescence,12912982,Oligomerization of Ebola virus VP30 is essential for viral transcription and can be inhibited by a synthetic peptide.,"Hartlieb B, Modrof J, Mühlberger E, Klenk HD, Becker S.",J Biol Chem. 2003
AVP0211,HLVAVIGSYR,10,White spot syndrome virus,WSSV,Nimaviridae,Peptide 2E6,Phage Display,,Shrimp Cells,High,-,Neutralization sites,Plaque assay,12917476,A phage-displayed peptide can inhibit infection by white spot syndrome virus of shrimp.,"Yi G, Qian J, Wang Z, Qi Y.",J Gen Virol. 2003
AVP0212,PSLFSWGFGS,10,White spot syndrome virus,WSSV,Nimaviridae,1D10,Phage Display,,Shrimp Cells,Low,-,Neutralization sites,Plaque assay,12917476,A phage-displayed peptide can inhibit infection by white spot syndrome virus of shrimp.,"Yi G, Qian J, Wang Z, Qi Y.",J Gen Virol. 2003
AVP0213,DWVAVKQSYF,10,White spot syndrome virus,WSSV,Nimaviridae,1D6,Phage Display,,Shrimp Cells,Medium,-,Neutralization sites,Plaque assay,12917476,A phage-displayed peptide can inhibit infection by white spot syndrome virus of shrimp.,"Yi G, Qian J, Wang Z, Qi Y.",J Gen Virol. 2003
AVP0214,ACFPWGNTWCGGK,13,Hepatitis C virus,HCV,Flaviviridae,NTW (S-S),Phage display,,Huh7,13,μM,RdRp,Surface plasmon resonance,12951030,Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase.,"Amin A, Zaccardi J, Mullen S, Olland S, Orlowski M, Feld B, Labonte P, Mak P.",Virology. 2003
AVP0215,ACFPWGNTWCGGK,13,Hepatitis C virus,HCV,Flaviviridae,NTW (L),Phage display,,Huh7,150,μM,RdRp,Surface plasmon resonance,12951030,Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase.,"Amin A, Zaccardi J, Mullen S, Olland S, Orlowski M, Feld B, Labonte P, Mak P.",Virology. 2003
AVP0216,ACFPWGKEYCGGK,13,Hepatitis C virus,HCV,Flaviviridae,KEY (S-S),Phage display,,Huh7,22,μM,RdRp,Surface plasmon resonance,12951030,Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase.,"Amin A, Zaccardi J, Mullen S, Olland S, Orlowski M, Feld B, Labonte P, Mak P.",Virology. 2003
AVP0217,ACFPWGKEYCGGK,13,Hepatitis C virus,HCV,Flaviviridae,KEY (L),Phage display,,Huh7,150,μM,RdRp,Surface plasmon resonance,12951030,Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase.,"Amin A, Zaccardi J, Mullen S, Olland S, Orlowski M, Feld B, Labonte P, Mak P.",Virology. 2003
AVP0218,ACFPWGNQWCGGK,13,Hepatitis C virus,HCV,Flaviviridae,NQW (S-S),Phage display,,Huh7,6,μM,RdRp,Surface plasmon resonance,12951030,Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase.,"Amin A, Zaccardi J, Mullen S, Olland S, Orlowski M, Feld B, Labonte P, Mak P.",Virology. 2003
AVP0219,ACFPWGNQWCGGK,13,Hepatitis C virus,HCV,Flaviviridae,NQW (L),Phage display,,Huh7,37,μM,RdRp,Surface plasmon resonance,12951030,Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase.,"Amin A, Zaccardi J, Mullen S, Olland S, Orlowski M, Feld B, Labonte P, Mak P.",Virology. 2003
AVP0220,CFPWGC,6,Hepatitis C virus,HCV,Flaviviridae,FPWG (S-S),Phage display,,Huh7,50,μM,RdRp,Surface plasmon resonance,12951030,Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase.,"Amin A, Zaccardi J, Mullen S, Olland S, Orlowski M, Feld B, Labonte P, Mak P.",Virology. 2003
AVP0221,CFPWGC,6,Hepatitis C virus,HCV,Flaviviridae,FPWG (L),Phage display,,Huh7,150,μM,RdRp,Surface plasmon resonance,12951030,Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase.,"Amin A, Zaccardi J, Mullen S, Olland S, Orlowski M, Feld B, Labonte P, Mak P.",Virology. 2003
AVP0222,DDSVVCAAMSYSYA,14,Hepatitis C virus,HCV,Flaviviridae,P1,HCV polyprotein,P26662,BL21(DE3),22,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0223,ADLEVVAATYVLVA,14,Hepatitis C virus,HCV,Flaviviridae,P10,HCV polyprotein,P26662,BL21(DE3),33,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0224,KKKKVVAGTYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P100,HCV polyprotein,P26662,BL21(DE3),30,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0225,KKKKVVAAGYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P101,HCV polyprotein,P26662,BL21(DE3),2,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0226,KKKKVVAATGVLV,13,Hepatitis C virus,HCV,Flaviviridae,P102,HCV polyprotein,P26662,BL21(DE3),6,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0227,KKKKVVAATYGLV,13,Hepatitis C virus,HCV,Flaviviridae,P103,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0228,KKKKVVAATYVGV,13,Hepatitis C virus,HCV,Flaviviridae,P104,HCV polyprotein,P26662,BL21(DE3),14,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0229,KKKKVVAATYVLG,13,Hepatitis C virus,HCV,Flaviviridae,P105,HCV polyprotein,P26662,BL21(DE3),13,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0230,KKKKVVAATYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P106,HCV polyprotein,P26662,BL21(DE3),17,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0231,KKKKPVAATYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P107,HCV polyprotein,P26662,BL21(DE3),24,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0232,KKKKVPAATYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P108,HCV polyprotein,P26662,BL21(DE3),3,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0233,KKKKVVAAPYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P109,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0234,ADLEVVAATFVLVA,14,Hepatitis C virus,HCV,Flaviviridae,P11,HCV polyprotein,P26662,BL21(DE3),49,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0235,KKKKVVAPTYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P110,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0236,KKKKVVAATPVLV,13,Hepatitis C virus,HCV,Flaviviridae,P111,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0237,KKKKVVAATYPLV,13,Hepatitis C virus,HCV,Flaviviridae,P112,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0238,KKKKVVAATYVPV,13,Hepatitis C virus,HCV,Flaviviridae,P113,HCV polyprotein,P26662,BL21(DE3),10,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0239,KKKKVVAATYVLP,13,Hepatitis C virus,HCV,Flaviviridae,P114,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0240,KKKKLLLPFLFFV,13,Hepatitis C virus,HCV,Flaviviridae,P115,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0241,KKKKVVLATLVLV,13,Hepatitis C virus,HCV,Flaviviridae,P116,HCV polyprotein,P26662,BL21(DE3),5,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0242,KKKKLLLPFLFLV,13,Hepatitis C virus,HCV,Flaviviridae,P117,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0243,KKKKVLLPFLFFV,13,Hepatitis C virus,HCV,Flaviviridae,P118,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0244,KKKKLVLPFLFFV,13,Hepatitis C virus,HCV,Flaviviridae,P119,HCV polyprotein,P26662,BL21(DE3),6,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0245,ADLEVVAATHVLVA,14,Hepatitis C virus,HCV,Flaviviridae,P12,HCV polyprotein,P26662,BL21(DE3),29,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0246,KKKKLLAPFLFFV,13,Hepatitis C virus,HCV,Flaviviridae,P120,HCV polyprotein,P26662,BL21(DE3),4,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0247,KKKKLLLAFLFFV,13,Hepatitis C virus,HCV,Flaviviridae,P121,HCV polyprotein,P26662,BL21(DE3),4,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0248,KKKKLLLPTLFFV,13,Hepatitis C virus,HCV,Flaviviridae,P122,HCV polyprotein,P26662,BL21(DE3),2,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0249,KKKKLLLPFYFFV,13,Hepatitis C virus,HCV,Flaviviridae,P123,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0250,KKKKLLLPFLVFV,13,Hepatitis C virus,HCV,Flaviviridae,P124,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0251,KKKKLLAATYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P125,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0252,KKKKLVLATYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P126,HCV polyprotein,P26662,BL21(DE3),2,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0253,KKKKLVAPTYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P127,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0254,KKKKLVAAFYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P128,HCV polyprotein,P26662,BL21(DE3),18,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0255,KKKKLVAATYVFV,13,Hepatitis C virus,HCV,Flaviviridae,P129,HCV polyprotein,P26662,BL21(DE3),8,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0256,ADLEVVAATYV,11,Hepatitis C virus,HCV,Flaviviridae,P13,HCV polyprotein,P26662,BL21(DE3),15,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0257,KKKKLVAATYVLF,13,Hepatitis C virus,HCV,Flaviviridae,P130,HCV polyprotein,P26662,BL21(DE3),14,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0258,KKKKVLLATYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P131,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0259,KKKKVLAPTYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P132,HCV polyprotein,P26662,BL21(DE3),1,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0260,KKKKVLAAFYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P133,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0261,KKKKVLAATLVLV,13,Hepatitis C virus,HCV,Flaviviridae,P134,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0262,KKKKVLAATYFLV,13,Hepatitis C virus,HCV,Flaviviridae,P135,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0263,KKKKVLAATYVFV,13,Hepatitis C virus,HCV,Flaviviridae,P136,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0264,KKKKVVLPTYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P137,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0265,KKKKVVLAFYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P138,HCV polyprotein,P26662,BL21(DE3),10,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0266,KKKKVVLATYVLF,13,Hepatitis C virus,HCV,Flaviviridae,P139,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0267,DLEVVAATYV,10,Hepatitis C virus,HCV,Flaviviridae,P14,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0268,KKKKVVAPFYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P140,HCV polyprotein,P26662,BL21(DE3),2,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0269,KKKKVVAPTLVLV,13,Hepatitis C virus,HCV,Flaviviridae,P141,HCV polyprotein,P26662,BL21(DE3),3,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0270,KKKKVVAPTYFLV,13,Hepatitis C virus,HCV,Flaviviridae,P142,HCV polyprotein,P26662,BL21(DE3),15,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0271,KKKKVVAPTYVFV,13,Hepatitis C virus,HCV,Flaviviridae,P143,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0272,KKKKVVAPTYVLF,13,Hepatitis C virus,HCV,Flaviviridae,P144,HCV polyprotein,P26662,BL21(DE3),15,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0273,KKKKVVAAFLVLV,13,Hepatitis C virus,HCV,Flaviviridae,P145,HCV polyprotein,P26662,BL21(DE3),20,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0274,KKKKVVAAFYFLV,13,Hepatitis C virus,HCV,Flaviviridae,P146,HCV polyprotein,P26662,BL21(DE3),7,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0275,KKKKVVAAFYVFV,13,Hepatitis C virus,HCV,Flaviviridae,P147,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0276,KKKKVVAAFYVLF,13,Hepatitis C virus,HCV,Flaviviridae,P148,HCV polyprotein,P26662,BL21(DE3),8,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0277,KKKKVVAATLFLV,13,Hepatitis C virus,HCV,Flaviviridae,P149,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0278,KKKKVVAATYVLVA,14,Hepatitis C virus,HCV,Flaviviridae,P15,HCV polyprotein,P26662,BL21(DE3),30,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0279,KKKKVVAATLVFV,13,Hepatitis C virus,HCV,Flaviviridae,P150,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0280,KKKKVVAATLVLF,13,Hepatitis C virus,HCV,Flaviviridae,P151,HCV polyprotein,P26662,BL21(DE3),9,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0281,KKKKVVAATYFFV,13,Hepatitis C virus,HCV,Flaviviridae,P152,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0282,KKKKVVAATYVFF,13,Hepatitis C virus,HCV,Flaviviridae,P153,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0283,KKKKVLLPFLFFF,13,Hepatitis C virus,HCV,Flaviviridae,P154,HCV polyprotein,P26662,BL21(DE3),2,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0284,KKKKLVLPFLFFF,13,Hepatitis C virus,HCV,Flaviviridae,P155,HCV polyprotein,P26662,BL21(DE3),12,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0285,KKKKLLAPFLFFF,13,Hepatitis C virus,HCV,Flaviviridae,P156,HCV polyprotein,P26662,BL21(DE3),14,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0286,KKKKLLLAFLFFF,13,Hepatitis C virus,HCV,Flaviviridae,P157,HCV polyprotein,P26662,BL21(DE3),16,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0287,KKKKLLLPTLFFF,13,Hepatitis C virus,HCV,Flaviviridae,P158,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0288,KKKKLLLPFYFFF,13,Hepatitis C virus,HCV,Flaviviridae,P159,HCV polyprotein,P26662,BL21(DE3),24,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0289,DDDEVVAATYVA,12,Hepatitis C virus,HCV,Flaviviridae,P16,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0290,KKKKLLLPFLVFF,13,Hepatitis C virus,HCV,Flaviviridae,P160,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0291,KKKKLLLPFLFLF,13,Hepatitis C virus,HCV,Flaviviridae,P161,HCV polyprotein,P26662,BL21(DE3),4,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0292,KKKKLLLPFLFFF,13,Hepatitis C virus,HCV,Flaviviridae,P162,HCV polyprotein,P26662,BL21(DE3),19,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0293,KKKKVVLPFLFFF,13,Hepatitis C virus,HCV,Flaviviridae,P163,HCV polyprotein,P26662,BL21(DE3),29,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0294,KKKKLVAPFLFFF,13,Hepatitis C virus,HCV,Flaviviridae,P164,HCV polyprotein,P26662,BL21(DE3),15,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0295,KKKKLLAAFLFFF,13,Hepatitis C virus,HCV,Flaviviridae,P165,HCV polyprotein,P26662,BL21(DE3),30,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0296,KKKKLLLATLFFF,13,Hepatitis C virus,HCV,Flaviviridae,P166,HCV polyprotein,P26662,BL21(DE3),16,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0297,KKKKLLLPTYFFF,13,Hepatitis C virus,HCV,Flaviviridae,P167,HCV polyprotein,P26662,BL21(DE3),3,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0298,KKKKLLLPFYVFF,13,Hepatitis C virus,HCV,Flaviviridae,P168,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0299,KKKKLLLPFLVLF,13,Hepatitis C virus,HCV,Flaviviridae,P169,HCV polyprotein,P26662,BL21(DE3),4,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0300,DDDEVVAATYVLVA,14,Hepatitis C virus,HCV,Flaviviridae,P17,HCV polyprotein,P26662,BL21(DE3),1,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0301,KKKKVLAPFLFFF,13,Hepatitis C virus,HCV,Flaviviridae,P170,HCV polyprotein,P26662,BL21(DE3),8,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0302,KKKKVLLAFLFFF,13,Hepatitis C virus,HCV,Flaviviridae,P171,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0303,KKKKVLLPFYFFF,13,Hepatitis C virus,HCV,Flaviviridae,P172,HCV polyprotein,P26662,BL21(DE3),27,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0304,KKKKVLLPFLLFF,13,Hepatitis C virus,HCV,Flaviviridae,P173,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0305,KKKKVLLPFLFVF,13,Hepatitis C virus,HCV,Flaviviridae,P174,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0306,KKKKLVLAFLFFF,13,Hepatitis C virus,HCV,Flaviviridae,P175,HCV polyprotein,P26662,BL21(DE3),18,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0307,KKKKLVLPTLFFF,13,Hepatitis C virus,HCV,Flaviviridae,P176,HCV polyprotein,P26662,BL21(DE3),29,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0308,KKKKLVLPFYFFF,13,Hepatitis C virus,HCV,Flaviviridae,P177,HCV polyprotein,P26662,BL21(DE3),14,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0309,KKKKLVLPFLLFF,13,Hepatitis C virus,HCV,Flaviviridae,P178,HCV polyprotein,P26662,BL21(DE3),18,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0310,KKKKLVLPFLFVF,13,Hepatitis C virus,HCV,Flaviviridae,P179,HCV polyprotein,P26662,BL21(DE3),40,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0311,ADLEVVAATYVDDD,14,Hepatitis C virus,HCV,Flaviviridae,P18,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0312,KKKKLLAPFLVFF,13,Hepatitis C virus,HCV,Flaviviridae,P180,HCV polyprotein,P26662,BL21(DE3),9,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0313,KKKKLLLAFYFFF,13,Hepatitis C virus,HCV,Flaviviridae,P181,HCV polyprotein,P26662,BL21(DE3),30,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0314,KKKKLLLAFLFLF,13,Hepatitis C virus,HCV,Flaviviridae,P182,HCV polyprotein,P26662,BL21(DE3),8,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0315,KKKKLLLPTLVFF,13,Hepatitis C virus,HCV,Flaviviridae,P183,HCV polyprotein,P26662,BL21(DE3),3,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0316,KKKKLLLPTLFLF,13,Hepatitis C virus,HCV,Flaviviridae,P184,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0317,KKKKLLLPFYFLF,13,Hepatitis C virus,HCV,Flaviviridae,P185,HCV polyprotein,P26662,BL21(DE3),22,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0318,AESTTPCSGSYLKA,14,Hepatitis C virus,HCV,Flaviviridae,P186,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0319,EDCSTPSSGSFLDR,14,Hepatitis C virus,HCV,Flaviviridae,P187,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0320,KKKKVVTSTYVLVEA,15,Hepatitis C virus,HCV,Flaviviridae,P188,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0321,AKDLEVVTSTYVLVEA,16,Hepatitis C virus,HCV,Flaviviridae,P189,HCV polyprotein,P26662,BL21(DE3),51,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0322,ADLEVVAATYVDDD,16,Hepatitis C virus,HCV,Flaviviridae,P19,HCV polyprotein,P26662,BL21(DE3),9,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0323,AKDLEVVCSTYVLVEA,16,Hepatitis C virus,HCV,Flaviviridae,P190,HCV polyprotein,P26662,BL21(DE3),64,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0324,FDEMEESSSHLPYI,14,Hepatitis C virus,HCV,Flaviviridae,P191,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0325,AKDEMEECASHLPYEA,16,Hepatitis C virus,HCV,Flaviviridae,P192,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0326,DEMEEC,8,Hepatitis C virus,HCV,Flaviviridae,P193,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0327,DEMEECASHLPYK,15,Hepatitis C virus,HCV,Flaviviridae,P194,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0328,FDEMEECSQHLPYA,14,Hepatitis C virus,HCV,Flaviviridae,P195,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0329,FDEMEECASHLPYA,14,Hepatitis C virus,HCV,Flaviviridae,P196,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0330,AECVVSCSMSYTKA,14,Hepatitis C virus,HCV,Flaviviridae,P197,HCV polyprotein,P26662,BL21(DE3),52,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0331,SEDVVSSSMSYTFT,14,Hepatitis C virus,HCV,Flaviviridae,P198,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0332,DEVVCC,8,Hepatitis C virus,HCV,Flaviviridae,P199,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0333,DDSVVCAAMSYSFA,14,Hepatitis C virus,HCV,Flaviviridae,P2,HCV polyprotein,P26662,BL21(DE3),29,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0334,ADLEVVAATYVDVA,14,Hepatitis C virus,HCV,Flaviviridae,P20,HCV polyprotein,P26662,BL21(DE3),54,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0335,ADLEVVAATYVLDA,14,Hepatitis C virus,HCV,Flaviviridae,P21,HCV polyprotein,P26662,BL21(DE3),22,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0336,ADLEVVAATYVLVD,14,Hepatitis C virus,HCV,Flaviviridae,P22,HCV polyprotein,P26662,BL21(DE3),38,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0337,ADLEVVAATYVDDA,14,Hepatitis C virus,HCV,Flaviviridae,P23,HCV polyprotein,P26662,BL21(DE3),20,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0338,ADLEVVAATYVLDD,14,Hepatitis C virus,HCV,Flaviviridae,P24,HCV polyprotein,P26662,BL21(DE3),44,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0339,ADLEVVAATYVDVD,14,Hepatitis C virus,HCV,Flaviviridae,P25,HCV polyprotein,P26662,BL21(DE3),19,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0340,KKKKVVAATYVLVA,14,Hepatitis C virus,HCV,Flaviviridae,P26,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0341,KKKKVVAATYVKKA,14,Hepatitis C virus,HCV,Flaviviridae,P27,HCV polyprotein,P26662,BL21(DE3),13,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0342,KKKKVVAATYVLKK,14,Hepatitis C virus,HCV,Flaviviridae,P28,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0343,KKKKVVAATYVLVK,14,Hepatitis C virus,HCV,Flaviviridae,P29,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0344,DDSVVCAAMSYSHA,14,Hepatitis C virus,HCV,Flaviviridae,P3,HCV polyprotein,P26662,BL21(DE3),26,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0345,KKKKVVAATYFFFA,14,Hepatitis C virus,HCV,Flaviviridae,P30,HCV polyprotein,P26662,BL21(DE3),5,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0346,KKKKVVAATYFLVA,14,Hepatitis C virus,HCV,Flaviviridae,P31,HCV polyprotein,P26662,BL21(DE3),4,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0347,KKKKVVAATYVFVA,14,Hepatitis C virus,HCV,Flaviviridae,P32,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0348,KKKKVVAATYVLVF,14,Hepatitis C virus,HCV,Flaviviridae,P33,HCV polyprotein,P26662,BL21(DE3),12,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0349,KKKKVVAATYVLFA,14,Hepatitis C virus,HCV,Flaviviridae,P34,HCV polyprotein,P26662,BL21(DE3),12,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0350,KKKKVVAATYKKKA,14,Hepatitis C virus,HCV,Flaviviridae,P35,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0351,KKKKVVAATYKLKA,14,Hepatitis C virus,HCV,Flaviviridae,P36,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0352,KKKKVVAATYKKVA,14,Hepatitis C virus,HCV,Flaviviridae,P37,HCV polyprotein,P26662,BL21(DE3),4,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0353,AKLKVVAATYVLKK,14,Hepatitis C virus,HCV,Flaviviridae,P38,HCV polyprotein,P26662,BL21(DE3),5,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0354,AKLKVVAATYVKKK,14,Hepatitis C virus,HCV,Flaviviridae,P39,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0355,DDSVVSAAMSYSYA,14,Hepatitis C virus,HCV,Flaviviridae,P4,HCV polyprotein,P26662,BL21(DE3),31,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0356,AKLEVVAATYVKKK,14,Hepatitis C virus,HCV,Flaviviridae,P40,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0357,AKLEVVAATYKKKK,14,Hepatitis C virus,HCV,Flaviviridae,P41,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0358,KKKKVVAATYKKKK,14,Hepatitis C virus,HCV,Flaviviridae,P42,HCV polyprotein,P26662,BL21(DE3),8,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0359,ADKEVVAATYVKKK,14,Hepatitis C virus,HCV,Flaviviridae,P43,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0360,ADLEVVAATYVKKK,14,Hepatitis C virus,HCV,Flaviviridae,P44,HCV polyprotein,P26662,BL21(DE3),2,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0361,ADLEVVAATYKKKK,14,Hepatitis C virus,HCV,Flaviviridae,P45,HCV polyprotein,P26662,BL21(DE3),7,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0362,ADLKVVAATYVLVA,14,Hepatitis C virus,HCV,Flaviviridae,P46,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0363,ADLEVVAATYAAAA,14,Hepatitis C virus,HCV,Flaviviridae,P47,HCV polyprotein,P26662,BL21(DE3),8,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0364,KDLKVVAATYVKKK,14,Hepatitis C virus,HCV,Flaviviridae,P48,HCV polyprotein,P26662,BL21(DE3),21,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0365,KKKKAVAATYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P49,HCV polyprotein,P26662,BL21(DE3),59,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0366,DDSVVSAAMSYSFA,14,Hepatitis C virus,HCV,Flaviviridae,P5,HCV polyprotein,P26662,BL21(DE3),14,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0367,KKKKVAAATYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P50,HCV polyprotein,P26662,BL21(DE3),32,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0368,KKKKVVAAAYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P51,HCV polyprotein,P26662,BL21(DE3),19,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0369,KKKKVVAATAVLV,13,Hepatitis C virus,HCV,Flaviviridae,P52,HCV polyprotein,P26662,BL21(DE3),13,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0370,KKKKVVAATYALV,13,Hepatitis C virus,HCV,Flaviviridae,P53,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0371,KKKKVVAATYVAV,13,Hepatitis C virus,HCV,Flaviviridae,P54,HCV polyprotein,P26662,BL21(DE3),21,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0372,KKKKVVAATYVLA,13,Hepatitis C virus,HCV,Flaviviridae,P55,HCV polyprotein,P26662,BL21(DE3),19,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0373,KKKKLVAATYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P56,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0374,KKKKVLAATYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P57,HCV polyprotein,P26662,BL21(DE3),12,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0375,KKKKVVLATYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P58,HCV polyprotein,P26662,BL21(DE3),32,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0376,KKKKVVALTYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P59,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0377,DDSVVSAAMSYSHA,14,Hepatitis C virus,HCV,Flaviviridae,P6,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0378,KKKKVVAALYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P60,HCV polyprotein,P26662,BL21(DE3),7,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0379,KKKKVVAATYLLV,13,Hepatitis C virus,HCV,Flaviviridae,P61,HCV polyprotein,P26662,BL21(DE3),26,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0380,KKKKVVAATYVLL,13,Hepatitis C virus,HCV,Flaviviridae,P62,HCV polyprotein,P26662,BL21(DE3),25,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0381,KKKKFVAATYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P63,HCV polyprotein,P26662,BL21(DE3),30,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0382,KKKKVFAATYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P64,HCV polyprotein,P26662,BL21(DE3),26,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0383,KKKKVVFATYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P65,HCV polyprotein,P26662,BL21(DE3),34,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0384,KKKKVVAFTYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P66,HCV polyprotein,P26662,BL21(DE3),23,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0385,KKKKVVAAFYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P67,HCV polyprotein,P26662,BL21(DE3),3,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0386,KKKKVVAATFVLV,13,Hepatitis C virus,HCV,Flaviviridae,P68,HCV polyprotein,P26662,BL21(DE3),28,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0387,KKKKVVAATYFLV,13,Hepatitis C virus,HCV,Flaviviridae,P69,HCV polyprotein,P26662,BL21(DE3),14,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0388,DDSVVAAMSYSYA,13,Hepatitis C virus,HCV,Flaviviridae,P7,HCV polyprotein,P26662,BL21(DE3),9,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0389,KKKKVVAATYVFV,13,Hepatitis C virus,HCV,Flaviviridae,P70,HCV polyprotein,P26662,BL21(DE3),15,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0390,KKKKVVAATYVLF,13,Hepatitis C virus,HCV,Flaviviridae,P71,HCV polyprotein,P26662,BL21(DE3),1,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0391,KKKKEVAATYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P72,HCV polyprotein,P26662,BL21(DE3),2,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0392,KKKKVEAATYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P73,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0393,KKKKVVEATYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P74,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0394,KKKKVVAETYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P75,HCV polyprotein,P26662,BL21(DE3),19,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0395,KKKKVVAAEYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P76,HCV polyprotein,P26662,BL21(DE3),5,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0396,KKKKVVAATEVLV,13,Hepatitis C virus,HCV,Flaviviridae,P77,HCV polyprotein,P26662,BL21(DE3),4,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0397,KKKKVVAATYELV,13,Hepatitis C virus,HCV,Flaviviridae,P78,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0398,KKKKVVAATYVEV,13,Hepatitis C virus,HCV,Flaviviridae,P79,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0399,DDSVVAAMSYSFA,13,Hepatitis C virus,HCV,Flaviviridae,P8,HCV polyprotein,P26662,BL21(DE3),2,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0400,KKKKVVAATYVLE,13,Hepatitis C virus,HCV,Flaviviridae,P80,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0401,KKKKKVAATYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P81,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0402,KKKKVKAATYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P82,HCV polyprotein,P26662,BL21(DE3),25,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0403,KKKKVVKATYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P83,HCV polyprotein,P26662,BL21(DE3),40,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0404,KKKKVVAKTYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P84,HCV polyprotein,P26662,BL21(DE3),12,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0405,KKKKVVAAKYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P85,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0406,KKKKVVAATKVLV,13,Hepatitis C virus,HCV,Flaviviridae,P86,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0407,KKKKVVAATYVKV,13,Hepatitis C virus,HCV,Flaviviridae,P87,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0408,KKKKVVAATYVLK,13,Hepatitis C virus,HCV,Flaviviridae,P88,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0409,KKKKTVAATYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P89,HCV polyprotein,P26662,BL21(DE3),27,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0410,DDSVVAAMSYSHA,13,Hepatitis C virus,HCV,Flaviviridae,P9,HCV polyprotein,P26662,BL21(DE3),22,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0411,KKKKVTAATYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P90,HCV polyprotein,P26662,BL21(DE3),32,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0412,KKKKVVTATYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P91,HCV polyprotein,P26662,BL21(DE3),1,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0413,KKKKVVATTYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P92,HCV polyprotein,P26662,BL21(DE3),16,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0414,KKKKVVAATTVLV,13,Hepatitis C virus,HCV,Flaviviridae,P93,HCV polyprotein,P26662,BL21(DE3),23,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0415,KKKKVVAATYTLV,13,Hepatitis C virus,HCV,Flaviviridae,P94,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0416,KKKKVVAATYVTV,13,Hepatitis C virus,HCV,Flaviviridae,P95,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0417,KKKKVVAATYVLT,13,Hepatitis C virus,HCV,Flaviviridae,P96,HCV polyprotein,P26662,BL21(DE3),8,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0418,KKKKGVAATYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P97,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0419,KKKKVGAATYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P98,HCV polyprotein,P26662,BL21(DE3),0,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0420,KKKKVVGATYVLV,13,Hepatitis C virus,HCV,Flaviviridae,P99,HCV polyprotein,P26662,BL21(DE3),14,%,NS3 protease,Fluorescent probe,14694985,Peptide inhibitors of hepatitis C virus NS3 protease.,"Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.",Antivir Chem Chemother. 2003
AVP0421,AALEAKICHQIEYYFGDF,18,Hepatitis C virus,HCV,Flaviviridae,LAP,Human lupus autoantigen protein,P05455,Huh7,12,μg,Translation,Luciferase assay,15016896,A peptide from autoantigen La blocks poliovirus and hepatitis C virus cap-independent translation and reveals a single tyrosine critical for La RNA binding and translation stimulation.,"Izumi RE, Das S, Barat B, Raychaudhuri S, Dasgupta A.",J Virol. 2004
AVP0422,KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL,35,Junin virus,JV,Arenaviridae,-,Cecropin A,P01508,Vero,3.4,EC50 (μM),Protein synthesis,Plaque assay,15081088,Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus.,"Albiol Matanic VC, Castilla V.",Int J Antimicrob Agents. 2004
AVP0423,KVLTTGLPALISWIKRKRQQ,20,Junin virus,JV,Arenaviridae,-,Melittin,P01501,Vero,0.86,EC50 (μM),Ion gradient,Plaque assay,15081088,Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus.,"Albiol Matanic VC, Castilla V.",Int J Antimicrob Agents. 2004
AVP0424,GIGKFLHSAGKFGKAFVGEIMKS,23,Herpes simplex virus 1,HSV 1,Herpesviridae,-,Magainin,P11006,Vero,36.59,EC50 (μM),Protein synthesis,Plaque assay,15081088,Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus.,"Albiol Matanic VC, Castilla V.",Int J Antimicrob Agents. 2004
AVP0425,GIGKFLHSAKKFGKAFVGEIMNS,23,Herpes simplex virus 1,HSV 1,Herpesviridae,-,Magainin,P11006,Vero,22.16,EC50 (μM),Protein synthesis,Plaque assay,15081088,Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus.,"Albiol Matanic VC, Castilla V.",Int J Antimicrob Agents. 2004
AVP0426,ILPWKWPWWPWRR,13,Herpes simplex virus 1,HSV 1,Herpesviridae,-,Indolicidin,P33046,Vero,28.68,EC50 (μM),Direct inactivation of virus particles,Plaque assay,15081088,Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus.,"Albiol Matanic VC, Castilla V.",Int J Antimicrob Agents. 2004
AVP0427,ILMCFSIDSPDSLEN,15,Respiratory syncytial virus,RSV,Paramyxoviridae,Peptide 80 to 94,RSV Rho-A protein,P08134,HEp2,1.6,μg/ml,Virus entry,Flow cytometry,15113882,"RhoA-derived peptide dimers share mechanistic properties with other polyanionic inhibitors of respiratory syncytial virus (RSV), including disruption of viral attachment and dependence on RSV G.","Budge PJ, Li Y, Beeler JA, Graham BS.",J Virol. 2004
AVP0428,ILMAFSIDSPDSLEN,15,Respiratory syncytial virus,RSV,Paramyxoviridae,Peptide 83A,RSV Rho-A protein,P08134,HEp2,>100,μg/ml,Virus entry,Flow cytometry,15113882,"RhoA-derived peptide dimers share mechanistic properties with other polyanionic inhibitors of respiratory syncytial virus (RSV), including disruption of viral attachment and dependence on RSV G.","Budge PJ, Li Y, Beeler JA, Graham BS.",J Virol. 2004
AVP0429,ILMCFSINSPNSLQN,15,Respiratory syncytial virus,RSV,Paramyxoviridae,Peptide 80 to 94-N,RSV Rho-A protein,P08134,HEp2,>100,μg/ml,Virus entry,Flow cytometry,15113882,"RhoA-derived peptide dimers share mechanistic properties with other polyanionic inhibitors of respiratory syncytial virus (RSV), including disruption of viral attachment and dependence on RSV G.","Budge PJ, Li Y, Beeler JA, Graham BS.",J Virol. 2004
AVP0430,GSRVQIRCRFRNSTR,16,Herpes simplex virus 1,HSV 1,Herpesviridae,Gly137 -Arg151,HSV glycoprotein (gC),P28986,GMK,19,μM,Virus entry,Plaque assay,15130536,Structural and functional features of the polycationic peptide required for inhibition of herpes simplex virus invasion of cells.,"Trybala E, Olofsson S, Mardberg K, Svennerholm B, Umemoto K, Glorioso JC, Bergstrom T.",Antiviral Res. 2004
AVP0431,CKFCYGSAQCPTFLFIVRLLRFVWV,25,Rabies virus,RV,Rhabdoviridae,C1,Synthetic,,BSR,High,-,Phosphoprotein,GFP assay,15220414,Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.,"Real E, Rain JC, Battaglia V, Jallet C, Perrin P, Tordo N, Chrisment P, D'Alayer J, Legrain P, Jacob Y.",J Virol. 2004
AVP0432,CTMCRYQQNCFTRRLIVGGMLLVFV,25,Rabies virus,RV,Rhabdoviridae,C2,Synthetic,,BSR,89,%,Phosphoprotein,GFP assay,15220414,Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.,"Real E, Rain JC, Battaglia V, Jallet C, Perrin P, Tordo N, Chrisment P, D'Alayer J, Legrain P, Jacob Y.",J Virol. 2004
AVP0433,CYSCPCERRCHKIARGLLILRSVLF,25,Rabies virus,RV,Rhabdoviridae,C3,Synthetic,,BSR,High,-,Phosphoprotein,GFP assay,15220414,Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.,"Real E, Rain JC, Battaglia V, Jallet C, Perrin P, Tordo N, Chrisment P, D'Alayer J, Legrain P, Jacob Y.",J Virol. 2004
AVP0434,CQRCGWETGVGVSGFLVRILRFVVL,25,Rabies virus,RV,Rhabdoviridae,C4,Synthetic,,BSR,High,-,Phosphoprotein,GFP assay,15220414,Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.,"Real E, Rain JC, Battaglia V, Jallet C, Perrin P, Tordo N, Chrisment P, D'Alayer J, Legrain P, Jacob Y.",J Virol. 2004
AVP0435,CTQCCAPSTCLNYRIFVGLLRFVVI,25,Rabies virus,RV,Rhabdoviridae,C5,Synthetic,,BSR,High,-,Phosphoprotein,GFP assay,15220414,Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.,"Real E, Rain JC, Battaglia V, Jallet C, Perrin P, Tordo N, Chrisment P, D'Alayer J, Legrain P, Jacob Y.",J Virol. 2004
AVP0436,CDSCERCWYVWLILLRVRLRLLVSL,25,Rabies virus,RV,Rhabdoviridae,C6,Synthetic,,BSR,83,%,Phosphoprotein,GFP assay,15220414,Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.,"Real E, Rain JC, Battaglia V, Jallet C, Perrin P, Tordo N, Chrisment P, D'Alayer J, Legrain P, Jacob Y.",J Virol. 2004
AVP0437,CKSCDTRCTCLRRRLRVGVGLPCMGC,26,Rabies virus,RV,Rhabdoviridae,C7,Synthetic,,BSR,High,-,Phosphoprotein,GFP assay,15220414,Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.,"Real E, Rain JC, Battaglia V, Jallet C, Perrin P, Tordo N, Chrisment P, D'Alayer J, Legrain P, Jacob Y.",J Virol. 2004
AVP0438,CRCCELKSLCPTLMRVVRLLGLVLL,25,Rabies virus,RV,Rhabdoviridae,C8,Synthetic,,BSR,78,%,Phosphoprotein,GFP assay,15220414,Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.,"Real E, Rain JC, Battaglia V, Jallet C, Perrin P, Tordo N, Chrisment P, D'Alayer J, Legrain P, Jacob Y.",J Virol. 2004
AVP0439,CLCCDKVRTCRRLLGLVMVLSVVRC,25,Rabies virus,RV,Rhabdoviridae,C9,Synthetic,,BSR,High,-,Phosphoprotein,GFP assay,15220414,Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.,"Real E, Rain JC, Battaglia V, Jallet C, Perrin P, Tordo N, Chrisment P, D'Alayer J, Legrain P, Jacob Y.",J Virol. 2004
AVP0440,CGECGGGHIVGRFCMVVRFLRLVFI,25,Rabies virus,RV,Rhabdoviridae,C10,Synthetic,,BSR,57,%,Phosphoprotein,GFP assay,15220414,Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.,"Real E, Rain JC, Battaglia V, Jallet C, Perrin P, Tordo N, Chrisment P, D'Alayer J, Legrain P, Jacob Y.",J Virol. 2004
AVP0441,CVTCKSTVLCDKMQHPCRRGPRCISC,26,Rabies virus,RV,Rhabdoviridae,C26,Synthetic,,BSR,5,%,Phosphoprotein,GFP assay,15220414,Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.,"Real E, Rain JC, Battaglia V, Jallet C, Perrin P, Tordo N, Chrisment P, D'Alayer J, Legrain P, Jacob Y.",J Virol. 2004
AVP0442,CGRCLQRACCKYCRLKCRLILFVIF,25,Rabies virus,RV,Rhabdoviridae,C27,Synthetic,,BSR,22,%,Phosphoprotein,GFP assay,15220414,Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.,"Real E, Rain JC, Battaglia V, Jallet C, Perrin P, Tordo N, Chrisment P, D'Alayer J, Legrain P, Jacob Y.",J Virol. 2004
AVP0443,PPIPIPDPPQRNRPPPRWFISLMVIRIH,28,Rabies virus,RV,Rhabdoviridae,P11,Synthetic,,BSR,Low,-,Phosphoprotein,GFP assay,15220414,Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.,"Real E, Rain JC, Battaglia V, Jallet C, Perrin P, Tordo N, Chrisment P, D'Alayer J, Legrain P, Jacob Y.",J Virol. 2004
AVP0444,PPRLLDSPEVMVILHLGFRIGLVRLWIH,28,Rabies virus,RV,Rhabdoviridae,P12,Synthetic,,BSR,High,-,Phosphoprotein,GFP assay,15220414,Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.,"Real E, Rain JC, Battaglia V, Jallet C, Perrin P, Tordo N, Chrisment P, D'Alayer J, Legrain P, Jacob Y.",J Virol. 2004
AVP0445,PPARSSPPMPPNLPPLRRRIILLRFLFH,28,Rabies virus,RV,Rhabdoviridae,P13,Synthetic,,BSR,High,-,Phosphoprotein,GFP assay,15220414,Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.,"Real E, Rain JC, Battaglia V, Jallet C, Perrin P, Tordo N, Chrisment P, D'Alayer J, Legrain P, Jacob Y.",J Virol. 2004
AVP0446,PPPLPYGPNRNGEPHLRVLLRLLCIRLH,28,Rabies virus,RV,Rhabdoviridae,P14,Synthetic,,BSR,High,-,Phosphoprotein,GFP assay,15220414,Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.,"Real E, Rain JC, Battaglia V, Jallet C, Perrin P, Tordo N, Chrisment P, D'Alayer J, Legrain P, Jacob Y.",J Virol. 2004
AVP0447,PPRTTPIPHLDVSLHLLILRILRVRVH,27,Rabies virus,RV,Rhabdoviridae,P15,Synthetic,,BSR,High,-,Phosphoprotein,GFP assay,15220414,Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.,"Real E, Rain JC, Battaglia V, Jallet C, Perrin P, Tordo N, Chrisment P, D'Alayer J, Legrain P, Jacob Y.",J Virol. 2004
AVP0448,PPDVHTPPHALWRLHLSLRVCLVRMWIH,28,Rabies virus,RV,Rhabdoviridae,P16,Synthetic,,BSR,71,%,Phosphoprotein,GFP assay,15220414,Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.,"Real E, Rain JC, Battaglia V, Jallet C, Perrin P, Tordo N, Chrisment P, D'Alayer J, Legrain P, Jacob Y.",J Virol. 2004
AVP0449,PPTSPLLPTVNLRPPPIIIVFLLRVWFH,28,Rabies virus,RV,Rhabdoviridae,P17,Synthetic,,BSR,High,-,Phosphoprotein,GFP assay,15220414,Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.,"Real E, Rain JC, Battaglia V, Jallet C, Perrin P, Tordo N, Chrisment P, D'Alayer J, Legrain P, Jacob Y.",J Virol. 2004
AVP0450,PPLYGRDPTTRRMPHLLLRCCLLRLVVH,28,Rabies virus,RV,Rhabdoviridae,P18,Synthetic,,BSR,High,-,Phosphoprotein,GFP assay,15220414,Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.,"Real E, Rain JC, Battaglia V, Jallet C, Perrin P, Tordo N, Chrisment P, D'Alayer J, Legrain P, Jacob Y.",J Virol. 2004
AVP0451,PPDQTTYPSAECPPPPLVSILLIGLWLH,28,Rabies virus,RV,Rhabdoviridae,P19,Synthetic,,BSR,Low,-,Phosphoprotein,GFP assay,15220414,Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.,"Real E, Rain JC, Battaglia V, Jallet C, Perrin P, Tordo N, Chrisment P, D'Alayer J, Legrain P, Jacob Y.",J Virol. 2004
AVP0452,PPRGAHRPNSTVVLHLVIRLCLLRFVVH,28,Rabies virus,RV,Rhabdoviridae,P20,Synthetic,,BSR,High,-,Phosphoprotein,GFP assay,15220414,Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.,"Real E, Rain JC, Battaglia V, Jallet C, Perrin P, Tordo N, Chrisment P, D'Alayer J, Legrain P, Jacob Y.",J Virol. 2004
AVP0453,PPDTSLLPPVGLHLVVRLFLLRLSVH,26,Rabies virus,RV,Rhabdoviridae,P21,Synthetic,,BSR,High,-,Phosphoprotein,GFP assay,15220414,Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.,"Real E, Rain JC, Battaglia V, Jallet C, Perrin P, Tordo N, Chrisment P, D'Alayer J, Legrain P, Jacob Y.",J Virol. 2004
AVP0454,PPGAPPAPFRTHTPPPRMVIVLIRVWCH,28,Rabies virus,RV,Rhabdoviridae,P22,Synthetic,,BSR,High,-,Phosphoprotein,GFP assay,15220414,Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.,"Real E, Rain JC, Battaglia V, Jallet C, Perrin P, Tordo N, Chrisment P, D'Alayer J, Legrain P, Jacob Y.",J Virol. 2004
AVP0455,PPGAPPQPDSVCELHLLCVLRLLVIRIH,28,Rabies virus,RV,Rhabdoviridae,P23,Synthetic,,BSR,High,-,Phosphoprotein,GFP assay,15220414,Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.,"Real E, Rain JC, Battaglia V, Jallet C, Perrin P, Tordo N, Chrisment P, D'Alayer J, Legrain P, Jacob Y.",J Virol. 2004
AVP0456,PPSHSFRPESLERLHLLRRVLLLMRIVH,28,Rabies virus,RV,Rhabdoviridae,P24,Synthetic,,BSR,High,-,Phosphoprotein,GFP assay,15220414,Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.,"Real E, Rain JC, Battaglia V, Jallet C, Perrin P, Tordo N, Chrisment P, D'Alayer J, Legrain P, Jacob Y.",J Virol. 2004
AVP0457,PPCYERMPRRLIRPPPLLSVLLILRLCH,28,Rabies virus,RV,Rhabdoviridae,P25,Synthetic,,BSR,Medium,-,Phosphoprotein,GFP assay,15220414,Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.,"Real E, Rain JC, Battaglia V, Jallet C, Perrin P, Tordo N, Chrisment P, D'Alayer J, Legrain P, Jacob Y.",J Virol. 2004
AVP0458,PPLFEDTPMVNSIPPLRVRLFLLRLVFH,28,Rabies virus,RV,Rhabdoviridae,P28,Synthetic,,BSR,High,-,Phosphoprotein,GFP assay,15220414,Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.,"Real E, Rain JC, Battaglia V, Jallet C, Perrin P, Tordo N, Chrisment P, D'Alayer J, Legrain P, Jacob Y.",J Virol. 2004
AVP0459,PPRGTETPQRCRRLHLVEMLCLVRVVFH,28,Rabies virus,RV,Rhabdoviridae,P29,Synthetic,,BSR,High,-,Phosphoprotein,GFP assay,15220414,Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.,"Real E, Rain JC, Battaglia V, Jallet C, Perrin P, Tordo N, Chrisment P, D'Alayer J, Legrain P, Jacob Y.",J Virol. 2004
AVP0460,YDHIQDHVNTMFSRLATSWCLLQNKERALWAEAA,34,Bovine herpesvirus type 1,BoHV 1,Herpesviridae,B477-510,BoHV-1 HR1 Region,P12640,MDBK,5,EC50 (μM),Replication,Plaque assay,15269351,A synthetic peptide from a heptad repeat region of herpesvirus glycoprotein B inhibits virus replication.,"Okazaki K, Kida H.",J Gen Virol. 2004
AVP0461,RLASWSVKQANLTTSLLGDLLDDVT,25,Avian sarcoma and leukosis virus- A,ASLV-A,Retroviridae,R42,ASLV-A HR1 Region,P03397,QT6,Nil,-,Virus entry,Cell-fusion assay,15564453,Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion intermediate.,"Netter RC, Amberg SM, Balliet JW, Biscone MJ, Vermeulen A, Earp LJ, White JM, Bates P.",J Virol. 2004
AVP0462,LLGDLLDDVTSIRHAVLQNRAAIDF,25,Avian sarcoma and leukosis virus- A,ASLV-A,Retroviridae,R57,ASLV-A HR1 Region,P03397,QT6,Nil,-,Virus entry,Cell-fusion assay,15564453,Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion intermediate.,"Netter RC, Amberg SM, Balliet JW, Biscone MJ, Vermeulen A, Earp LJ, White JM, Bates P.",J Virol. 2004
AVP0463,FNLSDHSESIQKKFQLMKEHVNKIG,25,Avian sarcoma and leukosis virus- A,ASLV-A,Retroviridae,R99,ASLV-A HR2 Region,P03397,QT6,170,nM,Virus entry,Cell-fusion assay,15564453,Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion intermediate.,"Netter RC, Amberg SM, Balliet JW, Biscone MJ, Vermeulen A, Earp LJ, White JM, Bates P.",J Virol. 2004
AVP0464,SDHSESIQKKFQLMKEHVNKIGVDS,25,Avian sarcoma and leukosis virus- A,ASLV-A,Retroviridae,R102,ASLV-A HR2 Region,P03397,QT6,5,μM,Virus entry,Cell-fusion assay,15564453,Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion intermediate.,"Netter RC, Amberg SM, Balliet JW, Biscone MJ, Vermeulen A, Earp LJ, White JM, Bates P.",J Virol. 2004
AVP0465,IEPHDWTKNITDKIDQIIHDFVDKT,25,Avian sarcoma and leukosis virus- A,ASLV-A,Retroviridae,E109,EBV envelope protein,Q05320,QT6,Nil,-,Virus entry,Cell-fusion assay,15564453,Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion intermediate.,"Netter RC, Amberg SM, Balliet JW, Biscone MJ, Vermeulen A, Earp LJ, White JM, Bates P.",J Virol. 2004
AVP0466,HDWTKNITDKIDQIIHDFVDKTLPD,25,Avian sarcoma and leukosis virus- A,ASLV-A,Retroviridae,E112,EBV envelope protein,Q05320,QT6,Nil,-,Virus entry,Cell-fusion assay,15564453,Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion intermediate.,"Netter RC, Amberg SM, Balliet JW, Biscone MJ, Vermeulen A, Earp LJ, White JM, Bates P.",J Virol. 2004
AVP0467,FHRKKGRGKHK,11,Influenza A virus,INFV A,Orthomyxoviridae,-,Synthetic,,MDCK,3.10x10^-6,mol/l (Kd),Fusion,High-performance affinity chromatography,15729820,Screening of inhibitors for influenza A virus using high-performance affinity chromatography and combinatorial peptide libraries.,"Zhao R, Fanga C, Yu X, Liu Y, Luo J, Shangguan D, Xiong S, Su T, Liu G.",J Chromatogr A. 2005
AVP0468,CQSLPTHNC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,2,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0469,CSSQNGRIC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,4,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0470,CRTLPPILC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,5,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0471,CHLLLPRPC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,16,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0472,CQAMHNRFC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,18,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0473,CTPTVTRSC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,21,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0474,CTESTINTC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,22,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0475,CQYNPLPYC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,27,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0476,CNHTRNMAC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,29,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0477,CPSRLSSQC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,35,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0478,CTKYWARNC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,37,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0479,CHPTGLHQC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,39,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0480,CLTDRHRTC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,39,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0481,CTPSLPWLC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,42,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0482,CQGPVKPLC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,44,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0483,CDATSAQVC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,46,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0484,CKPTHYNSC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,46,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0485,CRHNNLHHC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,46,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0486,CEWTESMMC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,47,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0487,CSTNPPTQC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,47,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0488,CVNSPPTMC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,48,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0489,CTNPATPFC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,48,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0490,CLWPTLKGC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,48,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0491,CHTKIFPNC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,49,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0492,CHARNSTQC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,49,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0493,CSLTNTLLC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,49,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0494,CNPYNTSMC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,49,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0495,CNGVIHNQC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,49,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0496,CYHPSFNTC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,51,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0497,CSGSETKVC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,52,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0498,CYETKTHSC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,52,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0499,CTNRHAAGC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,54,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0500,CNLLRQQTC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,54,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0501,CVSGQESIC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,56,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0502,CLALNMSYC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,58,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0503,CQPHTLPTC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,59,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0504,CNTKNFHSC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,61,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0505,CNPMKPLMC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,61,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0506,CPRSGTAYC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,63,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0507,CSTPELTFC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,63,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0508,CMTSHPTLC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,64,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0509,CPLGKLPWC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,66,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0510,CQSASPRLC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,70,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0511,CLTSPTSTC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,70,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0512,CNTSSTPHC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,71,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0513,CTQKNIAAC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,71,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0514,CTNSTLQSC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,72,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0515,CKPDAISVC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,72,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0516,CNQSTLLTC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,74,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0517,CHSPLTSSC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,74,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0518,CFPTTSRGC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,74,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0519,CGFSNFRSC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,76,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0520,CQSQNHNTC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,76,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0521,CQSIRGPMC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,76,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0522,CPSTGYSYC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,76,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0523,CPPGKSSMC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,77,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0524,CHNLKRPTC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,79,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0525,CLFNHPKYC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,79,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0526,CYSLLPRVC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,79,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0527,CTMLLFHRC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,80,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0528,CRNTDTALC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,80,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0529,CPPPQGQTC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,81,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0530,CIHAPHTQC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,83,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0531,CPGHIHRTC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,83,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0532,CLALRHSNC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,83,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0533,CSPQLAPFC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,83,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0534,CQLPAERWC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,84,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0535,CRSLTDNQC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,84,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0536,CLHKPWSRC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,89,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0537,CPFVKTQLC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,91,%,beta-3 integrins,Focus reduction assay,15919886,Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.,"Larson RS, Brown DC, Ye C, Hjelle B.",J Virol. 2005
AVP0538,MVDRGWGNHAGLFGKGSIV,19,West nile virus,WNV,Flaviviridae,DN80,Synthetic,,LLC-MK2,17±10,%,Virus entry,Plaque assay,15927084,Peptide inhibitors of dengue virus and West Nile virus infectivity.,"Hrobowski YM, Garry RF, Michael SF.",Virol J. 2005
AVP0539,AWLVHTQWFLDLPLPWLPGADTQGSNWI,28,West nile virus,WNV,Flaviviridae,DN57,Synthetic,,LLC-MK2,7±4,%,Virus entry,Plaque assay,15927084,Peptide inhibitors of dengue virus and West Nile virus infectivity.,"Hrobowski YM, Garry RF, Michael SF.",Virol J. 2005
AVP0540,AWLVHRQWFLDLPLPWLPG,19,West nile virus,WNV,Flaviviridae,DN81,Synthetic,,LLC-MK2,25±8,%,Virus entry,Plaque assay,15927084,Peptide inhibitors of dengue virus and West Nile virus infectivity.,"Hrobowski YM, Garry RF, Michael SF.",Virol J. 2005
AVP0541,MAILGDTAWDFGSLGGVFTSIGKALHQVFGAIY,33,West nile virus,WNV,Flaviviridae,DN59,Synthetic,,LLC-MK2,93±2,%,Virus entry,Plaque assay,15927084,Peptide inhibitors of dengue virus and West Nile virus infectivity.,"Hrobowski YM, Garry RF, Michael SF.",Virol J. 2005
AVP0542,VVDRGWGNGAGLFGKGSID,19,West nile virus,WNV,Flaviviridae,WN82,Synthetic,,LLC-MK2,4±13,%,Virus entry,Plaque assay,15927084,Peptide inhibitors of dengue virus and West Nile virus infectivity.,"Hrobowski YM, Garry RF, Michael SF.",Virol J. 2005
AVP0543,TFLVHREWFMDLNLPWSSAGSTVWR,25,West nile virus,WNV,Flaviviridae,WN53,Synthetic,,LLC-MK2,56±5,%,Virus entry,Plaque assay,15927084,Peptide inhibitors of dengue virus and West Nile virus infectivity.,"Hrobowski YM, Garry RF, Michael SF.",Virol J. 2005
AVP0544,TFLVHREWFMDLNLPWSSA,19,West nile virus,WNV,Flaviviridae,WN83,Synthetic,,LLC-MK2,70±2,%,Virus entry,Plaque assay,15927084,Peptide inhibitors of dengue virus and West Nile virus infectivity.,"Hrobowski YM, Garry RF, Michael SF.",Virol J. 2005
AVP0545,KYKETDLLILFKDDYFAKKNEERK,24,Hepatitis C virus,HCV,Flaviviridae,LaR2C,Human lupus autoantigen protein,P05455,Huh7,80-95,%,Translation,Filter binding assay,16014945,"A peptide derived from RNA recognition motif 2 of human la protein binds to hepatitis C virus internal ribosome entry site, prevents ribosomal assembly, and inhibits internal initiation of translation.","Pudi R, Ramamurthy SS, Das S.",J Virol. 2005
AVP0546,MWKTPTLKYFGGFNFSQI,18,SARS coronavirus,SARS-CoV,Coronaviridae,SARSWW-I,SARS-CoV spike protein,P11224,Vero E6,58,%,Fusion,Plaque assay,16616792,Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.,"Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF.",Virus Res. 2006
AVP0547,ATAGWTFGAGAALQIPFAMQMAY,23,SARS coronavirus,SARS-CoV,Coronaviridae,SARSWW-II,SARS-CoV spike protein,P11224,Vero E6,39,%,Fusion,Plaque assay,16616792,Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.,"Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF.",Virus Res. 2006
AVP0548,GYHLMSFPQAAPHGVVFLHVTW,22,SARS coronavirus,SARS-CoV,Coronaviridae,SARSWW-III,SARS-CoV spike protein,P11224,Vero E6,2,μM,Fusion,Plaque assay,16616792,Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.,"Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF.",Virus Res. 2006
AVP0549,GVFVFNGTSWFITQRNFFS,19,SARS coronavirus,SARS-CoV,Coronaviridae,SARSWW-IV,SARS-CoV spike protein,P11224,Vero E6,2,μM,Fusion,Plaque assay,16616792,Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.,"Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF.",Virus Res. 2006
AVP0550,NEVAKNLNESLIDLQELGKYEQYIKWPWYVW,31,SARS coronavirus,SARS-CoV,Coronaviridae,SARSWW-Va,SARS-CoV spike protein,P11224,Vero E6,Nil,-,Fusion,Plaque assay,16616792,Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.,"Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF.",Virus Res. 2006
AVP0551,AACEVAKNLNESLIDLQELGKYEQYIKW,28,SARS coronavirus,SARS-CoV,Coronaviridae,SARSWW-Vb,SARS-CoV spike protein,P11224,Vero E6,42,%,Fusion,Plaque assay,16616792,Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.,"Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF.",Virus Res. 2006
AVP0552,GNHILSLVQNAPYGLYFIHFSW,22,Murine hepatitis virus,MHV,Coronaviridae,MHVWW-III,MHV spike protein,P11224,L2,Nil,-,Fusion,Plaque assay,16616792,Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.,"Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF.",Virus Res. 2006
AVP0553,GYFVQDDGEWKFTGSSYYY,19,Murine hepatitis virus,MHV,Coronaviridae,MHVWW-IV,MHV spike protein,P11224,L2,4,μM,Fusion,Plaque assay,16616792,Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.,"Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF.",Virus Res. 2006
AVP0554,RRKKAAVALLPAVLLALLAP,20,Influenza A virus,INFV A,Orthomyxoviridae,EB,FGF-4 signal sequence,P08620,cRBCs,8,μM,Virus entry,Hemagglutinin assay,17005658,Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cells.,"Jones JC, Turpin EA, Bultmann H, Brandt CR, Schultz-Cherry S.",J Virol. 2006
AVP0555,DTRACDVIALLCHLNT,16,West nile virus,WNV,Flaviviridae,P1,Phage display,,Vero,High,-,Virus entry,Q-PCR,17151121,Antiviral peptides targeting the west nile virus envelope protein.,"Bai F, Town T, Pradhan D, Cox J, Ashish, Ledizet M, Anderson JF, Flavell RA, Krueger JK, Koski RA, Fikrig E.",J Virol. 2007
AVP0556,CDVIALLCHLNT,12,West nile virus,WNV,Flaviviridae,P8,Phage display,,Vero,High,-,Virus entry,Q-PCR,17151121,Antiviral peptides targeting the west nile virus envelope protein.,"Bai F, Town T, Pradhan D, Cox J, Ashish, Ledizet M, Anderson JF, Flavell RA, Krueger JK, Koski RA, Fikrig E.",J Virol. 2007
AVP0557,CDVIALLACHLNT,13,West nile virus,WNV,Flaviviridae,P9,Phage display,,Vero,96.3±2.8,%,Virus entry,Q-PCR,17151121,Antiviral peptides targeting the west nile virus envelope protein.,"Bai F, Town T, Pradhan D, Cox J, Ashish, Ledizet M, Anderson JF, Flavell RA, Krueger JK, Koski RA, Fikrig E.",J Virol. 2007
AVP0558,CDVIALLCHLNTPSF,15,West nile virus,WNV,Flaviviridae,P10,Phage display,,Vero,High,-,Virus entry,Q-PCR,17151121,Antiviral peptides targeting the west nile virus envelope protein.,"Bai F, Town T, Pradhan D, Cox J, Ashish, Ledizet M, Anderson JF, Flavell RA, Krueger JK, Koski RA, Fikrig E.",J Virol. 2007
AVP0559,CDVIALLCHLNTPSFNTTHYRESWY,25,West nile virus,WNV,Flaviviridae,P11,Phage display,,Vero,High,-,Virus entry,Q-PCR,17151121,Antiviral peptides targeting the west nile virus envelope protein.,"Bai F, Town T, Pradhan D, Cox J, Ashish, Ledizet M, Anderson JF, Flavell RA, Krueger JK, Koski RA, Fikrig E.",J Virol. 2007
AVP0560,TGPEFPGRPTRP,12,West nile virus,WNV,Flaviviridae,P2,Phage display,,Vero,Low,-,Virus entry,Q-PCR,17151121,Antiviral peptides targeting the west nile virus envelope protein.,"Bai F, Town T, Pradhan D, Cox J, Ashish, Ledizet M, Anderson JF, Flavell RA, Krueger JK, Koski RA, Fikrig E.",J Virol. 2007
AVP0561,NTTHYRVIRLTIG,13,West nile virus,WNV,Flaviviridae,P3,Phage display,,Vero,Low,-,Virus entry,Q-PCR,17151121,Antiviral peptides targeting the west nile virus envelope protein.,"Bai F, Town T, Pradhan D, Cox J, Ashish, Ledizet M, Anderson JF, Flavell RA, Krueger JK, Koski RA, Fikrig E.",J Virol. 2007
AVP0562,DTRACDVIALL,11,West nile virus,WNV,Flaviviridae,P4,Phage display,,Vero,Low,-,Virus entry,Q-PCR,17151121,Antiviral peptides targeting the west nile virus envelope protein.,"Bai F, Town T, Pradhan D, Cox J, Ashish, Ledizet M, Anderson JF, Flavell RA, Krueger JK, Koski RA, Fikrig E.",J Virol. 2007
AVP0563,DTRACDVIPLL,11,West nile virus,WNV,Flaviviridae,P5,Phage display,,Vero,Low,-,Virus entry,Q-PCR,17151121,Antiviral peptides targeting the west nile virus envelope protein.,"Bai F, Town T, Pradhan D, Cox J, Ashish, Ledizet M, Anderson JF, Flavell RA, Krueger JK, Koski RA, Fikrig E.",J Virol. 2007
AVP0564,CDVIALL,7,West nile virus,WNV,Flaviviridae,P6,Phage display,,Vero,Low,-,Virus entry,Q-PCR,17151121,Antiviral peptides targeting the west nile virus envelope protein.,"Bai F, Town T, Pradhan D, Cox J, Ashish, Ledizet M, Anderson JF, Flavell RA, Krueger JK, Koski RA, Fikrig E.",J Virol. 2007
AVP0565,DTRAPLAI,8,West nile virus,WNV,Flaviviridae,P7,Phage display,,Vero,Low,-,Virus entry,Q-PCR,17151121,Antiviral peptides targeting the west nile virus envelope protein.,"Bai F, Town T, Pradhan D, Cox J, Ashish, Ledizet M, Anderson JF, Flavell RA, Krueger JK, Koski RA, Fikrig E.",J Virol. 2007
AVP0566,CDVIALLACHLNTPSF,16,West nile virus,WNV,Flaviviridae,P12,Phage display,,Vero,Low,-,Virus entry,Q-PCR,17151121,Antiviral peptides targeting the west nile virus envelope protein.,"Bai F, Town T, Pradhan D, Cox J, Ashish, Ledizet M, Anderson JF, Flavell RA, Krueger JK, Koski RA, Fikrig E.",J Virol. 2007
AVP0567,CDVIALLACHLNTPSFNTTHYRESWY,26,West nile virus,WNV,Flaviviridae,P13,Phage display,,Vero,Low,-,Virus entry,Q-PCR,17151121,Antiviral peptides targeting the west nile virus envelope protein.,"Bai F, Town T, Pradhan D, Cox J, Ashish, Ledizet M, Anderson JF, Flavell RA, Krueger JK, Koski RA, Fikrig E.",J Virol. 2007
AVP0568,CDVIALLECHLNT,13,West nile virus,WNV,Flaviviridae,P14,Phage display,,Vero,Low,-,Virus entry,Q-PCR,17151121,Antiviral peptides targeting the west nile virus envelope protein.,"Bai F, Town T, Pradhan D, Cox J, Ashish, Ledizet M, Anderson JF, Flavell RA, Krueger JK, Koski RA, Fikrig E.",J Virol. 2007
AVP0569,TRACDVIALLECHLNT,16,West nile virus,WNV,Flaviviridae,P15,Phage display,,Vero,Low,-,Virus entry,Q-PCR,17151121,Antiviral peptides targeting the west nile virus envelope protein.,"Bai F, Town T, Pradhan D, Cox J, Ashish, Ledizet M, Anderson JF, Flavell RA, Krueger JK, Koski RA, Fikrig E.",J Virol. 2007
AVP0570,DTRACDVIALLECHLNT,17,West nile virus,WNV,Flaviviridae,P16,Phage display,,Vero,Low,-,Virus entry,Q-PCR,17151121,Antiviral peptides targeting the west nile virus envelope protein.,"Bai F, Town T, Pradhan D, Cox J, Ashish, Ledizet M, Anderson JF, Flavell RA, Krueger JK, Koski RA, Fikrig E.",J Virol. 2007
AVP0571,ATWVCGPCT,9,Hepatitis C virus,HCV,Flaviviridae,-,Phage Display,,TG1,High,-,Virus entry,ELISA,17178166,Selection of a phage-displayed peptide recognized by monoclonal antibody directed blocking the site of hepatitis C virus E2 for human CD81.,"Cao J, Liao XL, Wu SM, Zhao P, Zhao LJ, Wu WB, Qi ZT.",J Microbiol Methods. 2007
AVP0572,GGWTQWWWTAFY,12,Hepatitis B virus,HBV,Hepadnaviridae,p1,Phage display,,HepG2,10(Medium),CBD-PreS/CBD ratio,PreS-binding,ELISA,17192308,Identification and characterization of peptides that interact with hepatitis B virus via the putative receptor binding site.,"Deng Q, Zhai JW, Michel ML, Zhang J, Qin J, Kong YY, Zhang XX, Budkowska A, Tiollais P, Wang Y, Xie YH.",J Virol. 2007
AVP0573,NNWWYWWDTLVN,12,Hepatitis B virus,HBV,Hepadnaviridae,p2,Phage display,,HepG2,12(High),CBD-PreS/CBD ratio,PreS-binding,ELISA,17192308,Identification and characterization of peptides that interact with hepatitis B virus via the putative receptor binding site.,"Deng Q, Zhai JW, Michel ML, Zhang J, Qin J, Kong YY, Zhang XX, Budkowska A, Tiollais P, Wang Y, Xie YH.",J Virol. 2007
AVP0574,GLWRFWFGDFLT,12,Hepatitis B virus,HBV,Hepadnaviridae,p5,Phage display,,HepG2,10(Medium),CBD-PreS/CBD ratio,PreS-binding,ELISA,17192308,Identification and characterization of peptides that interact with hepatitis B virus via the putative receptor binding site.,"Deng Q, Zhai JW, Michel ML, Zhang J, Qin J, Kong YY, Zhang XX, Budkowska A, Tiollais P, Wang Y, Xie YH.",J Virol. 2007
AVP0575,QMMLTLLWAFWY,12,Hepatitis B virus,HBV,Hepadnaviridae,p12,Phage display,,HepG2,9(Medium),CBD-PreS/CBD ratio,PreS-binding,ELISA,17192308,Identification and characterization of peptides that interact with hepatitis B virus via the putative receptor binding site.,"Deng Q, Zhai JW, Michel ML, Zhang J, Qin J, Kong YY, Zhang XX, Budkowska A, Tiollais P, Wang Y, Xie YH.",J Virol. 2007
AVP0576,MSEALWTAWTQW,12,Hepatitis B virus,HBV,Hepadnaviridae,p15,Phage display,,HepG2,9(Medium),CBD-PreS/CBD ratio,PreS-binding,ELISA,17192308,Identification and characterization of peptides that interact with hepatitis B virus via the putative receptor binding site.,"Deng Q, Zhai JW, Michel ML, Zhang J, Qin J, Kong YY, Zhang XX, Budkowska A, Tiollais P, Wang Y, Xie YH.",J Virol. 2007
AVP0577,MTGRLISWWWSL,12,Hepatitis B virus,HBV,Hepadnaviridae,p17,Phage display,,HepG2,5(Low),CBD-PreS/CBD ratio,PreS-binding,ELISA,17192308,Identification and characterization of peptides that interact with hepatitis B virus via the putative receptor binding site.,"Deng Q, Zhai JW, Michel ML, Zhang J, Qin J, Kong YY, Zhang XX, Budkowska A, Tiollais P, Wang Y, Xie YH.",J Virol. 2007
AVP0578,WTDMFTAWWSTP,12,Hepatitis B virus,HBV,Hepadnaviridae,p18,Phage display,,HepG2,16(High),CBD-PreS/CBD ratio,PreS-binding,ELISA,17192308,Identification and characterization of peptides that interact with hepatitis B virus via the putative receptor binding site.,"Deng Q, Zhai JW, Michel ML, Zhang J, Qin J, Kong YY, Zhang XX, Budkowska A, Tiollais P, Wang Y, Xie YH.",J Virol. 2007
AVP0579,GLWRFWFGDFLT,12,Hepatitis B virus,HBV,Hepadnaviridae,p19,Phage display,,HepG2,5(Low),CBD-PreS/CBD ratio,PreS-binding,ELISA,17192308,Identification and characterization of peptides that interact with hepatitis B virus via the putative receptor binding site.,"Deng Q, Zhai JW, Michel ML, Zhang J, Qin J, Kong YY, Zhang XX, Budkowska A, Tiollais P, Wang Y, Xie YH.",J Virol. 2007
AVP0580,WVEYMYSWIPTA,12,Hepatitis B virus,HBV,Hepadnaviridae,p20,Phage display,,HepG2,6(Low),CBD-PreS/CBD ratio,PreS-binding,ELISA,17192308,Identification and characterization of peptides that interact with hepatitis B virus via the putative receptor binding site.,"Deng Q, Zhai JW, Michel ML, Zhang J, Qin J, Kong YY, Zhang XX, Budkowska A, Tiollais P, Wang Y, Xie YH.",J Virol. 2007
AVP0581,RVAAAAITWVPKPNVEVWPVDPPPPVNFNKTAEQEYGDKEVKLPHW,46,Epstein-Barr virus,EBV,Herpesviridae,peptide 36-81,EBV envelope protein (gp42),P03205,CHO-K1,50,nM,Fusion,Fusion assay,17581996,Binding-site interactions between Epstein-Barr virus fusion proteins gp42 and gH/gL reveal a peptide that inhibits both epithelial and B-cell membrane fusion.,"Kirschner AN, Lowrey AS, Longnecker R, Jardetzky TS.",J Virol. 2007
AVP0582,RRGRTGRGRRGIYR,14,Hepatitis C virus,HCV,Flaviviridae,p14,HCV non-structural protein 3,P26663,Huh7,82.85±7.28,EC50 (μM),Replication,Luciferase assay,18039921,"NS3 Peptide, a novel potent hepatitis C virus NS3 helicase inhibitor: its mechanism of action and antiviral activity in the replicon system.","Gozdek A, Zhukov I, Polkowska A, Poznanski J, Stankiewicz-Drogon A, Pawlowicz JM, Zagórski-Ostoja W, Borowski P, Boguszewska-Chachulska AM.",Antimicrob Agents Chemother. 2008
AVP0583,SWLRDIWDWICEVLSD,16,Hepatitis C virus,HCV,Flaviviridae,3,HCV non-structural protein 5A,P26664,Huh7,0.98,μM,Viral membrane,RT PCR,18287023,A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",Proc Natl Acad Sci U S A. 2008
AVP0584,SWLRDIWDWICEVLSDFK,18,Hepatitis C virus,HCV,Flaviviridae,1,HCV non-structural protein 5A,P26664,Huh7,0.79,μM,Viral membrane,RT PCR,18287023,A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",Proc Natl Acad Sci U S A. 2008
AVP0585,WICEVLSDFK,10,Hepatitis C virus,HCV,Flaviviridae,12,HCV non-structural protein 5A,P26664,Huh7,>27,μM,Viral membrane,RT PCR,18287023,A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",Proc Natl Acad Sci U S A. 2008
AVP0586,CEVLSDFK,8,Hepatitis C virus,HCV,Flaviviridae,13,HCV non-structural protein 5A,P26664,Huh7,>27,μM,Viral membrane,RT PCR,18287023,A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",Proc Natl Acad Sci U S A. 2008
AVP0587,SGSWLRDIWDWICEVLSDFK,20,Hepatitis C virus,HCV,Flaviviridae,14,HCV non-structural protein 5A,P26664,Huh7,1.7,μM,Viral membrane,RT PCR,18287023,A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",Proc Natl Acad Sci U S A. 2008
AVP0588,GSWLRDIWDWICEVLSDFK,19,Hepatitis C virus,HCV,Flaviviridae,15,HCV non-structural protein 5A,P26664,Huh7,0.51,μM,Viral membrane,RT PCR,18287023,A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",Proc Natl Acad Sci U S A. 2008
AVP0589,SWLRDIWDWICEVLSDFKT,19,Hepatitis C virus,HCV,Flaviviridae,16,HCV non-structural protein 5A,P26664,Huh7,1.7,μM,Viral membrane,RT PCR,18287023,A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",Proc Natl Acad Sci U S A. 2008
AVP0590,SWLRDIWDWICEVLSDFKTW,20,Hepatitis C virus,HCV,Flaviviridae,17,HCV non-structural protein 5A,P26664,Huh7,0.51,μM,Viral membrane,RT PCR,18287023,A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",Proc Natl Acad Sci U S A. 2008
AVP0591,SWRLIDWDWICEVLSDFK,18,Hepatitis C virus,HCV,Flaviviridae,18,HCV non-structural protein 5A,P26664,Huh7,4,μM,Viral membrane,RT PCR,18287023,A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",Proc Natl Acad Sci U S A. 2008
AVP0592,SWRLDIWDWICESVLDFK,18,Hepatitis C virus,HCV,Flaviviridae,19,HCV non-structural protein 5A,P26664,Huh7,>30,μM,Viral membrane,RT PCR,18287023,A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",Proc Natl Acad Sci U S A. 2008
AVP0593,GIGKFLHSAKKFGKAFVGEIMNS,23,Hepatitis C virus,HCV,Flaviviridae,20,HCV non-structural protein 5A,P26664,Huh7,>27,μM,Viral membrane,RT PCR,18287023,A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",Proc Natl Acad Sci U S A. 2008
AVP0594,DWLKAFYDKVAEKLKEAF,18,Hepatitis C virus,HCV,Flaviviridae,21,HCV non-structural protein 5A,P26664,Huh7,>28,μM,Viral membrane,RT PCR,18287023,A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",Proc Natl Acad Sci U S A. 2008
AVP0595,SWLRDIWDWICEVL,14,Hepatitis C virus,HCV,Flaviviridae,4,HCV non-structural protein 5A,P26664,Huh7,11.3,μM,Viral membrane,RT PCR,18287023,A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",Proc Natl Acad Sci U S A. 2008
AVP0596,VLDLIYSLHKQINRGLKKIVL,21,Hepatitis C virus,HCV,Flaviviridae,22,HCV non-structural protein 5A,P26664,Huh7,>36,μM,Viral membrane,RT PCR,18287023,A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",Proc Natl Acad Sci U S A. 2008
AVP0597,KFDSLVECIWDWIDRLWS,18,Hepatitis C virus,HCV,Flaviviridae,23,HCV non-structural protein 5A,P26664,Huh7,0.85,μM,Viral membrane,RT PCR,18287023,A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",Proc Natl Acad Sci U S A. 2008
AVP0598,KFDSLVECIWDWIDRLWS,18,Hepatitis C virus,HCV,Flaviviridae,24,HCV non-structural protein 5A,P26664,Huh7,0.48,μM,Viral membrane,RT PCR,18287023,A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",Proc Natl Acad Sci U S A. 2008
AVP0599,KWLCRIWSWISDVLDDFE,18,Hepatitis C virus,HCV,Flaviviridae,25,HCV non-structural protein 5A,P26664,Huh7,0.5,μM,Viral membrane,RT PCR,18287023,A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",Proc Natl Acad Sci U S A. 2008
AVP0600,SIWRDWVDLICEFLSDWK,18,Hepatitis C virus,HCV,Flaviviridae,26,HCV non-structural protein 5A,P26664,Huh7,0.4,μM,Viral membrane,RT PCR,18287023,A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",Proc Natl Acad Sci U S A. 2008
AVP0601,SWLRDVWDWICTVLTDFK,18,Hepatitis C virus,HCV,Flaviviridae,27,HCV non-structural protein 5A,P26664,Huh7,3.9,μM,Viral membrane,RT PCR,18287023,A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",Proc Natl Acad Sci U S A. 2008
AVP0602,SWLRDVWDWVCTILTDFK,18,Hepatitis C virus,HCV,Flaviviridae,28,HCV non-structural protein 5A,P26664,Huh7,2.1,μM,Viral membrane,RT PCR,18287023,A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",Proc Natl Acad Sci U S A. 2008
AVP0603,DWLRIIWDWVCSVVSDFK,18,Hepatitis C virus,HCV,Flaviviridae,29,HCV non-structural protein 5A,P26664,Huh7,0.55,μM,Viral membrane,RT PCR,18287023,A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",Proc Natl Acad Sci U S A. 2008
AVP0604,SWLWEVWDWVLHVLSDFK,18,Hepatitis C virus,HCV,Flaviviridae,30,HCV non-structural protein 5A,P26664,Huh7,7,μM,Viral membrane,RT PCR,18287023,A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",Proc Natl Acad Sci U S A. 2008
AVP0605,TWLRAIWDWVCTALTDFK,18,Hepatitis C virus,HCV,Flaviviridae,31,HCV non-structural protein 5A,P26664,Huh7,7.1,μM,Viral membrane,RT PCR,18287023,A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",Proc Natl Acad Sci U S A. 2008
AVP0606,SWLRDIWDWICEV,13,Hepatitis C virus,HCV,Flaviviridae,5,HCV non-structural protein 5A,P26664,Huh7,>27,μM,Viral membrane,RT PCR,18287023,A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",Proc Natl Acad Sci U S A. 2008
AVP0607,SWLRDVWDWVCTVLSDFK,18,Hepatitis C virus,HCV,Flaviviridae,32,HCV non-structural protein 5A,P26664,Huh7,3.5,μM,Viral membrane,RT PCR,18287023,A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",Proc Natl Acad Sci U S A. 2008
AVP0608,SWLRDIWDWISEVLSDFK,18,Hepatitis C virus,HCV,Flaviviridae,33,HCV non-structural protein 5A,P26664,Huh7,13.5,μM,Viral membrane,RT PCR,18287023,A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",Proc Natl Acad Sci U S A. 2008
AVP0609,SWLRDIWDWIREVLSDFK,18,Hepatitis C virus,HCV,Flaviviridae,34,HCV non-structural protein 5A,P26664,Huh7,12.5,μM,Viral membrane,RT PCR,18287023,A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",Proc Natl Acad Sci U S A. 2008
AVP0610,SWLRDIWDWIEEVLSDFK,18,Hepatitis C virus,HCV,Flaviviridae,35,HCV non-structural protein 5A,P26664,Huh7,13,μM,Viral membrane,RT PCR,18287023,A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",Proc Natl Acad Sci U S A. 2008
AVP0611,SWLDDIWDWICEVLSDFE,18,Hepatitis C virus,HCV,Flaviviridae,36,HCV non-structural protein 5A,P26664,Huh7,4.7,μM,Viral membrane,RT PCR,18287023,A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",Proc Natl Acad Sci U S A. 2008
AVP0612,SWLRDIWDWICEVLSDFK,18,Hepatitis C virus,HCV,Flaviviridae,37,HCV non-structural protein 5A,P26664,Huh7,0.79,μM,Viral membrane,RT PCR,18287023,A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",Proc Natl Acad Sci U S A. 2008
AVP0613,SWLRDIWDWICKVLSDFK,18,Hepatitis C virus,HCV,Flaviviridae,38,HCV non-structural protein 5A,P26664,Huh7,6.8,μM,Viral membrane,RT PCR,18287023,A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",Proc Natl Acad Sci U S A. 2008
AVP0614,SWLDRIWRWICKVLSRFE,18,Hepatitis C virus,HCV,Flaviviridae,39,HCV non-structural protein 5A,P26664,Huh7,1.7,μM,Viral membrane,RT PCR,18287023,A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",Proc Natl Acad Sci U S A. 2008
AVP0615,SWLRDIWRWICKVLSRFK,18,Hepatitis C virus,HCV,Flaviviridae,40,HCV non-structural protein 5A,P26664,Huh7,0.84,μM,Viral membrane,RT PCR,18287023,A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",Proc Natl Acad Sci U S A. 2008
AVP0616,SWLRRIWRWICKVLSRFK,18,Hepatitis C virus,HCV,Flaviviridae,41,HCV non-structural protein 5A,P26664,Huh7,0.89,μM,Viral membrane,RT PCR,18287023,A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",Proc Natl Acad Sci U S A. 2008
AVP0617,SWLRDIWDWICE,12,Hepatitis C virus,HCV,Flaviviridae,6,HCV non-structural protein 5A,P26664,Huh7,>27,μM,Viral membrane,RT PCR,18287023,A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",Proc Natl Acad Sci U S A. 2008
AVP0618,SWLRDIWDWI,10,Hepatitis C virus,HCV,Flaviviridae,7,HCV non-structural protein 5A,P26664,Huh7,>27,μM,Viral membrane,RT PCR,18287023,A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",Proc Natl Acad Sci U S A. 2008
AVP0619,SWLRDIWD,8,Hepatitis C virus,HCV,Flaviviridae,8,HCV non-structural protein 5A,P26664,Huh7,>27,μM,Viral membrane,RT PCR,18287023,A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",Proc Natl Acad Sci U S A. 2008
AVP0620,LRDIWDWICEVLSDFK,16,Hepatitis C virus,HCV,Flaviviridae,9,HCV non-structural protein 5A,P26664,Huh7,>27,μM,Viral membrane,RT PCR,18287023,A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",Proc Natl Acad Sci U S A. 2008
AVP0621,DIWDWICEVLSDFK,14,Hepatitis C virus,HCV,Flaviviridae,10,HCV non-structural protein 5A,P26664,Huh7,>27,μM,Viral membrane,RT PCR,18287023,A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",Proc Natl Acad Sci U S A. 2008
AVP0622,WDWICEVLSDFK,12,Hepatitis C virus,HCV,Flaviviridae,11,HCV non-structural protein 5A,P26664,Huh7,>27,μM,Viral membrane,RT PCR,18287023,A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",Proc Natl Acad Sci U S A. 2008
AVP0623,RTQRRGRTGRGKPGIYR,17,Hepatitis C virus,HCV,Flaviviridae,HCVA(1484-1500),HCV NS3 helicase protein,P26664,Vero,27.1±2.4,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0624,STQRRGRTGRGRRGIYR,17,Hepatitis C virus,HCV,Flaviviridae,HCVB(1484-1500),HCV NS3 helicase protein,P26663,Vero,24.3±1.8,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0625,RRGRTGRGRRGIYR,14,Hepatitis C virus,HCV,Flaviviridae,HCV(1487-1500),HCV NS3 helicase protein,P26663,Vero,0.2±0.01,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0626,RTGRGRRGIYR,11,Hepatitis C virus,HCV,Flaviviridae,HCV(1490-1500),HCV NS3 helicase protein,P26663,Vero,34.6±3.2,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0627,RGRRGIYR,8,Hepatitis C virus,HCV,Flaviviridae,HCV(1493-1500),HCV NS3 helicase protein,P26663,Vero,313±11.3,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0628,RGIYR,5,Hepatitis C virus,HCV,Flaviviridae,HCV(1496-1500),HCV NS3 helicase protein,P26663,Vero,>500,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0629,SQVGD,5,Hepatitis C virus,HCV,Flaviviridae,WNV(1968-1972),WNV NS3 helicase protein,P06935,Vero,>500,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0630,RNPSQVGD,8,Hepatitis C virus,HCV,Flaviviridae,WNV(1965-1972),WNV NS3 helicase protein,P06935,Vero,>500,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0631,RIGRNPSQVGD,11,Hepatitis C virus,HCV,Flaviviridae,WNV(1962-1972),WNV NS3 helicase protein,P06935,Vero,417±17.6,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0632,RRGRIGRNPSQVGD,14,Hepatitis C virus,HCV,Flaviviridae,WNV(1959-1972),WNV NS3 helicase protein,P06935,Vero,169±6.8,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0633,AAQRRGRIGRNPSQVGD,17,Hepatitis C virus,HCV,Flaviviridae,WNV(1956-1972),WNV NS3 helicase protein,P06935,Vero,358±13.2,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0634,NQVGD,5,Hepatitis C virus,HCV,Flaviviridae,JEV(1971-1975),JEV NS3 helicase protein,P27395,Vero,>500,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0635,RNPNQVGD,8,Hepatitis C virus,HCV,Flaviviridae,JEV(1968-1975),JEV NS3 helicase protein,P27395,Vero,>500,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0636,RVGRNPNQVGD,11,Hepatitis C virus,HCV,Flaviviridae,JEV(1965-1975),JEV NS3 helicase protein,P27395,Vero,374±12.8,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0637,RRGRVGRNPNQVGD,14,Hepatitis C virus,HCV,Flaviviridae,JEV(1962-1975),JEV NS3 helicase protein,P27395,Vero,196±9.4,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0638,AAQRRGRVGRNPNQVGD,17,Hepatitis C virus,HCV,Flaviviridae,JEV(1959-1975),JEV NS3 helicase protein,P27395,Vero,442±17.7,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0639,RTQRRGRTGRGKPGIYR,17,West nile virus,WNV,Flaviviridae,HCVA(1484-1500),HCV NS3 helicase protein,P26664,Vero,37.1±3.9,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0640,STQRRGRTGRGRRGIYR,17,West nile virus,WNV,Flaviviridae,HCVB(1484-1500),HCV NS3 helicase protein,P26663,Vero,33.6±3.5,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0641,RRGRTGRGRRGIYR,14,West nile virus,WNV,Flaviviridae,HCV(1487-1500),HCV NS3 helicase protein,P26663,Vero,2.7±0.3,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0642,RTGRGRRGIYR,11,West nile virus,WNV,Flaviviridae,HCV(1490-1500),HCV NS3 helicase protein,P26663,Vero,106±6.1,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0643,RGRRGIYR,8,West nile virus,WNV,Flaviviridae,HCV(1493-1500),HCV NS3 helicase protein,P26663,Vero,397±10.6,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0644,RGIYR,5,West nile virus,WNV,Flaviviridae,HCV(1496-1500,HCV NS3 helicase protein,P26663,Vero,>500,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0645,RTQRRGRTGRGKPGIYR,17,Japanese encephalitis virus,JEV,Flaviviridae,HCVA(1484-1500),HCV NS3 helicase protein,P26664,Vero,49.8±4.3,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0646,STQRRGRTGRGRRGIYR,17,Japanese encephalitis virus,JEV,Flaviviridae,HCVB(1484-1500),HCV NS3 helicase protein,P26663,Vero,47.2±4.7,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0647,RRGRTGRGRRGIYR,14,Japanese encephalitis virus,JEV,Flaviviridae,HCV(1487-1500),HCV NS3 helicase protein,P26663,Vero,21.1±2.2,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0648,RTGRGRRGIYR,11,Japanese encephalitis virus,JEV,Flaviviridae,HCV(1490-1500),HCV NS3 helicase protein,P26663,Vero,322±9.7,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0649,RGRRGIYR,8,Japanese encephalitis virus,JEV,Flaviviridae,HCV(1493-1500),HCV NS3 helicase protein,P26663,Vero,>500,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0650,RGIYR,5,Japanese encephalitis virus,JEV,Flaviviridae,HCV(1496-1500,HCV NS3 helicase protein,P26663,Vero,>500,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0651,SQVGD,5,West nile virus,WNV,Flaviviridae,WNV(1968-1972),WNV NS3 helicase protein,P06935,Vero,>500,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0652,RNPSQVGD,8,West nile virus,WNV,Flaviviridae,WNV(1965-1972),WNV NS3 helicase protein,P06935,Vero,383±12.3,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0653,RIGRNPSQVGD,11,West nile virus,WNV,Flaviviridae,WNV(1962-1972),WNV NS3 helicase protein,P06935,Vero,285±8.1,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0654,RRGRIGRNPSQVGD,14,West nile virus,WNV,Flaviviridae,WNV(1959-1972),WNV NS3 helicase protein,P06935,Vero,156±6.9,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0655,AAQRRGRIGRNPSQVGD,17,West nile virus,WNV,Flaviviridae,WNV(1956-1972),WNV NS3 helicase protein,P06935,Vero,>500,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0656,SQVGD,5,Japanese encephalitis virus,JEV,Flaviviridae,WNV(1968-1972),WNV NS3 helicase protein,P06935,Vero,>500,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0657,RNPSQVGD,8,Japanese encephalitis virus,JEV,Flaviviridae,WNV(1965-1972),WNV NS3 helicase protein,P06935,Vero,437±13.4,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0658,RIGRNPSQVGD,11,Japanese encephalitis virus,JEV,Flaviviridae,WNV(1962-1972),WNV NS3 helicase protein,P06935,Vero,334±12.1,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0659,RRGRIGRNPSQVGD,14,Japanese encephalitis virus,JEV,Flaviviridae,WNV(1959-1972),WNV NS3 helicase protein,P06935,Vero,191±7.3,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0660,AAQRRGRIGRNPSQVGD,17,Japanese encephalitis virus,JEV,Flaviviridae,WNV(1956-1972),WNV NS3 helicase protein,P06935,Vero,>500,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0661,NQVGD,5,West nile virus,WNV,Flaviviridae,JEV(1971-1975),JEV NS3 helicase protein,P27395,Vero,>500,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0662,RNPNQVGD,8,West nile virus,WNV,Flaviviridae,JEV(1968-1975),JEV NS3 helicase protein,P27395,Vero,>500,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0663,RVGRNPNQVGD,11,West nile virus,WNV,Flaviviridae,JEV(1965-1975),JEV NS3 helicase protein,P27395,Vero,448±14.3,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0664,RRGRVGRNPNQVGD,14,West nile virus,WNV,Flaviviridae,JEV(1962-1975),JEV NS3 helicase protein,P27395,Vero,215±7.2,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0665,AAQRRGRVGRNPNQVGD,17,West nile virus,WNV,Flaviviridae,JEV(1959-1975),JEV NS3 helicase protein,P27395,Vero,>500,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0666,NQVGD,5,Japanese encephalitis virus,JEV,Flaviviridae,JEV(1971-1975),JEV NS3 helicase protein,P27395,Vero,>500,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0667,RNPNQVGD,8,Japanese encephalitis virus,JEV,Flaviviridae,JEV(1968-1975),JEV NS3 helicase protein,P27395,Vero,>500,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0668,RVGRNPNQVGD,11,Japanese encephalitis virus,JEV,Flaviviridae,JEV(1965-1975),JEV NS3 helicase protein,P27395,Vero,>500,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0669,RRGRVGRNPNQVGD,14,Japanese encephalitis virus,JEV,Flaviviridae,JEV(1962-1975),JEV NS3 helicase protein,P27395,Vero,253±6.5,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0670,AAQRRGRVGRNPNQVGD,17,Japanese encephalitis virus,JEV,Flaviviridae,JEV(1959-1975),JEV NS3 helicase protein,P27395,Vero,>500,μM,Replication,Helicase assay,18479669,Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Biochem Pharmacol. 2008
AVP0671,TWLATRGLLRSPGRYVYFSPSASTWPVGIWTTGELVLGCDAAL,43,Herpes simplex virus 1,HSV 1,Herpesviridae,gH220-262,HSV-1 H glycoprotein (gH),Q9DHD5,Vero,Nil,-,Virus entry,Plaque assay,18572274,Peptides containing membrane-interacting motifs inhibit herpes simplex virus type 1 infectivity.,"Galdiero S, Falanga A, Vitiello M, D'Isanto M, Cantisani M, Kampanaraki A, Benedetti E, Browne H, Galdiero M.",Peptides. 2008
AVP0672,RLTGLLATSGFAFVNAAHANGAVCLSDLLGFLAHSRALAG,40,Herpes simplex virus 1,HSV 1,Herpesviridae,gH381-420,HSV-1 H glycoprotein (gH),Q9DHD5,Vero,Nil,-,Virus entry,Plaque assay,18572274,Peptides containing membrane-interacting motifs inhibit herpes simplex virus type 1 infectivity.,"Galdiero S, Falanga A, Vitiello M, D'Isanto M, Cantisani M, Kampanaraki A, Benedetti E, Browne H, Galdiero M.",Peptides. 2008
AVP0673,AAHLIDALYAEFLGGRVLTTPVVHRALFYASAVLRQPFLAGVPSA,45,Herpes simplex virus 1,HSV 1,Herpesviridae,gH493-537,HSV-1 H glycoprotein (gH),Q9DHD5,Vero,250,μM,Virus entry,Plaque assay,18572274,Peptides containing membrane-interacting motifs inhibit herpes simplex virus type 1 infectivity.,"Galdiero S, Falanga A, Vitiello M, D'Isanto M, Cantisani M, Kampanaraki A, Benedetti E, Browne H, Galdiero M.",Peptides. 2008
AVP0674,AAHLIDALYAEFLGGRVLTT,20,Herpes simplex virus 1,HSV 1,Herpesviridae,gH493-512,HSV-1 H glycoprotein (gH),Q9DHD5,Vero,250,μM,Virus entry,Plaque assay,18572274,Peptides containing membrane-interacting motifs inhibit herpes simplex virus type 1 infectivity.,"Galdiero S, Falanga A, Vitiello M, D'Isanto M, Cantisani M, Kampanaraki A, Benedetti E, Browne H, Galdiero M.",Peptides. 2008
AVP0675,GLASTLTRWAHYNALIRAF,19,Herpes simplex virus 1,HSV 1,Herpesviridae,gH626-644,HSV-1 H glycoprotein (gH),Q9DHD5,Vero,250,μM,Virus entry,Plaque assay,18572274,Peptides containing membrane-interacting motifs inhibit herpes simplex virus type 1 infectivity.,"Galdiero S, Falanga A, Vitiello M, D'Isanto M, Cantisani M, Kampanaraki A, Benedetti E, Browne H, Galdiero M.",Peptides. 2008
AVP0676,CCFLNITNSHVSILQERPPLENRVLTGWGL,30,Human T-cell leukaemia virus 1,HTLV 1,Retroviridae,Pcr-400,HTLV-1 envelope glycoprotein (gp21),P14075,HeLa,0.28±0.01,μM,Fusion,Syncitia assay,18680566,Highly specific inhibition of leukaemia virus membrane fusion by interaction of peptide antagonists with a conserved region of the coiled coil of envelope.,"Lamb D, Schuttelkopf AW, van Aalten DM, Brighty DW.",Retrovirology. 2008
AVP0677,CCFLRIQNDSIIRLGDLQPLSQRVSTDWQ,29,BK virus,BKV,Polyomaviridae,PBLV-391,BLV envelope glycoprotein (gp30),P25505,FLK,3.49±0.03,μM,Fusion,Syncitia assay,18680566,Highly specific inhibition of leukaemia virus membrane fusion by interaction of peptide antagonists with a conserved region of the coiled coil of envelope.,"Lamb D, Schuttelkopf AW, van Aalten DM, Brighty DW.",Retrovirology. 2008
AVP0678,TTPKFTVAWDWVPKR,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,High,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0679,VGQPQYYQANGGFLI,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,High,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0680,KTTSSIEFARLQFTY,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,High,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0681,IEFARLQFTYNHIQR,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,High,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0682,VAADNVIVQNSMRIS,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,High,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0683,GHRRYFTFGGGYVYF,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,High,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0684,HEFVPLEVYTRHEIK,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,High,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0685,APTSPGTPGVAAATQ,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0686,GTPGVAAATQAANGG,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0687,AAATQAANGGPATPA,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0688,AANGGPATPAPPPLG,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0689,PATPAPPPLGAAPTG,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0690,PPPLGAAPTGDPKPK,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0691,AAPTGDPKPKKNKKP,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0692,DPKPKKNKKPKNPTP,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0693,KNKKPKNPTPPRPAG,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0694,KNPTPPRPAGDNATV,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0695,PRPAGDNATVAAGHA,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0696,DNATVAAGHATLREH,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0697,AAGHATLREHLRDIK,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0698,TLREHLRDIKAENTD,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0699,LRDIKAENTDANFYV,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0700,AENTDANFYVCPPPT,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0701,ANFYVCPPPTGATVV,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0702,CPPPTGATVVQFEQP,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0703,GATVVQFEQPRRCPT,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0704,QFEQPRRCPTRPEGQ,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0705,RRCPTRPEGQNYTEG,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0706,RPEGQNYTEGIAVVF,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0707,NYTEGIAVVFKENIA,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0708,IAVVFKENIAPYKFK,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0709,KENIAPYKFKATMYY,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0710,PYKFKATMYYKDVTV,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0711,ATMYYKDVTVSQVWF,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0712,KDVTVSQVWFGHRYS,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0713,SQVWFGHRYSQFMGI,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0714,GHRYSQFMGIFEDRA,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0715,QFMGIFEDRAPVPFE,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0716,FEDRAPVPFEEVIDK,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0717,PVPFEEVIDKINAKG,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0718,EVIDKINAKGVCRST,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0719,INAKGVCRSTAKYVR,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0720,VCRSTAKYVRNNLET,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0721,AKYVRNNLETTAFHR,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0722,NNLETTAFHRDDHET,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0723,TAFHRDDHETDMELK,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0724,DDHETDMELKPANAA,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0725,DMELKPANAATRTSR,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0726,PANAATRTSRGWHTT,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0727,TRTSRGWHTTDLKYN,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0728,GWHTTDLKYNPSRVE,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0729,DLKYNPSRVEAFHRY,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0730,PSRVEAFHRYGTTVN,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0731,AFHRYGTTVNCIVEE,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0732,GTTVNCIVEEVDARS,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0733,CIVEEVDARSVYPYD,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0734,VDARSVYPYDEFVLA,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0735,VYPYDEFVLATGDFV,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0736,EFVLATGDFVYMSPF,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0737,TGDFVYMSPFYGYRE,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0738,YMSPFYGYREGSHTE,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0739,YGYREGSHTEHTTYA,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0740,GSHTEHTTYAADRFK,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0741,HTTYAADRFKQVDGF,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0742,ADRFKQVDGFYARDL,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0743,QVDGFYARDLTTKAR,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0744,YARDLTTKARATAPT,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0745,TTKARATAPTTRNLL,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0746,ATAPTTRNLLTTPKF,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0747,TRNLLTTPKFTVAWD,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0748,TVAWDWVPKRPSVCT,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0749,WVPKRPSVCTMTKWQ,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0750,PSVCTMTKWQEVDEM,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0751,MTKWQEVDEMLRSEY,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0752,EVDEMLRSEYGGSFR,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0753,LRSEYGGSFRFSSDA,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0754,GGSFRFSSDAISTTF,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0755,FSSDAISTTFTTNLT,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0756,ISTTFTTNLTEYPLS,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0757,TTNLTEYPLSRVDLG,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0758,EYPLSRVDLGDCIGK,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0759,RVDLGDCIGKDARDA,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0760,DCIGKDARDAMDRIF,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0761,DARDAMDRIFARRYN,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0762,MDRIFARRYNATHIK,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0763,ARRYNATHIKVGQPQ,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0764,ATHIKVGQPQYYQAN,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0765,YYQANGGFLIAYQPL,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0766,GGFLIAYQPLLSNTL,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0767,AYQPLLSNTLAELYV,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0768,LSNTLAELYVREHLR,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0769,AELYVREHLREQSRK,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0770,REHLREQSRKPPNPT,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0771,EQSRKPPNPTPPPPG,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0772,PPNPTPPPPGASANA,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0773,PPPPGASANASVERI,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0774,ASANASVERIKTTSS,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0775,SVERIKTTSSIEFAR,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0776,LQFTYNHIQRHVNDM,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0777,NHIQRHVNDMLGRVA,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0778,HVNDMLGRVAIAWCE,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0779,LGRVAIAWCELQNHE,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0780,IAWCELQNHELTLWN,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0781,LQNHELTLWNEARKL,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0782,LTLWNEARKLNPNAI,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0783,EARKLNPNAIASVTV,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0784,NPNAIASVTVGRRVS,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0785,ASVTVGRRVSARMLG,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0786,GRRVSARMLGDVMAV,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0787,ARMLGDVMAVSTCVP,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0788,DVMAVSTCVPVAADN,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0789,STCVPVAADNVIVQN,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0790,VIVQNSMRISSRPGA,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0791,SMRISSRPGACYSRP,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0792,SRPGACYSRPLVSFR,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0793,CYSRPLVSFRYEDQG,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0794,LVSFRYEDQGPLVEG,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0795,YEDQGPLVEGQLGEN,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0796,PLVEGQLGENNELRL,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0797,QLGENNELRLTRDAI,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0798,NELRLTRDAIEPCTV,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0799,TRDAIEPCTVGHRRY,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0800,EPCTVGHRRYFTFGG,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0801,FTFGGGYVYFEEYAY,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0802,GYVYFEEYAYSHQLS,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0803,EEYAYSHQLSRADIT,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0804,SHQLSRADITTVSTF,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0805,RADITTVSTFIDLNI,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0806,TVSTFIDLNITMLED,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0807,IDLNITMLEDHEFVP,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0808,TMLEDHEFVPLEVYT,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0809,LEVYTRHEIKDSGLL,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0810,RHEIKDSGLLDYTEV,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0811,DSGLLDYTEVQRRNQ,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0812,DYTEVQRRNQLHDLR,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0813,QRRNQLHDLRFADID,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0814,LHDLRFADIDTVIHA,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0815,FADIDTVIHADANAA,15,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV-1 B glycoprotein (gB),P06437,Vero,Low,-,Virus entry,beta-galactosidase activity,19104014,Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Antimicrob Agents Chemother. 2009
AVP0816,CCFLNITNSHVSILQERPPLENRVLTGWGL,30,Human T-cell leukaemia virus 1,HTLV 1,Retroviridae,Pcr-400,HTLV-1 envelope glycoprotein (gp21),P14075,293T,0.18±0.01,μM,Virus entry,Luciferase assay,19114713,Basic residues are critical to the activity of peptide inhibitors of human T cell leukemia virus type 1 entry.,"Lamb D, Mirsaliotis A, Kelly SM, Brighty DW.",J Biol Chem. 2009
AVP0817,LNITNSHVSILQERPPLENRVL,22,Human T-cell leukaemia virus 1,HTLV 1,Retroviridae,Pcr-delta8,HTLV-1 envelope glycoprotein (gp21),P14075,293T,5.8,μM,Virus entry,Luciferase assay,19114713,Basic residues are critical to the activity of peptide inhibitors of human T cell leukemia virus type 1 entry.,"Lamb D, Mirsaliotis A, Kelly SM, Brighty DW.",J Biol Chem. 2009
AVP0818,CFLNITNSHVSILQERPPLENRV,23,Human T-cell leukaemia virus 1,HTLV 1,Retroviridae,Pcr-delta7,HTLV-1 envelope glycoprotein (gp21),P14075,293T,0.19±0.01,μM,Virus entry,Luciferase assay,19114713,Basic residues are critical to the activity of peptide inhibitors of human T cell leukemia virus type 1 entry.,"Lamb D, Mirsaliotis A, Kelly SM, Brighty DW.",J Biol Chem. 2009
AVP0819,CFLNITNSHVSILQEAPPLENRV,23,Human T-cell leukaemia virus 1,HTLV 1,Retroviridae,Pcr-R416A,HTLV-1 envelope glycoprotein (gp21),P14075,293T,1.55±0.08,μM,Virus entry,Luciferase assay,19114713,Basic residues are critical to the activity of peptide inhibitors of human T cell leukemia virus type 1 entry.,"Lamb D, Mirsaliotis A, Kelly SM, Brighty DW.",J Biol Chem. 2009
AVP0820,CFLNITNSHVSILQEAPPLENAV,23,Human T-cell leukaemia virus 1,HTLV 1,Retroviridae,Pcr-R422A,HTLV-1 envelope glycoprotein (gp21),P14075,293T,8.5,μM,Virus entry,Luciferase assay,19114713,Basic residues are critical to the activity of peptide inhibitors of human T cell leukemia virus type 1 entry.,"Lamb D, Mirsaliotis A, Kelly SM, Brighty DW.",J Biol Chem. 2009
AVP0821,LYGNEGCGWAGWLLSPRG,18,Hepatitis C virus,HCV,Flaviviridae,SL173,Synthetic,,Huh7.5,80,%,Oligomerization,ELISA,19264632,Peptide inhibitors of hepatitis C virus core oligomerization and virus production.,"Kota S, Coito C, Mousseau G, Lavergne JP, Strosberg AD.",J Gen Virol. 2009
AVP0822,GWAGWLLSPRGSRPSWGP,18,Hepatitis C virus,HCV,Flaviviridae,SL174,Synthetic,,Huh7.5,15,%,Oligomerization,ELISA,19264632,Peptide inhibitors of hepatitis C virus core oligomerization and virus production.,"Kota S, Coito C, Mousseau G, Lavergne JP, Strosberg AD.",J Gen Virol. 2009
AVP0823,GWAGWLLSPRGSRPS,15,Hepatitis C virus,HCV,Flaviviridae,SL175,Synthetic,,Huh7.5,50,%,Oligomerization,ELISA,19264632,Peptide inhibitors of hepatitis C virus core oligomerization and virus production.,"Kota S, Coito C, Mousseau G, Lavergne JP, Strosberg AD.",J Gen Virol. 2009
AVP0824,RRKKAAVALLPAVLLALLAP,20,Vaccinia,VACV,Poxviridae,EB,FGF-4 signal sequence,P08620,HeLa,-0.27,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0825,RRKKAAVALLPAVLLALLA,19,Vaccinia,VACV,Poxviridae,-1,FGF-4 signal sequence,P08620,HeLa,-0.1,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0826,RRKKAAVALLPAVLLALL,18,Vaccinia,VACV,Poxviridae,-2,FGF-4 signal sequence,P08620,HeLa,0.01,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0827,RRKKAAVALLPAVLLAL,17,Vaccinia,VACV,Poxviridae,-3,FGF-4 signal sequence,P08620,HeLa,8.76,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0828,RRKKAAVALLPAVLLA,16,Vaccinia,VACV,Poxviridae,-4,FGF-4 signal sequence,P08620,HeLa,3.45,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0829,RRKKAAVALLPAVLL,15,Vaccinia,VACV,Poxviridae,-5,FGF-4 signal sequence,P08620,HeLa,5.55,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0830,RRKKAAVALLPAVL,14,Vaccinia,VACV,Poxviridae,-6,FGF-4 signal sequence,P08620,HeLa,4.76,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0831,RRKKAAVALLPAV,13,Vaccinia,VACV,Poxviridae,-7,FGF-4 signal sequence,P08620,HeLa,4.34,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0832,RRKKAAVALLPA,12,Vaccinia,VACV,Poxviridae,-8,FGF-4 signal sequence,P08620,HeLa,5.55,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0833,RRKKAAVALLP,11,Vaccinia,VACV,Poxviridae,-9,FGF-4 signal sequence,P08620,HeLa,4.45,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0834,RRKKAAVALL,10,Vaccinia,VACV,Poxviridae,-10,FGF-4 signal sequence,P08620,HeLa,4.83,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0835,RRKKAAVAL,9,Vaccinia,VACV,Poxviridae,-11,FGF-4 signal sequence,P08620,HeLa,4.3,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0836,RRKKAAVA,8,Vaccinia,VACV,Poxviridae,-12,FGF-4 signal sequence,P08620,HeLa,3.02,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0837,RRKKAAV,7,Vaccinia,VACV,Poxviridae,-13,FGF-4 signal sequence,P08620,HeLa,3.97,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0838,RRKKAA,6,Vaccinia,VACV,Poxviridae,-14,FGF-4 signal sequence,P08620,HeLa,4.1,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0839,RRKKA,5,Vaccinia,VACV,Poxviridae,-16,FGF-4 signal sequence,P08620,HeLa,4.46,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0840,RRKK,4,Vaccinia,VACV,Poxviridae,-17,FGF-4 signal sequence,P08620,HeLa,2.567,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0841,RRKKAVALLPAVLLALLAP,19,Vaccinia,VACV,Poxviridae,1-,FGF-4 signal sequence,P08620,HeLa,-0.2,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0842,RRKKVALLPAVLLALLAP,18,Vaccinia,VACV,Poxviridae,2-,FGF-4 signal sequence,P08620,HeLa,0.021,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0843,RRKKALLPAVLLALLAP,17,Vaccinia,VACV,Poxviridae,3-,FGF-4 signal sequence,P08620,HeLa,0.46,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0844,RRKKLLPAVLLALLAP,16,Vaccinia,VACV,Poxviridae,4-,FGF-4 signal sequence,P08620,HeLa,0.07,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0845,RRKKLPAVLLALLAP,15,Vaccinia,VACV,Poxviridae,5-,FGF-4 signal sequence,P08620,HeLa,4.68,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0846,RRKKVLLALLAP,12,Vaccinia,VACV,Poxviridae,7-,FGF-4 signal sequence,P08620,HeLa,8.91,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0847,RRKKLLALLAP,11,Vaccinia,VACV,Poxviridae,8-,FGF-4 signal sequence,P08620,HeLa,5.67,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0848,RRKKALLAP,9,Vaccinia,VACV,Poxviridae,9-,FGF-4 signal sequence,P08620,HeLa,4,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0849,RRKKLLAP,8,Vaccinia,VACV,Poxviridae,10-,FGF-4 signal sequence,P08620,HeLa,4.5,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0850,RRKKLAP,7,Vaccinia,VACV,Poxviridae,11-,FGF-4 signal sequence,P08620,HeLa,4.58,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0851,RRKKAP,6,Vaccinia,VACV,Poxviridae,12-,FGF-4 signal sequence,P08620,HeLa,4.72,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0852,RRKKP,5,Vaccinia,VACV,Poxviridae,13-,FGF-4 signal sequence,P08620,HeLa,6.36,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0853,RRKKLAALPLVLAAPLAVLA,20,Vaccinia,VACV,Poxviridae,EBX,FGF-4 signal sequence,P08620,HeLa,8.98,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0854,RRKKAAVALLPAVLLALLAP,20,Vaccinia,VACV,Poxviridae,EB,FGF-4 signal sequence,P08620,HeLa,0.26,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0855,RRKKLAALPLVLAAPLAVLA,20,Vaccinia,VACV,Poxviridae,EBX,FGF-4 signal sequence,P08620,HeLa,7.28,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0856,RRKKAAVAALPAVLLALLAP,20,Vaccinia,VACV,Poxviridae,F2,FGF-4 signal sequence,P08620,HeLa,1.09,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0857,RRKKAAVALAPAVLLALLAP,20,Vaccinia,VACV,Poxviridae,F1,FGF-4 signal sequence,P08620,HeLa,1.09,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0858,RRKKAAVALLPAVALALLAP,20,Vaccinia,VACV,Poxviridae,C7,FGF-4 signal sequence,P08620,HeLa,3.38,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0859,RRKKAAVALLPAVLAALLAP,20,Vaccinia,VACV,Poxviridae,C6,FGF-4 signal sequence,P08620,HeLa,0.8,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0860,RRKKAAVALLKAVLLAALAP,20,Vaccinia,VACV,Poxviridae,C4,FGF-4 signal sequence,P08620,HeLa,-0.06,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0861,RRKKAAVALLKAVLLALAAP,20,Vaccinia,VACV,Poxviridae,C3,FGF-4 signal sequence,P08620,HeLa,-0.21,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0862,RRKKAAVAKLPAVLLALLAP,20,Vaccinia,VACV,Poxviridae,D2,FGF-4 signal sequence,P08620,HeLa,4.06,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0863,RRKKAAVALKPAVLLALLAP,20,Vaccinia,VACV,Poxviridae,D1,FGF-4 signal sequence,P08620,HeLa,1.58,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0864,RRKKAAVALLPAVKLALLAP,20,Vaccinia,VACV,Poxviridae,A7,FGF-4 signal sequence,P08620,HeLa,-0.03,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0865,RRKKAAVALLPAVLKALLAP,20,Vaccinia,VACV,Poxviridae,A6,FGF-4 signal sequence,P08620,HeLa,1.05,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0866,RRKKAAVALLPAVLLAKLAP,20,Vaccinia,VACV,Poxviridae,A4,FGF-4 signal sequence,P08620,HeLa,2.46,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0867,RRKKAAVALLKAVLLALKAP,20,Vaccinia,VACV,Poxviridae,A3,FGF-4 signal sequence,P08620,HeLa,0.11,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0868,RRKKAAVAELPAVLLALLAP,20,Vaccinia,VACV,Poxviridae,E2,FGF-4 signal sequence,P08620,HeLa,5.11,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0869,RRKKAAVALEPAVLLALLAP,20,Vaccinia,VACV,Poxviridae,E1,FGF-4 signal sequence,P08620,HeLa,4.7,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0870,RRKKAAVALLPAVELALLAP,20,Vaccinia,VACV,Poxviridae,B7,FGF-4 signal sequence,P08620,HeLa,4.32,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0871,RRKKAAVALLPAVLEALLAP,20,Vaccinia,VACV,Poxviridae,B6,FGF-4 signal sequence,P08620,HeLa,0.53,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0872,RRKKAAVALLPAVLLAELAP,20,Vaccinia,VACV,Poxviridae,B4,FGF-4 signal sequence,P08620,HeLa,6.43,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0873,RRKKAAVALLPAVLLALEAP,20,Vaccinia,VACV,Poxviridae,B3,FGF-4 signal sequence,P08620,HeLa,4.87,mOD/min,Virus entry,Plaque assay,19395056,Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.,"Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.",Virology. 2009
AVP0874,RQLVLRTR,8,Vaccinia,VACV,Poxviridae,72,Synthetic,,Flp-In-293,75,%,Replication,RT PCR,19428604,Inhibition of vaccinia virus replication by peptide aptamers.,"Saccucci L, Crance JM, Colas P, Bickle M, Garin D, Iseni F.",Antiviral Res. 2009
AVP0875,EALMWEGF,8,Vaccinia,VACV,Poxviridae,38,Synthetic,,Flp-In-293,40,%,Replication,RT PCR,19428604,Inhibition of vaccinia virus replication by peptide aptamers.,"Saccucci L, Crance JM, Colas P, Bickle M, Garin D, Iseni F.",Antiviral Res. 2009
AVP0876,CDQRTTRLC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,8.45,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0877,CPHDPNHPC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,9.94,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0878,CQSQTRNHC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,11.76,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0879,CLQDMRQFC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,13.26,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0880,CLPTDPIQC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,15.7,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0881,CPDHPFLRC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,16.65,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0882,CSTRAENQC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,17.56,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0883,CPSHLDAFC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,18.98,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0884,CKTGHMRIC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,20.84,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0885,CVRTPTHHC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,20.89,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0886,CSGVINTTC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,21.57,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0887,CPLASTRTC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,21.65,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0888,CSQFPPRLC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,22.19,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0889,CLLNKQNAC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,22.34,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0890,CKFPLNAAC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,22.89,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0891,CSLTPHRSC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,23.63,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0892,CKPWPMYSC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,23.71,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0893,CLQHDALNC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,24.01,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0894,CNANKPKMC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,24.67,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0895,CPKHVLKVC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,25.3,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0896,CTPDKKSFC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,26.91,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0897,CHGKAALAC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,27.22,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0898,CNLMGNPHC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,28.08,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0899,CLKNWFQPC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,28.64,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0900,CKEYGRQMC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,28.76,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0901,CQPSDPHLC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,29.44,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0902,CSHLPPNRC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,29.7,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0903,CSPLLRTVC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,33.05,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0904,CHKGHTWNC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,34.17,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0905,CINASHAHC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,35.62,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0906,CWPPSSRTC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,36.75,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0907,CPSSPFNHC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,37.78,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0908,CEHLSHAAC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,38.47,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0909,CQDRKTSQC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,38.74,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0910,CTDVYRPTC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,38.9,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0911,CGEKSAQLC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,39.11,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0912,CSAAERLNC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,40.13,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0913,CFRTLEHLC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,42.07,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0914,CEKLHTASC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,43.6,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0915,CSLHSHKGC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,45.11,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0916,CNSHSPVHC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,45.4,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0917,CMQSAAAHC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,48.88,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0918,CPAASHPRC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,51.84,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0919,CKSLGSSQC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,53.9,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0920,CPSNVNNIC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,61.11,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0921,CHPGSSSRC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,1.01,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0922,CSLSPLGRC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,10.56,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0923,CTARYTQHC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,12.86,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0924,CHGVYALHC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,12.91,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0925,CLQHNEREC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,16.79,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0926,CHPSTHRYC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,17.23,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0927,CPGNWWSTC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,19.34,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0928,CGMLNWNRC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,19.48,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0929,CPHTQFWQC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,20.44,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0930,CTPTMHNHC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,20.92,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0931,CDQVAGYSC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,21.79,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0932,CIPMMTEFC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,24.33,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0933,CERPYSRLC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,24.38,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0934,CPSLHTREC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,25.06,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0935,CSPLQIPYC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,26.3,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0936,CTTMTRMTC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,29.27,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0937,CNKPFSLPC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,30.09,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0938,CHNLESGTC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,31.63,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0939,CNSVPPYQC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,31.96,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0940,CSDSWLPRC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,32.95,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0941,CSAPFTKSC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,33.4,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0942,CEGLPNIDC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,35.63,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0943,CTSTHTKTC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,36.28,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0944,CLSIHSSVC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,36.4,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0945,CPWSTQYAC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,36.81,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0946,CTGSNLPIC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,36.83,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0947,CSLAPANTC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,39.73,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0948,CGLKTNPAC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,39.75,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0949,CRDTTPWWC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,40.08,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0950,CHTNASPHC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,40.26,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0951,CTSMAYHHC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,41.89,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0952,CSLSSPRIC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,42.13,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0953,CVSLEHQNC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,45.54,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0954,CRVTQTHTC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,46.55,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0955,CPTTKSNVC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,49.28,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0956,CSPGPHRVC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,49.5,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0957,CKSTSNVYC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,51.2,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0958,CTVGPTRSC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,57.3,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0959,CPMSQNPTC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,65.6,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0960,CPKLHPGGC,9,Andes virus,ANDV,Bunyaviridae,-,Phage display,,Vero E6,71.88,%,Surface glycoproteins (Gn/Gc),Immunofluorescence,19515773,Phage display selection of cyclic peptides that inhibit Andes virus infection.,"Hall PR, Hjelle B, Njus H, Ye C, Bondu-Hawkins V, Brown DC, Kilpatrick KA, Larson RS.",J Virol. 2009
AVP0961,GWWYKGRARPVSAVA,15,Influenza A virus,INFV A,Orthomyxoviridae,18-c01,Phage display,,B16,3.2,μM,Virus entry,Plaque assay,19558186,Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library.,"Matsubara T, Sumi M, Kubota H, Taki T, Okahata Y, Sato T.",J Med Chem. 2009
AVP0962,RAVWRHSVATPSHSV,15,Influenza A virus,INFV A,Orthomyxoviridae,C18-c03,Phage display,,B16,6.5,μM,Virus entry,Plaque assay,19558186,Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library.,"Matsubara T, Sumi M, Kubota H, Taki T, Okahata Y, Sato T.",J Med Chem. 2009
AVP0963,GAWYKGRARPVSAVA,15,Influenza A virus,INFV A,Orthomyxoviridae,C18-c01W2A,Phage display,,B16,53,μM,Virus entry,Plaque assay,19558186,Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library.,"Matsubara T, Sumi M, Kubota H, Taki T, Okahata Y, Sato T.",J Med Chem. 2009
AVP0964,GWWYKGRARAVSAVA,15,Influenza A virus,INFV A,Orthomyxoviridae,C18-c01P10A,Phage display,,B16,89,μM,Virus entry,Plaque assay,19558186,Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library.,"Matsubara T, Sumi M, Kubota H, Taki T, Okahata Y, Sato T.",J Med Chem. 2009
AVP0965,AVASVPRARGKYWWG,15,Influenza A virus,INFV A,Orthomyxoviridae,C18-c01r,Phage display,,B16,44,μM,Virus entry,Plaque assay,19558186,Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library.,"Matsubara T, Sumi M, Kubota H, Taki T, Okahata Y, Sato T.",J Med Chem. 2009
AVP0966,DFRRLPGAFWQLRQP,15,Influenza A virus,INFV A,Orthomyxoviridae,C18-p1b,Phage display,,B16,52,μM,Virus entry,Plaque assay,19558186,Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library.,"Matsubara T, Sumi M, Kubota H, Taki T, Okahata Y, Sato T.",J Med Chem. 2009
AVP0967,AETVESCLAKPHTEN,15,Influenza A virus,INFV A,Orthomyxoviridae,C18-cp3c,Phage display,,B16,66,μM,Virus entry,Plaque assay,19558186,Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library.,"Matsubara T, Sumi M, Kubota H, Taki T, Okahata Y, Sato T.",J Med Chem. 2009
AVP0968,GWWYKGRARPVSAVA,15,Influenza A virus,INFV A,Orthomyxoviridae,c01,Phage display,,B16,>500,μM,Virus entry,Plaque assay,19558186,Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library.,"Matsubara T, Sumi M, Kubota H, Taki T, Okahata Y, Sato T.",J Med Chem. 2009
AVP0969,RAVWRHSVATPSHSV,15,Influenza A virus,INFV A,Orthomyxoviridae,c03,Phage display,,B16,>500,μM,Virus entry,Plaque assay,19558186,Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library.,"Matsubara T, Sumi M, Kubota H, Taki T, Okahata Y, Sato T.",J Med Chem. 2009
AVP0970,SFYSVLFLWGTCGGFSHSWY,20,Hepatitis B virus,HBV,Hepadnaviridae,C1-1,Random peptide library,,HepG2,58.1,%,Replication,Q-PCR,19619601,An adenovirus-delivered peptide aptamer C1-1 targeting the core protein of hepatitis B virus inhibits viral DNA replication and production in vitro and in vivo.,"Zhang W, Ke W, Wu SS, Gan L, Zhou R, Sun CY, Long QS, Jiang W, Xin HB.",Peptides. 2009
AVP0971,CNDFRSKTC,9,Avian influenza virus,AIV,Orthomyxoviridae,P1,Synthetic,,MDCK,53,%,Replication,Flow cytometry,19680476,A novel peptide inhibits the influenza virus replication by preventing the viral attachment to the host cells.,"Rajik M, Omar AR, Ideris A, Hassan SS, Yusoff K.",Int J Biol Sci. 2009
AVP0972,AALEAKICHQIEYYFGDF,18,Hepatitis C virus,HCV,Flaviviridae,LAP,Human lupus autoantigen protein,P05455,Huh7.5.1,High,-,Translation,Luciferase assay,19740508,A cell-permeable peptide inhibits hepatitis C virus replication by sequestering IRES transacting factors.,"Fontanes V, Raychaudhuri S, Dasgupta A.",Virology. 2009
AVP0973,SSCNMGWDTPACCVWFPYWV,20,Human cytomegalovirus,HCMV,Herpesviridae,A4,Synthetic,,HeLa,70,%,Replication,GFP assay,19740994,Inhibition of human cytomegalovirus replication via peptide aptamers directed against the nonconventional nuclear localization signal of the essential viral replication factor pUL84.,"Kaiser N, Lischka P, Wagenknecht N, Stamminger T.",J Virol. 2009
AVP0974,MAVGLVLCDWWLGEYLLEA,19,Human cytomegalovirus,HCMV,Herpesviridae,A8,Synthetic,,HeLa,70,%,Replication,GFP assay,19740994,Inhibition of human cytomegalovirus replication via peptide aptamers directed against the nonconventional nuclear localization signal of the essential viral replication factor pUL84.,"Kaiser N, Lischka P, Wagenknecht N, Stamminger T.",J Virol. 2009
AVP0975,PVLQPALSLSCGPEPLLLSC,20,Human cytomegalovirus,HCMV,Herpesviridae,A56,Synthetic,,HeLa,40,%,Replication,GFP assay,19740994,Inhibition of human cytomegalovirus replication via peptide aptamers directed against the nonconventional nuclear localization signal of the essential viral replication factor pUL84.,"Kaiser N, Lischka P, Wagenknecht N, Stamminger T.",J Virol. 2009
AVP0976,IEVTFVNRRGDGAELWYLSA,20,Human cytomegalovirus,HCMV,Herpesviridae,A110,Synthetic,,HeLa,35,%,Replication,GFP assay,19740994,Inhibition of human cytomegalovirus replication via peptide aptamers directed against the nonconventional nuclear localization signal of the essential viral replication factor pUL84.,"Kaiser N, Lischka P, Wagenknecht N, Stamminger T.",J Virol. 2009
AVP0977,MDVNPTLLFLKVPAQNAISTTFPYT,25,Influenza A virus,INFV A,Orthomyxoviridae,45658,INFV A polymerase (PB1),Q6DNS6,MDCK,1.8,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP0978,VNPTLLFLKVPAQNAISTTFPYT,23,Influenza A virus,INFV A,Orthomyxoviridae,45717,INFV A polymerase (PB1),Q6DNS6,MDCK,661.77,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP0979,PTLLFLKVPAQNAISTTFPYT,21,Influenza A virus,INFV A,Orthomyxoviridae,45778,INFV A polymerase (PB1),Q6DNS6,MDCK,483,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP0980,LLFLKVPAQNAISTTFPYT,19,Influenza A virus,INFV A,Orthomyxoviridae,45839,INFV A polymerase (PB1),Q6DNS6,MDCK,>3000,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP0981,FLKVPAQNAISTTFPYT,17,Influenza A virus,INFV A,Orthomyxoviridae,45901,INFV A polymerase (PB1),Q6DNS6,MDCK,>3000,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP0982,KVPAQNAISTTFPYT,15,Influenza A virus,INFV A,Orthomyxoviridae,45962,INFV A polymerase (PB1),Q6DNS6,MDCK,>3000,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP0983,MDVNPTLLFLKVPAQNAIST,20,Influenza A virus,INFV A,Orthomyxoviridae,43831,INFV A polymerase (PB1),Q6DNS6,MDCK,33.8,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP0984,MDVNPTLLFLKVPAQNAI,18,Influenza A virus,INFV A,Orthomyxoviridae,43101,INFV A polymerase (PB1),Q6DNS6,MDCK,29.45,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP0985,MDVNPTLLFLKVPAQN,16,Influenza A virus,INFV A,Orthomyxoviridae,42370,INFV A polymerase (PB1),Q6DNS6,MDCK,45.86,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP0986,MDVNPTLLFLKVPAQ,15,Influenza A virus,INFV A,Orthomyxoviridae,42005,INFV A polymerase (PB1),Q6DNS6,MDCK,43.32,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP0987,MDVNPTLLFLKVPA,14,Influenza A virus,INFV A,Orthomyxoviridae,41640,INFV A polymerase (PB1),Q6DNS6,MDCK,34.53,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP0988,MDVNPTLLFLKVP,13,Influenza A virus,INFV A,Orthomyxoviridae,41275,INFV A polymerase (PB1),Q6DNS6,MDCK,138.17,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP0989,MDVNPTLLFLKV,12,Influenza A virus,INFV A,Orthomyxoviridae,41609,INFV A polymerase (PB1),Q6DNS6,MDCK,644,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP0990,MDVNPTLLFLK,11,Influenza A virus,INFV A,Orthomyxoviridae,41579,INFV A polymerase (PB1),Q6DNS6,MDCK,899,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP0991,MDVNPTLLFL,10,Influenza A virus,INFV A,Orthomyxoviridae,41548,INFV A polymerase (PB1),Q6DNS6,MDCK,>3000,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP0992,MDVNPTLLF,9,Influenza A virus,INFV A,Orthomyxoviridae,41518,INFV A polymerase (PB1),Q6DNS6,MDCK,>3000,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP0993,MDVNPTLL,8,Influenza A virus,INFV A,Orthomyxoviridae,41487,INFV A polymerase (PB1),Q6DNS6,MDCK,>3000,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP0994,MDVNPTL,7,Influenza A virus,INFV A,Orthomyxoviridae,41456,INFV A polymerase (PB1),Q6DNS6,MDCK,>3000,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP0995,MDVNPT,6,Influenza A virus,INFV A,Orthomyxoviridae,41426,INFV A polymerase (PB1),Q6DNS6,MDCK,>3000,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP0996,MNINPYPLFIDVPIQ,15,Influenza A virus,INFV A,Orthomyxoviridae,PB1-1-15 B,INFV A polymerase (PB1),Q6DNS6,MDCK,>3000,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP0997,MNINPTLLFLKVPIQ,15,Influenza A virus,INFV A,Orthomyxoviridae,"PB1-1-15 A D2N,V3I,L14I",INFV A polymerase (PB1),Q6DNS6,MDCK,6.69,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP0998,MDVNPTLLFIDVPAQ,15,Influenza A virus,INFV A,Orthomyxoviridae,"PB1-1-15 A L10I,K11D",INFV A polymerase (PB1),Q6DNS6,MDCK,>3000,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP0999,MNINPTLLFLKVPAQ,15,Influenza A virus,INFV A,Orthomyxoviridae,"PB1-1-15 A D2N,V3I",INFV A polymerase (PB1),Q6DNS6,MDCK,12.96,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP1000,MDVNPYFLFLKVPAQ,15,Influenza A virus,INFV A,Orthomyxoviridae,"PB1-1-15 A T6Y,L7F",INFV A polymerase (PB1),Q6DNS6,MDCK,7.51,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP1001,MDVNPTFLFLKVPAQ,15,Influenza A virus,INFV A,Orthomyxoviridae,PB1-1-15 A L7F,INFV A polymerase (PB1),Q6DNS6,MDCK,>3000,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP1002,MDVNPYLLFLKVPAQ,15,Influenza A virus,INFV A,Orthomyxoviridae,PB1-1-15 A T6Y,INFV A polymerase (PB1),Q6DNS6,MDCK,21.64,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP1003,MDVNPFLLFLKVPAQ,15,Influenza A virus,INFV A,Orthomyxoviridae,PB1-1-15 A T6F,INFV A polymerase (PB1),Q6DNS6,MDCK,2.84,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP1004,MDVNPWLLFLKVPAQ,15,Influenza A virus,INFV A,Orthomyxoviridae,PB1-1-15 A T6W,INFV A polymerase (PB1),Q6DNS6,MDCK,3.4,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP1005,MDVNPHLLFLKVPAQ,15,Influenza A virus,INFV A,Orthomyxoviridae,PB1-1-15 A T6H,INFV A polymerase (PB1),Q6DNS6,MDCK,292.16,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP1006,MDVNPCLLFLKVPAQ,15,Influenza A virus,INFV A,Orthomyxoviridae,PB1-1-15 A T6C,INFV A polymerase (PB1),Q6DNS6,MDCK,43.58,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP1007,MDVNPTLLFLKVPAQ,15,Influenza B virus,INFV B,Orthomyxoviridae,PB1-1-15 A,INFV A polymerase (PB1),Q6DNS6,MDCK,>3000,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP1008,MNINPYPLFIDVPIQ,15,Influenza B virus,INFV B,Orthomyxoviridae,PB1-1-15 B,INFV A polymerase (PB1),Q6DNS6,MDCK,45,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP1009,MNINPTLLFLKVPIQ,15,Influenza B virus,INFV B,Orthomyxoviridae,"PB1-1-15 A D2N,V3I,L14I",INFV A polymerase (PB1),Q6DNS6,MDCK,>3000,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP1010,MDVNPTLLFIDVPAQ,15,Influenza B virus,INFV B,Orthomyxoviridae,"PB1-1-15 A L10I,K11D",INFV A polymerase (PB1),Q6DNS6,MDCK,>3000,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP1011,MNINPTLLFLKVPAQ,15,Influenza B virus,INFV B,Orthomyxoviridae,"PB1-1-15 A D2N,V3I",INFV A polymerase (PB1),Q6DNS6,MDCK,>3000,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP1012,MDVNPYFLFLKVPAQ,15,Influenza B virus,INFV B,Orthomyxoviridae,"PB1-1-15 A T6Y,L7F",INFV A polymerase (PB1),Q6DNS6,MDCK,345,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP1013,MDVNPTFLFLKVPAQ,15,Influenza B virus,INFV B,Orthomyxoviridae,PB1-1-15 A L7F,INFV A polymerase (PB1),Q6DNS6,MDCK,>3000,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP1014,MDVNPYLLFLKVPAQ,15,Influenza B virus,INFV B,Orthomyxoviridae,PB1-1-15 A T6Y,INFV A polymerase (PB1),Q6DNS6,MDCK,107,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP1015,MDVNPFLLFLKVPAQ,15,Influenza B virus,INFV B,Orthomyxoviridae,PB1-1-15 A T6F,INFV A polymerase (PB1),Q6DNS6,MDCK,750,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP1016,MDVNPWLLFLKVPAQ,15,Influenza B virus,INFV B,Orthomyxoviridae,PB1-1-15 A T6W,INFV A polymerase (PB1),Q6DNS6,MDCK,628,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP1017,MDVNPHLLFLKVPAQ,15,Influenza B virus,INFV B,Orthomyxoviridae,PB1-1-15 A T6H,INFV A polymerase (PB1),Q6DNS6,MDCK,>3000,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP1018,MDVNPCLLFLKVPAQ,15,Influenza B virus,INFV B,Orthomyxoviridae,PB1-1-15 A T6C,INFV A polymerase (PB1),Q6DNS6,MDCK,>3000,nM,Replication,ELISA,19841738,Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Manz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",PLoS One. 2009
AVP1019,QKKIRVRLSA,10,Human cytomegalovirus,HCMV,Herpesviridae,SB101,Synthetic,,UL54 2F7,Low,-,Virus entry,EGFP expression,20083141,Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate.,"Luganini A, Giuliani A, Pirri G, Pizzuto L, Landolfo S, Gribaudo G.",Antiviral Res. 2010
AVP1020,QKKIRVRL,8,Human cytomegalovirus,HCMV,Herpesviridae,SB102,Synthetic,,UL54 2F7,Low,-,Virus entry,EGFP expression,20083141,Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate.,"Luganini A, Giuliani A, Pirri G, Pizzuto L, Landolfo S, Gribaudo G.",Antiviral Res. 2010
AVP1021,QKKIRVRWSA,10,Human cytomegalovirus,HCMV,Herpesviridae,SB103,Synthetic,,UL54 2F7,High,-,Virus entry,EGFP expression,20083141,Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate.,"Luganini A, Giuliani A, Pirri G, Pizzuto L, Landolfo S, Gribaudo G.",Antiviral Res. 2010
AVP1022,NKKIRVRL,8,Human cytomegalovirus,HCMV,Herpesviridae,SB104,Synthetic,,UL54 2F7,Low,-,Virus entry,EGFP expression,20083141,Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate.,"Luganini A, Giuliani A, Pirri G, Pizzuto L, Landolfo S, Gribaudo G.",Antiviral Res. 2010
AVP1023,ASLRVRIKKQ,10,Human cytomegalovirus,HCMV,Herpesviridae,SB105,Synthetic,,UL54 2F7,>90,%,Virus entry,EGFP expression,20083141,Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate.,"Luganini A, Giuliani A, Pirri G, Pizzuto L, Landolfo S, Gribaudo G.",Antiviral Res. 2010
AVP1024,ASLRVRIKK,9,Human cytomegalovirus,HCMV,Herpesviridae,SB105_A10,Synthetic,,UL54 2F7,>90,%,Virus entry,EGFP expression,20083141,Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate.,"Luganini A, Giuliani A, Pirri G, Pizzuto L, Landolfo S, Gribaudo G.",Antiviral Res. 2010
AVP1025,FKKIRVRL,8,Human cytomegalovirus,HCMV,Herpesviridae,SB106,Synthetic,,UL54 2F7,Low,-,Virus entry,EGFP expression,20083141,Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate.,"Luganini A, Giuliani A, Pirri G, Pizzuto L, Landolfo S, Gribaudo G.",Antiviral Res. 2010
AVP1026,QKKIRVRISA,10,Human cytomegalovirus,HCMV,Herpesviridae,SB107,Synthetic,,UL54 2F7,High,-,Virus entry,EGFP expression,20083141,Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate.,"Luganini A, Giuliani A, Pirri G, Pizzuto L, Landolfo S, Gribaudo G.",Antiviral Res. 2010
AVP1027,QKKIRVRLSW,10,Human cytomegalovirus,HCMV,Herpesviridae,SB108,Synthetic,,UL54 2F7,High,-,Virus entry,EGFP expression,20083141,Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate.,"Luganini A, Giuliani A, Pirri G, Pizzuto L, Landolfo S, Gribaudo G.",Antiviral Res. 2010
AVP1028,QKKIRVRFSA,10,Human cytomegalovirus,HCMV,Herpesviridae,SB109,Synthetic,,UL54 2F7,High,-,Virus entry,EGFP expression,20083141,Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate.,"Luganini A, Giuliani A, Pirri G, Pizzuto L, Landolfo S, Gribaudo G.",Antiviral Res. 2010
AVP1029,QKKIRFRLSA,10,Human cytomegalovirus,HCMV,Herpesviridae,SB110,Synthetic,,UL54 2F7,Medium,-,Virus entry,EGFP expression,20083141,Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate.,"Luganini A, Giuliani A, Pirri G, Pizzuto L, Landolfo S, Gribaudo G.",Antiviral Res. 2010
AVP1030,QKKIRIRLSA,10,Human cytomegalovirus,HCMV,Herpesviridae,SB111,Synthetic,,UL54 2F7,High,-,Virus entry,EGFP expression,20083141,Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate.,"Luganini A, Giuliani A, Pirri G, Pizzuto L, Landolfo S, Gribaudo G.",Antiviral Res. 2010
AVP1031,QKKIRWRLSA,10,Human cytomegalovirus,HCMV,Herpesviridae,SB112,Synthetic,,UL54 2F7,Medium,-,Virus entry,EGFP expression,20083141,Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate.,"Luganini A, Giuliani A, Pirri G, Pizzuto L, Landolfo S, Gribaudo G.",Antiviral Res. 2010
AVP1032,QKKFRVRLSA,10,Human cytomegalovirus,HCMV,Herpesviridae,SB113,Synthetic,,UL54 2F7,Medium,-,Virus entry,EGFP expression,20083141,Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate.,"Luganini A, Giuliani A, Pirri G, Pizzuto L, Landolfo S, Gribaudo G.",Antiviral Res. 2010
AVP1033,SFAIKWEYVLLLFLL,15,Hepatitis C virus,HCV,Flaviviridae,-,"HCV envelope glycoprotein (E1, E2)",P26663,Huh7,91,%,Virus entry,Luciferase assay,20156485,A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry.,"Liu R, Tewari M, Kong R, Zhang R, Ingravallo P, Ralston R.",Antiviral Res. 2010
AVP1034,FAIKWEYVLLLFLL,14,Hepatitis C virus,HCV,Flaviviridae,-,"HCV envelope glycoprotein (E1, E2)",P26663,Huh7,95,%,Virus entry,Luciferase assay,20156485,A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry.,"Liu R, Tewari M, Kong R, Zhang R, Ingravallo P, Ralston R.",Antiviral Res. 2010
AVP1035,AIKWEYVLLLFLL,13,Hepatitis C virus,HCV,Flaviviridae,-,"HCV envelope glycoprotein (E1, E2)",P26663,Huh7,92,%,Virus entry,Luciferase assay,20156485,A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry.,"Liu R, Tewari M, Kong R, Zhang R, Ingravallo P, Ralston R.",Antiviral Res. 2010
AVP1036,IKWEYVLLLFLL,12,Hepatitis C virus,HCV,Flaviviridae,-,"HCV envelope glycoprotein (E1, E2)",P26663,Huh7,88,%,Virus entry,Luciferase assay,20156485,A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry.,"Liu R, Tewari M, Kong R, Zhang R, Ingravallo P, Ralston R.",Antiviral Res. 2010
AVP1037,KWEYVLLLFLL,11,Hepatitis C virus,HCV,Flaviviridae,-,"HCV envelope glycoprotein (E1, E2)",P26663,Huh7,78,%,Virus entry,Luciferase assay,20156485,A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry.,"Liu R, Tewari M, Kong R, Zhang R, Ingravallo P, Ralston R.",Antiviral Res. 2010
AVP1038,WEYVLLLFLL,10,Hepatitis C virus,HCV,Flaviviridae,-,"HCV envelope glycoprotein (E1, E2)",P26663,Huh7,82,%,Virus entry,Luciferase assay,20156485,A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry.,"Liu R, Tewari M, Kong R, Zhang R, Ingravallo P, Ralston R.",Antiviral Res. 2010
AVP1039,VSFAIKWEYVLLLFL,15,Hepatitis C virus,HCV,Flaviviridae,-,"HCV envelope glycoprotein (E1, E2)",P26663,Huh7,63,%,Virus entry,Luciferase assay,20156485,A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry.,"Liu R, Tewari M, Kong R, Zhang R, Ingravallo P, Ralston R.",Antiviral Res. 2010
AVP1040,VSFAIKWEYVLLLF,14,Hepatitis C virus,HCV,Flaviviridae,-,"HCV envelope glycoprotein (E1, E2)",P26663,Huh7,49,%,Virus entry,Luciferase assay,20156485,A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry.,"Liu R, Tewari M, Kong R, Zhang R, Ingravallo P, Ralston R.",Antiviral Res. 2010
AVP1041,VSFAIKWEYVLLL,13,Hepatitis C virus,HCV,Flaviviridae,-,"HCV envelope glycoprotein (E1, E2)",P26663,Huh7,49,%,Virus entry,Luciferase assay,20156485,A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry.,"Liu R, Tewari M, Kong R, Zhang R, Ingravallo P, Ralston R.",Antiviral Res. 2010
AVP1042,VSFAIKWEYVLL,12,Hepatitis C virus,HCV,Flaviviridae,-,"HCV envelope glycoprotein (E1, E2)",P26663,Huh7,44,%,Virus entry,Luciferase assay,20156485,A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry.,"Liu R, Tewari M, Kong R, Zhang R, Ingravallo P, Ralston R.",Antiviral Res. 2010
AVP1043,VSFAIKWEYVL,11,Hepatitis C virus,HCV,Flaviviridae,-,"HCV envelope glycoprotein (E1, E2)",P26663,Huh7,17,%,Virus entry,Luciferase assay,20156485,A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry.,"Liu R, Tewari M, Kong R, Zhang R, Ingravallo P, Ralston R.",Antiviral Res. 2010
AVP1044,MEHFPGP,7,Encephalomyocarditis virus,ECMV,Picornaviridae,1,Synthetic,,MDCK,40,%,Hybrid physiological effects,Survival of mice,20506839,Antiviral properties of structural fragments of the peptide Selank.,"Andreeva LA, Nagaev IY, Mezentseva MV, Shapoval IM, Podchernyaeva RY, Shcherbenko VE, Potapova LA, Russu LI, Ershov FI, Myasoedov NF.",Dokl Biol Sci. 2010
AVP1045,TLPRPGP,7,Encephalomyocarditis virus,ECMV,Picornaviridae,2,Synthetic,,MDCK,20,%,Hybrid physiological effects,Survival of mice,20506839,Antiviral properties of structural fragments of the peptide Selank.,"Andreeva LA, Nagaev IY, Mezentseva MV, Shapoval IM, Podchernyaeva RY, Shcherbenko VE, Potapova LA, Russu LI, Ershov FI, Myasoedov NF.",Dokl Biol Sci. 2010
AVP1046,LPRPGP,6,Encephalomyocarditis virus,ECMV,Picornaviridae,3,Synthetic,,MDCK,60,%,Hybrid physiological effects,Survival of mice,20506839,Antiviral properties of structural fragments of the peptide Selank.,"Andreeva LA, Nagaev IY, Mezentseva MV, Shapoval IM, Podchernyaeva RY, Shcherbenko VE, Potapova LA, Russu LI, Ershov FI, Myasoedov NF.",Dokl Biol Sci. 2010
AVP1047,PRPGP,5,Encephalomyocarditis virus,ECMV,Picornaviridae,4,Synthetic,,MDCK,40,%,Hybrid physiological effects,Survival of mice,20506839,Antiviral properties of structural fragments of the peptide Selank.,"Andreeva LA, Nagaev IY, Mezentseva MV, Shapoval IM, Podchernyaeva RY, Shcherbenko VE, Potapova LA, Russu LI, Ershov FI, Myasoedov NF.",Dokl Biol Sci. 2010
AVP1048,RPGP,4,Encephalomyocarditis virus,ECMV,Picornaviridae,5,Synthetic,,MDCK,100,%,Hybrid physiological effects,Survival of mice,20506839,Antiviral properties of structural fragments of the peptide Selank.,"Andreeva LA, Nagaev IY, Mezentseva MV, Shapoval IM, Podchernyaeva RY, Shcherbenko VE, Potapova LA, Russu LI, Ershov FI, Myasoedov NF.",Dokl Biol Sci. 2010
AVP1049,PGP,3,Encephalomyocarditis virus,ECMV,Picornaviridae,6,Synthetic,,MDCK,80,%,Hybrid physiological effects,Survival of mice,20506839,Antiviral properties of structural fragments of the peptide Selank.,"Andreeva LA, Nagaev IY, Mezentseva MV, Shapoval IM, Podchernyaeva RY, Shcherbenko VE, Potapova LA, Russu LI, Ershov FI, Myasoedov NF.",Dokl Biol Sci. 2010
AVP1050,TLPGP,5,Encephalomyocarditis virus,ECMV,Picornaviridae,7,Synthetic,,MDCK,40,%,Hybrid physiological effects,Survival of mice,20506839,Antiviral properties of structural fragments of the peptide Selank.,"Andreeva LA, Nagaev IY, Mezentseva MV, Shapoval IM, Podchernyaeva RY, Shcherbenko VE, Potapova LA, Russu LI, Ershov FI, Myasoedov NF.",Dokl Biol Sci. 2010
AVP1051,TLPR,4,Encephalomyocarditis virus,ECMV,Picornaviridae,8,Synthetic,,MDCK,20,%,Hybrid physiological effects,Survival of mice,20506839,Antiviral properties of structural fragments of the peptide Selank.,"Andreeva LA, Nagaev IY, Mezentseva MV, Shapoval IM, Podchernyaeva RY, Shcherbenko VE, Potapova LA, Russu LI, Ershov FI, Myasoedov NF.",Dokl Biol Sci. 2010
AVP1052,TLP,3,Encephalomyocarditis virus,ECMV,Picornaviridae,9,Synthetic,,MDCK,40,%,Hybrid physiological effects,Survival of mice,20506839,Antiviral properties of structural fragments of the peptide Selank.,"Andreeva LA, Nagaev IY, Mezentseva MV, Shapoval IM, Podchernyaeva RY, Shcherbenko VE, Potapova LA, Russu LI, Ershov FI, Myasoedov NF.",Dokl Biol Sci. 2010
AVP1053,LPR,3,Encephalomyocarditis virus,ECMV,Picornaviridae,10,Synthetic,,MDCK,40,%,Hybrid physiological effects,Survival of mice,20506839,Antiviral properties of structural fragments of the peptide Selank.,"Andreeva LA, Nagaev IY, Mezentseva MV, Shapoval IM, Podchernyaeva RY, Shcherbenko VE, Potapova LA, Russu LI, Ershov FI, Myasoedov NF.",Dokl Biol Sci. 2010
AVP1054,RP,2,Encephalomyocarditis virus,ECMV,Picornaviridae,11,Synthetic,,MDCK,40,%,Hybrid physiological effects,Survival of mice,20506839,Antiviral properties of structural fragments of the peptide Selank.,"Andreeva LA, Nagaev IY, Mezentseva MV, Shapoval IM, Podchernyaeva RY, Shcherbenko VE, Potapova LA, Russu LI, Ershov FI, Myasoedov NF.",Dokl Biol Sci. 2010
AVP1055,GP,2,Encephalomyocarditis virus,ECMV,Picornaviridae,12,Synthetic,,MDCK,60,%,Hybrid physiological effects,Survival of mice,20506839,Antiviral properties of structural fragments of the peptide Selank.,"Andreeva LA, Nagaev IY, Mezentseva MV, Shapoval IM, Podchernyaeva RY, Shcherbenko VE, Potapova LA, Russu LI, Ershov FI, Myasoedov NF.",Dokl Biol Sci. 2010
AVP1056,RWMVWRHWFHRLRLPYNPGKNKQNQQWP,28,Dengue 2 virus,DENV 2,Flaviviridae,DN57opt,Synthetic,,LLC-MK2,8±1,μM,Virus entry,Focus reduction assay,20582308,Structural optimization and de novo design of dengue virus entry inhibitory peptides.,"Costin JM, Jenwitheesuk E, Lok SM, Hunsperger E, Conrads KA, Fontaine KA, Rees CR, Rossmann MG, Isern S, Samudrala R, Michael SF.",PLoS Negl Trop Dis. 2010
AVP1057,RQMRAWGQDYQHGGMGYSC,19,Dengue 2 virus,DENV 2,Flaviviridae,DN81opt,Synthetic,,LLC-MK2,36±6,μM,Virus entry,Focus reduction assay,20582308,Structural optimization and de novo design of dengue virus entry inhibitory peptides.,"Costin JM, Jenwitheesuk E, Lok SM, Hunsperger E, Conrads KA, Fontaine KA, Rees CR, Rossmann MG, Isern S, Samudrala R, Michael SF.",PLoS Negl Trop Dis. 2010
AVP1058,FWFTLIKTQAKQPARYRRFC,20,Dengue 2 virus,DENV 2,Flaviviridae,1OAN1,Synthetic,,LLC-MK2,7±4,μM,Virus entry,Focus reduction assay,20582308,Structural optimization and de novo design of dengue virus entry inhibitory peptides.,"Costin JM, Jenwitheesuk E, Lok SM, Hunsperger E, Conrads KA, Fontaine KA, Rees CR, Rossmann MG, Isern S, Samudrala R, Michael SF.",PLoS Negl Trop Dis. 2010
AVP1059,RRRRRRRRHPAEPGSTVTTQNTASQTMS,28,African swine fever virus,ASFV,Asfarviridae,DNBLK1,Synthetic,,Vero,20,μM,Transport,Immunofluorescence,20686048,Small peptide inhibitors disrupt a high-affinity interaction between cytoplasmic dynein and a viral cargo protein.,"Hernaez B, Tarrago T, Giralt E, Escribano JM, Alonso C.",J Virol. 2010
AVP1060,MSTNPKPQRKTKRNTNRRPQDVKFPGGGQIVGGVYL,36,Hepatitis C virus,HCV,Flaviviridae,HCVc1-36,HCV core protein,P26663,Huh7,High,-,Replication,Luciferase assay,20862261,Hepatitis C virus core-derived peptides inhibit genotype 1b viral genome replication via interaction with DDX3X.,"Sun C, Pager CT, Luo G, Sarnow P, Cate JH.",PLoS One. 2010
AVP1061,MSTNPKPQRKTKRNTNRRPQDVKFPGGGQIVGGVY,35,Hepatitis C virus,HCV,Flaviviridae,HCVc1-35,HCV core protein,P26663,Huh7,Nil,-,Replication,Luciferase assay,20862261,Hepatitis C virus core-derived peptides inhibit genotype 1b viral genome replication via interaction with DDX3X.,"Sun C, Pager CT, Luo G, Sarnow P, Cate JH.",PLoS One. 2010
AVP1062,MSTNPKPQRKTKRNTNRRPQDVKFPGGGQIVGGV,34,Hepatitis C virus,HCV,Flaviviridae,HCVc1-34,HCV core protein,P26663,Huh7,Nil,-,Replication,Luciferase assay,20862261,Hepatitis C virus core-derived peptides inhibit genotype 1b viral genome replication via interaction with DDX3X.,"Sun C, Pager CT, Luo G, Sarnow P, Cate JH.",PLoS One. 2010
AVP1063,TKRNTNRRPQDVKFPGGGQIVGGVYL,26,Hepatitis C virus,HCV,Flaviviridae,HCVc11-36,HCV core protein,P26663,Huh7,High,-,Replication,Luciferase assay,20862261,Hepatitis C virus core-derived peptides inhibit genotype 1b viral genome replication via interaction with DDX3X.,"Sun C, Pager CT, Luo G, Sarnow P, Cate JH.",PLoS One. 2010
AVP1064,NRRPQDVKFPGGGQIVGGVYL,21,Hepatitis C virus,HCV,Flaviviridae,HCVc16-36,HCV core protein,P26663,Huh7,High,-,Replication,Luciferase assay,20862261,Hepatitis C virus core-derived peptides inhibit genotype 1b viral genome replication via interaction with DDX3X.,"Sun C, Pager CT, Luo G, Sarnow P, Cate JH.",PLoS One. 2010
AVP1065,DVKFPGGGQIVGGVYL,16,Hepatitis C virus,HCV,Flaviviridae,HCVc21-36,HCV core protein,P26663,Huh7,Nil,-,Replication,Luciferase assay,20862261,Hepatitis C virus core-derived peptides inhibit genotype 1b viral genome replication via interaction with DDX3X.,"Sun C, Pager CT, Luo G, Sarnow P, Cate JH.",PLoS One. 2010
AVP1066,NRRPQDVKFPGGGQIVGGVY,20,Hepatitis C virus,HCV,Flaviviridae,HCVc16-35,HCV core protein,P26663,Huh7,Nil,-,Replication,Luciferase assay,20862261,Hepatitis C virus core-derived peptides inhibit genotype 1b viral genome replication via interaction with DDX3X.,"Sun C, Pager CT, Luo G, Sarnow P, Cate JH.",PLoS One. 2010
AVP1067,NRRPQDVKFPGGGQIVGGV,19,Hepatitis C virus,HCV,Flaviviridae,HCVc16-34,HCV core protein,P26663,Huh7,Nil,-,Replication,Luciferase assay,20862261,Hepatitis C virus core-derived peptides inhibit genotype 1b viral genome replication via interaction with DDX3X.,"Sun C, Pager CT, Luo G, Sarnow P, Cate JH.",PLoS One. 2010
AVP1068,CHRCFHFRRHPVAVF,15,Hepatitis C virus,HCV,Flaviviridae,P9,Phage display,,MC/9,High,-,Immunostimulaton,Surface plasmon resonance,21154952,Improved dendritic cell-based immunization against hepatitis C virus using peptide inhibitors of interleukin 10.,"Diaz-Valdes N, Manterola L, Belsue V, Riezu-Boj JI, Larrea E, Echeverria I, Llopiz D, Lopez-Sagaseta J, Lerat H, Pawlotsky JM, Prieto J, Lasarte JJ, Borras-Cuesta F, Sarobe P.",Hepatology. 2011
AVP1069,TRHRHVPRFLPLRHV,15,Hepatitis C virus,HCV,Flaviviridae,P13,Phage display,,MC/9,High,-,Immunostimulaton,Surface plasmon resonance,21154952,Improved dendritic cell-based immunization against hepatitis C virus using peptide inhibitors of interleukin 10.,"Diaz-Valdes N, Manterola L, Belsue V, Riezu-Boj JI, Larrea E, Echeverria I, Llopiz D, Lopez-Sagaseta J, Lerat H, Pawlotsky JM, Prieto J, Lasarte JJ, Borras-Cuesta F, Sarobe P.",Hepatology. 2011
AVP1070,RRKKAAVALLPAVLLALLAP,20,Influenza A virus,INFV A,Orthomyxoviridae,EB,FGF-4 signal sequence,P08620,MDCK,95±2,%,Virus entry,Hemagglutinin assay,21220525,Identification of the minimal active sequence of an anti-influenza virus peptide.,"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.",Antimicrob Agents Chemother. 2011
AVP1071,RRKKAAVALLPAVLLALLA,19,Influenza A virus,INFV A,Orthomyxoviridae,A2,FGF-4 signal sequence,P08620,MDCK,94±2,%,Virus entry,Hemagglutinin assay,21220525,Identification of the minimal active sequence of an anti-influenza virus peptide.,"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.",Antimicrob Agents Chemother. 2011
AVP1072,RRKKAAVALLPAVLLALL,18,Influenza A virus,INFV A,Orthomyxoviridae,A3,FGF-4 signal sequence,P08620,MDCK,95±2,%,Virus entry,Hemagglutinin assay,21220525,Identification of the minimal active sequence of an anti-influenza virus peptide.,"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.",Antimicrob Agents Chemother. 2011
AVP1073,RRKKAAVALLPAVLLAL,17,Influenza A virus,INFV A,Orthomyxoviridae,A4,FGF-4 signal sequence,P08620,MDCK,89±3,%,Virus entry,Hemagglutinin assay,21220525,Identification of the minimal active sequence of an anti-influenza virus peptide.,"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.",Antimicrob Agents Chemother. 2011
AVP1074,RRKKAAVALLPAVLLA,16,Influenza A virus,INFV A,Orthomyxoviridae,A5,FGF-4 signal sequence,P08620,MDCK,96±3,%,Virus entry,Hemagglutinin assay,21220525,Identification of the minimal active sequence of an anti-influenza virus peptide.,"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.",Antimicrob Agents Chemother. 2011
AVP1075,RRKKAAVALLPAVLL,15,Influenza A virus,INFV A,Orthomyxoviridae,A6,FGF-4 signal sequence,P08620,MDCK,0,%,Virus entry,Hemagglutinin assay,21220525,Identification of the minimal active sequence of an anti-influenza virus peptide.,"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.",Antimicrob Agents Chemother. 2011
AVP1076,RRKKAAVALLPAVL,14,Influenza A virus,INFV A,Orthomyxoviridae,A7,FGF-4 signal sequence,P08620,MDCK,0,%,Virus entry,Hemagglutinin assay,21220525,Identification of the minimal active sequence of an anti-influenza virus peptide.,"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.",Antimicrob Agents Chemother. 2011
AVP1077,RRKKAAVALLPAV,13,Influenza A virus,INFV A,Orthomyxoviridae,A8,FGF-4 signal sequence,P08620,MDCK,0,%,Virus entry,Hemagglutinin assay,21220525,Identification of the minimal active sequence of an anti-influenza virus peptide.,"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.",Antimicrob Agents Chemother. 2011
AVP1078,RRKKAAVALLPA,12,Influenza A virus,INFV A,Orthomyxoviridae,A9,FGF-4 signal sequence,P08620,MDCK,0,%,Virus entry,Hemagglutinin assay,21220525,Identification of the minimal active sequence of an anti-influenza virus peptide.,"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.",Antimicrob Agents Chemother. 2011
AVP1079,RRKKAAVALLP,11,Influenza A virus,INFV A,Orthomyxoviridae,A10,FGF-4 signal sequence,P08620,MDCK,4±8,%,Virus entry,Hemagglutinin assay,21220525,Identification of the minimal active sequence of an anti-influenza virus peptide.,"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.",Antimicrob Agents Chemother. 2011
AVP1080,RRKKAAVALL,10,Influenza A virus,INFV A,Orthomyxoviridae,A11,FGF-4 signal sequence,P08620,MDCK,0,%,Virus entry,Hemagglutinin assay,21220525,Identification of the minimal active sequence of an anti-influenza virus peptide.,"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.",Antimicrob Agents Chemother. 2011
AVP1081,RRKKAAVAL,9,Influenza A virus,INFV A,Orthomyxoviridae,A12,FGF-4 signal sequence,P08620,MDCK,0,%,Virus entry,Hemagglutinin assay,21220525,Identification of the minimal active sequence of an anti-influenza virus peptide.,"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.",Antimicrob Agents Chemother. 2011
AVP1082,RRKKAAVA,8,Influenza A virus,INFV A,Orthomyxoviridae,B1,FGF-4 signal sequence,P08620,MDCK,0,%,Virus entry,Hemagglutinin assay,21220525,Identification of the minimal active sequence of an anti-influenza virus peptide.,"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.",Antimicrob Agents Chemother. 2011
AVP1083,RRKKAAV,7,Influenza A virus,INFV A,Orthomyxoviridae,B2,FGF-4 signal sequence,P08620,MDCK,0,%,Virus entry,Hemagglutinin assay,21220525,Identification of the minimal active sequence of an anti-influenza virus peptide.,"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.",Antimicrob Agents Chemother. 2011
AVP1084,RRKKAA,6,Influenza A virus,INFV A,Orthomyxoviridae,B3,FGF-4 signal sequence,P08620,MDCK,0,%,Virus entry,Hemagglutinin assay,21220525,Identification of the minimal active sequence of an anti-influenza virus peptide.,"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.",Antimicrob Agents Chemother. 2011
AVP1085,RRKKA,5,Influenza A virus,INFV A,Orthomyxoviridae,B4,FGF-4 signal sequence,P08620,MDCK,0,%,Virus entry,Hemagglutinin assay,21220525,Identification of the minimal active sequence of an anti-influenza virus peptide.,"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.",Antimicrob Agents Chemother. 2011
AVP1086,RRKK,4,Influenza A virus,INFV A,Orthomyxoviridae,B5,FGF-4 signal sequence,P08620,MDCK,0,%,Virus entry,Hemagglutinin assay,21220525,Identification of the minimal active sequence of an anti-influenza virus peptide.,"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.",Antimicrob Agents Chemother. 2011
AVP1087,RRKKAVALLPAVLLALLAP,19,Influenza A virus,INFV A,Orthomyxoviridae,B6,FGF-4 signal sequence,P08620,MDCK,94±6,%,Virus entry,Hemagglutinin assay,21220525,Identification of the minimal active sequence of an anti-influenza virus peptide.,"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.",Antimicrob Agents Chemother. 2011
AVP1088,RRKKVALLPAVLLALLAP,18,Influenza A virus,INFV A,Orthomyxoviridae,B7,FGF-4 signal sequence,P08620,MDCK,94±4,%,Virus entry,Hemagglutinin assay,21220525,Identification of the minimal active sequence of an anti-influenza virus peptide.,"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.",Antimicrob Agents Chemother. 2011
AVP1089,RRKKALLPAVLLALLAP,17,Influenza A virus,INFV A,Orthomyxoviridae,B8,FGF-4 signal sequence,P08620,MDCK,94±3,%,Virus entry,Hemagglutinin assay,21220525,Identification of the minimal active sequence of an anti-influenza virus peptide.,"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.",Antimicrob Agents Chemother. 2011
AVP1090,RRKKLLPAVLLALLAP,16,Influenza A virus,INFV A,Orthomyxoviridae,B9,FGF-4 signal sequence,P08620,MDCK,94±4,%,Virus entry,Hemagglutinin assay,21220525,Identification of the minimal active sequence of an anti-influenza virus peptide.,"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.",Antimicrob Agents Chemother. 2011
AVP1091,RRKKLPAVLLALLAP,15,Influenza A virus,INFV A,Orthomyxoviridae,B10,FGF-4 signal sequence,P08620,MDCK,94±4,%,Virus entry,Hemagglutinin assay,21220525,Identification of the minimal active sequence of an anti-influenza virus peptide.,"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.",Antimicrob Agents Chemother. 2011
AVP1092,RRKKPAVLLALLAP,14,Influenza A virus,INFV A,Orthomyxoviridae,B11,FGF-4 signal sequence,P08620,MDCK,96±0,%,Virus entry,Hemagglutinin assay,21220525,Identification of the minimal active sequence of an anti-influenza virus peptide.,"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.",Antimicrob Agents Chemother. 2011
AVP1093,RRKKAVLLALLAP,13,Influenza A virus,INFV A,Orthomyxoviridae,B12,FGF-4 signal sequence,P08620,MDCK,97±2,%,Virus entry,Hemagglutinin assay,21220525,Identification of the minimal active sequence of an anti-influenza virus peptide.,"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.",Antimicrob Agents Chemother. 2011
AVP1094,RRKKVLLALLAP,12,Influenza A virus,INFV A,Orthomyxoviridae,C1,FGF-4 signal sequence,P08620,MDCK,40±19,%,Virus entry,Hemagglutinin assay,21220525,Identification of the minimal active sequence of an anti-influenza virus peptide.,"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.",Antimicrob Agents Chemother. 2011
AVP1095,RRKKLLALLAP,11,Influenza A virus,INFV A,Orthomyxoviridae,C2,FGF-4 signal sequence,P08620,MDCK,0,%,Virus entry,Hemagglutinin assay,21220525,Identification of the minimal active sequence of an anti-influenza virus peptide.,"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.",Antimicrob Agents Chemother. 2011
AVP1096,RRKKLALLAP,10,Influenza A virus,INFV A,Orthomyxoviridae,C3,FGF-4 signal sequence,P08620,MDCK,0,%,Virus entry,Hemagglutinin assay,21220525,Identification of the minimal active sequence of an anti-influenza virus peptide.,"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.",Antimicrob Agents Chemother. 2011
AVP1097,RRKKALLAP,9,Influenza A virus,INFV A,Orthomyxoviridae,C4,FGF-4 signal sequence,P08620,MDCK,0,%,Virus entry,Hemagglutinin assay,21220525,Identification of the minimal active sequence of an anti-influenza virus peptide.,"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.",Antimicrob Agents Chemother. 2011
AVP1098,RRKKLLAP,8,Influenza A virus,INFV A,Orthomyxoviridae,C5,FGF-4 signal sequence,P08620,MDCK,0,%,Virus entry,Hemagglutinin assay,21220525,Identification of the minimal active sequence of an anti-influenza virus peptide.,"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.",Antimicrob Agents Chemother. 2011
AVP1099,RRKKLAP,7,Influenza A virus,INFV A,Orthomyxoviridae,C6,FGF-4 signal sequence,P08620,MDCK,0,%,Virus entry,Hemagglutinin assay,21220525,Identification of the minimal active sequence of an anti-influenza virus peptide.,"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.",Antimicrob Agents Chemother. 2011
AVP1100,RRKKAP,6,Influenza A virus,INFV A,Orthomyxoviridae,C7,FGF-4 signal sequence,P08620,MDCK,0,%,Virus entry,Hemagglutinin assay,21220525,Identification of the minimal active sequence of an anti-influenza virus peptide.,"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.",Antimicrob Agents Chemother. 2011
AVP1101,RRKKP,5,Influenza A virus,INFV A,Orthomyxoviridae,C8,FGF-4 signal sequence,P08620,MDCK,0,%,Virus entry,Hemagglutinin assay,21220525,Identification of the minimal active sequence of an anti-influenza virus peptide.,"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.",Antimicrob Agents Chemother. 2011
AVP1102,DQYLESVKKIHKRLDV,16,Human cytomegalovirus,HCMV,Herpesviridae,UL128 147-162,HCMV UL128 protein,P16837,MCR-5,Nil,-,Immunostimulaton,GFP assay,21310190,Peptides from cytomegalovirus UL130 and UL131 proteins induce high titer antibodies that block viral entry into mucosal epithelial cells.,"Saccoccio FM, Sauer AL, Cui X, Armstrong AE, Habib el-SE, Johnson DC, Ryckman BJ, Klingelhutz AJ, Adler SP, McVoy MA.",Vaccine. 2011
AVP1103,SWSTLTANQNPSPPWSKLTY,20,Human cytomegalovirus,HCMV,Herpesviridae,UL130 27-46,HCMV UL130 protein,P16772,MCR-5,High,-,Immunostimulaton,GFP assay,21310190,Peptides from cytomegalovirus UL130 and UL131 proteins induce high titer antibodies that block viral entry into mucosal epithelial cells.,"Saccoccio FM, Sauer AL, Cui X, Armstrong AE, Habib el-SE, Johnson DC, Ryckman BJ, Klingelhutz AJ, Adler SP, McVoy MA.",Vaccine. 2011
AVP1104,SDFRRQNRRGGTNKRTT,17,Human cytomegalovirus,HCMV,Herpesviridae,UL131 90-106,HCMV UL131 protein,F5HET4,MCR-5,High,-,Immunostimulaton,GFP assay,21310190,Peptides from cytomegalovirus UL130 and UL131 proteins induce high titer antibodies that block viral entry into mucosal epithelial cells.,"Saccoccio FM, Sauer AL, Cui X, Armstrong AE, Habib el-SE, Johnson DC, Ryckman BJ, Klingelhutz AJ, Adler SP, McVoy MA.",Vaccine. 2011
AVP1105,LAEGPPVKECAVTCRYDKDADINVVTQARN,30,Classical swine fever virus,CSFV,Flaviviridae,S2,CSFV envelope protein (E2),P21530,PK15,0,%,CSFV entering,Plaque assay,21400206,Identification of host cell binding peptide from an overlapping peptide library for inhibition of classical swine fever virus infection.,"Li X, Wang L, Zhao D, Zhang G, Luo J, Deng R, Yang Y.",Virus Genes. 2011
AVP1106,AVSPTTLRTEVVKTFRRDKPFPHRMDCVTT,30,Classical swine fever virus,CSFV,Flaviviridae,S6,CSFV envelope protein (E2),P21530,PK15,80,%,CSFV entering,Plaque assay,21400206,Identification of host cell binding peptide from an overlapping peptide library for inhibition of classical swine fever virus infection.,"Li X, Wang L, Zhao D, Zhang G, Luo J, Deng R, Yang Y.",Virus Genes. 2011
AVP1107,WCNWHNIDPWIQLMNRTQADLAEGPPVKEC,30,Classical swine fever virus,CSFV,Flaviviridae,S25,CSFV envelope protein (E2),P21530,PK15,42,%,CSFV entering,Plaque assay,21400206,Identification of host cell binding peptide from an overlapping peptide library for inhibition of classical swine fever virus infection.,"Li X, Wang L, Zhao D, Zhang G, Luo J, Deng R, Yang Y.",Virus Genes. 2011
AVP1108,VSRRYLASLHKKALPTSVTFELLFDGTNPS,30,Classical swine fever virus,CSFV,Flaviviridae,S24,CSFV envelope protein (E2),P21530,PK15,80,%,CSFV entering,Plaque assay,21400206,Identification of host cell binding peptide from an overlapping peptide library for inhibition of classical swine fever virus infection.,"Li X, Wang L, Zhao D, Zhang G, Luo J, Deng R, Yang Y.",Virus Genes. 2011
AVP1109,YLRGVNRSLHGIWPGKICKGVPTHLATDVE,30,Classical swine fever virus,CSFV,Flaviviridae,S32,CSFV envelope protein (E2),P21530,PK15,90,%,CSFV entering,Plaque assay,21400206,Identification of host cell binding peptide from an overlapping peptide library for inhibition of classical swine fever virus infection.,"Li X, Wang L, Zhao D, Zhang G, Luo J, Deng R, Yang Y.",Virus Genes. 2011
AVP1110,VPTHLATDVELKEIQGMMDASEGTNYTCCK,30,Classical swine fever virus,CSFV,Flaviviridae,S43,CSFV envelope protein (E2),P21530,PK15,40,%,CSFV entering,Plaque assay,21400206,Identification of host cell binding peptide from an overlapping peptide library for inhibition of classical swine fever virus infection.,"Li X, Wang L, Zhao D, Zhang G, Luo J, Deng R, Yang Y.",Virus Genes. 2011
AVP1111,TTVKVHASDERLGPMPCRPKEIVSSAGPVM,30,Classical swine fever virus,CSFV,Flaviviridae,S20,CSFV envelope protein (E2),P21530,PK15,80,%,CSFV entering,Plaque assay,21400206,Identification of host cell binding peptide from an overlapping peptide library for inhibition of classical swine fever virus infection.,"Li X, Wang L, Zhao D, Zhang G, Luo J, Deng R, Yang Y.",Virus Genes. 2011
AVP1112,ELLFDGTNPSTEEMGDDFRSGLCPFDTSPV,30,Classical swine fever virus,CSFV,Flaviviridae,S15,CSFV envelope protein (E2),P21530,PK15,25,%,CSFV entering,Plaque assay,21400206,Identification of host cell binding peptide from an overlapping peptide library for inhibition of classical swine fever virus infection.,"Li X, Wang L, Zhao D, Zhang G, Luo J, Deng R, Yang Y.",Virus Genes. 2011
AVP1113,VEDTLYGDHECGSLLQDAALYLVDGMTNTI,30,Classical swine fever virus,CSFV,Flaviviridae,S28,CSFV envelope protein (E2),P21530,PK15,25,%,CSFV entering,Plaque assay,21400206,Identification of host cell binding peptide from an overlapping peptide library for inhibition of classical swine fever virus infection.,"Li X, Wang L, Zhao D, Zhang G, Luo J, Deng R, Yang Y.",Virus Genes. 2011
AVP1114,VKQCRWCGFDFDGPDGLPHYPIGKCILANE,30,Classical swine fever virus,CSFV,Flaviviridae,S42,CSFV envelope protein (E2),P21530,PK15,35,%,CSFV entering,Plaque assay,21400206,Identification of host cell binding peptide from an overlapping peptide library for inhibition of classical swine fever virus infection.,"Li X, Wang L, Zhao D, Zhang G, Luo J, Deng R, Yang Y.",Virus Genes. 2011
AVP1115,TLKNRYYEPRDSYFQQYMLKGEYQYWFDLD,30,Classical swine fever virus,CSFV,Flaviviridae,S5,CSFV envelope protein (E2),P21530,PK15,0,%,CSFV entering,Plaque assay,21400206,Identification of host cell binding peptide from an overlapping peptide library for inhibition of classical swine fever virus infection.,"Li X, Wang L, Zhao D, Zhang G, Luo J, Deng R, Yang Y.",Virus Genes. 2011
AVP1116,GLCPFDTSPVVKGKYNTTLLNGSAFYLVCP,30,Classical swine fever virus,CSFV,Flaviviridae,S48,CSFV envelope protein (E2),P21530,PK15,90,%,CSFV entering,Plaque assay,21400206,Identification of host cell binding peptide from an overlapping peptide library for inhibition of classical swine fever virus infection.,"Li X, Wang L, Zhao D, Zhang G, Luo J, Deng R, Yang Y.",Virus Genes. 2011
AVP1117,YGRKKRRQRRRGSGIEPHDWTKNITDKIDQIIHDFVDK,38,Ebola virus,EBoV,Filoviridae,Tat-Ebo,EboV C protein/HIV Tat,Q05320,Vero,99,%,Virus entry,Focus reduction assay,21454542,Inhibition of Ebola virus entry by a C-peptide targeted to endosomes.,"Miller EH, Harrison JS, Radoshitzky SR, Higgins CD, Chi X, Dong L, Kuhn JH, Bavari S, Lai JR, Chandran K.",J Biol Chem. 2011
AVP1118,ASLRVRIKKQ,10,Herpes simplex virus 1,HSV 1,Herpesviridae,SB105,Synthetic,,Vero,0.21±0.04,EC50 (μM),Replication,Plaque assay,21576348,Reduced HIV transmission at subsequent pregnancy in a resource-poor setting.,"Gumbo FZ, Kandawasvika GQ, Duri K, Mapingure MP, Kurewa NE, Nathoo K, Rusakaniko S, Chirenje MZ, Stray-Pedersen B.",Trop Doct. 2011
AVP1119,ASLRVRIKK,9,Herpes simplex virus 1,HSV 1,Herpesviridae,SB105-A10,Synthetic,,Vero,0.25±0.01,EC50 (μM),Replication,Plaque assay,21576348,Reduced HIV transmission at subsequent pregnancy in a resource-poor setting.,"Gumbo FZ, Kandawasvika GQ, Duri K, Mapingure MP, Kurewa NE, Nathoo K, Rusakaniko S, Chirenje MZ, Stray-Pedersen B.",Trop Doct. 2011
AVP1120,ASLRVRIKKQ,10,Herpes simplex virus 2,HSV 2,Herpesviridae,SB105,Synthetic,,Vero,0.78±0.02,EC50 (μM),Replication,Plaque assay,21576348,Reduced HIV transmission at subsequent pregnancy in a resource-poor setting.,"Gumbo FZ, Kandawasvika GQ, Duri K, Mapingure MP, Kurewa NE, Nathoo K, Rusakaniko S, Chirenje MZ, Stray-Pedersen B.",Trop Doct. 2011
AVP1121,ASLRVRIKK,9,Herpes simplex virus 2,HSV 2,Herpesviridae,SB105-A10,Synthetic,,Vero,0.77±0.05,EC50 (μM),Replication,Plaque assay,21576348,Reduced HIV transmission at subsequent pregnancy in a resource-poor setting.,"Gumbo FZ, Kandawasvika GQ, Duri K, Mapingure MP, Kurewa NE, Nathoo K, Rusakaniko S, Chirenje MZ, Stray-Pedersen B.",Trop Doct. 2011
AVP1122,LRSRTKIIRIRH,12,Herpes simplex virus 1,HSV 1,Herpesviridae,G1,Phage display,,CHO-K1,0.02to0.03,nM,Virus entry,Plaque assay,21596749,Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo.,"Tiwari V, Liu J, Valyi-Nagy T, Shukla D.",J Biol Chem. 2011
AVP1123,MPRRRRIRRRQK,12,Herpes simplex virus 1,HSV 1,Herpesviridae,G2,Phage display,,CHO-K1,0.02to0.03,nM,Virus entry,Plaque assay,21596749,Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo.,"Tiwari V, Liu J, Valyi-Nagy T, Shukla D.",J Biol Chem. 2011
AVP1124,YADHTGLVRDNMAKLRERLKQRQQLFDSQQGWFEGWFNRSPWFTT,45,Feline leukemia virus,FeLV,Retroviridae,FeLV 15E,FeLV transmembrane protein (TM),P06752,FEA,Low,-,Fusion,ELISA,21900723,In vitro inhibition of feline leukaemia virus infection by synthetic peptides derived from the transmembrane domain.,"Boenzli E, Robert-Tissot C, Sabatino G, Cattori V, Meli ML, Gutte B, Rovero P, Flynn N, Hofmann-Lehmann R, Lutz H.",Antivir Ther. 2011
AVP1125,YADHTGLVRDNMAKL,15,Feline leukemia virus,FeLV,Retroviridae,EPK205,FeLV transmembrane protein (TM),P06752,FEA,Low,-,Fusion,ELISA,21900723,In vitro inhibition of feline leukaemia virus infection by synthetic peptides derived from the transmembrane domain.,"Boenzli E, Robert-Tissot C, Sabatino G, Cattori V, Meli ML, Gutte B, Rovero P, Flynn N, Hofmann-Lehmann R, Lutz H.",Antivir Ther. 2011
AVP1126,GLVRDNMAKLRERLK,15,Feline leukemia virus,FeLV,Retroviridae,EPK206,FeLV transmembrane protein (TM),P06752,FEA,Low,-,Fusion,ELISA,21900723,In vitro inhibition of feline leukaemia virus infection by synthetic peptides derived from the transmembrane domain.,"Boenzli E, Robert-Tissot C, Sabatino G, Cattori V, Meli ML, Gutte B, Rovero P, Flynn N, Hofmann-Lehmann R, Lutz H.",Antivir Ther. 2011
AVP1127,NMAKLRERLKQRQQL,15,Feline leukemia virus,FeLV,Retroviridae,EPK207,FeLV transmembrane protein (TM),P06752,FEA,Low,-,Fusion,ELISA,21900723,In vitro inhibition of feline leukaemia virus infection by synthetic peptides derived from the transmembrane domain.,"Boenzli E, Robert-Tissot C, Sabatino G, Cattori V, Meli ML, Gutte B, Rovero P, Flynn N, Hofmann-Lehmann R, Lutz H.",Antivir Ther. 2011
AVP1128,RERLKQRQQLFDSQQ,15,Feline leukemia virus,FeLV,Retroviridae,EPK208,FeLV transmembrane protein (TM),P06752,FEA,Low,-,Fusion,ELISA,21900723,In vitro inhibition of feline leukaemia virus infection by synthetic peptides derived from the transmembrane domain.,"Boenzli E, Robert-Tissot C, Sabatino G, Cattori V, Meli ML, Gutte B, Rovero P, Flynn N, Hofmann-Lehmann R, Lutz H.",Antivir Ther. 2011
AVP1129,QRQQLFDSQQGWFEG,15,Feline leukemia virus,FeLV,Retroviridae,EPK209,FeLV transmembrane protein (TM),P06752,FEA,Low,-,Fusion,ELISA,21900723,In vitro inhibition of feline leukaemia virus infection by synthetic peptides derived from the transmembrane domain.,"Boenzli E, Robert-Tissot C, Sabatino G, Cattori V, Meli ML, Gutte B, Rovero P, Flynn N, Hofmann-Lehmann R, Lutz H.",Antivir Ther. 2011
AVP1130,FDSQQGWFEGWFNRS,15,Feline leukemia virus,FeLV,Retroviridae,EPK210,FeLV transmembrane protein (TM),P06752,FEA,Low,-,Fusion,ELISA,21900723,In vitro inhibition of feline leukaemia virus infection by synthetic peptides derived from the transmembrane domain.,"Boenzli E, Robert-Tissot C, Sabatino G, Cattori V, Meli ML, Gutte B, Rovero P, Flynn N, Hofmann-Lehmann R, Lutz H.",Antivir Ther. 2011
AVP1131,GWFEGWFNRSPWFTT,15,Feline leukemia virus,FeLV,Retroviridae,EPK211,FeLV transmembrane protein (TM),P06752,FEA,Medium,-,Fusion,ELISA,21900723,In vitro inhibition of feline leukaemia virus infection by synthetic peptides derived from the transmembrane domain.,"Boenzli E, Robert-Tissot C, Sabatino G, Cattori V, Meli ML, Gutte B, Rovero P, Flynn N, Hofmann-Lehmann R, Lutz H.",Antivir Ther. 2011
AVP1132,KQRQQLFDSQQGWFEGWFNRSPWFT,25,Feline leukemia virus,FeLV,Retroviridae,EPK237,FeLV transmembrane protein (TM),P06752,FEA,Medium,-,Fusion,ELISA,21900723,In vitro inhibition of feline leukaemia virus infection by synthetic peptides derived from the transmembrane domain.,"Boenzli E, Robert-Tissot C, Sabatino G, Cattori V, Meli ML, Gutte B, Rovero P, Flynn N, Hofmann-Lehmann R, Lutz H.",Antivir Ther. 2011
AVP1133,VRDNMAKLRERLKQRQQLFDSQQGWFEGWFNRSPWFT,37,Feline leukemia virus,FeLV,Retroviridae,EPK364,FeLV transmembrane protein (TM),P06752,FEA,High,-,Fusion,ELISA,21900723,In vitro inhibition of feline leukaemia virus infection by synthetic peptides derived from the transmembrane domain.,"Boenzli E, Robert-Tissot C, Sabatino G, Cattori V, Meli ML, Gutte B, Rovero P, Flynn N, Hofmann-Lehmann R, Lutz H.",Antivir Ther. 2011
AVP1134,VEENMKKLEERLKKREELFKKQEEWFKKWFERSKKFT,37,Feline leukemia virus,FeLV,Retroviridae,EPK397,FeLV transmembrane protein (TM),P06752,FEA,Medium,-,Fusion,ELISA,21900723,In vitro inhibition of feline leukaemia virus infection by synthetic peptides derived from the transmembrane domain.,"Boenzli E, Robert-Tissot C, Sabatino G, Cattori V, Meli ML, Gutte B, Rovero P, Flynn N, Hofmann-Lehmann R, Lutz H.",Antivir Ther. 2011
AVP1135,VEELMKLLEELLKKLEELFKKLEEWFKKWFELSKKFT,37,Feline leukemia virus,FeLV,Retroviridae,EPK398,FeLV transmembrane protein (TM),P06752,FEA,Medium,-,Fusion,ELISA,21900723,In vitro inhibition of feline leukaemia virus infection by synthetic peptides derived from the transmembrane domain.,"Boenzli E, Robert-Tissot C, Sabatino G, Cattori V, Meli ML, Gutte B, Rovero P, Flynn N, Hofmann-Lehmann R, Lutz H.",Antivir Ther. 2011
AVP1136,YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF,36,Feline leukemia virus,FeLV,Retroviridae,T-20,FeLV transmembrane protein (TM),P06752,FEA,High,-,Fusion,ELISA,21900723,In vitro inhibition of feline leukaemia virus infection by synthetic peptides derived from the transmembrane domain.,"Boenzli E, Robert-Tissot C, Sabatino G, Cattori V, Meli ML, Gutte B, Rovero P, Flynn N, Hofmann-Lehmann R, Lutz H.",Antivir Ther. 2011
AVP1137,PPLASMSPLPATDPPPLEGAHPELGVPPP,29,Influenza A virus,INFV A,Orthomyxoviridae,NP9-1,Conotoxin,P01519,293T,Low,-,Nucleoprotein,Luciferase assay,22095520,Inhibition of influenza virus replication by constrained peptides targeting nucleoprotein.,"Jiang H, Xu Y, Li L, Weng L, Wang Q, Zhang S, Jia B, Hu H, He Y, Jacob Y, Toyoda T.",Antivir Chem Chemother. 2011
AVP1138,PPGETPTPVSDLWPPPSYQGRPSRQGHPP,29,Influenza A virus,INFV A,Orthomyxoviridae,NP9-2,Conotoxin,P01519,293T,Low,-,Nucleoprotein,Luciferase assay,22095520,Inhibition of influenza virus replication by constrained peptides targeting nucleoprotein.,"Jiang H, Xu Y, Li L, Weng L, Wang Q, Zhang S, Jia B, Hu H, He Y, Jacob Y, Toyoda T.",Antivir Chem Chemother. 2011
AVP1139,PPFLSYLPAETDFPPPEARETPEPFSNPP,29,Influenza A virus,INFV A,Orthomyxoviridae,NP9-3,Conotoxin,P01519,293T,Low,-,Nucleoprotein,Luciferase assay,22095520,Inhibition of influenza virus replication by constrained peptides targeting nucleoprotein.,"Jiang H, Xu Y, Li L, Weng L, Wang Q, Zhang S, Jia B, Hu H, He Y, Jacob Y, Toyoda T.",Antivir Chem Chemother. 2011
AVP1140,PPEPSDLPPGNPVPPPLNYGDPTKLRSPP,29,Influenza A virus,INFV A,Orthomyxoviridae,NP9-4,Conotoxin,P01519,293T,Low,-,Nucleoprotein,Luciferase assay,22095520,Inhibition of influenza virus replication by constrained peptides targeting nucleoprotein.,"Jiang H, Xu Y, Li L, Weng L, Wang Q, Zhang S, Jia B, Hu H, He Y, Jacob Y, Toyoda T.",Antivir Chem Chemother. 2011
AVP1141,PPWCCCSPMKRASPPPAQSDLPATPKCPP,29,Influenza A virus,INFV A,Orthomyxoviridae,NP9-5,Conotoxin,P01519,293T,40,%,Nucleoprotein,Luciferase assay,22095520,Inhibition of influenza virus replication by constrained peptides targeting nucleoprotein.,"Jiang H, Xu Y, Li L, Weng L, Wang Q, Zhang S, Jia B, Hu H, He Y, Jacob Y, Toyoda T.",Antivir Chem Chemother. 2011
AVP1142,PPGTGEEPEQAGLPPPELLVEPDYMWSPP,29,Influenza A virus,INFV A,Orthomyxoviridae,NP9-6,Conotoxin,P01519,293T,Low,-,Nucleoprotein,Luciferase assay,22095520,Inhibition of influenza virus replication by constrained peptides targeting nucleoprotein.,"Jiang H, Xu Y, Li L, Weng L, Wang Q, Zhang S, Jia B, Hu H, He Y, Jacob Y, Toyoda T.",Antivir Chem Chemother. 2011
AVP1143,PPPTHQSPNTTDMPPPATLSGPTGINRPP,29,Influenza A virus,INFV A,Orthomyxoviridae,NP10-1,Conotoxin,P01519,293T,Low,-,Nucleoprotein,Luciferase assay,22095520,Inhibition of influenza virus replication by constrained peptides targeting nucleoprotein.,"Jiang H, Xu Y, Li L, Weng L, Wang Q, Zhang S, Jia B, Hu H, He Y, Jacob Y, Toyoda T.",Antivir Chem Chemother. 2011
AVP1144,PPLRYSPPGQRVIPPPADERFLRFLVFHLNKIRIRAREIYES,42,Influenza A virus,INFV A,Orthomyxoviridae,PA A3,Conotoxin,P01519,293T,Low,-,Nucleoprotein,Luciferase assay,22095520,Inhibition of influenza virus replication by constrained peptides targeting nucleoprotein.,"Jiang H, Xu Y, Li L, Weng L, Wang Q, Zhang S, Jia B, Hu H, He Y, Jacob Y, Toyoda T.",Antivir Chem Chemother. 2011
AVP1145,PPTCYVPPHSPATPPPSVRISLLRLVFTLIRSEFELERSMNRRY,44,Influenza A virus,INFV A,Orthomyxoviridae,PA A6,Conotoxin,P01519,293T,Low,-,Nucleoprotein,Luciferase assay,22095520,Inhibition of influenza virus replication by constrained peptides targeting nucleoprotein.,"Jiang H, Xu Y, Li L, Weng L, Wang Q, Zhang S, Jia B, Hu H, He Y, Jacob Y, Toyoda T.",Antivir Chem Chemother. 2011
AVP1146,PPVCETGPLHPPSPPPLVRISLILVFVHLNKIRIRAREIYES,42,Influenza A virus,INFV A,Orthomyxoviridae,PA A11,Conotoxin,P01519,293T,Low,-,Nucleoprotein,Luciferase assay,22095520,Inhibition of influenza virus replication by constrained peptides targeting nucleoprotein.,"Jiang H, Xu Y, Li L, Weng L, Wang Q, Zhang S, Jia B, Hu H, He Y, Jacob Y, Toyoda T.",Antivir Chem Chemother. 2011
AVP1147,PPLAVMRPGIQILPPPGTDVHPK,23,Influenza A virus,INFV A,Orthomyxoviridae,PA A13,Conotoxin,P01519,293T,Low,-,Nucleoprotein,Luciferase assay,22095520,Inhibition of influenza virus replication by constrained peptides targeting nucleoprotein.,"Jiang H, Xu Y, Li L, Weng L, Wang Q, Zhang S, Jia B, Hu H, He Y, Jacob Y, Toyoda T.",Antivir Chem Chemother. 2011
AVP1148,PPSHRTTPASRSLPPLRVFVVLSFSGVHLNKIRIRAREIYES,42,Influenza A virus,INFV A,Orthomyxoviridae,PA A15,Conotoxin,P01519,293T,Low,-,Nucleoprotein,Luciferase assay,22095520,Inhibition of influenza virus replication by constrained peptides targeting nucleoprotein.,"Jiang H, Xu Y, Li L, Weng L, Wang Q, Zhang S, Jia B, Hu H, He Y, Jacob Y, Toyoda T.",Antivir Chem Chemother. 2011
AVP1149,PPGKQHTPTSFTHPPPADILLPLSAMIHLNKIRIRAREIYES,42,Influenza A virus,INFV A,Orthomyxoviridae,PA A16,Conotoxin,P01519,293T,Low,-,Nucleoprotein,Luciferase assay,22095520,Inhibition of influenza virus replication by constrained peptides targeting nucleoprotein.,"Jiang H, Xu Y, Li L, Weng L, Wang Q, Zhang S, Jia B, Hu H, He Y, Jacob Y, Toyoda T.",Antivir Chem Chemother. 2011
AVP1150,PPGSLGWPPNTTEPPPYLRLRLIFLFIHLNKIRIRAREIYES,42,Influenza A virus,INFV A,Orthomyxoviridae,PA A17,Conotoxin,P01519,293T,Low,-,Nucleoprotein,Luciferase assay,22095520,Inhibition of influenza virus replication by constrained peptides targeting nucleoprotein.,"Jiang H, Xu Y, Li L, Weng L, Wang Q, Zhang S, Jia B, Hu H, He Y, Jacob Y, Toyoda T.",Antivir Chem Chemother. 2011
AVP1151,PPDGCNRPQQSRKPPPRCLICLMVGLIHLNKIRIRAREIYES,42,Influenza A virus,INFV A,Orthomyxoviridae,PA A19,Conotoxin,P01519,293T,Low,-,Nucleoprotein,Luciferase assay,22095520,Inhibition of influenza virus replication by constrained peptides targeting nucleoprotein.,"Jiang H, Xu Y, Li L, Weng L, Wang Q, Zhang S, Jia B, Hu H, He Y, Jacob Y, Toyoda T.",Antivir Chem Chemother. 2011
AVP1152,PPDEGYPPMRMQVPPLGGRIILVRVLLHLNKIRIRAREIYES,42,Influenza A virus,INFV A,Orthomyxoviridae,PA A22,Conotoxin,P01519,293T,Low,-,Nucleoprotein,Luciferase assay,22095520,Inhibition of influenza virus replication by constrained peptides targeting nucleoprotein.,"Jiang H, Xu Y, Li L, Weng L, Wang Q, Zhang S, Jia B, Hu H, He Y, Jacob Y, Toyoda T.",Antivir Chem Chemother. 2011
AVP1153,PPESNHPPWKGPYPPPTSNVNPLILLSHLNKIRIRAREIYES,42,Influenza A virus,INFV A,Orthomyxoviridae,PA A23,Conotoxin,P01519,293T,Low,-,Nucleoprotein,Luciferase assay,22095520,Inhibition of influenza virus replication by constrained peptides targeting nucleoprotein.,"Jiang H, Xu Y, Li L, Weng L, Wang Q, Zhang S, Jia B, Hu H, He Y, Jacob Y, Toyoda T.",Antivir Chem Chemother. 2011
AVP1154,CTLCRVVDCCLYAIVFVMVRVVVLCVNKIRIRAREIYES,39,Influenza A virus,INFV A,Orthomyxoviridae,PB1 1-2,Conotoxin,P01519,293T,Low,-,Nucleoprotein,Luciferase assay,22095520,Inhibition of influenza virus replication by constrained peptides targeting nucleoprotein.,"Jiang H, Xu Y, Li L, Weng L, Wang Q, Zhang S, Jia B, Hu H, He Y, Jacob Y, Toyoda T.",Antivir Chem Chemother. 2011
AVP1155,CICCCMCVLYAVLWWLSVLVSLCELLIRSEFELERSMNRRY,41,Influenza A virus,INFV A,Orthomyxoviridae,PB1 4-1,Conotoxin,P01519,293T,Low,-,Nucleoprotein,Luciferase assay,22095520,Inhibition of influenza virus replication by constrained peptides targeting nucleoprotein.,"Jiang H, Xu Y, Li L, Weng L, Wang Q, Zhang S, Jia B, Hu H, He Y, Jacob Y, Toyoda T.",Antivir Chem Chemother. 2011
AVP1156,CSRCLELALCLDPAN,15,Influenza A virus,INFV A,Orthomyxoviridae,PA R1,Conotoxin,P01519,293T,Low,-,Nucleoprotein,Luciferase assay,22095520,Inhibition of influenza virus replication by constrained peptides targeting nucleoprotein.,"Jiang H, Xu Y, Li L, Weng L, Wang Q, Zhang S, Jia B, Hu H, He Y, Jacob Y, Toyoda T.",Antivir Chem Chemother. 2011
AVP1157,CCGCCYIAACARNNSNCSSHLECSTC,26,Influenza A virus,INFV A,Orthomyxoviridae,NP3-2,Conotoxin,P01519,293T,Low,-,Nucleoprotein,Luciferase assay,22095520,Inhibition of influenza virus replication by constrained peptides targeting nucleoprotein.,"Jiang H, Xu Y, Li L, Weng L, Wang Q, Zhang S, Jia B, Hu H, He Y, Jacob Y, Toyoda T.",Antivir Chem Chemother. 2011
AVP1158,CS,2,Influenza A virus,INFV A,Orthomyxoviridae,NP6-1,Conotoxin,P01519,293T,Low,-,Nucleoprotein,Luciferase assay,22095520,Inhibition of influenza virus replication by constrained peptides targeting nucleoprotein.,"Jiang H, Xu Y, Li L, Weng L, Wang Q, Zhang S, Jia B, Hu H, He Y, Jacob Y, Toyoda T.",Antivir Chem Chemother. 2011
AVP1159,EELRVRLASHLRKLRKRLLRDADDLQKRLAVYEEQAQQIRLQAEAFQARLKSWFEPLVEDM,61,Hepatitis C virus,HCV,Flaviviridae,hEP-1,Human apolipoprotein (apoE),P02649,Huh7.5.1,0.67,μM,Virus entry,RT PCR,22334503,Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.,"Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T.",Hepatology. 2012
AVP1160,CEELRVRLASHLRKLRKRLLRDADDLQKRLAVY,33,Hepatitis C virus,HCV,Flaviviridae,hEP-2,Human apolipoprotein (apoE),P02649,Huh7.5.1,0.5,μM,Virus entry,RT PCR,22334503,Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.,"Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T.",Hepatology. 2012
AVP1161,EELRVRLASHLRKLRKRLLRDADDLQKRLAVY,32,Hepatitis C virus,HCV,Flaviviridae,hEP-2/deltaCys,Human apolipoprotein (apoE),P02649,Huh7.5.1,>10,μM,Virus entry,RT PCR,22334503,Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.,"Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T.",Hepatology. 2012
AVP1162,CEEIRARLSTHLRKMRKRLMRDADDLQKRLAVY,33,Hepatitis C virus,HCV,Flaviviridae,mEP-2,Human apolipoprotein (apoE),P02649,Huh7.5.1,>10,μM,Virus entry,RT PCR,22334503,Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.,"Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T.",Hepatology. 2012
AVP1163,CEEQAQQIRLQAEAFQARLKSWFEPLVEDM,30,Hepatitis C virus,HCV,Flaviviridae,hEP-3,Human apolipoprotein (apoE),P02649,Huh7.5.1,>10,μM,Virus entry,RT PCR,22334503,Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.,"Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T.",Hepatology. 2012
AVP1164,CVRLASHLRKLRKRLLRDADDL,22,Hepatitis C virus,HCV,Flaviviridae,hEP-4,Human apolipoprotein (apoE),P02649,Huh7.5.1,>10,μM,Virus entry,RT PCR,22334503,Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.,"Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T.",Hepatology. 2012
AVP1165,CIRLQAEAFQARLKSWFEPLV,21,Hepatitis C virus,HCV,Flaviviridae,hEP-5,Human apolipoprotein (apoE),P02649,Huh7.5.1,>10,μM,Virus entry,RT PCR,22334503,Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.,"Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T.",Hepatology. 2012
AVP1166,VRLASHLRKLRKRLLRDADDLIRLQAEAFQARLKSWFEPLV,41,Hepatitis C virus,HCV,Flaviviridae,hEP-6,Human apolipoprotein (apoE),P02649,Huh7.5.1,>10,μM,Virus entry,RT PCR,22334503,Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.,"Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T.",Hepatology. 2012
AVP1167,LRVRLASHLRKLRKRLLRDADDLQKRLAVY,30,Hepatitis C virus,HCV,Flaviviridae,hEP-7,Human apolipoprotein (apoE),P02649,Huh7.5.1,>10,μM,Virus entry,RT PCR,22334503,Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.,"Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T.",Hepatology. 2012
AVP1168,EELRVRLASHLRKLRKRLLRDADDL,25,Hepatitis C virus,HCV,Flaviviridae,hEP-8,Human apolipoprotein (apoE),P02649,Huh7.5.1,>10,μM,Virus entry,RT PCR,22334503,Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.,"Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T.",Hepatology. 2012
AVP1169,VRLASHLRKLRKRLLRDADDLQKRLAVY,28,Hepatitis C virus,HCV,Flaviviridae,hEP-9,Human apolipoprotein (apoE),P02649,Huh7.5.1,>10,μM,Virus entry,RT PCR,22334503,Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.,"Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T.",Hepatology. 2012
AVP1170,CVRLASHLRKLRKRLLRDADDLQKRLAVY,29,Hepatitis C virus,HCV,Flaviviridae,hEP-10,Human apolipoprotein (apoE),P02649,Huh7.5.1,0.8,μM,Virus entry,RT PCR,22334503,Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.,"Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T.",Hepatology. 2012
AVP1171,CLRVRLASHLRKLRKRLLRDADDL,24,Hepatitis C virus,HCV,Flaviviridae,hEP-11,Human apolipoprotein (apoE),P02649,Huh7.5.1,4,μM,Virus entry,RT PCR,22334503,Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.,"Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T.",Hepatology. 2012
AVP1172,CLRKLRKRLLRC,12,Hepatitis C virus,HCV,Flaviviridae,hEP-12,Human apolipoprotein (apoE),P28995,Huh7.5.1,>10,μM,Virus entry,RT PCR,22334503,Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.,"Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T.",Hepatology. 2012
AVP1173,MANAGLQLLGFILAFLGW,18,Hepatitis C virus,HCV,Flaviviridae,CL58,Human claudin-1 (CLDN1),O95832,Huh7.5.1,2.1±0.5,μM,Virus entry,Pseudoviral particle infection assay,22378192,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W.",Hepatology. 2012
AVP1174,GLQLLGFILAFLGWIGAI,18,Hepatitis C virus,HCV,Flaviviridae,CL58.1,Human claudin-1 (CLDN1),O95832,Huh7.5.1,>25,μM,Virus entry,Pseudoviral particle infection assay,22378192,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W.",Hepatology. 2012
AVP1175,LLGFILAFLGWIGAIVST,18,Hepatitis C virus,HCV,Flaviviridae,CL58.2,Human claudin-1 (CLDN1),O95832,Huh7.5.1,4.3±0.3,μM,Virus entry,Pseudoviral particle infection assay,22378192,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W.",Hepatology. 2012
AVP1176,FILAFLGWIGAIVSTALP,18,Hepatitis C virus,HCV,Flaviviridae,CL58.3,Human claudin-1 (CLDN1),O95832,Huh7.5.1,8.9±1.0,μM,Virus entry,Pseudoviral particle infection assay,22378192,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W.",Hepatology. 2012
AVP1177,AFLGWIGAIVSTALPQWR,18,Hepatitis C virus,HCV,Flaviviridae,CL58.4,Human claudin-1 (CLDN1),O95832,Huh7.5.1,12.5±1.5,μM,Virus entry,Pseudoviral particle infection assay,22378192,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W.",Hepatology. 2012
AVP1178,GWIGAIVSTALPQWRIYS,18,Hepatitis C virus,HCV,Flaviviridae,CL58.5,Human claudin-1 (CLDN1),O95832,Huh7.5.1,21.5±1.9,μM,Virus entry,Pseudoviral particle infection assay,22378192,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W.",Hepatology. 2012
AVP1179,GAIVSTALPQWRIYSYAG,18,Hepatitis C virus,HCV,Flaviviridae,CL58.6,Human claudin-1 (CLDN1),O95832,Huh7.5.1,23.8±2.1,μM,Virus entry,Pseudoviral particle infection assay,22378192,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W.",Hepatology. 2012
AVP1180,VSTALPQWRIYSYAGDNI,18,Hepatitis C virus,HCV,Flaviviridae,CL58.7,Human claudin-1 (CLDN1),O95832,Huh7.5.1,>25,μM,Virus entry,Pseudoviral particle infection assay,22378192,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W.",Hepatology. 2012
AVP1181,ALPQWRIYSYAGDNIVTA,18,Hepatitis C virus,HCV,Flaviviridae,CL58.8,Human claudin-1 (CLDN1),O95832,Huh7.5.1,>25,μM,Virus entry,Pseudoviral particle infection assay,22378192,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W.",Hepatology. 2012
AVP1182,MANAGLQLLGFILA,14,Hepatitis C virus,HCV,Flaviviridae,CL58-4,Human claudin-1 (CLDN1),O95832,Huh7.5.1,>25,μM,Virus entry,Pseudoviral particle infection assay,22378192,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W.",Hepatology. 2012
AVP1183,MANAGLQLLGFILAFL,16,Hepatitis C virus,HCV,Flaviviridae,CL58-2,Human claudin-1 (CLDN1),O95832,Huh7.5.1,7.6±0.9,μM,Virus entry,Pseudoviral particle infection assay,22378192,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W.",Hepatology. 2012
AVP1184,MANAGLQLLGFILAFLGWIG,20,Hepatitis C virus,HCV,Flaviviridae,CL58+2,Human claudin-1 (CLDN1),O95832,Huh7.5.1,17.8±1.1,μM,Virus entry,Pseudoviral particle infection assay,22378192,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W.",Hepatology. 2012
AVP1185,MANAGLQLLGFILAFLGWIGAI,22,Hepatitis C virus,HCV,Flaviviridae,CL58+4,Human claudin-1 (CLDN1),O95832,Huh7.5.1,4.0±0.3,μM,Virus entry,Pseudoviral particle infection assay,22378192,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W.",Hepatology. 2012
AVP1186,MANAGLQLLGFILAFLGWIGAIVS,24,Hepatitis C virus,HCV,Flaviviridae,CL58+6,Human claudin-1 (CLDN1),O95832,Huh7.5.1,5.1±0.6,μM,Virus entry,Pseudoviral particle infection assay,22378192,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W.",Hepatology. 2012
AVP1188,AGALMFAWLLLGLQGIFN,18,Hepatitis C virus,HCV,Flaviviridae,CL58.S,Human claudin-1 (CLDN1),O95832,Huh7.5.1,>25,μM,Virus entry,Pseudoviral particle infection assay,22378192,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W.",Hepatology. 2012
AVP1189,MASAGMQILGVVLTLLGW,18,Hepatitis C virus,HCV,Flaviviridae,CL-6,Human claudin-6 (CLDN6),P56747,Huh7.5.1,>25,μM,Virus entry,Pseudoviral particle infection assay,22378192,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W.",Hepatology. 2012
AVP1190,MANSGLQLLGFSMALLGW,18,Hepatitis C virus,HCV,Flaviviridae,CL-7,Human claudin-7 (CLDN7),Q3B794,Huh7.5.1,>25,μM,Virus entry,Pseudoviral particle infection assay,22378192,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W.",Hepatology. 2012
AVP1191,MASTGLELLGMTLAVLGW,18,Hepatitis C virus,HCV,Flaviviridae,CL-9,Human claudin-9 (CLDN9),O95484,Huh7.5.1,>25,μM,Virus entry,Pseudoviral particle infection assay,22378192,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W.",Hepatology. 2012
AVP1192,ATSSANSKA,9,Japanese encephalitis virus,JEV,Flaviviridae,Loop3,JEV envelope protein domain iii (EDIII),P14403,BHK-21,10,μM,Virus entry,Plaque assay,22465300,Inhibition of Japanese encephalitis virus entry into the cells by the envelope glycoprotein domain III (EDIII) and the loop3 peptide derived from EDIII.,"Li C, Zhang LY, Sun MX, Li PP, Huang L, Wei JC, Yao YL, Isahg H, Chen PY, Mao X.",Antiviral Res. 2012
AVP1193,GMCTEKFY,8,Japanese encephalitis virus,JEV,Flaviviridae,Loop1,JEV envelope protein domain iii (EDIII),P14403,BHK-21,20,%,Virus entry,Plaque assay,22465300,Inhibition of Japanese encephalitis virus entry into the cells by the envelope glycoprotein domain III (EDIII) and the loop3 peptide derived from EDIII.,"Li C, Zhang LY, Sun MX, Li PP, Huang L, Wei JC, Yao YL, Isahg H, Chen PY, Mao X.",Antiviral Res. 2012
AVP1194,SKHSSLDCVLRP,12,Influenza A virus,INFV A,Orthomyxoviridae,-,Bovine Lactoferrin,P24627,MDCK,4±0.37,EC50 (pM),Fusion,Hemagglutinin assay,22595270,Bovine lactoferrin-derived peptides as novel broad-spectrum inhibitors of influenza virus.,"Ammendolia MG, Agamennone M, Pietrantoni A, Lannutti F, Siciliano RA, De Giulio B, Amici C, Superti F.",Pathog Glob Health. 2012
AVP1195,AGDDQGLDKCVPNSKEK,18,Influenza A virus,INFV A,Orthomyxoviridae,-,Bovine Lactoferrin,P24627,MDCK,3.7±0.35,EC50 (pM),Fusion,Hemagglutinin assay,22595270,Bovine lactoferrin-derived peptides as novel broad-spectrum inhibitors of influenza virus.,"Ammendolia MG, Agamennone M, Pietrantoni A, Lannutti F, Siciliano RA, De Giulio B, Amici C, Superti F.",Pathog Glob Health. 2012
AVP1196,NGESSADWAKN,11,Influenza A virus,INFV A,Orthomyxoviridae,-,Bovine Lactoferrin,P24627,MDCK,225±1.16,EC50 (pM),Fusion,Hemagglutinin assay,22595270,Bovine lactoferrin-derived peptides as novel broad-spectrum inhibitors of influenza virus.,"Ammendolia MG, Agamennone M, Pietrantoni A, Lannutti F, Siciliano RA, De Giulio B, Amici C, Superti F.",Pathog Glob Health. 2012
AVP1197,VCYFMVFLQYGRKKRRQRR,20,Epstein-Barr virus,EBV,Herpesviridae,E1WT-TAT,EBNA1 Sequence peptide,Q9WC57,FE1-OF,High,-,Transcription,EMSA,22735264,Small molecule and peptide-mediated inhibition of Epstein-Barr virus nuclear antigen 1 dimerization.,"Kim SY, Song KA, Kieff E, Kang MS.",Biochem Biophys Res Commun. 2012
AVP1199,CGYKLC,6,Dengue 2 virus,DENV 2,Flaviviridae,MrIA-SL,Conotoxin,,-,16.7,μM,Replication,Flouroscence spectrtophotometery,22780881,Critical effect of peptide cyclization on the potency of peptide inhibitors against Dengue virus NS2B-NS3 protease.,"Xu S, Li H, Shao X, Fan C, Ericksen B, Liu J, Chi C, Wang C.",J Med Chem. 2012
AVP1200,CGYGLC,7,Dengue 2 virus,DENV 2,Flaviviridae,Inhibitor 1,Synthetic,,-,15.1,Ki (μM),Replication,Flouroscence spectrtophotometery,22780881,Critical effect of peptide cyclization on the potency of peptide inhibitors against Dengue virus NS2B-NS3 protease.,"Xu S, Li H, Shao X, Fan C, Ericksen B, Liu J, Chi C, Wang C.",J Med Chem. 2012
AVP1201,CGYGLC,6,Dengue 2 virus,DENV 2,Flaviviridae,Inhibitor 2,Synthetic,,-,>100,Ki (μM),Replication,Flouroscence spectrtophotometery,22780881,Critical effect of peptide cyclization on the potency of peptide inhibitors against Dengue virus NS2B-NS3 protease.,"Xu S, Li H, Shao X, Fan C, Ericksen B, Liu J, Chi C, Wang C.",J Med Chem. 2012
AVP1202,CGYKGC,6,Dengue 2 virus,DENV 2,Flaviviridae,Inhibitor 3,Synthetic,,-,12,Ki (μM),Replication,Flouroscence spectrtophotometery,22780881,Critical effect of peptide cyclization on the potency of peptide inhibitors against Dengue virus NS2B-NS3 protease.,"Xu S, Li H, Shao X, Fan C, Ericksen B, Liu J, Chi C, Wang C.",J Med Chem. 2012
AVP1203,CGYKRC,6,Dengue 2 virus,DENV 2,Flaviviridae,Inhibitor 4,Synthetic,,-,5,Ki (μM),Replication,Flouroscence spectrtophotometery,22780881,Critical effect of peptide cyclization on the potency of peptide inhibitors against Dengue virus NS2B-NS3 protease.,"Xu S, Li H, Shao X, Fan C, Ericksen B, Liu J, Chi C, Wang C.",J Med Chem. 2012
AVP1204,CGKRRC,6,Dengue 2 virus,DENV 2,Flaviviridae,Inhibitor 5,Synthetic,,-,3.5,Ki (μM),Replication,Flouroscence spectrtophotometery,22780881,Critical effect of peptide cyclization on the potency of peptide inhibitors against Dengue virus NS2B-NS3 protease.,"Xu S, Li H, Shao X, Fan C, Ericksen B, Liu J, Chi C, Wang C.",J Med Chem. 2012
AVP1205,CGKRKLC,7,Dengue 2 virus,DENV 2,Flaviviridae,Inhibitor 6,Synthetic,,-,6.7,μM,Replication,Flouroscence spectrtophotometery,22780881,Critical effect of peptide cyclization on the potency of peptide inhibitors against Dengue virus NS2B-NS3 protease.,"Xu S, Li H, Shao X, Fan C, Ericksen B, Liu J, Chi C, Wang C.",J Med Chem. 2012
AVP1206,CGKRKSC,9,Dengue 2 virus,DENV 2,Flaviviridae,Inhibitor 7,Synthetic,,-,3.3,μM,Replication,Flouroscence spectrtophotometery,22780881,Critical effect of peptide cyclization on the potency of peptide inhibitors against Dengue virus NS2B-NS3 protease.,"Xu S, Li H, Shao X, Fan C, Ericksen B, Liu J, Chi C, Wang C.",J Med Chem. 2012
AVP1207,AGKRKSG,8,Dengue 2 virus,DENV 2,Flaviviridae,Inhibitor 8,Synthetic,,-,16.7,μM,Replication,Flouroscence spectrtophotometery,22780881,Critical effect of peptide cyclization on the potency of peptide inhibitors against Dengue virus NS2B-NS3 protease.,"Xu S, Li H, Shao X, Fan C, Ericksen B, Liu J, Chi C, Wang C.",J Med Chem. 2012
AVP1208,CAGKRKSG,12,Dengue 2 virus,DENV 2,Flaviviridae,Inhibitor 9,Synthetic,,-,6.7,μM,Replication,Flouroscence spectrtophotometery,22780881,Critical effect of peptide cyclization on the potency of peptide inhibitors against Dengue virus NS2B-NS3 protease.,"Xu S, Li H, Shao X, Fan C, Ericksen B, Liu J, Chi C, Wang C.",J Med Chem. 2012
AVP1210,ASLRVRIKK,9,Respiratory syncytial virus,RSV,Paramyxoviridae,SB105-A10,Synthetic,,A549,0.25,μM,Virus entry,Plaque assay,22850525,Inhibition of human respiratory syncytial virus infectivity by a dendrimeric heparan sulfate-binding peptide.,"Donalisio M, Rusnati M, Cagno V, Civra A, Bugatti A, Giuliani A, Pirri G, Volante M, Papotti M, Landolfo S, Lembo D.",Antimicrob Agents Chemother. 2012
AVP1211,GELGRLVYLLDGPGYDPIHCSLAYGDASTLVVF,33,Hepatitis C virus,HCV,Flaviviridae,K5-66,Synthetic,,E. coli,20.7±3.6,nM,Replication,FRET assay,22965230,High affinity peptide inhibitors of the hepatitis C virus NS3-4A protease refractory to common resistant mutants.,"Kugler J, Schmelz S, Gentzsch J, Haid S, Pollmann E, van den Heuvel J, Franke R, Pietschmann T, Heinz DW, Collins J.",J Biol Chem. 2012
AVP1212,GELGRLVYLLDGPGYDPI,18,Hepatitis C virus,HCV,Flaviviridae,K5-66-A,Synthetic,,E. coli,125.4,nM,Replication,FRET assay,22965230,High affinity peptide inhibitors of the hepatitis C virus NS3-4A protease refractory to common resistant mutants.,"Kugler J, Schmelz S, Gentzsch J, Haid S, Pollmann E, van den Heuvel J, Franke R, Pietschmann T, Heinz DW, Collins J.",J Biol Chem. 2012
AVP1213,HCSLAYGDASTLVVF,15,Hepatitis C virus,HCV,Flaviviridae,K5-66-B,Synthetic,,E. coli,>>1,nM,Replication,FRET assay,22965230,High affinity peptide inhibitors of the hepatitis C virus NS3-4A protease refractory to common resistant mutants.,"Kugler J, Schmelz S, Gentzsch J, Haid S, Pollmann E, van den Heuvel J, Franke R, Pietschmann T, Heinz DW, Collins J.",J Biol Chem. 2012
AVP1214,GELGRPVYVLGDPGYYATHCIYATTNDALIFSV,33,Hepatitis C virus,HCV,Flaviviridae,K6-10,Synthetic,,E. coli,25.6±3.5,nM,Replication,FRET assay,22965230,High affinity peptide inhibitors of the hepatitis C virus NS3-4A protease refractory to common resistant mutants.,"Kugler J, Schmelz S, Gentzsch J, Haid S, Pollmann E, van den Heuvel J, Franke R, Pietschmann T, Heinz DW, Collins J.",J Biol Chem. 2012
AVP1215,GELGRPVYVLGDPGYYAT,18,Hepatitis C virus,HCV,Flaviviridae,K6-10-A,Synthetic,,E. coli,227.6,nM,Replication,FRET assay,22965230,High affinity peptide inhibitors of the hepatitis C virus NS3-4A protease refractory to common resistant mutants.,"Kugler J, Schmelz S, Gentzsch J, Haid S, Pollmann E, van den Heuvel J, Franke R, Pietschmann T, Heinz DW, Collins J.",J Biol Chem. 2012
AVP1216,HCIYATTNDALIFSV,15,Hepatitis C virus,HCV,Flaviviridae,K6-10-B,Synthetic,,E. coli,>>1,nM,Replication,FRET assay,22965230,High affinity peptide inhibitors of the hepatitis C virus NS3-4A protease refractory to common resistant mutants.,"Kugler J, Schmelz S, Gentzsch J, Haid S, Pollmann E, van den Heuvel J, Franke R, Pietschmann T, Heinz DW, Collins J.",J Biol Chem. 2012
AVP1217,GELGRIPSDTYDLAVGALHCPFYLVSGLVYLDG,33,Hepatitis C virus,HCV,Flaviviridae,K5-66-R,Synthetic,,E. coli,>>1,nM,Replication,FRET assay,22965230,High affinity peptide inhibitors of the hepatitis C virus NS3-4A protease refractory to common resistant mutants.,"Kugler J, Schmelz S, Gentzsch J, Haid S, Pollmann E, van den Heuvel J, Franke R, Pietschmann T, Heinz DW, Collins J.",J Biol Chem. 2012
AVP1218,GELGRLVYLLDGPGYDPIHCDVVTRGGSHLFNF,33,Hepatitis C virus,HCV,Flaviviridae,CP5-46,Synthetic,,E. coli,11.3±1.6,nM,Replication,FRET assay,22965230,High affinity peptide inhibitors of the hepatitis C virus NS3-4A protease refractory to common resistant mutants.,"Kugler J, Schmelz S, Gentzsch J, Haid S, Pollmann E, van den Heuvel J, Franke R, Pietschmann T, Heinz DW, Collins J.",J Biol Chem. 2012
AVP1219,GELDELVYLLDGPGYDPIHCDVVTRGGSRLFNF,33,Hepatitis C virus,HCV,Flaviviridae,CP5-46-4D5E,Synthetic,,E. coli,1.14±0.053,nM,Replication,FRET assay,22965230,High affinity peptide inhibitors of the hepatitis C virus NS3-4A protease refractory to common resistant mutants.,"Kugler J, Schmelz S, Gentzsch J, Haid S, Pollmann E, van den Heuvel J, Franke R, Pietschmann T, Heinz DW, Collins J.",J Biol Chem. 2012
AVP1220,GELGRLVYLLDGPGYDPIHCD,21,Hepatitis C virus,HCV,Flaviviridae,CP5-46-A,Synthetic,,E. coli,124,nM,Replication,FRET assay,22965230,High affinity peptide inhibitors of the hepatitis C virus NS3-4A protease refractory to common resistant mutants.,"Kugler J, Schmelz S, Gentzsch J, Haid S, Pollmann E, van den Heuvel J, Franke R, Pietschmann T, Heinz DW, Collins J.",J Biol Chem. 2012
AVP1221,GELDELVYLLDGPGYDPIHS,20,Hepatitis C virus,HCV,Flaviviridae,CP5-46A-4D5E,Synthetic,,E. coli,22.8,nM,Replication,FRET assay,22965230,High affinity peptide inhibitors of the hepatitis C virus NS3-4A protease refractory to common resistant mutants.,"Kugler J, Schmelz S, Gentzsch J, Haid S, Pollmann E, van den Heuvel J, Franke R, Pietschmann T, Heinz DW, Collins J.",J Biol Chem. 2012
AVP1222,RQIKINFQNRRMKNKKGELDELVYLLDGPGYDPIHS,36,Hepatitis C virus,HCV,Flaviviridae,Ant-CP5-46A-4D5E,Synthetic,,E. coli,23.6,nM,Replication,FRET assay,22965230,High affinity peptide inhibitors of the hepatitis C virus NS3-4A protease refractory to common resistant mutants.,"Kugler J, Schmelz S, Gentzsch J, Haid S, Pollmann E, van den Heuvel J, Franke R, Pietschmann T, Heinz DW, Collins J.",J Biol Chem. 2012
AVP1223,LLDCWVRLGRYLLRRLKT,18,Hepatitis C virus,HCV,Flaviviridae,GBVA1,GBVA non-structutal protein 5A,Q69422,Huh7.5.1,10,μM,Virus entry,RT PCR,23175359,Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",J Virol. 2013
AVP1224,LLDCWVRLGRYLLRRLKTPFTRL,23,Hepatitis C virus,HCV,Flaviviridae,GBVA2,GBVA non-structutal protein 5A,Q69422,Huh7.5.1,15,μM,Virus entry,RT PCR,23175359,Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",J Virol. 2013
AVP1225,LLDCWVRLGRYLLRRLKTPFT,21,Hepatitis C virus,HCV,Flaviviridae,GBVA3,GBVA non-structutal protein 5A,Q69422,Huh7.5.1,>20,μM,Virus entry,RT PCR,23175359,Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",J Virol. 2013
AVP1226,LLDCWVRLGRYLLRRLKTP,19,Hepatitis C virus,HCV,Flaviviridae,GBVA4,GBVA non-structutal protein 5A,Q69422,Huh7.5.1,3,μM,Virus entry,RT PCR,23175359,Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",J Virol. 2013
AVP1227,LLDCWVRLGRYLLRRLK,17,Hepatitis C virus,HCV,Flaviviridae,GBVA5,GBVA non-structutal protein 5A,Q69422,Huh7.5.1,5,μM,Virus entry,RT PCR,23175359,Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",J Virol. 2013
AVP1228,LDCWVRLGRYLLRRLKTPFTRL,22,Hepatitis C virus,HCV,Flaviviridae,GBVA6,GBVA non-structutal protein 5A,Q69422,Huh7.5.1,>20,μM,Virus entry,RT PCR,23175359,Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",J Virol. 2013
AVP1229,CWVRLGRYLLRRLKTPFTRL,20,Hepatitis C virus,HCV,Flaviviridae,GBVA7,GBVA non-structutal protein 5A,Q69422,Huh7.5.1,12,μM,Virus entry,RT PCR,23175359,Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",J Virol. 2013
AVP1230,LDCWVRLGRYLLRRLKTP,18,Hepatitis C virus,HCV,Flaviviridae,GBVA8,GBVA non-structutal protein 5A,Q69422,Huh7.5.1,4,μM,Virus entry,RT PCR,23175359,Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",J Virol. 2013
AVP1231,DCWVRLGRYLLRRLKTPF,18,Hepatitis C virus,HCV,Flaviviridae,GBVA9,GBVA non-structutal protein 5A,Q69422,Huh7.5.1,12,μM,Virus entry,RT PCR,23175359,Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",J Virol. 2013
AVP1232,CWVRLGRYLLRRLKTPFT,18,Hepatitis C virus,HCV,Flaviviridae,GBVA10,GBVA non-structutal protein 5A,Q69422,Huh7.5.1,2,μM,Virus entry,RT PCR,23175359,Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",J Virol. 2013
AVP1233,WVRLGRYLLRRLKTPFTR,18,Hepatitis C virus,HCV,Flaviviridae,GBVA11,GBVA non-structutal protein 5A,Q69422,Huh7.5.1,12,μM,Virus entry,RT PCR,23175359,Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",J Virol. 2013
AVP1234,VRLGRYLLRRLKTPFTRL,18,Hepatitis C virus,HCV,Flaviviridae,GBVA12,GBVA non-structutal protein 5A,Q69422,Huh7.5.1,>20,μM,Virus entry,RT PCR,23175359,Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",J Virol. 2013
AVP1235,MAILGDTAWDFGSLGGVFTSIGKALHQVFGAIY,33,Dengue 2 virus,DENV 2,Flaviviridae,DN59,DENV envelope glycoprotein (gpE),P29984,LLC-MK2,2to5,μM,Virucidal,Focus reduction assay,23226444,Release of dengue virus genome induced by a peptide inhibitor.,"Lok SM, Costin JM, Hrobowski YM, Hoffmann AR, Rowe DK, Kukkaro P, Holdaway H, Chipman P, Fontaine KA, Holbrook MR, Garry RF, Kostyuchenko V, Wimley WC, Isern S, Rossmann MG, Michael SF.",PLoS One. 2012
AVP1236,ESGRIKKEEFAEIMKICSTIEELRRQK,27,Influenza A virus,INFV A,Orthomyxoviridae,PB1731-757,INFV-A Rna dependent RNA polymerase (PB1 subunit),Q2LFH3,HEK293T,High,-,Replication,Fluorescence assay,23279951,A peptide derived from the C-terminus of PB1 inhibits influenza virus replication by interfering with viral polymerase assembly.,"Li C, Ba Q, Wu A, Zhang H, Deng T, Jiang T.",FEBS J. 2013
AVP1237,KYKETDL,7,Hepatitis C virus,HCV,Flaviviridae,LaR2C-N7,Human lupus autoantigen protein,P05455,Huh7,High,-,Translation,RT PCR,23291201,A cyclic peptide mimic of an RNA recognition motif of human La protein is a potent inhibitor of hepatitis C virus.,"Manna AK, Kumar A, Ray U, Das S, Basu G, Roy S.",Antiviral Res. 2013
AVP1238,GIGKFLHSAKKFGKAFVGEIMNS,23,Herpes simplex virus 1,HSV 1,Herpesviridae,Magainin,Magainin,P11006,Vero,High,-,Virucidal,Viral titer,23389903,Peptide inhibitors against herpes simplex virus infections.,"Galdiero S, Falanga A, Tarallo R, Russo L, Galdiero E, Cantisani M, Morelli G, Galdiero M.",J Pept Sci. 2013
AVP1239,ALWMTLLKKVLKAAAKALNAVLVGANA,27,Herpes simplex virus 1,HSV 1,Herpesviridae,Dermaseptin,Dermaseptin,P80280,Vero,High,-,Virus entry,Viral titer,23389903,Peptide inhibitors against herpes simplex virus infections.,"Galdiero S, Falanga A, Tarallo R, Russo L, Galdiero E, Cantisani M, Morelli G, Galdiero M.",J Pept Sci. 2013
AVP1240,GIGAVLKVLTTGLPALISWIKRKRQQ,26,Herpes simplex virus 1,HSV 1,Herpesviridae,Melittin,Melittin,P01501,Vero,High,-,Virus entry,Viral titer,23389903,Peptide inhibitors against herpes simplex virus infections.,"Galdiero S, Falanga A, Tarallo R, Russo L, Galdiero E, Cantisani M, Morelli G, Galdiero M.",J Pept Sci. 2013
AVP1241,DHYNCVSSGGQCLYSACPIFTKIQGTCYRGKAKCCK,36,Herpes simplex virus 1,HSV 1,Herpesviridae,Defensin (hBD-1),Human beta defensin,P60022,Vero,High,-,Virus entry,Viral titer,23389903,Peptide inhibitors against herpes simplex virus infections.,"Galdiero S, Falanga A, Tarallo R, Russo L, Galdiero E, Cantisani M, Morelli G, Galdiero M.",J Pept Sci. 2013
AVP1242,FKCRRWQWRMKKLGAPSITCVRRAF,25,Herpes simplex virus 1,HSV 1,Herpesviridae,Lactoferricin,Bovine Lactoferrin,P24627,Vero,High,-,Virus entry,Viral titer,23389903,Peptide inhibitors against herpes simplex virus infections.,"Galdiero S, Falanga A, Tarallo R, Russo L, Galdiero E, Cantisani M, Morelli G, Galdiero M.",J Pept Sci. 2013
AVP1243,KWCFRVCYRGICYRRCR,17,Herpes simplex virus 1,HSV 1,Herpesviridae,Tachyplesin,Tachyplesin,P14213,Vero,High,-,Virucidal,Viral titer,23389903,Peptide inhibitors against herpes simplex virus infections.,"Galdiero S, Falanga A, Tarallo R, Russo L, Galdiero E, Cantisani M, Morelli G, Galdiero M.",J Pept Sci. 2013
AVP1244,GCASRCKAKCAGRRCKGWASAFRGRCYCKCFRC,33,Herpes simplex virus 1,HSV 1,Herpesviridae,Mytilin-A,Mytilin-A,P81612,Vero,High,-,Virus entry,Viral titer,23389903,Peptide inhibitors against herpes simplex virus infections.,"Galdiero S, Falanga A, Tarallo R, Russo L, Galdiero E, Cantisani M, Morelli G, Galdiero M.",J Pept Sci. 2013
AVP1245,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,37,Herpes simplex virus 1,HSV 1,Herpesviridae,Cathelicidin (LL-37),Human cathelicidin,P49913,Vero,High,-,Virucidal,Viral titer,23389903,Peptide inhibitors against herpes simplex virus infections.,"Galdiero S, Falanga A, Tarallo R, Russo L, Galdiero E, Cantisani M, Morelli G, Galdiero M.",J Pept Sci. 2013
AVP1246,FLPVLAGIAAKVVPALFCKITKKC,24,Herpes simplex virus 1,HSV 1,Herpesviridae,Brevinin-1,Brevinin-1,P32423,Vero,High,-,Virucidal,Viral titer,23389903,Peptide inhibitors against herpes simplex virus infections.,"Galdiero S, Falanga A, Tarallo R, Russo L, Galdiero E, Cantisani M, Morelli G, Galdiero M.",J Pept Sci. 2013
AVP1247,ILPWKWPWWPWRR,13,Herpes simplex virus 1,HSV 1,Herpesviridae,Indolicidin,Indolicidin,P33046,Vero,High,-,Virucidal on progeny virions,Viral titer,23389903,Peptide inhibitors against herpes simplex virus infections.,"Galdiero S, Falanga A, Tarallo R, Russo L, Galdiero E, Cantisani M, Morelli G, Galdiero M.",J Pept Sci. 2013
AVP1248,KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK,37,Herpes simplex virus 1,HSV 1,Herpesviridae,Cecropin,Cecropin,P01507,Vero,High,-,Virus entry,Viral titer,23389903,Peptide inhibitors against herpes simplex virus infections.,"Galdiero S, Falanga A, Tarallo R, Russo L, Galdiero E, Cantisani M, Morelli G, Galdiero M.",J Pept Sci. 2013
AVP1249,QVYKGGYTRPIPRPPPFVRPLPGGPIGPYNGCPVSSCRGISFSQARSCCSRLGRCCHVGKGYS,63,Herpes simplex virus 1,HSV 1,Herpesviridae,Penaeidin-3a,Penaeidin-3a,P81058,Vero,High,-,Virus entry,Viral titer,23389903,Peptide inhibitors against herpes simplex virus infections.,"Galdiero S, Falanga A, Tarallo R, Russo L, Galdiero E, Cantisani M, Morelli G, Galdiero M.",J Pept Sci. 2013
AVP1250,HGLASTLTRWAHYNALIRAF,20,Herpes simplex virus 1,HSV 1,Herpesviridae,gH625,HSV-1 H glycoprotein (gH),Q9DHD5,Vero,100,nM,Virus entry,Plaque assay,23429490,Dendrimers functionalized with membrane-interacting peptides for viral inhibition.,"Tarallo R, Carberry TP, Falanga A, Vitiello M, Galdiero S, Galdiero M, Weck M.",Int J Nanomedicine. 2013
AVP1251,YPYYPGEARGAP,12,Herpes simplex virus 1,HSV 1,Herpesviridae,Scaffold Peptide,HSV Capsid scaffolding protein,P10210,CV1,1000,fold,Replication,Viral titer,23576509,A herpes simplex virus scaffold Peptide that binds the portal vertex inhibits early steps in viral replication.,"Yang K, Wills E, Baines JD.",J Virol. 2013
AVP1252,GWVKPAKLDG,10,Dengue 2 virus,DENV 2,Flaviviridae,DET1,Synthetic,,LLC-MK2,0,%,Virus entry,Plaque assay,23630436,Inhibition of dengue virus entry into target cells using synthetic antiviral peptides.,"Alhoot MA, Rathinam AK, Wang SM, Manikam R, Sekaran SD.",Int J Med Sci. 2013
AVP1253,PWLKPGDLDL,10,Dengue 2 virus,DENV 2,Flaviviridae,DET2,Synthetic,,LLC-MK2,40.6,%,Virus entry,Plaque assay,23630436,Inhibition of dengue virus entry into target cells using synthetic antiviral peptides.,"Alhoot MA, Rathinam AK, Wang SM, Manikam R, Sekaran SD.",Int J Med Sci. 2013
AVP1254,IGVRPGKLDL,10,Dengue 2 virus,DENV 2,Flaviviridae,DET3,Synthetic,,LLC-MK2,0,%,Virus entry,Plaque assay,23630436,Inhibition of dengue virus entry into target cells using synthetic antiviral peptides.,"Alhoot MA, Rathinam AK, Wang SM, Manikam R, Sekaran SD.",Int J Med Sci. 2013
AVP1255,AGVKDGKLDF,10,Dengue 2 virus,DENV 2,Flaviviridae,DET4,Synthetic,,LLC-MK2,84.6,%,Virus entry,Plaque assay,23630436,Inhibition of dengue virus entry into target cells using synthetic antiviral peptides.,"Alhoot MA, Rathinam AK, Wang SM, Manikam R, Sekaran SD.",Int J Med Sci. 2013
AVP1256,YTPNITLNNSVALDPIDISIELNKAKSDLEESKE,34,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-189,HPIV3 fusion (F) protein,P06828,Vero,Nil,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1257,TPNITLNNSVALDPIDISIELNKAKSDLEESKEW,34,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-190,HPIV3 fusion (F) protein,P06828,Vero,Nil,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1258,PNITLNNSVALDPIDISIELNKAKSDLEESKEWI,34,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-191,HPIV3 fusion (F) protein,P06828,Vero,Nil,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1259,NITLNNSVALDPIDISIELNKAKSDLEESKEWIR,34,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-192,HPIV3 fusion (F) protein,P06828,Vero,Nil,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1260,ITLNNSVALDPIDISIELNKAKSDLEESKEWIRR,34,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-193,HPIV3 fusion (F) protein,P06828,Vero,Nil,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1261,TLNNSVALDPIDISIELNKAKSDLEESKEWIRRS,34,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-194,HPIV3 fusion (F) protein,P06828,Vero,Low,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1262,LNNSVALDPIDISIELNKAKSDLEESKEWIRRSN,34,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-195,HPIV3 fusion (F) protein,P06828,Vero,Low,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1263,NNSVALDPIDISIELNKAKSDLEESKEWIRRSNQ,34,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-196,HPIV3 fusion (F) protein,P06828,Vero,Low,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1264,NSVALDPIDISIELNKAKSDLEESKEWIRRSNQK,34,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-197,HPIV3 fusion (F) protein,P06828,Vero,Low,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1265,SVALDPIDISIELNKAKSDLEESKEWIRRSNQKL,34,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-198,HPIV3 fusion (F) protein,P06828,Vero,High,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1266,VALDPIDISIELNKAKSDLEESKEWIRRSNQKLD,34,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-199,HPIV3 fusion (F) protein,P06828,Vero,High,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1267,ALDPIDISIELNKAKSDLEESKEWIRRSNQKLDS,34,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-200,HPIV3 fusion (F) protein,P06828,Vero,Nil,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1268,LDPIDISIELNKAKSDLEESKEWIRRSNQKLDSI,34,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-201,HPIV3 fusion (F) protein,P06828,Vero,High,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1269,DPIDISIELNKAKSDLEESKEWIRRSNQKLDSIG,34,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-202,HPIV3 fusion (F) protein,P06828,Vero,High,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1270,PIDISIELNKAKSDLEESKEWIRRSNQKLDSIGN,34,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-203,HPIV3 fusion (F) protein,P06828,Vero,High,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1271,IDISIELNKAKSDLEESKEWIRRSNQKLDSIGNW,34,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-204,HPIV3 fusion (F) protein,P06828,Vero,High,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1272,DISIELNKAKSDLEESKEWIRRSNQKLDSIGNWH,34,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-205,HPIV3 fusion (F) protein,P06828,Vero,High,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1273,ISIELNKAKSDLEESKEWIRRSNQKLDSIGNWHQ,34,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-206,HPIV3 fusion (F) protein,P06828,Vero,Medium,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1274,SIELNKAKSDLEESKEWIRRSNQKLDSIGNWHQS,34,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-207,HPIV3 fusion (F) protein,P06828,Vero,Medium,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1275,IELNKAKSDLEESKEWIRRSNQKLDSIGNWHQSS,34,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-208,HPIV3 fusion (F) protein,P06828,Vero,Medium,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1276,ELNKAKSDLEESKEWIRRSNQKLDSIGNWHQSST,34,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-209,HPIV3 fusion (F) protein,P06828,Vero,High,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1277,LNKAKSDLEESKEWIRRSNQKLDSIGNWHQSSTT,34,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-210,HPIV3 fusion (F) protein,P06828,Vero,High,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1278,ALGVATSAQITAAVALVEAKQARSDIEKLKEAIRD,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-157,HPIV3 fusion (F) protein,P06828,Vero,Medium,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1279,LGVATSAQITAAVALVEAKQARSDIEKLKEAIRDT,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-158,HPIV3 fusion (F) protein,P06828,Vero,Medium,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1280,GVATSAQITAAVALVEAKQARSDIEKLKEAIRDTN,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-159,HPIV3 fusion (F) protein,P06828,Vero,Low,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1281,VATSAQITAAVALVEAKQARSDIEKLKEAIRDTNK,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-160,HPIV3 fusion (F) protein,P06828,Vero,Medium,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1282,ATSAQITAAVALVEAKQARSDIEKLKEAIRDTNKA,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-161,HPIV3 fusion (F) protein,P06828,Vero,Medium,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1283,TSAQITAAVALVEAKQARSDIEKLKEAIRDTNKAV,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-162,HPIV3 fusion (F) protein,P06828,Vero,Low,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1284,SAQITAAVALVEAKQARSDIEKLKEAIRDTNKAVQ,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-163,HPIV3 fusion (F) protein,P06828,Vero,Medium,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1285,AQITAAVALVEAKQARSDIEKLKEAIRDTNKAVQS,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-164,HPIV3 fusion (F) protein,P06828,Vero,High,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1286,QITAAVALVEAKQARSDIEKLKEAIRDTNKAVQSV,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-165,HPIV3 fusion (F) protein,P06828,Vero,Medium,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1287,ITAAVALVEAKQARSDIEKLKEAIRDTNKAVQSVQ,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-166,HPIV3 fusion (F) protein,P06828,Vero,Low,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1288,TAAVALVEAKQARSDIEKLKEAIRDTNKAVQSVQS,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-167,HPIV3 fusion (F) protein,P06828,Vero,Low,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1289,AAVALVEAKQARSDIEKLKEAIRDTNKAVQSVQSS,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-168,HPIV3 fusion (F) protein,P06828,Vero,Low,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1290,AVALVEAKQARSDIEKLKEAIRDTNKAVQSVQSSI,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-169,HPIV3 fusion (F) protein,P06828,Vero,Low,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1291,VALVEAKQARSDIEKLKEAIRDTNKAVQSVQSSIG,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-170,HPIV3 fusion (F) protein,P06828,Vero,Low,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1292,ALVEAKQARSDIEKLKEAIRDTNKAVQSVQSSIGN,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-171,HPIV3 fusion (F) protein,P06828,Vero,Low,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1293,LVEAKQARSDIEKLKEAIRDTNKAVQSVQSSIGNL,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-172,HPIV3 fusion (F) protein,P06828,Vero,Low,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1294,VEAKQARSDIEKLKEAIRDTNKAVQSVQSSIGNLI,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-173,HPIV3 fusion (F) protein,P06828,Vero,Low,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1295,EAKQARSDIEKLKEAIRDTNKAVQSVQSSIGNLIV,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-174,HPIV3 fusion (F) protein,P06828,Vero,High,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1296,KQARSDIEKLKEAIRDTNKAVQSVQSSIGNLIVAI,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-175,HPIV3 fusion (F) protein,P06828,Vero,High,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1297,QARSDIEKLKEAIRDTNKAVQSVQSSIGNLIVAIK,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-176,HPIV3 fusion (F) protein,P06828,Vero,High,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1298,ARSDIEKLKEAIRDTNKAVQSVQSSIGNLIVAIKS,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-177,HPIV3 fusion (F) protein,P06828,Vero,Low,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1299,RSDIEKLKEAIRDTNKAVQSVQSSIGNLIVAIKSV,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-178,HPIV3 fusion (F) protein,P06828,Vero,Low,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1300,SDIEKLKEAIRDTNKAVQSVQSSIGNLIVAIKSVQ,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-179,HPIV3 fusion (F) protein,P06828,Vero,Nil,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1301,DIEKLKEAIRDTNKAVQSVQSSIGNLIVAIKSVQD,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-180,HPIV3 fusion (F) protein,P06828,Vero,Nil,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1302,IEKLKEAIRDTNKAVQSVQSSIGNLIVAIKSVQDY,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-181,HPIV3 fusion (F) protein,P06828,Vero,Nil,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1303,EKLKEAIRDTNKAVQSVQSSIGNLIVAIKSVQDYV,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-182,HPIV3 fusion (F) protein,P06828,Vero,Nil,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1304,KLKEAIRDTNKAVQSVQSSIGNLIVAIKSVQDYVN,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-183,HPIV3 fusion (F) protein,P06828,Vero,High,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1305,LKEAIRDTNKAVQSVQSSIGNLIVAIKSVQDYVNK,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-184,HPIV3 fusion (F) protein,P06828,Vero,High,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1306,KEAIRDTNKAVQSVQSSIGNLIVAIKSVQDYVNKE,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-185,HPIV3 fusion (F) protein,P06828,Vero,Nil,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1307,EAIRDTNKAVQSVQSSIGNLIVAIKSVQDYVNKEI,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-186,HPIV3 fusion (F) protein,P06828,Vero,Nil,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1308,AIRDTNKAVQSVQSSIGNLIVAIKSVQDYVNKEIV,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-187,HPIV3 fusion (F) protein,P06828,Vero,Nil,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1309,IRDTNKAVQSVQSSIGNLIVAIKSVQDYVNKEIVP,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,T-188,HPIV3 fusion (F) protein,P06828,Vero,Nil,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1310,YTSVITIELSNIKENKCNGTDAKVKLIKQELDKYK,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-142,RSV fusion (F) protein,P03420,Vero,Medium,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1311,TSVITIELSNIKENKCNGTDAKVKLIKQELDKYKN,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-143,RSV fusion (F) protein,P03420,Vero,High,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1312,SVITIELSNIKENKCNGTDAKVKLIKQELDKYKNA,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-144,RSV fusion (F) protein,P03420,Vero,Nil,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1313,VITIELSNIKENKCNGTDAKVKLIKQELDKYKNAV,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-145,RSV fusion (F) protein,P03420,Vero,Nil,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1314,ITIELSNIKENKCNGTDAKVKLIKQELDKYKNAVT,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-146,RSV fusion (F) protein,P03420,Vero,Nil,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1315,TIELSNIKENKCNGTDAKVKLIKQELDKYKNAVTE,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-147,RSV fusion (F) protein,P03420,Vero,Nil,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1316,IELSNIKENKCNGTDAKVKLIKQELDKYKNAVTEL,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-148,RSV fusion (F) protein,P03420,Vero,Nil,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1317,ELSNIKENKCNGTDAKVKLIKQELDKYKNAVTELQ,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-149,RSV fusion (F) protein,P03420,Vero,Nil,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1318,LSNIKENKCNGTDAKVKLIKQELDKYKNAVTELQL,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-150,RSV fusion (F) protein,P03420,Vero,Nil,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1319,SNIKENKCNGTDAKVKLIKQELDKYKNAVTELQLL,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-151,RSV fusion (F) protein,P03420,Vero,Nil,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1320,NIKENKCNGTDAKVKLIKQELDKYKNAVTELQLLM,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-152,RSV fusion (F) protein,P03420,Vero,Nil,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1321,IKENKCNGTDAKVKLIKQELDKYKNAVTELQLLMQ,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-153,RSV fusion (F) protein,P03420,Vero,Nil,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1322,KENKCNGTDAKVKLIKQELDKYKNAVTELQLLMQS,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-154,RSV fusion (F) protein,P03420,Vero,Nil,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1323,ENKCNGTDAKVKLIKQELDKYKNAVTELQLLMQST,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-155,RSV fusion (F) protein,P03420,Vero,Nil,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1324,IINFYDPLVFPSDEFDASISQVNEKINQSLAFIRK,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-104,RSV fusion (F) protein,P03420,Vero,Low,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1325,INFYDPLVFPSDEFDASISQVNEKINQSLAFIRKS,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-105,RSV fusion (F) protein,P03420,Vero,Low,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1326,NFYDPLVFPSDEFDASISQVNEKINQSLAFIRKSD,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-106,RSV fusion (F) protein,P03420,Vero,Low,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1327,FYDPLVFPSDEFDASISQVNEKINQSLAFIRKSDE,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-107,RSV fusion (F) protein,P03420,Vero,Medium,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1328,YDPLVFPSDEFDASISQVNEKINQSLAFIRKSDEL,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-108,RSV fusion (F) protein,P03420,Vero,High,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1329,DPLVFPSDEFDASISQVNEKINQSLAFIRKSDELL,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-109,RSV fusion (F) protein,P03420,Vero,High,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1330,PLVFPSDEFDASISQVNEKINQSLAFIRKSDELLH,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-110,RSV fusion (F) protein,P03420,Vero,Medium,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1331,LVFPSDEFDASISQVNEKINQSLAFIRKSDELLHN,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-111,RSV fusion (F) protein,P03420,Vero,High,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1332,VFPSDEFDASISQVNEKINQSLAFIRKSDELLHNV,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-112,RSV fusion (F) protein,P03420,Vero,High,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1333,FPSDEFDASISQVNEKINQSLAFIRKSDELLHNVN,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-113,RSV fusion (F) protein,P03420,Vero,High,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1334,PSDEFDASISQVNEKINQSLAFIRKSDELLHNVNA,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-114,RSV fusion (F) protein,P03420,Vero,High,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1335,SDEFDASISQVNEKINQSLAFIRKSDELLHNVNAG,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-115,RSV fusion (F) protein,P03420,Vero,High,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1336,DEFDASISQVNEKINQSLAFIRKSDELLHNVNAGK,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-116,RSV fusion (F) protein,P03420,Vero,High,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1337,EFDASISQVNEKINQSLAFIRKSDELLHNVNAGKS,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-117,RSV fusion (F) protein,P03420,Vero,High,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1338,FDASISQVNEKINQSLAFIRKSDELLHNVNAGKSI,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-118,RSV fusion (F) protein,P03420,Vero,High,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1339,DASISQVNEKINQSLAFIRKSDELLHNVNAGKSIT,35,Respiratory syncytial virus,RSV,Paramyxoviridae,T-119,RSV fusion (F) protein,P03420,Vero,High,-,Fusion,Immunoprecipitation,US6440656,Methods for the inhibition of respiratory syncytial virus transmission,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Shawn O'Lin Barney,Dennis Michael Lambert, Stephen Robert Petteway","Trimeris, Inc., Durham NC"
AVP1340,ADGALLGRMKGA,12,Hepatitis B virus,HBV,Hepadnaviridae,SEQ ID NO: 1,Synthetic,,HepG2,152±5,Kd Rel (nM),Viral assembly,Phage binding assay,US6544520,Hepatitis B virus inhibitors,"Kenneth Murray, Michael Richard Dyson","Biogen, Inc., Cambridge MA"
AVP1341,ADGALLGRMKPA,12,Hepatitis B virus,HBV,Hepadnaviridae,SEQ ID NO: 2,Synthetic,,HepG2,767±8,Kd Rel (nM),Viral assembly,Phage binding assay,US6544520,Hepatitis B virus inhibitors,"Kenneth Murray, Michael Richard Dyson","Biogen, Inc., Cambridge MA"
AVP1342,ADGSLLGRMKPA,12,Hepatitis B virus,HBV,Hepadnaviridae,SEQ ID NO: 3,Synthetic,,HepG2,322±50,Kd Rel (nM),Viral assembly,Phage binding assay,US6544520,Hepatitis B virus inhibitors,"Kenneth Murray, Michael Richard Dyson","Biogen, Inc., Cambridge MA"
AVP1343,ADGALLGRMKRA,12,Hepatitis B virus,HBV,Hepadnaviridae,SEQ ID NO: 4,Synthetic,,HepG2,181±12,Kd Rel (nM),Viral assembly,Phage binding assay,US6544520,Hepatitis B virus inhibitors,"Kenneth Murray, Michael Richard Dyson","Biogen, Inc., Cambridge MA"
AVP1344,ADGTLLGRMKLA,12,Hepatitis B virus,HBV,Hepadnaviridae,SEQ ID NO: 5,Synthetic,,HepG2,20±2,Kd Rel (nM),Viral assembly,Phage binding assay,US6544520,Hepatitis B virus inhibitors,"Kenneth Murray, Michael Richard Dyson","Biogen, Inc., Cambridge MA"
AVP1345,ADGSLLGRMKGA,12,Hepatitis B virus,HBV,Hepadnaviridae,SEQ ID NO: 6,Synthetic,,HepG2,1.7±0.3,Kd Rel (nM),Viral assembly,Phage binding assay,US6544520,Hepatitis B virus inhibitors,"Kenneth Murray, Michael Richard Dyson","Biogen, Inc., Cambridge MA"
AVP1346,ADRSLLGRMKGA,12,Hepatitis B virus,HBV,Hepadnaviridae,SEQ ID NO: 7,Synthetic,,HepG2,1.09±0.02,Kd Rel (nM),Viral assembly,Phage binding assay,US6544520,Hepatitis B virus inhibitors,"Kenneth Murray, Michael Richard Dyson","Biogen, Inc., Cambridge MA"
AVP1347,ADGSRSSLLGRMKGA,15,Hepatitis B virus,HBV,Hepadnaviridae,SEQ ID NO: 8,Synthetic,,HepG2,1.96±0.32,Kd Rel (nM),Viral assembly,Phage binding assay,US6544520,Hepatitis B virus inhibitors,"Kenneth Murray, Michael Richard Dyson","Biogen, Inc., Cambridge MA"
AVP1348,ADGAHSSLLGRMKGA,15,Hepatitis B virus,HBV,Hepadnaviridae,SEQ ID NO: 9,Synthetic,,HepG2,1.72±0.17,Kd Rel (nM),Viral assembly,Phage binding assay,US6544520,Hepatitis B virus inhibitors,"Kenneth Murray, Michael Richard Dyson","Biogen, Inc., Cambridge MA"
AVP1349,ADGHRSSLLGRMKGA,15,Hepatitis B virus,HBV,Hepadnaviridae,SEQ ID NO: 10,Synthetic,,HepG2,1.40±0.13,Kd Rel (nM),Viral assembly,Phage binding assay,US6544520,Hepatitis B virus inhibitors,"Kenneth Murray, Michael Richard Dyson","Biogen, Inc., Cambridge MA"
AVP1350,ADGPRSSLLGRMKGA,15,Hepatitis B virus,HBV,Hepadnaviridae,SEQ ID NO: 11,Synthetic,,HepG2,0.84±0.07,Kd Rel (nM),Viral assembly,Phage binding assay,US6544520,Hepatitis B virus inhibitors,"Kenneth Murray, Michael Richard Dyson","Biogen, Inc., Cambridge MA"
AVP1351,ADGAHRSLLGRMKGA,15,Hepatitis B virus,HBV,Hepadnaviridae,SEQ ID NO: 12,Synthetic,,HepG2,0.94±0.12,Kd Rel (nM),Viral assembly,Phage binding assay,US6544520,Hepatitis B virus inhibitors,"Kenneth Murray, Michael Richard Dyson","Biogen, Inc., Cambridge MA"
AVP1352,ADGYQRSLLGRMKGA,15,Hepatitis B virus,HBV,Hepadnaviridae,SEQ ID NO: 13,Synthetic,,HepG2,0.88±0.08,Kd Rel (nM),Viral assembly,Phage binding assay,US6544520,Hepatitis B virus inhibitors,"Kenneth Murray, Michael Richard Dyson","Biogen, Inc., Cambridge MA"
AVP1353,ADGTQRSLLGRMKGA,15,Hepatitis B virus,HBV,Hepadnaviridae,SEQ ID NO: 14,Synthetic,,HepG2,0.84±0.06,Kd Rel (nM),Viral assembly,Phage binding assay,US6544520,Hepatitis B virus inhibitors,"Kenneth Murray, Michael Richard Dyson","Biogen, Inc., Cambridge MA"
AVP1354,ADGMHRSLLGRMKGA,15,Hepatitis B virus,HBV,Hepadnaviridae,SEQ ID NO: 15,Synthetic,,HepG2,0.55±0.03,Kd Rel (nM),Viral assembly,Phage binding assay,US6544520,Hepatitis B virus inhibitors,"Kenneth Murray, Michael Richard Dyson","Biogen, Inc., Cambridge MA"
AVP1355,ALLGRMKG,8,Hepatitis B virus,HBV,Hepadnaviridae,SEQ ID NO: 16,Synthetic,,HepG2,11.0±0.8,μM,Viral assembly,Phage binding assay,US6544520,Hepatitis B virus inhibitors,"Kenneth Murray, Michael Richard Dyson","Biogen, Inc., Cambridge MA"
AVP1356,LLGRMKG,7,Hepatitis B virus,HBV,Hepadnaviridae,SEQ ID NO: 17,Synthetic,,HepG2,46.2±7.4,μM,Viral assembly,Phage binding assay,US6544520,Hepatitis B virus inhibitors,"Kenneth Murray, Michael Richard Dyson","Biogen, Inc., Cambridge MA"
AVP1357,LGRMKG,6,Hepatitis B virus,HBV,Hepadnaviridae,SEQ ID NO: 18,Synthetic,,HepG2,980±157,μM,Viral assembly,Phage binding assay,US6544520,Hepatitis B virus inhibitors,"Kenneth Murray, Michael Richard Dyson","Biogen, Inc., Cambridge MA"
AVP1358,GRMKG,5,Hepatitis B virus,HBV,Hepadnaviridae,SEQ ID NO: 19,Synthetic,,HepG2,Nil,-,Viral assembly,Phage binding assay,US6544520,Hepatitis B virus inhibitors,"Kenneth Murray, Michael Richard Dyson","Biogen, Inc., Cambridge MA"
AVP1359,LLGRM,5,Hepatitis B virus,HBV,Hepadnaviridae,SEQ ID NO: 20,Synthetic,,HepG2,Nil,-,Viral assembly,Phage binding assay,US6544520,Hepatitis B virus inhibitors,"Kenneth Murray, Michael Richard Dyson","Biogen, Inc., Cambridge MA"
AVP1360,CLLGRMKC,8,Hepatitis B virus,HBV,Hepadnaviridae,SEQ ID NO: 21,Synthetic,,HepG2,652±74,μM,Viral assembly,Phage binding assay,US6544520,Hepatitis B virus inhibitors,"Kenneth Murray, Michael Richard Dyson","Biogen, Inc., Cambridge MA"
AVP1361,ALLPRMKG,8,Hepatitis B virus,HBV,Hepadnaviridae,SEQ ID NO: 22,Synthetic,,HepG2,Nil,-,Viral assembly,Phage binding assay,US6544520,Hepatitis B virus inhibitors,"Kenneth Murray, Michael Richard Dyson","Biogen, Inc., Cambridge MA"
AVP1362,SLLGRMKG,8,Hepatitis B virus,HBV,Hepadnaviridae,SEQ ID NO: 23,Synthetic,,HepG2,6.4±0.7,μM,Viral assembly,Phage binding assay,US6544520,Hepatitis B virus inhibitors,"Kenneth Murray, Michael Richard Dyson","Biogen, Inc., Cambridge MA"
AVP1363,SLLGRMK,7,Hepatitis B virus,HBV,Hepadnaviridae,SEQ ID NO: 24,Synthetic,,HepG2,40.7±4.8,μM,Viral assembly,Phage binding assay,US6544520,Hepatitis B virus inhibitors,"Kenneth Murray, Michael Richard Dyson","Biogen, Inc., Cambridge MA"
AVP1364,SLLGRMKGA,9,Hepatitis B virus,HBV,Hepadnaviridae,SEQ ID NO: 25,Synthetic,,HepG2,2.4±0.2,μM,Viral assembly,Phage binding assay,US6544520,Hepatitis B virus inhibitors,"Kenneth Murray, Michael Richard Dyson","Biogen, Inc., Cambridge MA"
AVP1365,GSLLGRMKGA,10,Hepatitis B virus,HBV,Hepadnaviridae,SEQ ID NO: 26,Synthetic,,HepG2,0.79±0.23,μM,Viral assembly,Phage binding assay,US6544520,Hepatitis B virus inhibitors,"Kenneth Murray, Michael Richard Dyson","Biogen, Inc., Cambridge MA"
AVP1366,DGSLLGRMKGAA,12,Hepatitis B virus,HBV,Hepadnaviridae,SEQ ID NO: 27,Synthetic,,HepG2,3.0±0.4,μM,Viral assembly,Phage binding assay,US6544520,Hepatitis B virus inhibitors,"Kenneth Murray, Michael Richard Dyson","Biogen, Inc., Cambridge MA"
AVP1367,ADGSLLGRMKGAAG,15,Hepatitis B virus,HBV,Hepadnaviridae,SEQ ID NO: 28,Synthetic,,HepG2,4.5±0.8,μM,Viral assembly,Phage binding assay,US6544520,Hepatitis B virus inhibitors,"Kenneth Murray, Michael Richard Dyson","Biogen, Inc., Cambridge MA"
AVP1368,SLLGRMKG,10,Hepatitis B virus,HBV,Hepadnaviridae,SEQ ID NO: 29,Synthetic,,HepG2,26.2±5.0,μM,Viral assembly,Phage binding assay,US6544520,Hepatitis B virus inhibitors,"Kenneth Murray, Michael Richard Dyson","Biogen, Inc., Cambridge MA"
AVP1369,RSLLGRMKGA,10,Hepatitis B virus,HBV,Hepadnaviridae,SEQ ID NO: 31,Synthetic,,HepG2,0.29±0.02,μM,Viral assembly,Phage binding assay,US6544520,Hepatitis B virus inhibitors,"Kenneth Murray, Michael Richard Dyson","Biogen, Inc., Cambridge MA"
AVP1370,HRSLLGRMKGA,11,Hepatitis B virus,HBV,Hepadnaviridae,SEQ ID NO: 32,Synthetic,,HepG2,0.50±0.04,μM,Viral assembly,Phage binding assay,US6544520,Hepatitis B virus inhibitors,"Kenneth Murray, Michael Richard Dyson","Biogen, Inc., Cambridge MA"
AVP1371,MHRSLLGRMKGA,12,Hepatitis B virus,HBV,Hepadnaviridae,SEQ ID NO: 33,Synthetic,,HepG2,0.80±0.10,μM,Viral assembly,Phage binding assay,US6544520,Hepatitis B virus inhibitors,"Kenneth Murray, Michael Richard Dyson","Biogen, Inc., Cambridge MA"
AVP1372,TLNNSVALDPIDISIELNKAKSDLEESKEWIRRSN,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,Sequenece No:33,HPIV3 fusion (F) protein,P06828,-,High,-,Hemagglutinin-Neuraminidase,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1373,LNNSVALDPIDISIELNKAKSDLEESKEWIRRSNQ,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,Sequenece No:34,HPIV3 fusion (F) protein,P06828,-,High,-,Hemagglutinin-Neuraminidase,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1374,NNSVALDPIDISIELNKAKSDLEESKEWIRRSNQK,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,Sequenece No:35,HPIV3 fusion (F) protein,P06828,-,High,-,Hemagglutinin-Neuraminidase,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1375,NSVALDPIDISIELNKAKSDLEESKEWIRRSNQKL,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,Sequenece No:36,HPIV3 fusion (F) protein,P06828,-,High,-,Hemagglutinin-Neuraminidase,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1376,SVALDPIDISIELNKAKSDLEESKEWIRRSNQKLD,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,Sequenece No:37,HPIV3 fusion (F) protein,P06828,-,High,-,Hemagglutinin-Neuraminidase,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1377,VALDPIDISIELNKAKSDLEESKEWIRRSNQKLDS,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,Sequenece No:38,HPIV3 fusion (F) protein,P06828,-,High,-,Hemagglutinin-Neuraminidase,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1378,ALDPIDISIELNKAKSDLEESKEWIRRSNQKLDSI,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,Sequenece No:39,HPIV3 fusion (F) protein,P06828,-,High,-,Hemagglutinin-Neuraminidase,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1379,LDPIDISIELNKAKSDLEESKEWIRRSNQKLDSIG,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,Sequenece No:40,HPIV3 fusion (F) protein,P06828,-,High,-,Hemagglutinin-Neuraminidase,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1380,DPIDISIELNKAKSDLEESKEWIRRSNQKLDSIGN,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,Sequenece No:41,HPIV3 fusion (F) protein,P06828,-,High,-,Hemagglutinin-Neuraminidase,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1381,PIDISIELNKAKSDLEESKEWIRRSNQKLDSIGNW,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,Sequenece No:42,HPIV3 fusion (F) protein,P06828,-,High,-,Hemagglutinin-Neuraminidase,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1382,IDISIELNKAKSDLEESKEWIRRSNQKLDSIGNWH,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,Sequenece No:43,HPIV3 fusion (F) protein,P06828,-,High,-,Hemagglutinin-Neuraminidase,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1383,DISIELNKAKSDLEESKEWIRRSNQKLDSIGNWHQ,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,Sequenece No:44,HPIV3 fusion (F) protein,P06828,-,High,-,Hemagglutinin-Neuraminidase,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1384,ISIELNKAKSDLEESKEWIRRSNQKLDSIGNWHQS,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,Sequenece No:45,HPIV3 fusion (F) protein,P06828,-,High,-,Hemagglutinin-Neuraminidase,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1385,SIELNKAKSDLEESKEWIRRSNQKLDSIGNWHQSS,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,Sequenece No:46,HPIV3 fusion (F) protein,P06828,-,High,-,Hemagglutinin-Neuraminidase,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1386,IELNKAKSDLEESKEWIRRSNQKLDSIGNWHQSST,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,Sequenece No:47,HPIV3 fusion (F) protein,P06828,-,High,-,Hemagglutinin-Neuraminidase,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1387,ELNKAKSDLEESKEWIRRSNQKLDSIGNWHQSSTT,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,Sequenece No:48,HPIV3 fusion (F) protein,P06828,-,High,-,Hemagglutinin-Neuraminidase,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1388,TAAVALVEAKQARSDIEKLKEAIRDTNKAVQSVQS,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,Sequenece No:49,HPIV3 fusion (F) protein,P06828,-,High,-,Hemagglutinin-Neuraminidase,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1389,AVALVEAKQARSDIEKLKEAIRDTNKAVQSVQSSI,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,Sequenece No:50,HPIV3 fusion (F) protein,P06828,-,High,-,Hemagglutinin-Neuraminidase,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1390,LVEAKQARSDIEKLKEAIRDTNKAVQSVQSSIGNL,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,Sequenece No:51,HPIV3 fusion (F) protein,P06828,-,High,-,Hemagglutinin-Neuraminidase,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1391,VEAKQARSDIEKLKEAIRDTNKAVQSVQSSIGNLI,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,Sequenece No:52,HPIV3 fusion (F) protein,P06828,-,High,-,Hemagglutinin-Neuraminidase,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1392,EAKQARSDIEKLKEAIRDTNKAVQSVQSSIGNLIV,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,Sequenece No:53,HPIV3 fusion (F) protein,P06828,-,High,-,Hemagglutinin-Neuraminidase,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1393,AKQARSDIEKLKEAIRDTNKAVQSVQSSIGNLIVA,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,Sequenece No:54,HPIV3 fusion (F) protein,P06828,-,High,-,Hemagglutinin-Neuraminidase,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1394,KQARSDIEKLKEAIRDTNKAVQSVQSSIGNLIVAI,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,Sequenece No:55,HPIV3 fusion (F) protein,P06828,-,High,-,Hemagglutinin-Neuraminidase,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1395,QARSDIEKLKEAIRDTNKAVQSVQSSIGNLIVAIK,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,Sequenece No:56,HPIV3 fusion (F) protein,P06828,-,High,-,Hemagglutinin-Neuraminidase,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1396,ARSDIEKLKEAIRDTNKAVQSVQSSIGNLIVAIKS,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,Sequenece No:57,HPIV3 fusion (F) protein,P06828,-,High,-,Hemagglutinin-Neuraminidase,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1397,RSDIEKLKEAIRDTNKAVQSVQSSIGNLIVAIKSV,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,Sequenece No:58,HPIV3 fusion (F) protein,P06828,-,High,-,Hemagglutinin-Neuraminidase,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1398,SDIEKLKEAIRDTNKAVQSVQSSIGNLIVAIKSVQ,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,Sequenece No:59,HPIV3 fusion (F) protein,P06828,-,High,-,Hemagglutinin-Neuraminidase,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1399,KLKEAIRDTNKAVQSVQSSIGNLIVAIKSVQDYVN,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,Sequenece No:60,HPIV3 fusion (F) protein,P06828,-,High,-,Hemagglutinin-Neuraminidase,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1400,LKEAIRDTNKAVQSVQSSIGNLIVAIKSVQDYVNK,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,Sequenece No:61,HPIV3 fusion (F) protein,P06828,-,High,-,Hemagglutinin-Neuraminidase,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1401,AIRDTNKAVQSVQSSIGNLIVAIKSVQDYVNKEIV,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,Sequenece No:62,HPIV3 fusion (F) protein,P06828,-,High,-,Hemagglutinin-Neuraminidase,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1402,LHRIDLGPPISLERLDVGTNLGNAIAKLEAKELL,34,Measles virus,MV,Paramyxoviridae,Sequenece No:73,MV fusion (F) protein,P69353,-,High,-,Fusion,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1403,HRIDLGPPISLERLDVGTNLGNAIAKLEAKELLE,34,Measles virus,MV,Paramyxoviridae,Sequenece No:74,MV fusion (F) protein,P69353,-,High,-,Fusion,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1404,RIDLGPPISLERLDVGTNLGNAIAKLEAKELLES,34,Measles virus,MV,Paramyxoviridae,Sequenece No:75,MV fusion (F) protein,P69353,-,High,-,Fusion,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1405,IDLGPPISLERLDVGTNLGNAIAKLEAKELLESS,34,Measles virus,MV,Paramyxoviridae,Sequenece No:76,MV fusion (F) protein,P69353,-,High,-,Fusion,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1406,DLGPPISLERLDVGTNLGNAIAKLEAKELLESSD,34,Measles virus,MV,Paramyxoviridae,Sequenece No:77,MV fusion (F) protein,P69353,-,High,-,Fusion,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1407,LGPPISLERLDVGTNLGNAIAKLEAKELLESSDQ,34,Measles virus,MV,Paramyxoviridae,Sequenece No:78,MV fusion (F) protein,P69353,-,High,-,Fusion,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1408,GPPISLERLDVGTNLGNAIAKLEAKELLESSDQI,34,Measles virus,MV,Paramyxoviridae,Sequenece No:79,MV fusion (F) protein,P69353,-,High,-,Fusion,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1409,PPISLERLDVGTNLGNAIAKLEAKELLESSDQIL,34,Measles virus,MV,Paramyxoviridae,Sequenece No:80,MV fusion (F) protein,P69353,-,High,-,Fusion,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1410,PISLERLDVGTNLGNAIAKLEAKELLESSDQILR,34,Measles virus,MV,Paramyxoviridae,Sequenece No:81,MV fusion (F) protein,P69353,-,High,-,Fusion,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1411,SLERLDVGTNLGNAIAKLEAKELLESSDQILRSM,34,Measles virus,MV,Paramyxoviridae,Sequenece No:82,MV fusion (F) protein,P69353,-,High,-,Fusion,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1412,LERLDVGTNLGNAIAKLEAKELLESSDQILRSMK,34,Measles virus,MV,Paramyxoviridae,Sequenece No:83,MV fusion (F) protein,P69353,-,High,-,Fusion,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1413,VAVSKVLHLEGEVNKIALLSTNKAVVSLSNGVS,33,Respiratory syncytial virus,RSV,Paramyxoviridae,Sequenece No:20,RSV fusion (F) protein,P03420,-,High,-,Major surface glycoprotein G,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1414,AVSKVLHLEGEVNKIALLSTNKAVVSLSNGVSV,33,Respiratory syncytial virus,RSV,Paramyxoviridae,Sequenece No:21,RSV fusion (F) protein,P03420,-,High,-,Major surface glycoprotein G,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1415,VSKVLHLEGEVNKIALLSTNKAVVSLSNGVSVL,33,Respiratory syncytial virus,RSV,Paramyxoviridae,Sequenece No:22,RSV fusion (F) protein,P03420,-,High,-,Major surface glycoprotein G,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1416,SKVLHLEGEVNKIALLSTNKAVVSLSNGVSVLT,33,Respiratory syncytial virus,RSV,Paramyxoviridae,Sequenece No:23,RSV fusion (F) protein,P03420,-,High,-,Major surface glycoprotein G,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1417,KVLHLEGEVNKIALLSTNKAVVSLSNGVSVLTS,33,Respiratory syncytial virus,RSV,Paramyxoviridae,Sequenece No:24,RSV fusion (F) protein,P03420,-,High,-,Major surface glycoprotein G,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1418,LEGEVNKIALLSTNKAVVSLSNGVSVLTSKVLD,33,Respiratory syncytial virus,RSV,Paramyxoviridae,Sequenece No:25,RSV fusion (F) protein,P03420,-,High,-,Major surface glycoprotein G,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1419,GEVNKIALLSTNKAVVSLSNGVSVLTSKVLDLK,33,Respiratory syncytial virus,RSV,Paramyxoviridae,Sequenece No:26,RSV fusion (F) protein,P03420,-,High,-,Major surface glycoprotein G,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1420,EVNKIALLSTNKAVVSLSNGVSVLTSKVLDLKN,33,Respiratory syncytial virus,RSV,Paramyxoviridae,Sequenece No:27,RSV fusion (F) protein,P03420,-,High,-,Major surface glycoprotein G,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1421,VNKIALLSTNKAVVSLSNGVSVLTSKVLDLKNY,33,Respiratory syncytial virus,RSV,Paramyxoviridae,Sequenece No:28,RSV fusion (F) protein,P03420,-,High,-,Major surface glycoprotein G,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1422,NKIALLSTNKAVVSLSNGVSVLTSKVLDLKNYI,33,Respiratory syncytial virus,RSV,Paramyxoviridae,Sequenece No:29,RSV fusion (F) protein,P03420,-,High,-,Major surface glycoprotein G,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1423,KIALLSTNKAVVSLSNGVSVLTSKVLDLKNYID,33,Respiratory syncytial virus,RSV,Paramyxoviridae,Sequenece No:30,RSV fusion (F) protein,P03420,-,High,-,Major surface glycoprotein G,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1424,IALLSTNKAVVSLSNGVSVLTSKVLDLKNYIDK,33,Respiratory syncytial virus,RSV,Paramyxoviridae,Sequenece No:31,RSV fusion (F) protein,P03420,-,High,-,Major surface glycoprotein G,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1425,ALLSTNKAVVSLSNGVSVLTSKVLDLKNYIDKQ,33,Respiratory syncytial virus,RSV,Paramyxoviridae,Sequenece No:32,RSV fusion (F) protein,P03420,-,High,-,Major surface glycoprotein G,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1426,VAVSKVLHLEGEVNKIALLSTNKAVVSLSNGVS,33,Respiratory syncytial virus,RSV,Paramyxoviridae,Sequenece No:20,RSV fusion (F) protein,P03420,-,High,-,Major surface glycoprotein G,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1427,AVSKVLHLEGEVNKIALLSTNKAVVSLSNGVSV,33,Respiratory syncytial virus,RSV,Paramyxoviridae,Sequenece No:21,RSV fusion (F) protein,P03420,-,High,-,Major surface glycoprotein G,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1428,VSKVLHLEGEVNKIALLSTNKAVVSLSNGVSVL,33,Respiratory syncytial virus,RSV,Paramyxoviridae,Sequenece No:22,RSV fusion (F) protein,P03420,-,High,-,Major surface glycoprotein G,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1429,SKVLHLEGEVNKIALLSTNKAVVSLSNGVSVLT,33,Respiratory syncytial virus,RSV,Paramyxoviridae,Sequenece No:23,RSV fusion (F) protein,P03420,-,High,-,Major surface glycoprotein G,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1430,KVLHLEGEVNKIALLSTNKAVVSLSNGVSVLTS,33,Respiratory syncytial virus,RSV,Paramyxoviridae,Sequenece No:24,RSV fusion (F) protein,P03420,-,High,-,Major surface glycoprotein G,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1431,LEGEVNKIALLSTNKAVVSLSNGVSVLTSKVLD,33,Respiratory syncytial virus,RSV,Paramyxoviridae,Sequenece No:25,RSV fusion (F) protein,P03420,-,High,-,Major surface glycoprotein G,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1432,GEVNKIALLSTNKAVVSLSNGVSVLTSKVLDLK,33,Respiratory syncytial virus,RSV,Paramyxoviridae,Sequenece No:26,RSV fusion (F) protein,P03420,-,High,-,Major surface glycoprotein G,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1433,EVNKIALLSTNKAVVSLSNGVSVLTSKVLDLKN,33,Respiratory syncytial virus,RSV,Paramyxoviridae,Sequenece No:27,RSV fusion (F) protein,P03420,-,High,-,Major surface glycoprotein G,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1434,VNKIALLSTNKAVVSLSNGVSVLTSKVLDLKNY,33,Respiratory syncytial virus,RSV,Paramyxoviridae,Sequenece No:28,RSV fusion (F) protein,P03420,-,High,-,Major surface glycoprotein G,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1435,NKIALLSTNKAVVSLSNGVSVLTSKVLDLKNYI,33,Respiratory syncytial virus,RSV,Paramyxoviridae,Sequenece No:29,RSV fusion (F) protein,P03420,-,High,-,Major surface glycoprotein G,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1436,KIALLSTNKAVVSLSNGVSVLTSKVLDLKNYID,33,Respiratory syncytial virus,RSV,Paramyxoviridae,Sequenece No:30,RSV fusion (F) protein,P03420,-,High,-,Major surface glycoprotein G,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1437,IALLSTNKAVVSLSNGVSVLTSKVLDLKNYIDK,33,Respiratory syncytial virus,RSV,Paramyxoviridae,Sequenece No:31,RSV fusion (F) protein,P03420,-,High,-,Major surface glycoprotein G,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1438,ALLSTNKAVVSLSNGVSVLTSKVLDLKNYIDKQ,33,Respiratory syncytial virus,RSV,Paramyxoviridae,Sequenece No:32,RSV fusion (F) protein,P03420,-,High,-,Major surface glycoprotein G,Cell-fusion assay,US6951717,Methods and compositions for inhibition of membrane fusion-associated events,"Shawn O'Lin, Dennis Michael, Stephen Robert","Trimeris, Inc., Durham NC (US)"
AVP1439,WQEWERKVDFLEENITALLEEAQIQQEKNMYELQK,35,Simian immunodeficiency virus,SIV,Retroviridae,Sequenece No:63,SIV fusion (F) protein,P03420,-,High,-,gp160,Cell-fusion assay,US7122190,Fusion proteins comprising DP-178 and other viral fusion inhibitor peptides useful for treating aids,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Durham, Shawn O'Lin Barney, Dennis Michael Lambert, Stephen Robert Petteway, Alphonse J. Langlois","Duke University, Durham, NC (US)"
AVP1440,QEWERKVDFLEENITALLEEAQIQQEKNMYELQKL,35,Simian immunodeficiency virus,SIV,Retroviridae,Sequenece No:64,SIV fusion (F) protein,P03420,-,High,-,gp160,Cell-fusion assay,US7122190,Fusion proteins comprising DP-178 and other viral fusion inhibitor peptides useful for treating aids,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Durham, Shawn O'Lin Barney, Dennis Michael Lambert, Stephen Robert Petteway, Alphonse J. Langlois","Duke University, Durham, NC (US)"
AVP1441,EWERKVDFLEENITALLEEAQIQQEKNMYELQKLN,35,Simian immunodeficiency virus,SIV,Retroviridae,Sequenece No:65,SIV fusion (F) protein,P03420,-,High,-,gp160,Cell-fusion assay,US7122190,Fusion proteins comprising DP-178 and other viral fusion inhibitor peptides useful for treating aids,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Durham, Shawn O'Lin Barney, Dennis Michael Lambert, Stephen Robert Petteway, Alphonse J. Langlois","Duke University, Durham, NC (US)"
AVP1442,WERKVDFLEENITALLEEAQIQQEKNMYELQKLNS,35,Simian immunodeficiency virus,SIV,Retroviridae,Sequenece No:66,SIV fusion (F) protein,P03420,-,High,-,gp160,Cell-fusion assay,US7122190,Fusion proteins comprising DP-178 and other viral fusion inhibitor peptides useful for treating aids,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Durham, Shawn O'Lin Barney, Dennis Michael Lambert, Stephen Robert Petteway, Alphonse J. Langlois","Duke University, Durham, NC (US)"
AVP1443,ERKVDFLEENITALLEEAQIQQEKNMYELQKLNSW,35,Simian immunodeficiency virus,SIV,Retroviridae,Sequenece No:67,SIV fusion (F) protein,P03420,-,High,-,gp160,Cell-fusion assay,US7122190,Fusion proteins comprising DP-178 and other viral fusion inhibitor peptides useful for treating aids,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Durham, Shawn O'Lin Barney, Dennis Michael Lambert, Stephen Robert Petteway, Alphonse J. Langlois","Duke University, Durham, NC (US)"
AVP1444,RKVDFLEENITALLEEAQIQQEKNMYELQKLNSWD,35,Simian immunodeficiency virus,SIV,Retroviridae,Sequenece No:68,SIV fusion (F) protein,P03420,-,High,-,gp160,Cell-fusion assay,US7122190,Fusion proteins comprising DP-178 and other viral fusion inhibitor peptides useful for treating aids,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Durham, Shawn O'Lin Barney, Dennis Michael Lambert, Stephen Robert Petteway, Alphonse J. Langlois","Duke University, Durham, NC (US)"
AVP1445,KVDFLEENITALLEEAQIQQEKNMYELQKLNSWDV,35,Simian immunodeficiency virus,SIV,Retroviridae,Sequenece No:69,SIV fusion (F) protein,P03420,-,High,-,gp160,Cell-fusion assay,US7122190,Fusion proteins comprising DP-178 and other viral fusion inhibitor peptides useful for treating aids,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Durham, Shawn O'Lin Barney, Dennis Michael Lambert, Stephen Robert Petteway, Alphonse J. Langlois","Duke University, Durham, NC (US)"
AVP1446,VDFLEENITALLEEAQIQQEKNMYELQKLNSWDVF,35,Simian immunodeficiency virus,SIV,Retroviridae,Sequenece No:70,SIV fusion (F) protein,P03420,-,High,-,gp160,Cell-fusion assay,US7122190,Fusion proteins comprising DP-178 and other viral fusion inhibitor peptides useful for treating aids,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Durham, Shawn O'Lin Barney, Dennis Michael Lambert, Stephen Robert Petteway, Alphonse J. Langlois","Duke University, Durham, NC (US)"
AVP1447,DFLEENITALLEEAQIQQEKNMYELQKLNSWDVFG,35,Simian immunodeficiency virus,SIV,Retroviridae,Sequenece No:71,SIV fusion (F) protein,P03420,-,High,-,gp160,Cell-fusion assay,US7122190,Fusion proteins comprising DP-178 and other viral fusion inhibitor peptides useful for treating aids,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Durham, Shawn O'Lin Barney, Dennis Michael Lambert, Stephen Robert Petteway, Alphonse J. Langlois","Duke University, Durham, NC (US)"
AVP1448,FLEENITALLEEAQIQQEKNMYELQKLNSWDVFGN,35,Simian immunodeficiency virus,SIV,Retroviridae,Sequenece No:72,SIV fusion (F) protein,P03420,-,High,-,gp160,Cell-fusion assay,US7122190,Fusion proteins comprising DP-178 and other viral fusion inhibitor peptides useful for treating aids,"Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Durham, Shawn O'Lin Barney, Dennis Michael Lambert, Stephen Robert Petteway, Alphonse J. Langlois","Duke University, Durham, NC (US)"
AVP1449,SCLTVPASAYQVRNSSGL,18,Hepatitis C virus,HCV,Flaviviridae,SEQ ID NO:38,"HCV envelope glycoprotein (E1, E2)",P27958,293T,-17.16,%,Fusion,Luciferase assay,US7416733,Flavivirus fusion inhibitors,"Robert F., Srikanta, David H., Jane A","Tulane Educational Fund, The Rockefeller University (US)"
AVP1450,SAYQVRNSSGLYHVTNDC,18,Hepatitis C virus,HCV,Flaviviridae,SEQ ID NO:39,"HCV envelope glycoprotein (E1, E2)",P27958,293T,0.23,%,Fusion,Luciferase assay,US7416733,Flavivirus fusion inhibitors,"Robert F., Srikanta, David H., Jane A","Tulane Educational Fund, The Rockefeller University (US)"
AVP1451,SSGLYHVTNDCPNSSIVY,18,Hepatitis C virus,HCV,Flaviviridae,SEQ ID NO:40,"HCV envelope glycoprotein (E1, E2)",P27958,293T,99.93,%,Fusion,Luciferase assay,US7416733,Flavivirus fusion inhibitors,"Robert F., Srikanta, David H., Jane A","Tulane Educational Fund, The Rockefeller University (US)"
AVP1452,TNDCPNSSVVYEAADAIL,18,Hepatitis C virus,HCV,Flaviviridae,SEQ ID NO:41,"HCV envelope glycoprotein (E1, E2)",P27958,293T,1.12,%,Fusion,Luciferase assay,US7416733,Flavivirus fusion inhibitors,"Robert F., Srikanta, David H., Jane A","Tulane Educational Fund, The Rockefeller University (US)"
AVP1453,SIVYEAADAILHTPGCVP,18,Hepatitis C virus,HCV,Flaviviridae,SEQ ID NO:42,"HCV envelope glycoprotein (E1, E2)",P27958,293T,42.32,%,Fusion,Luciferase assay,US7416733,Flavivirus fusion inhibitors,"Robert F., Srikanta, David H., Jane A","Tulane Educational Fund, The Rockefeller University (US)"
AVP1454,DAILHTPGCVPCVREGNA,18,Hepatitis C virus,HCV,Flaviviridae,SEQ ID NO:43,"HCV envelope glycoprotein (E1, E2)",P27958,293T,-49.35,%,Fusion,Luciferase assay,US7416733,Flavivirus fusion inhibitors,"Robert F., Srikanta, David H., Jane A","Tulane Educational Fund, The Rockefeller University (US)"
AVP1455,GCVPCVREGNASRCWVAV,18,Hepatitis C virus,HCV,Flaviviridae,SEQ ID NO:44,"HCV envelope glycoprotein (E1, E2)",P27958,293T,-4.42,%,Fusion,Luciferase assay,US7416733,Flavivirus fusion inhibitors,"Robert F., Srikanta, David H., Jane A","Tulane Educational Fund, The Rockefeller University (US)"
AVP1456,WVAVTPTVATRDGKLPTT,18,Hepatitis C virus,HCV,Flaviviridae,SEQ ID NO:45,"HCV envelope glycoprotein (E1, E2)",P27958,293T,19.29,%,Fusion,Luciferase assay,US7416733,Flavivirus fusion inhibitors,"Robert F., Srikanta, David H., Jane A","Tulane Educational Fund, The Rockefeller University (US)"
AVP1457,WVAVTPTVATRDGKLPTT,18,Hepatitis C virus,HCV,Flaviviridae,SEQ ID NO:46,"HCV envelope glycoprotein (E1, E2)",P27958,293T,13.16,%,Fusion,Luciferase assay,US7416733,Flavivirus fusion inhibitors,"Robert F., Srikanta, David H., Jane A","Tulane Educational Fund, The Rockefeller University (US)"
AVP1458,VATRDGKLPTTQLRRHID,18,Hepatitis C virus,HCV,Flaviviridae,SEQ ID NO:47,"HCV envelope glycoprotein (E1, E2)",P27958,293T,-30.83,%,Fusion,Luciferase assay,US7416733,Flavivirus fusion inhibitors,"Robert F., Srikanta, David H., Jane A","Tulane Educational Fund, The Rockefeller University (US)"
AVP1459,LPTTQLRRHIDLLVGSAT,18,Hepatitis C virus,HCV,Flaviviridae,SEQ ID NO:48,"HCV envelope glycoprotein (E1, E2)",P27958,293T,-1.96,%,Fusion,Luciferase assay,US7416733,Flavivirus fusion inhibitors,"Robert F., Srikanta, David H., Jane A","Tulane Educational Fund, The Rockefeller University (US)"
AVP1460,RHIDLLVGSATLCSALYV,18,Hepatitis C virus,HCV,Flaviviridae,SEQ ID NO:49,"HCV envelope glycoprotein (E1, E2)",P27958,293T,49.08,%,Fusion,Luciferase assay,US7416733,Flavivirus fusion inhibitors,"Robert F., Srikanta, David H., Jane A","Tulane Educational Fund, The Rockefeller University (US)"
AVP1461,GSATLCSALYVGDLCGSV,18,Hepatitis C virus,HCV,Flaviviridae,SEQ ID NO:50,"HCV envelope glycoprotein (E1, E2)",P27958,293T,0.55,%,Fusion,Luciferase assay,US7416733,Flavivirus fusion inhibitors,"Robert F., Srikanta, David H., Jane A","Tulane Educational Fund, The Rockefeller University (US)"
AVP1462,ALYVGDLCGSVFLVGQLF,18,Hepatitis C virus,HCV,Flaviviridae,SEQ ID NO:51,"HCV envelope glycoprotein (E1, E2)",P27958,293T,22.87,%,Fusion,Luciferase assay,US7416733,Flavivirus fusion inhibitors,"Robert F., Srikanta, David H., Jane A","Tulane Educational Fund, The Rockefeller University (US)"
AVP1463,CGSVFLVGQLFTFSPRHH,18,Hepatitis C virus,HCV,Flaviviridae,SEQ ID NO:52,"HCV envelope glycoprotein (E1, E2)",P27958,293T,79.46,%,Fusion,Luciferase assay,US7416733,Flavivirus fusion inhibitors,"Robert F., Srikanta, David H., Jane A","Tulane Educational Fund, The Rockefeller University (US)"
AVP1464,GQLFTFSPRHHWTTQDCN,18,Hepatitis C virus,HCV,Flaviviridae,SEQ ID NO:53,"HCV envelope glycoprotein (E1, E2)",P27958,293T,43.2,%,Fusion,Luciferase assay,US7416733,Flavivirus fusion inhibitors,"Robert F., Srikanta, David H., Jane A","Tulane Educational Fund, The Rockefeller University (US)"
AVP1465,PRHHWTTQDCNCSIYPGH,18,Hepatitis C virus,HCV,Flaviviridae,SEQ ID NO:54,"HCV envelope glycoprotein (E1, E2)",P27958,293T,31.28,%,Fusion,Luciferase assay,US7416733,Flavivirus fusion inhibitors,"Robert F., Srikanta, David H., Jane A","Tulane Educational Fund, The Rockefeller University (US)"
AVP1466,QDCNCSIYPGHITGHRMA,18,Hepatitis C virus,HCV,Flaviviridae,SEQ ID NO:55,"HCV envelope glycoprotein (E1, E2)",P27958,293T,-73.14,%,Fusion,Luciferase assay,US7416733,Flavivirus fusion inhibitors,"Robert F., Srikanta, David H., Jane A","Tulane Educational Fund, The Rockefeller University (US)"
AVP1467,YPGHITGHRMANMMMNW,17,Hepatitis C virus,HCV,Flaviviridae,SEQ ID NO:56,"HCV envelope glycoprotein (E1, E2)",P27958,293T,86.19,%,Fusion,Luciferase assay,US7416733,Flavivirus fusion inhibitors,"Robert F., Srikanta, David H., Jane A","Tulane Educational Fund, The Rockefeller University (US)"
AVP1468,HRMANMMMNWSPTAALV,17,Hepatitis C virus,HCV,Flaviviridae,SEQ ID NO:57,"HCV envelope glycoprotein (E1, E2)",P27958,293T,26.6,%,Fusion,Luciferase assay,US7416733,Flavivirus fusion inhibitors,"Robert F., Srikanta, David H., Jane A","Tulane Educational Fund, The Rockefeller University (US)"
AVP1469,MMNWSPTAALVVAQLLRI,18,Hepatitis C virus,HCV,Flaviviridae,SEQ ID NO:58,"HCV envelope glycoprotein (E1, E2)",P27958,293T,33.39,%,Fusion,Luciferase assay,US7416733,Flavivirus fusion inhibitors,"Robert F., Srikanta, David H., Jane A","Tulane Educational Fund, The Rockefeller University (US)"
AVP1470,AALVVAQLLRIPQAIMDM,18,Hepatitis C virus,HCV,Flaviviridae,SEQ ID NO:59,"HCV envelope glycoprotein (E1, E2)",P27958,293T,11.49,%,Fusion,Luciferase assay,US7416733,Flavivirus fusion inhibitors,"Robert F., Srikanta, David H., Jane A","Tulane Educational Fund, The Rockefeller University (US)"
AVP1471,LLRIPQAIMDMIAGAHWG,18,Hepatitis C virus,HCV,Flaviviridae,SEQ ID NO:60,"HCV envelope glycoprotein (E1, E2)",P27958,293T,71.09,%,Fusion,Luciferase assay,US7416733,Flavivirus fusion inhibitors,"Robert F., Srikanta, David H., Jane A","Tulane Educational Fund, The Rockefeller University (US)"
AVP1472,IMDMIAGAHWGVLAGIKY,18,Hepatitis C virus,HCV,Flaviviridae,SEQ ID NO:61,"HCV envelope glycoprotein (E1, E2)",P27958,293T,0.32,%,Fusion,Luciferase assay,US7416733,Flavivirus fusion inhibitors,"Robert F., Srikanta, David H., Jane A","Tulane Educational Fund, The Rockefeller University (US)"
AVP1473,AHWGVLAGIKYFSMVGNW,18,Hepatitis C virus,HCV,Flaviviridae,SEQ ID NO:62,"HCV envelope glycoprotein (E1, E2)",P27958,293T,15.34,%,Fusion,Luciferase assay,US7416733,Flavivirus fusion inhibitors,"Robert F., Srikanta, David H., Jane A","Tulane Educational Fund, The Rockefeller University (US)"
AVP1474,GIKYFSMVGNWAKVLVVL,18,Hepatitis C virus,HCV,Flaviviridae,SEQ ID NO:63,"HCV envelope glycoprotein (E1, E2)",P27958,293T,50.39,%,Fusion,Luciferase assay,US7416733,Flavivirus fusion inhibitors,"Robert F., Srikanta, David H., Jane A","Tulane Educational Fund, The Rockefeller University (US)"
AVP1475,VGNWAKVLVVLLLFAGVD,18,Hepatitis C virus,HCV,Flaviviridae,SEQ ID NO:64,"HCV envelope glycoprotein (E1, E2)",P27958,293T,-21.07,%,Fusion,Luciferase assay,US7416733,Flavivirus fusion inhibitors,"Robert F., Srikanta, David H., Jane A","Tulane Educational Fund, The Rockefeller University (US)"
AVP1476,LVVLLLFAGVDAETHVTG,18,Hepatitis C virus,HCV,Flaviviridae,SEQ ID NO:65,"HCV envelope glycoprotein (E1, E2)",P27958,293T,10.58,%,Fusion,Luciferase assay,US7416733,Flavivirus fusion inhibitors,"Robert F., Srikanta, David H., Jane A","Tulane Educational Fund, The Rockefeller University (US)"
AVP1477,FKLPLGINITNFRAILTAFS,20,SARS coronavirus,SARS-CoV,Coronaviridae,SEQ ID NO:1,Synthetic,,FRhK-4,>500,IC90 (μg/ml),S protein,Viral titer,US7491489,Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof,"Bojian, Yi, Jiandong, Ming-Liang","The University of Hong Knog, (CN)"
AVP1478,PTTFMLKYDENGTITDAVDC,20,SARS coronavirus,SARS-CoV,Coronaviridae,SEQ ID NO:2,Synthetic,,FRhK-4,112.5±26.3,IC90 (μg/ml),S protein,Viral titer,US7491489,Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof,"Bojian, Yi, Jiandong, Ming-Liang","The University of Hong Knog, (CN)"
AVP1479,VLYNSTFFSTFKCYGVSATK,20,SARS coronavirus,SARS-CoV,Coronaviridae,SEQ ID NO:3,Synthetic,,FRhK-4,>500,IC90 (μg/ml),S protein,Viral titer,US7491489,Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof,"Bojian, Yi, Jiandong, Ming-Liang","The University of Hong Knog, (CN)"
AVP1480,PALNCYWPLNDYGFYTTSGI,20,SARS coronavirus,SARS-CoV,Coronaviridae,SEQ ID NO:4,Synthetic,,FRhK-4,>500,IC90 (μg/ml),S protein,Viral titer,US7491489,Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof,"Bojian, Yi, Jiandong, Ming-Liang","The University of Hong Knog, (CN)"
AVP1481,RDVSDFTDSVRDPKTSEILD,20,SARS coronavirus,SARS-CoV,Coronaviridae,SEQ ID NO:5,Synthetic,,FRhK-4,>500,IC90 (μg/ml),S protein,Viral titer,US7491489,Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof,"Bojian, Yi, Jiandong, Ming-Liang","The University of Hong Knog, (CN)"
AVP1482,YQDVNCTDVSTAIHADQLTP,20,SARS coronavirus,SARS-CoV,Coronaviridae,SEQ ID NO:6,Synthetic,,FRhK-4,113.0±27.6,IC90 (μg/ml),S protein,Viral titer,US7491489,Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof,"Bojian, Yi, Jiandong, Ming-Liang","The University of Hong Knog, (CN)"
AVP1483,SNNTIAIPTNFSISITTEVM,20,SARS coronavirus,SARS-CoV,Coronaviridae,SEQ ID NO:7,Synthetic,,FRhK-4,>500,IC90 (μg/ml),S protein,Viral titer,US7491489,Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof,"Bojian, Yi, Jiandong, Ming-Liang","The University of Hong Knog, (CN)"
AVP1484,QYGSFCTQLNRALSGIAAEQ,20,SARS coronavirus,SARS-CoV,Coronaviridae,SEQ ID NO:8,Synthetic,,FRhK-4,24.9±6.2,IC90 (μg/ml),S protein,Viral titer,US7491489,Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof,"Bojian, Yi, Jiandong, Ming-Liang","The University of Hong Knog, (CN)"
AVP1485,GIGVTQNVLYENQKQIANQF,20,SARS coronavirus,SARS-CoV,Coronaviridae,SEQ ID NO:9,Synthetic,,FRhK-4,>500,IC90 (μg/ml),S protein,Viral titer,US7491489,Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof,"Bojian, Yi, Jiandong, Ming-Liang","The University of Hong Knog, (CN)"
AVP1486,IQKEIDRLNEVAKNLNESLI,20,SARS coronavirus,SARS-CoV,Coronaviridae,SEQ ID NO:10,Synthetic,,FRhK-4,73.5±15.7,IC90 (μg/ml),S protein,Viral titer,US7491489,Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof,"Bojian, Yi, Jiandong, Ming-Liang","The University of Hong Knog, (CN)"
AVP1487,IPESSELTLQELLGEERR,18,Human papillomavirus,HPV,Papillomaviridae,-,E6-associated protein (E6AP),Q05086,-,10.5±1.4,μM,E6 protein,CD spectroscopy,15182185,Design and characterization of helical peptides that inhibit the E6 protein of papillomavirus.,"Liu Y, Liu Z, Androphy E, Chen J, Baleja JD.",Biochemistry. 2004
AVP1488,KKFACPECPKRFMRSDHLSKHIKTHQNKK,29,Human papillomavirus,HPV,Papillomaviridae,-,E6-associated protein (E6AP),Q05086,-,ND,μM,E6 protein,CD spectroscopy,15182185,Design and characterization of helical peptides that inhibit the E6 protein of papillomavirus.,"Liu Y, Liu Z, Androphy E, Chen J, Baleja JD.",Biochemistry. 2004
AVP1489,YKFACPECPKRFMRSDHLTLHILLHENKK,29,Human papillomavirus,HPV,Papillomaviridae,-,E6-associated protein (E6AP),Q05086,-,>1000,μM,E6 protein,CD spectroscopy,15182185,Design and characterization of helical peptides that inhibit the E6 protein of papillomavirus.,"Liu Y, Liu Z, Androphy E, Chen J, Baleja JD.",Biochemistry. 2004
AVP1490,YKFACPECPKRFMRSDHLSKHITLHELLGEERR,33,Human papillomavirus,HPV,Papillomaviridae,-,E6-associated protein (E6AP),Q05086,-,19.3±2.9,μM,E6 protein,CD spectroscopy,15182185,Design and characterization of helical peptides that inhibit the E6 protein of papillomavirus.,"Liu Y, Liu Z, Androphy E, Chen J, Baleja JD.",Biochemistry. 2004
AVP1491,NLYIQWLKDGGPSSGRPPPS,20,Human papillomavirus,HPV,Papillomaviridae,-,E6-associated protein (E6AP),Q05086,-,ND,μM,E6 protein,CD spectroscopy,15182185,Design and characterization of helical peptides that inhibit the E6 protein of papillomavirus.,"Liu Y, Liu Z, Androphy E, Chen J, Baleja JD.",Biochemistry. 2004
AVP1492,ALQELLGQWLKDGGPSSGRPPPS,23,Human papillomavirus,HPV,Papillomaviridae,-,E6-associated protein (E6AP),Q05086,-,36.8±3.2,μM,E6 protein,CD spectroscopy,15182185,Design and characterization of helical peptides that inhibit the E6 protein of papillomavirus.,"Liu Y, Liu Z, Androphy E, Chen J, Baleja JD.",Biochemistry. 2004
AVP1493,ALQELLGEYIQWLKDGGPSSGRPPPS,26,Human papillomavirus,HPV,Papillomaviridae,-,E6-associated protein (E6AP),Q05086,-,26.2±4.8,μM,E6 protein,CD spectroscopy,15182185,Design and characterization of helical peptides that inhibit the E6 protein of papillomavirus.,"Liu Y, Liu Z, Androphy E, Chen J, Baleja JD.",Biochemistry. 2004
AVP1494,YLQELLGE,8,Human papillomavirus,HPV,Papillomaviridae,-,E6-associated protein (E6AP),Q05086,-,74.3±1.9,μM,E6 protein,CD spectroscopy,15182185,Design and characterization of helical peptides that inhibit the E6 protein of papillomavirus.,"Liu Y, Liu Z, Androphy E, Chen J, Baleja JD.",Biochemistry. 2004
AVP1495,TFWWHPNYYVDW,12,Human papillomavirus,HPV,Papillomaviridae,Pep-1,Phage display,,C33a,Medium,-,Transcription,Luciferase assay,14614029,Peptides inhibitory for the transcriptional regulatory function of human papillomavirus E2.,"Fujii T, Austin D, Guo D, Srimatkandada S, Wang T, Kubushiro K, Masumoto N, Tsukazaki K, Nozawa S, Deisseroth AB.",Clin Cancer Res. 2003
AVP1496,TLWPWAWRHNWQ,12,Human papillomavirus,HPV,Papillomaviridae,Pep-2,Phage display,,C33a,Medium,-,Transcription,Luciferase assay,14614029,Peptides inhibitory for the transcriptional regulatory function of human papillomavirus E2.,"Fujii T, Austin D, Guo D, Srimatkandada S, Wang T, Kubushiro K, Masumoto N, Tsukazaki K, Nozawa S, Deisseroth AB.",Clin Cancer Res. 2003
AVP1497,TWFNPFGYYSWA,12,Human papillomavirus,HPV,Papillomaviridae,Pep-3,Phage display,,C33a,High,-,Transcription,Luciferase assay,14614029,Peptides inhibitory for the transcriptional regulatory function of human papillomavirus E2.,"Fujii T, Austin D, Guo D, Srimatkandada S, Wang T, Kubushiro K, Masumoto N, Tsukazaki K, Nozawa S, Deisseroth AB.",Clin Cancer Res. 2003
AVP1498,TWFWPYPYPHLP,12,Human papillomavirus,HPV,Papillomaviridae,Pep-4,Phage display,,C33a,High,-,Transcription,Luciferase assay,14614029,Peptides inhibitory for the transcriptional regulatory function of human papillomavirus E2.,"Fujii T, Austin D, Guo D, Srimatkandada S, Wang T, Kubushiro K, Masumoto N, Tsukazaki K, Nozawa S, Deisseroth AB.",Clin Cancer Res. 2003
AVP1499,TWWTGTYPWYPR,12,Human papillomavirus,HPV,Papillomaviridae,Pep-5,Phage display,,C33a,Nil,-,Transcription,Luciferase assay,14614029,Peptides inhibitory for the transcriptional regulatory function of human papillomavirus E2.,"Fujii T, Austin D, Guo D, Srimatkandada S, Wang T, Kubushiro K, Masumoto N, Tsukazaki K, Nozawa S, Deisseroth AB.",Clin Cancer Res. 2003
AVP1500,ENGLHNRSLNPR,12,Human papillomavirus,HPV,Papillomaviridae,Pep-6,Phage display,,C33a,Nil,-,Transcription,Luciferase assay,14614029,Peptides inhibitory for the transcriptional regulatory function of human papillomavirus E2.,"Fujii T, Austin D, Guo D, Srimatkandada S, Wang T, Kubushiro K, Masumoto N, Tsukazaki K, Nozawa S, Deisseroth AB.",Clin Cancer Res. 2003
AVP1501,GQPSHDPVPPTT,12,Human papillomavirus,HPV,Papillomaviridae,Pep-7,Phage display,,C33a,Nil,-,Transcription,Luciferase assay,14614029,Peptides inhibitory for the transcriptional regulatory function of human papillomavirus E2.,"Fujii T, Austin D, Guo D, Srimatkandada S, Wang T, Kubushiro K, Masumoto N, Tsukazaki K, Nozawa S, Deisseroth AB.",Clin Cancer Res. 2003
AVP1502,SSTSTVTPAHST,12,Human papillomavirus,HPV,Papillomaviridae,Pep-8,Phage display,,C33a,Nil,-,Transcription,Luciferase assay,14614029,Peptides inhibitory for the transcriptional regulatory function of human papillomavirus E2.,"Fujii T, Austin D, Guo D, Srimatkandada S, Wang T, Kubushiro K, Masumoto N, Tsukazaki K, Nozawa S, Deisseroth AB.",Clin Cancer Res. 2003
AVP1503,SSPLAHYLNAPT,12,Human papillomavirus,HPV,Papillomaviridae,Pep-9,Phage display,,C33a,Nil,-,Transcription,Luciferase assay,14614029,Peptides inhibitory for the transcriptional regulatory function of human papillomavirus E2.,"Fujii T, Austin D, Guo D, Srimatkandada S, Wang T, Kubushiro K, Masumoto N, Tsukazaki K, Nozawa S, Deisseroth AB.",Clin Cancer Res. 2003
AVP1504,SWLRDIWDWICEVLSDFK,18,Hepatitis C virus,HCV,Flaviviridae,C5A,HCV non-structural protein 5A,P26664,Huh7.5,0.80±0.09,μM,Virus entry,RT PCR,21801309,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,"Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.",Chem Biol Drug Des. 2011
AVP1505,SWLRDLWDWICEVLSDFK,18,Hepatitis C virus,HCV,Flaviviridae,I6L,HCV non-structural protein 5A,P26664,Huh7.5,1.40±0.13,μM,Virus entry,RT PCR,21801309,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,"Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.",Chem Biol Drug Des. 2011
AVP1506,SWLRDIWDWLCEVLSDFK,18,Hepatitis C virus,HCV,Flaviviridae,I10L,HCV non-structural protein 5A,P26664,Huh7.5,1.20±0.09,μM,Virus entry,RT PCR,21801309,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,"Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.",Chem Biol Drug Des. 2011
AVP1507,SWLRDIWDWICELLSDFK,18,Hepatitis C virus,HCV,Flaviviridae,V13L,HCV non-structural protein 5A,P26664,Huh7.5,1.20±0.11,μM,Virus entry,RT PCR,21801309,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,"Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.",Chem Biol Drug Des. 2011
AVP1508,SWLRDLWDWLCEVLSDFK,18,Hepatitis C virus,HCV,Flaviviridae,I6L/I10L,HCV non-structural protein 5A,P26664,Huh7.5,1.40±0.15,μM,Virus entry,RT PCR,21801309,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,"Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.",Chem Biol Drug Des. 2011
AVP1509,SWLRDLWDWICELLSDFK,18,Hepatitis C virus,HCV,Flaviviridae,I6L/V13L,HCV non-structural protein 5A,P26664,Huh7.5,0.78±0.07,μM,Virus entry,RT PCR,21801309,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,"Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.",Chem Biol Drug Des. 2011
AVP1510,SWLRDIWDWLCELLSDFK,18,Hepatitis C virus,HCV,Flaviviridae,I10L/V13L,HCV non-structural protein 5A,P26664,Huh7.5,0.82±0.10,μM,Virus entry,RT PCR,21801309,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,"Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.",Chem Biol Drug Des. 2011
AVP1511,SWLRDLWDWLCELLSDFK,18,Hepatitis C virus,HCV,Flaviviridae,I6L/I10L/V13L,HCV non-structural protein 5A,P26664,Huh7.5,1.20±0.14,μM,Virus entry,RT PCR,21801309,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,"Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.",Chem Biol Drug Des. 2011
AVP1512,SWLRDIWDWLCEVLSDFK,18,Hepatitis C virus,HCV,Flaviviridae,I10L,HCV non-structural protein 5A,P26664,Huh7.5,1.20±0.09,μM,Virus entry,RT PCR,21801309,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,"Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.",Chem Biol Drug Des. 2011
AVP1513,SWLRDIWDWVCEVLSDFK,18,Hepatitis C virus,HCV,Flaviviridae,I10V,HCV non-structural protein 5A,P26664,Huh7.5,1.40±0.17,μM,Virus entry,RT PCR,21801309,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,"Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.",Chem Biol Drug Des. 2011
AVP1514,SWLRDIWDWACEVLSDFK,18,Hepatitis C virus,HCV,Flaviviridae,I10A,HCV non-structural protein 5A,P26664,Huh7.5,4.00±0.36,μM,Virus entry,RT PCR,21801309,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,"Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.",Chem Biol Drug Des. 2011
AVP1515,SWLRDIWDWGCEVLSDFK,18,Hepatitis C virus,HCV,Flaviviridae,I10G,HCV non-structural protein 5A,P26664,Huh7.5,>5.00,μM,Virus entry,RT PCR,21801309,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,"Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.",Chem Biol Drug Des. 2011
AVP1516,SWLRDIWDWSCEVLSDFK,18,Hepatitis C virus,HCV,Flaviviridae,I10S,HCV non-structural protein 5A,P26664,Huh7.5,>5.00,μM,Virus entry,RT PCR,21801309,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,"Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.",Chem Biol Drug Des. 2011
AVP1517,SWLRDIWDWECEVLSDFK,18,Hepatitis C virus,HCV,Flaviviridae,I10E,HCV non-structural protein 5A,P26664,Huh7.5,>5.00,μM,Virus entry,RT PCR,21801309,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,"Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.",Chem Biol Drug Des. 2011
AVP1518,SWLRDIWDWKCEVLSDFK,18,Hepatitis C virus,HCV,Flaviviridae,I10K,HCV non-structural protein 5A,P26664,Huh7.5,>5.00,μM,Virus entry,RT PCR,21801309,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,"Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.",Chem Biol Drug Des. 2011
AVP1519,TSQNIRS,7,Hepatitis C virus,HCV,Flaviviridae,41281,Phage display,,Huh7.5,High,-,HCV E2,RT PCR,21193836,Selection of peptides binding to HCV e2 and inhibiting viral infectivity.,"Hong HW, Lee SW, Myung H.",J Microbiol Biotechnol. 2010
AVP1520,TSYHRSA,7,Hepatitis C virus,HCV,Flaviviridae,41312,Phage display,,Huh7.5,Medium,-,HCV E2,RT PCR,21193836,Selection of peptides binding to HCV e2 and inhibiting viral infectivity.,"Hong HW, Lee SW, Myung H.",J Microbiol Biotechnol. 2010
AVP1521,SVSVGMKPSPRP,12,Hepatitis C virus,HCV,Flaviviridae,41286,Phage display,,Huh7.5,Medium,-,HCV E2,RT PCR,21193836,Selection of peptides binding to HCV e2 and inhibiting viral infectivity.,"Hong HW, Lee SW, Myung H.",J Microbiol Biotechnol. 2010
AVP1522,SVSVGTKPRPRP,12,Hepatitis C virus,HCV,Flaviviridae,41317,Phage display,,Huh7.5,Medium,-,HCV E2,RT PCR,21193836,Selection of peptides binding to HCV e2 and inhibiting viral infectivity.,"Hong HW, Lee SW, Myung H.",J Microbiol Biotechnol. 2010
AVP1523,SVSWGMKPSPRQ,12,Hepatitis C virus,HCV,Flaviviridae,41345,Phage display,,Huh7.5,Medium,-,HCV E2,RT PCR,21193836,Selection of peptides binding to HCV e2 and inhibiting viral infectivity.,"Hong HW, Lee SW, Myung H.",J Microbiol Biotechnol. 2010
AVP1524,STLPLPP,7,Hepatitis C virus,HCV,Flaviviridae,-,Phage display,,Huh7,Nil,-,HCV E2,RT PCR,21193836,Selection of peptides binding to HCV e2 and inhibiting viral infectivity.,"Hong HW, Lee SW, Myung H.",J Microbiol Biotechnol. 2010
AVP1525,SDDPKESEGDLHCVC,15,Vaccinia,VACV,Poxviridae,PD1,Thrombin-induced platelet-derived protein,P83470,Vero,Nil,-,Multifunctional,Plaque assay,20347875,Antiviral activity of selected antimicrobial peptides against vaccinia virus.,"Mohan KV, Rao SS, Atreya CD.",Antiviral Res. 2010
AVP1526,CVCVKTTSLVRPRHI,15,Vaccinia,VACV,Poxviridae,PD2,Thrombin-induced platelet-derived protein,P83470,Vero,Nil,-,Multifunctional,Plaque assay,20347875,Antiviral activity of selected antimicrobial peptides against vaccinia virus.,"Mohan KV, Rao SS, Atreya CD.",Antiviral Res. 2010
AVP1527,KNGRKLCLDLQAALY,15,Vaccinia,VACV,Poxviridae,PD3,Thrombin-induced platelet-derived protein,P83470,Vero,40,μg/ml,Multifunctional,Plaque assay,20347875,Antiviral activity of selected antimicrobial peptides against vaccinia virus.,"Mohan KV, Rao SS, Atreya CD.",Antiviral Res. 2010
AVP1528,AALYKKKIIKKLLES,15,Vaccinia,VACV,Poxviridae,PD4,Thrombin-induced platelet-derived protein,P02776,Vero,50,μg/ml,Multifunctional,Plaque assay,20347875,Antiviral activity of selected antimicrobial peptides against vaccinia virus.,"Mohan KV, Rao SS, Atreya CD.",Antiviral Res. 2010
AVP1529,RW,2,Vaccinia,VACV,Poxviridae,RW1,Synthetic,,Vero,Nil,-,Multifunctional,Plaque assay,20347875,Antiviral activity of selected antimicrobial peptides against vaccinia virus.,"Mohan KV, Rao SS, Atreya CD.",Antiviral Res. 2010
AVP1530,RWRW,4,Vaccinia,VACV,Poxviridae,RW2,Synthetic,,Vero,Nil,-,Multifunctional,Plaque assay,20347875,Antiviral activity of selected antimicrobial peptides against vaccinia virus.,"Mohan KV, Rao SS, Atreya CD.",Antiviral Res. 2010
AVP1531,RWRWRW,6,Vaccinia,VACV,Poxviridae,RW3,Synthetic,,Vero,6.5,μM,Multifunctional,Plaque assay,20347875,Antiviral activity of selected antimicrobial peptides against vaccinia virus.,"Mohan KV, Rao SS, Atreya CD.",Antiviral Res. 2010
AVP1532,RWRWRWRW,8,Vaccinia,VACV,Poxviridae,RW4,Synthetic,,Vero,Nil,-,Multifunctional,Plaque assay,20347875,Antiviral activity of selected antimicrobial peptides against vaccinia virus.,"Mohan KV, Rao SS, Atreya CD.",Antiviral Res. 2010
AVP1533,RWRWRWRWRW,10,Vaccinia,VACV,Poxviridae,RW5,Synthetic,,Vero,Nil,-,Multifunctional,Plaque assay,20347875,Antiviral activity of selected antimicrobial peptides against vaccinia virus.,"Mohan KV, Rao SS, Atreya CD.",Antiviral Res. 2010
AVP1534,YQSTCSAVSKGYLSALR,17,Respiratory syncytial virus,RSV,Paramyxoviridae,F2,RSV fusion (F) protein,P03420,Vero,Nil,-,Virus entry,Flow cytometry,17050595,Identification of linear heparin-binding peptides derived from human respiratory syncytial virus fusion glycoprotein that inhibit infectivity.,"Crim RL, Audet SA, Feldman SA, Mostowski HS, Beeler JA.",J Virol. 2007
AVP1535,TSVITIELSNIKKIKCN,17,Respiratory syncytial virus,RSV,Paramyxoviridae,F5,RSV fusion (F) protein,P03420,Vero,Nil,-,Virus entry,Flow cytometry,17050595,Identification of linear heparin-binding peptides derived from human respiratory syncytial virus fusion glycoprotein that inhibit infectivity.,"Crim RL, Audet SA, Feldman SA, Mostowski HS, Beeler JA.",J Virol. 2007
AVP1536,LSNIKKIKCNGTDAKVK,17,Respiratory syncytial virus,RSV,Paramyxoviridae,F6,RSV fusion (F) protein,P03420,Vero,Nil,-,Virus entry,Flow cytometry,17050595,Identification of linear heparin-binding peptides derived from human respiratory syncytial virus fusion glycoprotein that inhibit infectivity.,"Crim RL, Audet SA, Feldman SA, Mostowski HS, Beeler JA.",J Virol. 2007
AVP1537,NNAKKTNVTLSKKRKRR,17,Respiratory syncytial virus,RSV,Paramyxoviridae,F78,RSV fusion (F) protein,P03420,Vero,Nil,-,Virus entry,Flow cytometry,17050595,Identification of linear heparin-binding peptides derived from human respiratory syncytial virus fusion glycoprotein that inhibit infectivity.,"Crim RL, Audet SA, Feldman SA, Mostowski HS, Beeler JA.",J Virol. 2007
AVP1538,KTNVTLSKKRKRRFLGF,17,Respiratory syncytial virus,RSV,Paramyxoviridae,F15,RSV fusion (F) protein,P03420,Vero,Nil,-,Virus entry,Flow cytometry,17050595,Identification of linear heparin-binding peptides derived from human respiratory syncytial virus fusion glycoprotein that inhibit infectivity.,"Crim RL, Audet SA, Feldman SA, Mostowski HS, Beeler JA.",J Virol. 2007
AVP1539,KKRKRRFLGFLLGVGSA,17,Respiratory syncytial virus,RSV,Paramyxoviridae,F16,RSV fusion (F) protein,P03420,Vero,High,-,Virus entry,Flow cytometry,17050595,Identification of linear heparin-binding peptides derived from human respiratory syncytial virus fusion glycoprotein that inhibit infectivity.,"Crim RL, Audet SA, Feldman SA, Mostowski HS, Beeler JA.",J Virol. 2007
AVP1540,KQLLPIVNKQSCSISNI,17,Respiratory syncytial virus,RSV,Paramyxoviridae,F26,RSV fusion (F) protein,P03420,Vero,Low,-,Virus entry,Flow cytometry,17050595,Identification of linear heparin-binding peptides derived from human respiratory syncytial virus fusion glycoprotein that inhibit infectivity.,"Crim RL, Audet SA, Feldman SA, Mostowski HS, Beeler JA.",J Virol. 2007
AVP1541,LLSLINDMPITNDQKKL,17,Respiratory syncytial virus,RSV,Paramyxoviridae,F34,RSV fusion (F) protein,P03420,Vero,Nil,-,Virus entry,Flow cytometry,17050595,Identification of linear heparin-binding peptides derived from human respiratory syncytial virus fusion glycoprotein that inhibit infectivity.,"Crim RL, Audet SA, Feldman SA, Mostowski HS, Beeler JA.",J Virol. 2007
AVP1542,MPITNDQKKLMSNNVQI,17,Respiratory syncytial virus,RSV,Paramyxoviridae,F35,RSV fusion (F) protein,P03420,Vero,Nil,-,Virus entry,Flow cytometry,17050595,Identification of linear heparin-binding peptides derived from human respiratory syncytial virus fusion glycoprotein that inhibit infectivity.,"Crim RL, Audet SA, Feldman SA, Mostowski HS, Beeler JA.",J Virol. 2007
AVP1543,KKLMSNNVQIVRQQSYS,17,Respiratory syncytial virus,RSV,Paramyxoviridae,F36,RSV fusion (F) protein,P03420,Vero,Nil,-,Virus entry,Flow cytometry,17050595,Identification of linear heparin-binding peptides derived from human respiratory syncytial virus fusion glycoprotein that inhibit infectivity.,"Crim RL, Audet SA, Feldman SA, Mostowski HS, Beeler JA.",J Virol. 2007
AVP1544,KEGSNICLTRTDRGWYC,17,Respiratory syncytial virus,RSV,Paramyxoviridae,F44,RSV fusion (F) protein,P03420,Vero,Nil,-,Virus entry,Flow cytometry,17050595,Identification of linear heparin-binding peptides derived from human respiratory syncytial virus fusion glycoprotein that inhibit infectivity.,"Crim RL, Audet SA, Feldman SA, Mostowski HS, Beeler JA.",J Virol. 2007
AVP1545,SSVITSLGAIVSCYGKT,17,Respiratory syncytial virus,RSV,Paramyxoviridae,F55,RSV fusion (F) protein,P03420,Vero,High,-,Virus entry,Flow cytometry,17050595,Identification of linear heparin-binding peptides derived from human respiratory syncytial virus fusion glycoprotein that inhibit infectivity.,"Crim RL, Audet SA, Feldman SA, Mostowski HS, Beeler JA.",J Virol. 2007
AVP1546,GKTKCTASNKNRGIIKT,17,Respiratory syncytial virus,RSV,Paramyxoviridae,F57,RSV fusion (F) protein,P03420,Vero,Nil,-,Virus entry,Flow cytometry,17050595,Identification of linear heparin-binding peptides derived from human respiratory syncytial virus fusion glycoprotein that inhibit infectivity.,"Crim RL, Audet SA, Feldman SA, Mostowski HS, Beeler JA.",J Virol. 2007
AVP1547,IIIVIIVILLSLIAVGL,17,Respiratory syncytial virus,RSV,Paramyxoviridae,F73,RSV fusion (F) protein,P03420,Vero,Nil,-,Virus entry,Flow cytometry,17050595,Identification of linear heparin-binding peptides derived from human respiratory syncytial virus fusion glycoprotein that inhibit infectivity.,"Crim RL, Audet SA, Feldman SA, Mostowski HS, Beeler JA.",J Virol. 2007
AVP1548,VGLLLYCKARSTPVTLS,17,Respiratory syncytial virus,RSV,Paramyxoviridae,F75,RSV fusion (F) protein,P03420,Vero,Nil,-,Virus entry,Flow cytometry,17050595,Identification of linear heparin-binding peptides derived from human respiratory syncytial virus fusion glycoprotein that inhibit infectivity.,"Crim RL, Audet SA, Feldman SA, Mostowski HS, Beeler JA.",J Virol. 2007
AVP1549,AICKRIPNKKPGKKT,15,Respiratory syncytial virus,RSV,Paramyxoviridae,Ga19b,RSV fusion (F) protein,P03423,Vero,Medium,-,Virus entry,Flow cytometry,17050595,Identification of linear heparin-binding peptides derived from human respiratory syncytial virus fusion glycoprotein that inhibit infectivity.,"Crim RL, Audet SA, Feldman SA, Mostowski HS, Beeler JA.",J Virol. 2007
AVP1550,NPTCWAICKRIPNKK,15,Respiratory syncytial virus,RSV,Paramyxoviridae,Ga20b,RSV fusion (F) protein,P03423,Vero,Medium,-,Virus entry,Flow cytometry,17050595,Identification of linear heparin-binding peptides derived from human respiratory syncytial virus fusion glycoprotein that inhibit infectivity.,"Crim RL, Audet SA, Feldman SA, Mostowski HS, Beeler JA.",J Virol. 2007
AVP1551,ENREILKEPVHGVYY,15,Respiratory syncytial virus,RSV,Paramyxoviridae,RT2.2b,RSV fusion (F) protein,Q9QBZ9,Vero,Nil,-,Virus entry,Flow cytometry,17050595,Identification of linear heparin-binding peptides derived from human respiratory syncytial virus fusion glycoprotein that inhibit infectivity.,"Crim RL, Audet SA, Feldman SA, Mostowski HS, Beeler JA.",J Virol. 2007
AVP1552,AKKQRFRHRNRKG,13,Respiratory syncytial virus,RSV,Paramyxoviridae,VN-HBD,RSV fusion (F) protein,P04004,Vero,Nil,-,Virus entry,Flow cytometry,17050595,Identification of linear heparin-binding peptides derived from human respiratory syncytial virus fusion glycoprotein that inhibit infectivity.,"Crim RL, Audet SA, Feldman SA, Mostowski HS, Beeler JA.",J Virol. 2007
AVP1553,ACYCRIPACIAGERRYGTCIYQGRLWAFCC,30,BK virus,BKV,Polyomaviridae,HNP1,Human alpha defensin,P59665,Vero,80,%,Virus entry,Flow cytometry,18782756,Human alpha-defensins inhibit BK virus infection by aggregating virions and blocking binding to host cells.,"Dugan AS, Maginnis MS, Jordan JA, Gasparovic ML, Manley K, Page R, Williams G, Porter E, O'Hara BA, Atwood WJ.",J Biol Chem. 2008
AVP1554,DHYNCVSSGGQCLYSACPIFTKIQGTCYRGKAKCCK,36,BK virus,BKV,Polyomaviridae,HBD1,Human alpha defensin,P60022,Vero,5,%,Virus entry,Flow cytometry,18782756,Human alpha-defensins inhibit BK virus infection by aggregating virions and blocking binding to host cells.,"Dugan AS, Maginnis MS, Jordan JA, Gasparovic ML, Manley K, Page R, Williams G, Porter E, O'Hara BA, Atwood WJ.",J Biol Chem. 2008
AVP1555,DPVTCLKSGAICHPVFCPRRYKQIGTCGLPGTKCCKP,37,BK virus,BKV,Polyomaviridae,HBD2,Human alpha defensin,Q9TT12,Vero,45,%,Virus entry,Flow cytometry,18782756,Human alpha-defensins inhibit BK virus infection by aggregating virions and blocking binding to host cells.,"Dugan AS, Maginnis MS, Jordan JA, Gasparovic ML, Manley K, Page R, Williams G, Porter E, O'Hara BA, Atwood WJ.",J Biol Chem. 2008
AVP1556,ARATCYCRTGRCATRESLSGVCEISGRLYRLCCR,34,BK virus,BKV,Polyomaviridae,HD5,Human alpha defensin,Q01523,Vero,98,%,Virus entry,Flow cytometry,18782756,Human alpha-defensins inhibit BK virus infection by aggregating virions and blocking binding to host cells.,"Dugan AS, Maginnis MS, Jordan JA, Gasparovic ML, Manley K, Page R, Williams G, Porter E, O'Hara BA, Atwood WJ.",J Biol Chem. 2008
AVP1557,PPVYTKDVDISSQISSMNQSLQQSKDYIKEAQKILDTVNPSL,42,Hendra Virus,HeV,Paramyxoviridae,-,HeV fusion (F) protein ,O89342,HeLa,40,nM,Fusion,Luminescence fusion assay,16973588,Inhibition of hendra virus fusion.,"Porotto M, Doctor L, Carta P, Fornabaio M, Greengard O, Kellogg GE, Moscona A.",J Virol. 2006
AVP1558,VYTDKVDISSQISSMNQSLQQSKDYIKEAQKILDTV,36,Hendra Virus,HeV,Paramyxoviridae,-,HeV fusion (F) protein ,O89342,HeLa,40,nM,Fusion,Luminescence fusion assay,16973588,Inhibition of hendra virus fusion.,"Porotto M, Doctor L, Carta P, Fornabaio M, Greengard O, Kellogg GE, Moscona A.",J Virol. 2006
AVP1559,DITLNNSVALDPIDISIELNKAKSDLEESKEWIRRSNQKLDSIGN,46,Hendra Virus,HeV,Paramyxoviridae,-,HPIV3 fusion (F) protein,P06828,HeLa,7.5,nM,Fusion,Luminescence fusion assay,16973588,Inhibition of hendra virus fusion.,"Porotto M, Doctor L, Carta P, Fornabaio M, Greengard O, Kellogg GE, Moscona A.",J Virol. 2006
AVP1560,VALDPIDISIELNKAKSDLEESKEWIRRSNQKLDSI,36,Hendra Virus,HeV,Paramyxoviridae,-,HPIV3 fusion (F) protein,P06828,HeLa,7.5,nM,Fusion,Luminescence fusion assay,16973588,Inhibition of hendra virus fusion.,"Porotto M, Doctor L, Carta P, Fornabaio M, Greengard O, Kellogg GE, Moscona A.",J Virol. 2006
AVP1561,IDISIELNKAKSDLEESKEWIRRSNQKLDSIGNWH,35,Hendra Virus,HeV,Paramyxoviridae,-,HPIV3 fusion (F) protein,P06828,HeLa,5000,nM,Fusion,Luminescence fusion assay,16973588,Inhibition of hendra virus fusion.,"Porotto M, Doctor L, Carta P, Fornabaio M, Greengard O, Kellogg GE, Moscona A.",J Virol. 2006
AVP1562,VANDPIDISIELNKAKSDLEESKEWIRRSNQKLDSI,36,Hendra Virus,HeV,Paramyxoviridae,-,HPIV3 fusion (F) protein,P06828,HeLa,3000,nM,Fusion,Luminescence fusion assay,16973588,Inhibition of hendra virus fusion.,"Porotto M, Doctor L, Carta P, Fornabaio M, Greengard O, Kellogg GE, Moscona A.",J Virol. 2006
AVP1563,VALDPIDISIELNKAKSDLEESKEWIRRSNQKLDSD,36,Hendra Virus,HeV,Paramyxoviridae,-,HPIV3 fusion (F) protein,P06828,HeLa,8000,nM,Fusion,Luminescence fusion assay,16973588,Inhibition of hendra virus fusion.,"Porotto M, Doctor L, Carta P, Fornabaio M, Greengard O, Kellogg GE, Moscona A.",J Virol. 2006
AVP1564,VANDPIDISIELNKAKSDLEESKEWIRRSNQKLDSD,36,Hendra Virus,HeV,Paramyxoviridae,-,HPIV3 fusion (F) protein,P06828,HeLa,>10^4,nM,Fusion,Luminescence fusion assay,16973588,Inhibition of hendra virus fusion.,"Porotto M, Doctor L, Carta P, Fornabaio M, Greengard O, Kellogg GE, Moscona A.",J Virol. 2006
AVP1565,VALDPIDISIELNKAKSDLEESKEWIRR,28,Hendra Virus,HeV,Paramyxoviridae,-,HPIV3 fusion (F) protein,P06828,HeLa,>10^4,nM,Fusion,Luminescence fusion assay,16973588,Inhibition of hendra virus fusion.,"Porotto M, Doctor L, Carta P, Fornabaio M, Greengard O, Kellogg GE, Moscona A.",J Virol. 2006
AVP1566,SIELNKAKSDLEESKEWIRRSNQKLDSI,28,Hendra Virus,HeV,Paramyxoviridae,-,HPIV3 fusion (F) protein,P06828,HeLa,>10^4,nM,Fusion,Luminescence fusion assay,16973588,Inhibition of hendra virus fusion.,"Porotto M, Doctor L, Carta P, Fornabaio M, Greengard O, Kellogg GE, Moscona A.",J Virol. 2006
AVP1567,PPVYTKDVDISSQISSMNQSLQQSKDYIKEAQKILDTVNPSL,42,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,-,HeV fusion (F) protein ,O89342,HeLa,>10^4,nM,Fusion,Luminescence fusion assay,16973588,Inhibition of hendra virus fusion.,"Porotto M, Doctor L, Carta P, Fornabaio M, Greengard O, Kellogg GE, Moscona A.",J Virol. 2006
AVP1568,VYTDKVDISSQISSMNQSLQQSKDYIKEAQKILDTV,36,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,-,HeV fusion (F) protein ,O89342,HeLa,>10^4,nM,Fusion,Luminescence fusion assay,16973588,Inhibition of hendra virus fusion.,"Porotto M, Doctor L, Carta P, Fornabaio M, Greengard O, Kellogg GE, Moscona A.",J Virol. 2006
AVP1569,DITLNNSVALDPIDISIELNKAKSDLEESKEWIRRSNQKLDSIGN,46,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,-,HPIV3 fusion (F) protein,P06828,HeLa,500,nM,Fusion,Luminescence fusion assay,16973588,Inhibition of hendra virus fusion.,"Porotto M, Doctor L, Carta P, Fornabaio M, Greengard O, Kellogg GE, Moscona A.",J Virol. 2006
AVP1570,VALDPIDISIELNKAKSDLEESKEWIRRSNQKLDSI,36,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,-,HPIV3 fusion (F) protein,P06828,HeLa,500,nM,Fusion,Luminescence fusion assay,16973588,Inhibition of hendra virus fusion.,"Porotto M, Doctor L, Carta P, Fornabaio M, Greengard O, Kellogg GE, Moscona A.",J Virol. 2006
AVP1571,IDISIELNKAKSDLEESKEWIRRSNQKLDSIGNWH,35,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,-,HPIV3 fusion (F) protein,P06828,HeLa,1500,nM,Fusion,Luminescence fusion assay,16973588,Inhibition of hendra virus fusion.,"Porotto M, Doctor L, Carta P, Fornabaio M, Greengard O, Kellogg GE, Moscona A.",J Virol. 2006
AVP1572,VANDPIDISIELNKAKSDLEESKEWIRRSNQKLDSI,36,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,-,HPIV3 fusion (F) protein,P06828,HeLa,750,nM,Fusion,Luminescence fusion assay,16973588,Inhibition of hendra virus fusion.,"Porotto M, Doctor L, Carta P, Fornabaio M, Greengard O, Kellogg GE, Moscona A.",J Virol. 2006
AVP1573,VALDPIDISIELNKAKSDLEESKEWIRRSNQKLDSD,36,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,-,HPIV3 fusion (F) protein,P06828,HeLa,350,nM,Fusion,Luminescence fusion assay,16973588,Inhibition of hendra virus fusion.,"Porotto M, Doctor L, Carta P, Fornabaio M, Greengard O, Kellogg GE, Moscona A.",J Virol. 2006
AVP1574,VANDPIDISIELNKAKSDLEESKEWIRRSNQKLDSD,36,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,-,HPIV3 fusion (F) protein,P06828,HeLa,750,nM,Fusion,Luminescence fusion assay,16973588,Inhibition of hendra virus fusion.,"Porotto M, Doctor L, Carta P, Fornabaio M, Greengard O, Kellogg GE, Moscona A.",J Virol. 2006
AVP1575,VALDPIDISIELNKAKSDLEESKEWIRR,28,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,-,HPIV3 fusion (F) protein,P06828,HeLa,>10^4,nM,Fusion,Luminescence fusion assay,16973588,Inhibition of hendra virus fusion.,"Porotto M, Doctor L, Carta P, Fornabaio M, Greengard O, Kellogg GE, Moscona A.",J Virol. 2006
AVP1576,SIELNKAKSDLEESKEWIRRSNQKLDSI,28,Human parainfluenza virus type 3,HPIV 3,Paramyxoviridae,-,HPIV3 fusion (F) protein,P06828,HeLa,>10^4,nM,Fusion,Luminescence fusion assay,16973588,Inhibition of hendra virus fusion.,"Porotto M, Doctor L, Carta P, Fornabaio M, Greengard O, Kellogg GE, Moscona A.",J Virol. 2006
AVP1577,KVDISSQISSMNQSLQQSKDYIKEAQRLLDTVNPSL,37,Hendra Virus,HeV,Paramyxoviridae,NiV FC2,NiV fusion glycoprotein,Q9IH63,HeLa,17.59,nM,Fusion,Immunofluorescence,16026621,Inhibition of Henipavirus fusion and infection by heptad-derived peptides of the Nipah virus fusion glycoprotein.,"Bossart KN, Mungall BA, Crameri G, Wang LF, Eaton BT, Broder CC.",Virol J. 2005
AVP1578,KVDISSQISSMNQSLQQSKDYIKEAQRLLDTVNPSL,37,Nipah virus,NiV,Paramyxoviridae,NiV FC2,NiV fusion glycoprotein,Q9IH63,HeLa,13.08,nM,Fusion,Immunofluorescence,16026621,Inhibition of Henipavirus fusion and infection by heptad-derived peptides of the Nipah virus fusion glycoprotein.,"Bossart KN, Mungall BA, Crameri G, Wang LF, Eaton BT, Broder CC.",Virol J. 2005
AVP1579,FWFTLIKTQAKQPARYRRFC,20,Dengue 2 virus,DENV 2,Flaviviridae,1OAN1,Synthetic,,K562,3,μM,Antibody dependent enhancement effect,ADE inhibition assay,21093488,Viral entry inhibitors block dengue antibody-dependent enhancement in vitro.,"Nicholson CO, Costin JM, Rowe DK, Lin L, Jenwitheesuk E, Samudrala R, Isern S, Michael SF.",Antiviral Res. 2011
AVP1580,MAILGDTAWDFGSLGGVFTSIGKALHQVFGAIY,33,Dengue 2 virus,DENV 2,Flaviviridae,DN59,Synthetic,,K562,6,μM,Antibody dependent enhancement effect,ADE inhibition assay,21093488,Viral entry inhibitors block dengue antibody-dependent enhancement in vitro.,"Nicholson CO, Costin JM, Rowe DK, Lin L, Jenwitheesuk E, Samudrala R, Isern S, Michael SF.",Antiviral Res. 2011
AVP1581,YDPLVFPSDEFDASISQVNEKINQSLAFIRKSDELLHNV,39,Respiratory syncytial virus,RSV,Paramyxoviridae,F478-516,RSV fusion (F) protein,P03420,HEp-2,High,-,Virus entry,Syncitia assay,20534864,Neutralization of human respiratory syncytial virus infectivity by antibodies and low-molecular-weight compounds targeted against the fusion glycoprotein.,"Magro M, Andreu D, Gomez-Puertas P, Melero JA, Palomo C.",J Virol. 2010
AVP1582,LVRDSMAKLRERLNQRQKLFESTQ,24,Murine leukemia virus,MLV,Retroviridae,MLV NH,MLV envelope protein,P03385,HEK293,High,-,Fusion,Luciferase assay,15795264,Inhibition of murine leukemia virus envelope protein (env) processing by intracellular expression of the env N-terminal heptad repeat region.,"Ou W, Silver J.",J Virol. 2005
AVP1583,GINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE,37,SARS coronavirus,SARS-CoV,Coronaviridae,P1,SARS-CoV spike protein,P59594,HeLa,0.62,μM,Virus entry,beta-galactosidase activity,18983873,Identification of a minimal peptide derived from heptad repeat (HR) 2 of spike protein of SARS-CoV and combination of HR1-derived peptides as fusion inhibitors.,"Liu IJ, Kao CL, Hsieh SC, Wey MT, Kan LS, Wang WK.",Antiviral Res. 2009
AVP1584,GINASVVNIQKEIDRLNEVAKNLNESLIDL,30,SARS coronavirus,SARS-CoV,Coronaviridae,P4,SARS-CoV spike protein,P59594,HeLa,0.8,μM,Virus entry,beta-galactosidase activity,18983873,Identification of a minimal peptide derived from heptad repeat (HR) 2 of spike protein of SARS-CoV and combination of HR1-derived peptides as fusion inhibitors.,"Liu IJ, Kao CL, Hsieh SC, Wey MT, Kan LS, Wang WK.",Antiviral Res. 2009
AVP1585,GINASVVNIQKEIDRLNEVAKNL,23,SARS coronavirus,SARS-CoV,Coronaviridae,P6,SARS-CoV spike protein,P59594,HeLa,1.04,μM,Virus entry,beta-galactosidase activity,18983873,Identification of a minimal peptide derived from heptad repeat (HR) 2 of spike protein of SARS-CoV and combination of HR1-derived peptides as fusion inhibitors.,"Liu IJ, Kao CL, Hsieh SC, Wey MT, Kan LS, Wang WK.",Antiviral Res. 2009
AVP1586,QKQIANQFNKAISQIQESLTTTSTALGKLQDVVNQNAQALNTLVKQ,46,SARS coronavirus,SARS-CoV,Coronaviridae,N46,SARS-CoV spike protein,P59594,HeLa,3.97,μM,Virus entry,beta-galactosidase activity,18983873,Identification of a minimal peptide derived from heptad repeat (HR) 2 of spike protein of SARS-CoV and combination of HR1-derived peptides as fusion inhibitors.,"Liu IJ, Kao CL, Hsieh SC, Wey MT, Kan LS, Wang WK.",Antiviral Res. 2009
AVP1587,QNQSANQFQKEISQINEVLTTTNTSLGKLQDDVNQNNQSLNTLQKE,46,SARS coronavirus,SARS-CoV,Coronaviridae,N46eg,SARS-CoV spike protein,P59594,HeLa,5.07,μM,Virus entry,beta-galactosidase activity,18983873,Identification of a minimal peptide derived from heptad repeat (HR) 2 of spike protein of SARS-CoV and combination of HR1-derived peptides as fusion inhibitors.,"Liu IJ, Kao CL, Hsieh SC, Wey MT, Kan LS, Wang WK.",Antiviral Res. 2009
AVP1588,ELQREESPTGPPGSIRTWFQRIPLGWFHCTYQKGKQHCRLRIRQKVEE,48,Ebola virus,EBoV,Filoviridae,delta-Fc,EboV delta peptide,Q7T9E0,Vero E6,25,nM,Virus entry,Flow cytometry,21697477,Ebolavirus delta-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry.,"Radoshitzky SR, Warfield KL, Chi X, Dong L, Kota K, Bradfute SB, Gearhart JD, Retterer C, Kranzusch PJ, Misasi JN, Hogenbirk MA, Wahl-Jensen V, Volchkov VE, Cunningham JM, Jahrling PB, Aman MJ, Bavari S, Farzan M, Kuhn JH.",J Virol. 2011
AVP1589,ELQREESPTGPPGSIRTWFQRIPLGWFH,28,Ebola virus,EBoV,Filoviridae,delta1-28-Fc,EboV delta peptide,Q7T9E0,Vero E6,High,-,Virus entry,Flow cytometry,21697477,Ebolavirus delta-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry.,"Radoshitzky SR, Warfield KL, Chi X, Dong L, Kota K, Bradfute SB, Gearhart JD, Retterer C, Kranzusch PJ, Misasi JN, Hogenbirk MA, Wahl-Jensen V, Volchkov VE, Cunningham JM, Jahrling PB, Aman MJ, Bavari S, Farzan M, Kuhn JH.",J Virol. 2011
AVP1590,ELQREESPTGPPGSIRTWFQRIPLGWFHCTYQK,33,Ebola virus,EBoV,Filoviridae,delta1-33-Fc,EboV delta peptide,Q7T9E0,Vero E6,High,-,Virus entry,Flow cytometry,21697477,Ebolavirus delta-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry.,"Radoshitzky SR, Warfield KL, Chi X, Dong L, Kota K, Bradfute SB, Gearhart JD, Retterer C, Kranzusch PJ, Misasi JN, Hogenbirk MA, Wahl-Jensen V, Volchkov VE, Cunningham JM, Jahrling PB, Aman MJ, Bavari S, Farzan M, Kuhn JH.",J Virol. 2011
AVP1591,ELQREESPTGPPGSIRTWFQRIPLGWFHCTYQKGKQHCR,39,Ebola virus,EBoV,Filoviridae,delta1-39-Fc,EboV delta peptide,Q7T9E0,Vero E6,High,-,Virus entry,Flow cytometry,21697477,Ebolavirus delta-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry.,"Radoshitzky SR, Warfield KL, Chi X, Dong L, Kota K, Bradfute SB, Gearhart JD, Retterer C, Kranzusch PJ, Misasi JN, Hogenbirk MA, Wahl-Jensen V, Volchkov VE, Cunningham JM, Jahrling PB, Aman MJ, Bavari S, Farzan M, Kuhn JH.",J Virol. 2011
AVP1592,GSIRTWFQRIPLGWFHCTYQKGKQHCRLRIRQKVEE,36,Ebola virus,EBoV,Filoviridae,delta13-48-Fc,EboV delta peptide,Q7T9E0,Vero E6,High,-,Virus entry,Flow cytometry,21697477,Ebolavirus delta-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry.,"Radoshitzky SR, Warfield KL, Chi X, Dong L, Kota K, Bradfute SB, Gearhart JD, Retterer C, Kranzusch PJ, Misasi JN, Hogenbirk MA, Wahl-Jensen V, Volchkov VE, Cunningham JM, Jahrling PB, Aman MJ, Bavari S, Farzan M, Kuhn JH.",J Virol. 2011
AVP1593,HCTYQKGKQHCRLRIRQKVEE,21,Ebola virus,EBoV,Filoviridae,delta28-48-Fc,EboV delta peptide,Q7T9E0,Vero E6,High,-,Virus entry,Flow cytometry,21697477,Ebolavirus delta-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry.,"Radoshitzky SR, Warfield KL, Chi X, Dong L, Kota K, Bradfute SB, Gearhart JD, Retterer C, Kranzusch PJ, Misasi JN, Hogenbirk MA, Wahl-Jensen V, Volchkov VE, Cunningham JM, Jahrling PB, Aman MJ, Bavari S, Farzan M, Kuhn JH.",J Virol. 2011
AVP1594,SPTGPPGSIRTWFQRIPLGWFHCTYQKGKQHCRLRIRQKVEE,42,Ebola virus,EBoV,Filoviridae,delta7-48-Fc,EboV delta peptide,Q7T9E0,Vero E6,High,-,Virus entry,Flow cytometry,21697477,Ebolavirus delta-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry.,"Radoshitzky SR, Warfield KL, Chi X, Dong L, Kota K, Bradfute SB, Gearhart JD, Retterer C, Kranzusch PJ, Misasi JN, Hogenbirk MA, Wahl-Jensen V, Volchkov VE, Cunningham JM, Jahrling PB, Aman MJ, Bavari S, Farzan M, Kuhn JH.",J Virol. 2011
AVP1595,WFQRIPLGWFHCTYQKGKQHCRLRIRQKVEE,31,Ebola virus,EBoV,Filoviridae,delta18-48-Fc,EboV delta peptide,Q7T9E0,Vero E6,High,-,Virus entry,Flow cytometry,21697477,Ebolavirus delta-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry.,"Radoshitzky SR, Warfield KL, Chi X, Dong L, Kota K, Bradfute SB, Gearhart JD, Retterer C, Kranzusch PJ, Misasi JN, Hogenbirk MA, Wahl-Jensen V, Volchkov VE, Cunningham JM, Jahrling PB, Aman MJ, Bavari S, Farzan M, Kuhn JH.",J Virol. 2011
AVP1596,ELQREESPTGPPGSIRT,17,Ebola virus,EBoV,Filoviridae,delta1-17-Fc,EboV delta peptide,Q7T9E0,Vero E6,High,-,Virus entry,Flow cytometry,21697477,Ebolavirus delta-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry.,"Radoshitzky SR, Warfield KL, Chi X, Dong L, Kota K, Bradfute SB, Gearhart JD, Retterer C, Kranzusch PJ, Misasi JN, Hogenbirk MA, Wahl-Jensen V, Volchkov VE, Cunningham JM, Jahrling PB, Aman MJ, Bavari S, Farzan M, Kuhn JH.",J Virol. 2011
AVP1597,EEMKKSDEEIKKYIEEIKKVEEESKYDEE,29,Marek's disease virus,MDV,Herpesviridae,gHH1-EK,MDV H glycoprotein (gH),Q9E6P6,CEF,4.0±0.12,mM,Virus entry,Plaque assay,23405092,Interaction domain of glycoproteins gB and gH of Marek's disease virus and identification of an antiviral peptide with dual functions.,"Chi XJ, Lu YX, Zhao P, Li CG, Wang XJ, Wang M.",PLoS One. 2013
AVP1598,HMNASDMEIKSYINMIESVEESSNYDF,27,Marek's disease virus,MDV,Herpesviridae,gHH1,MDV H glycoprotein (gH),Q9E6P6,CEF,4.1±0.26,mM,Virus entry,Plaque assay,23405092,Interaction domain of glycoproteins gB and gH of Marek's disease virus and identification of an antiviral peptide with dual functions.,"Chi XJ, Lu YX, Zhao P, Li CG, Wang XJ, Wang M.",PLoS One. 2013
AVP1599,KKNEEIIKKLEETKKNEEKNKKSEEILKKLEELRKK,36,Marek's disease virus,MDV,Herpesviridae,gHH3-EK,MDV H glycoprotein (gH),Q9E6P6,CEF,6.3±1.16,mM,Virus entry,Plaque assay,23405092,Interaction domain of glycoproteins gB and gH of Marek's disease virus and identification of an antiviral peptide with dual functions.,"Chi XJ, Lu YX, Zhao P, Li CG, Wang XJ, Wang M.",PLoS One. 2013
AVP1600,NADIIKSLIRKTIINASKNTASLSILQHLYVLRS,34,Marek's disease virus,MDV,Herpesviridae,gHH3,MDV H glycoprotein (gH),Q9E6P6,CEF,12.2±0.28,mM,Virus entry,Plaque assay,23405092,Interaction domain of glycoproteins gB and gH of Marek's disease virus and identification of an antiviral peptide with dual functions.,"Chi XJ, Lu YX, Zhao P, Li CG, Wang XJ, Wang M.",PLoS One. 2013
AVP1601,EERKKLGEEIKKEAEEAKKQIEETKKNDEE,30,Marek's disease virus,MDV,Herpesviridae,gHB1-EK,MDV B glycoprotein (gB),P18538,CEF,8.7±1.29,mM,Virus entry,Plaque assay,23405092,Interaction domain of glycoproteins gB and gH of Marek's disease virus and identification of an antiviral peptide with dual functions.,"Chi XJ, Lu YX, Zhao P, Li CG, Wang XJ, Wang M.",PLoS One. 2013
AVP1602,NAHCALL,7,Human cytomegalovirus,HCMV,Herpesviridae,H22-LP,Phage display,,HELF,0.53,ng/ml(EC50),Virus entry,Cytopathic effect,22803320,Anti-HCMV and KSHV effect of a trapping ligand antagonist for herpesvirus-encoded GPCR.,"Liu HA, Sun HX, Mo XM, Li SY, Li XY, Zhang G, Lu L.",Indian J Exp Biol. 2012
AVP1603,NQGRHFCGGALIHARFVMTAASCFQ,25,Adenovirus 5,Ad5,Adenoviridae,CAP3720-44,Antimicrobial peptide CAP37,P20160,A549,High,-,Assembly,Direct time kill assay,19274533,CAP37-derived antimicrobial peptides have in vitro antiviral activity against adenovirus and herpes simplex virus type 1.,"Gordon YJ, Romanowski EG, Shanks RM, Yates KA, Hinsley H, Pereira HA.",Curr Eye Res. 2009
AVP1604,NQGRHFCGGALIHARFVMTAASSFQ,25,Adenovirus 5,Ad5,Adenoviridae,CAP3720-44ser42,Antimicrobial peptide CAP37,P20160,A549,Low,-,Assembly,Direct time kill assay,19274533,CAP37-derived antimicrobial peptides have in vitro antiviral activity against adenovirus and herpes simplex virus type 1.,"Gordon YJ, Romanowski EG, Shanks RM, Yates KA, Hinsley H, Pereira HA.",Curr Eye Res. 2009
AVP1605,NQGRHFSGGALIHARFVMTAASCFQ,25,Adenovirus 5,Ad5,Adenoviridae,CAP3720-44ser26,Antimicrobial peptide CAP37,P20160,A549,Medium,-,Assembly,Direct time kill assay,19274533,CAP37-derived antimicrobial peptides have in vitro antiviral activity against adenovirus and herpes simplex virus type 1.,"Gordon YJ, Romanowski EG, Shanks RM, Yates KA, Hinsley H, Pereira HA.",Curr Eye Res. 2009
AVP1606,NQGRHFSGGALIHARFVMTAASSFQ,25,Adenovirus 5,Ad5,Adenoviridae,CAP3720-44ser26/42,Antimicrobial peptide CAP37,P20160,A549,Nil,-,Assembly,Direct time kill assay,19274533,CAP37-derived antimicrobial peptides have in vitro antiviral activity against adenovirus and herpes simplex virus type 1.,"Gordon YJ, Romanowski EG, Shanks RM, Yates KA, Hinsley H, Pereira HA.",Curr Eye Res. 2009
AVP1607,GKVIDTLTCGFADLMGYI,18,Hepatitis C virus,HCV,Flaviviridae,120-137,HCV core protein,P27958,-,High,-,Assembly,EMSA,22452666,Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.,"Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.",Can J Microbiol. 2012
AVP1608,GWAGWLLSPRGSRPSWGP,18,Hepatitis C virus,HCV,Flaviviridae,92-109,HCV core protein,P27958,-,High,-,Assembly,EMSA,22452666,Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.,"Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.",Can J Microbiol. 2012
AVP1609,LYGNEGCGWAGWLLSPRG,18,Hepatitis C virus,HCV,Flaviviridae,85-102,HCV core protein,P27958,-,High,-,Assembly,EMSA,22452666,Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.,"Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.",Can J Microbiol. 2012
AVP1610,QPGYPWPLYGNEGCGWAG,18,Hepatitis C virus,HCV,Flaviviridae,78-95,HCV core protein,P27958,-,High,-,Assembly,EMSA,22452666,Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.,"Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.",Can J Microbiol. 2012
AVP1611,RLGVRATRKTSERSQPRG,18,Hepatitis C virus,HCV,Flaviviridae,43-60,HCV core protein,P27958,-,High,-,Assembly,EMSA,22452666,Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.,"Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.",Can J Microbiol. 2012
AVP1612,TCGFADLMGYIPLVGAPL,18,Hepatitis C virus,HCV,Flaviviridae,127-144,HCV core protein,P27958,-,High,-,Assembly,EMSA,22452666,Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.,"Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.",Can J Microbiol. 2012
AVP1613,VKFPGGGQIVGGVYLLPR,18,Hepatitis C virus,HCV,Flaviviridae,22-39,HCV core protein,P27958,-,High,-,Assembly,EMSA,22452666,Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.,"Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.",Can J Microbiol. 2012
AVP1614,TVSSGADTEDVVC,13,Hepatitis C virus,HCV,Flaviviridae,2407-2419,HCV non-structural protein 5A,P27958,-,High,-,Assembly,EMSA,22452666,Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.,"Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.",Can J Microbiol. 2012
AVP1615,ARALAHGVRVLEDGVNYA,18,Hepatitis C virus,HCV,Flaviviridae,148-165,HCV core protein,P27958,-,Low,-,Assembly,EMSA,22452666,Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.,"Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.",Can J Microbiol. 2012
AVP1616,GAPLGGAARALAHGVRVL,18,Hepatitis C virus,HCV,Flaviviridae,141-158,HCV core protein,P27958,-,Low,-,Assembly,EMSA,22452666,Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.,"Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.",Can J Microbiol. 2012
AVP1617,LLPRRGPRLGVRATRKTS,18,Hepatitis C virus,HCV,Flaviviridae,36-53,HCV core protein,P27958,-,Low,-,Assembly,EMSA,22452666,Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.,"Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.",Can J Microbiol. 2012
AVP1618,MGYIPLVGAPLGGAARAL,18,Hepatitis C virus,HCV,Flaviviridae,134-151,HCV core protein,P27958,-,Low,-,Assembly,EMSA,22452666,Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.,"Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.",Can J Microbiol. 2012
AVP1619,MSTNPKPQRKTKRNTNRR,18,Hepatitis C virus,HCV,Flaviviridae,43101,HCV core protein,P27958,-,Low,-,Assembly,EMSA,22452666,Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.,"Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.",Can J Microbiol. 2012
AVP1620,PEGRTWAQPGYPWPLYGN,18,Hepatitis C virus,HCV,Flaviviridae,71-88,HCV core protein,P27958,-,Low,-,Assembly,EMSA,22452666,Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.,"Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.",Can J Microbiol. 2012
AVP1621,PIPKARRPEGRTWAQPGY,18,Hepatitis C virus,HCV,Flaviviridae,64-81,HCV core protein,P27958,-,Low,-,Assembly,EMSA,22452666,Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.,"Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.",Can J Microbiol. 2012
AVP1622,QIVGGVYLLPRRGPRLGV,18,Hepatitis C virus,HCV,Flaviviridae,29-46,HCV core protein,P27958,-,Low,-,Assembly,EMSA,22452666,Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.,"Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.",Can J Microbiol. 2012
AVP1623,QPRGRRQPIPKARRPEGR,18,Hepatitis C virus,HCV,Flaviviridae,57-74,HCV core protein,P27958,-,Low,-,Assembly,EMSA,22452666,Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.,"Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.",Can J Microbiol. 2012
AVP1624,QRKTKRNTNRRPQDVKFP,18,Hepatitis C virus,HCV,Flaviviridae,45870,HCV core protein,P27958,-,Low,-,Assembly,EMSA,22452666,Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.,"Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.",Can J Microbiol. 2012
AVP1625,RKTSERSQPRGRRQPIPK,18,Hepatitis C virus,HCV,Flaviviridae,50-67,HCV core protein,P27958,-,Low,-,Assembly,EMSA,22452666,Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.,"Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.",Can J Microbiol. 2012
AVP1626,RRRSRNLGKVIDTLTCGF,18,Hepatitis C virus,HCV,Flaviviridae,113-130,HCV core protein,P27958,-,Low,-,Assembly,EMSA,22452666,Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.,"Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.",Can J Microbiol. 2012
AVP1627,SPRGSRPSWGPTDPRRRS,18,Hepatitis C virus,HCV,Flaviviridae,99-116,HCV core protein,P27958,-,Low,-,Assembly,EMSA,22452666,Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.,"Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.",Can J Microbiol. 2012
AVP1628,SWGPTDPRRRSRNLGKVI,18,Hepatitis C virus,HCV,Flaviviridae,106-123,HCV core protein,P27958,-,Low,-,Assembly,EMSA,22452666,Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.,"Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.",Can J Microbiol. 2012
AVP1629,TNRRPQDVKFPGGGQIVG,18,Hepatitis C virus,HCV,Flaviviridae,15-32,HCV core protein,P27958,-,Low,-,Assembly,EMSA,22452666,Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.,"Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.",Can J Microbiol. 2012
AVP1630,VRVLEDGVNYATGNLPGC,18,Hepatitis C virus,HCV,Flaviviridae,155-172,HCV core protein,P27958,-,Low,-,Assembly,EMSA,22452666,Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.,"Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.",Can J Microbiol. 2012
AVP1631,DGSWSTVSSGADTED,15,Hepatitis C virus,HCV,Flaviviridae,2402-2416,HCV non-structural protein 5A,P27958,-,Low,-,Assembly,EMSA,22452666,Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.,"Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.",Can J Microbiol. 2012
AVP1632,PGDPDLSDGSWSTVSSGA,18,Hepatitis C virus,HCV,Flaviviridae,2395-2412,HCV non-structural protein 5A,P27958,-,Low,-,Assembly,EMSA,22452666,Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.,"Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.",Can J Microbiol. 2012
AVP1633,FYHSKRRLIFSKRKP,15,Hepatitis C virus,HCV,Flaviviridae,150-164,Host p21 protein,P38936,-,Nil,-,Assembly,EMSA,22452666,Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.,"Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.",Can J Microbiol. 2012
AVP1634,GRKRRQTSMTDFYHS,15,Hepatitis C virus,HCV,Flaviviridae,139-153,Host p21 protein,P38936,-,Nil,-,Assembly,EMSA,22452666,Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.,"Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.",Can J Microbiol. 2012
AVP1635,SMTDFYHSKRRLIFS,15,Hepatitis C virus,HCV,Flaviviridae,146-160,Host p21 protein,P38936,-,Nil,-,Assembly,EMSA,22452666,Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.,"Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.",Can J Microbiol. 2012
AVP1636,AFKQSPPAIPALGTN,15,Hepatitis C virus,HCV,Flaviviridae,321-335,Host p73 protein,Q9JJP2,-,Nil,-,Assembly,EMSA,22452666,Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.,"Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.",Can J Microbiol. 2012
AVP1637,AIPALGTNVKKRRHG,15,Hepatitis C virus,HCV,Flaviviridae,328-342,Host p73 protein,Q9JJP2,-,Nil,-,Assembly,EMSA,22452666,Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.,"Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.",Can J Microbiol. 2012
AVP1638,QSPPAIPALGTNVKK,15,Hepatitis C virus,HCV,Flaviviridae,324-338,Host p73 protein,Q9JJP2,-,Nil,-,Assembly,EMSA,22452666,Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.,"Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.",Can J Microbiol. 2012
AVP1639,RRHGDEDMFYMHVRG,15,Hepatitis C virus,HCV,Flaviviridae,339-353,Host p73 protein,Q9JJP2,-,Nil,-,Assembly,EMSA,22452666,Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.,"Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.",Can J Microbiol. 2012
AVP1640,VKKRRHGDEDMFYMH,15,Hepatitis C virus,HCV,Flaviviridae,336-350,Host p73 protein,Q9JJP2,-,Nil,-,Assembly,EMSA,22452666,Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.,"Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.",Can J Microbiol. 2012
AVP1641,KKKKYRNIRRPG,12,SARS coronavirus,SARS-CoV,Coronaviridae,EPL5,Combinatorial peptide library,,-,45,μg/ml,Virus entry,ELISA,18383098,"Design, synthesis and screening of antisense peptide based combinatorial peptide libraries towards an aromatic region of SARS-CoV.","Huang Y, Zhao R, Luo J, Xiong S, Shangguan D, Zhang H, Liu G, Chen Y.",J Mol Recognit. 2008
AVP1642,MARHRNWPLVMV,12,Hepatitis C virus,HCV,Flaviviridae,PE2D,Ribosome display library,,Huh7.5.1,High,-,Virus entry,Flow cytometry,20479194,Functional selection of hepatitis C virus envelope E2-binding Peptide ligands by using ribosome display.,"Chen F, Zhao Y, Liu M, Li D, Wu H, Chen H, Zhu Y, Luo F, Zhong J, Zhou Y, Qi Z, Zhang XL.",Antimicrob Agents Chemother. 2010
AVP1643,CTNPESLTC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,9,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1644,CTTHISQTC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,9,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1645,CKHHNWWTC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,12,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1646,CSLRTYAAC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,12,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1647,CFSSARLSC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,13,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1648,CHPSKALQC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,13,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1649,CERLNLPQC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,14,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1650,CTDNALKAC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,15,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1651,CQRTTEANC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,16,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1652,CTGYHNNTC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,16,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1653,CYKMDNHTC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,19,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1654,CHVLDPHLC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,21,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1655,CSQWLQGS,8,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,22,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1656,CNSMWVRNC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,25,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1657,CSRNHILTC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,25,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1658,CVMSKHQHC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,30,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1659,CLMGSSHSC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,32,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1660,CPSHYTQAC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,34,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1661,CDLLLPGRC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,35,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1662,CHTLPHTKC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,35,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1663,CSTTNATWC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,36,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1664,CHADQLPMC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,39,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1665,CHGSTKWAC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,39,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1666,CYRTQFTQC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,39,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1667,CTPGRSATC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,40,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1668,CTPLSTLQC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,40,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1669,CLPTPHHVC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,41,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1670,CQLSLAPYC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,41,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1671,CTFHSPRFC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,43,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1672,CNPMHSRTC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,44,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1673,CGPSLRGVC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,45,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1674,CKPSTSGQC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,45,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1675,CYATTLGAC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,45,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1676,CFNTHTANC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,47,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1677,CNKQFSAAC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,48,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1678,CPGHHLSHC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,48,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1679,CSPYAKHNC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,50,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1680,CNSPKGKPC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,53,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1681,CHSLRNAFC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,56,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1682,CQGSPYRHC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,59,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1683,CQWPGQSGC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,60,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1684,CSAGAPEFC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,60,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1685,CKSFTTTRC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,61,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1686,CNSSSPTAC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,61,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1687,CQVLNGNHC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,61,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1688,CTQSGLLSC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,61,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1689,CTYPYPKFC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,64,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1690,CHQLMQNLC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,65,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1691,CKSTFSPNC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,65,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1692,CQPHLPWHC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,68,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1693,CTSAAVHMC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,68,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1694,CQATTARNC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,78,%,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1695,CPFVKTQLC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,263,μM,Virus entry,Focus reduction assay,17441904,Characterization and NMR solution structure of a novel cyclic pentapeptide inhibitor of pathogenic hantaviruses.,"Hall PR, Malone L, Sillerud LO, Ye C, Hjelle BL, Larson RS.",Chem Biol Drug Des. 2007
AVP1696,CPFVC,5,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,267,μM,Virus entry,Focus reduction assay,17441904,Characterization and NMR solution structure of a novel cyclic pentapeptide inhibitor of pathogenic hantaviruses.,"Hall PR, Malone L, Sillerud LO, Ye C, Hjelle BL, Larson RS.",Chem Biol Drug Des. 2007
AVP1697,CLVRNLAWC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,1.0x10^6,phage/μl,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1698,CQTTNWNTC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,3.5x10^5,phage/μl,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1699,CSASTESLC,9,Sin nombre virus,SNV,Bunyaviridae,-,Phage display,,Vero E6,7x10^8,phage/μl,Virus entry,Focus reduction assay,18391034,Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.,"Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.",Antimicrob Agents Chemother. 2008
AVP1700,FLHFLHHLF,9,Hepatitis C virus,HCV,Flaviviridae,Ctry2459-H3,Scorpion venom,Q8I0K7,Huh7.5.1,0.85,EC50(μg/ml),Virucidal,RT PCR,23415044,Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus.,"Hong W, Zhang R, Di Z, He Y, Zhao Z, Hu J, Wu Y, Li W, Cao Z.",Biomaterials. 2013
AVP1701,FLGFLHHLF,9,Hepatitis C virus,HCV,Flaviviridae,Ctry2459-H2,Scorpion venom,Q8I0K7,Huh7.5.1,1.08,EC50(μg/ml),Virucidal,RT PCR,23415044,Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus.,"Hong W, Zhang R, Di Z, He Y, Zhao Z, Hu J, Wu Y, Li W, Cao Z.",Biomaterials. 2013
AVP1702,FLGFLKNLF,9,Hepatitis C virus,HCV,Flaviviridae,Ctry2459,Scorpion venom,Q8I0K7,Huh7.5.1,1.84,EC50(μg/ml),Virucidal,RT PCR,23415044,Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus.,"Hong W, Zhang R, Di Z, He Y, Zhao Z, Hu J, Wu Y, Li W, Cao Z.",Biomaterials. 2013
AVP1703,AKVTMTCSAS,10,Influenza A virus,INFV A,Orthomyxoviridae,Killer decapeptide (KP),Yeast killer toxin,Q00948,LLC-MK2,2.686x10^-6,mol/liter,Replication,Hemagglutinin assay,18824612,Therapeutic activity of an anti-idiotypic antibody-derived killer peptide against influenza A virus experimental infection.,"Conti G, Magliani W, Conti S, Nencioni L, Sgarbanti R, Palamara AT, Polonelli L.",Antimicrob Agents Chemother. 2008
AVP1704,LGCETAALRLGIKLTQHYFGLLTAFGSNFGTIG,33,Sendai virus,SeV,Paramyxoviridae,SV-197,SeV fusion protein,P04856,Human RBCs,High,-,Hemolysis,Hemagglutinin assay,10995225,Sendai virus internal fusion peptide: structural and functional characterization and a plausible mode of viral entry inhibition.,"Ghosh JK, Peisajovich SG, Shai Y.",Biochemistry. 2000
AVP1705,ISGINASVVNIQEEIKKLNEEAKKLNESLIDLQEL,35,SARS coronavirus,SARS-CoV,Coronaviridae,SR9EK13,SARS-CoV spike protein,P59594,Vero E6,4,nM,Virus entry,ELISA,17942557,Heptad repeat-derived peptides block protease-mediated direct entry from the cell surface of severe acute respiratory syndrome coronavirus but not entry via the endosomal pathway.,"Ujike M, Nishikawa H, Otaka A, Yamamoto N, Yamamoto N, Matsuoka M, Kodama E, Fujii N, Taguchi F.",J Virol. 2008
AVP1706,ISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL,35,SARS coronavirus,SARS-CoV,Coronaviridae,SR9,SARS-CoV spike protein,P59594,Vero E6,5,nM,Virus entry,ELISA,17942557,Heptad repeat-derived peptides block protease-mediated direct entry from the cell surface of severe acute respiratory syndrome coronavirus but not entry via the endosomal pathway.,"Ujike M, Nishikawa H, Otaka A, Yamamoto N, Yamamoto N, Matsuoka M, Kodama E, Fujii N, Taguchi F.",J Virol. 2008
AVP1707,IEEINKKVEEIQKKIEELNKKAEELNKKLEELQKK,35,SARS coronavirus,SARS-CoV,Coronaviridae,SR9EK1,SARS-CoV spike protein,P59594,Vero E6,>100,μM,Virus entry,ELISA,17942557,Heptad repeat-derived peptides block protease-mediated direct entry from the cell surface of severe acute respiratory syndrome coronavirus but not entry via the endosomal pathway.,"Ujike M, Nishikawa H, Otaka A, Yamamoto N, Yamamoto N, Matsuoka M, Kodama E, Fujii N, Taguchi F.",J Virol. 2008
AVP1708,PRPISYLKGSSGGPL,15,Hepatitis C virus,HCV,Flaviviridae,NS3proC-C15,HCV NS3 Protease,P26662,Huh7,5,μmol/l,Translation,ELISA,22910295,Inhibition of the interaction between NS3 protease and HCV IRES with a small peptide: a novel therapeutic strategy.,"Ray U, Roy CL, Kumar A, Mani P, Joseph AP, Sudha G, Sarkar DP, Srinivasan N, Das S.",Mol Ther. 2013
AVP1709,WSFFSNI,7,Hepatitis B virus,HBV,Hepadnaviridae,-,Phage display,,E. coli,18.5,μM(Kd),Assembly,Isothermal titration calorimetery,17918821,Interactions of hepatitis B core antigen and peptide inhibitors.,"Tang KF, Abdullah MP, Yusoff K, Tan WS.",J Med Chem. 2007
AVP1710,MHRSLLGRMKGA,12,Hepatitis B virus,HBV,Hepadnaviridae,-,Phage display,,E. coli,79.4,μM(Kd),Assembly,Isothermal titration calorimetery,17918821,Interactions of hepatitis B core antigen and peptide inhibitors.,"Tang KF, Abdullah MP, Yusoff K, Tan WS.",J Med Chem. 2007
AVP1711,DPTARLQLEARLQHLVAEILEREQSLALHA,30,Herpes simplex virus 1,HSV 1,Herpesviridae,pep-gHwt30,HSV-1 H glycoprotein (gH),Q9DHD5,J-nectin 1,50,%,Virus entry,LacZ assay,15890943,"A heptad repeat in herpes simplex virus 1 gH, located downstream of the alpha-helix with attributes of a fusion peptide, is critical for virus entry and fusion.","Gianni T, Menotti L, Campadelli-Fiume G.",J Virol. 2005
AVP1712,TARLQLEARLQHLVAEILEREQSLA,25,Herpes simplex virus 1,HSV 1,Herpesviridae,pep-gHwt25,HSV-1 H glycoprotein (gH),Q9DHD5,J-nectin 1,500,μM,Virus entry,LacZ assay,15890943,"A heptad repeat in herpes simplex virus 1 gH, located downstream of the alpha-helix with attributes of a fusion peptide, is critical for virus entry and fusion.","Gianni T, Menotti L, Campadelli-Fiume G.",J Virol. 2005
AVP1713,AQLLESVLQEERILALHAQARERLT,25,Herpes simplex virus 1,HSV 1,Herpesviridae,pep-gHscr25,HSV-1 H glycoprotein (gH),Q9DHD5,J-nectin 1,Nil,-,Virus entry,LacZ assay,15890943,"A heptad repeat in herpes simplex virus 1 gH, located downstream of the alpha-helix with attributes of a fusion peptide, is critical for virus entry and fusion.","Gianni T, Menotti L, Campadelli-Fiume G.",J Virol. 2005
AVP1714,QPELAPEDPEDSALLEDPVGTVAPQ,25,Herpes simplex virus 1,HSV 1,Herpesviridae,pep-gD265-289,HSV-1 H glycoprotein (gH),Q9DHD5,J-nectin 1,Nil,-,Virus entry,LacZ assay,15890943,"A heptad repeat in herpes simplex virus 1 gH, located downstream of the alpha-helix with attributes of a fusion peptide, is critical for virus entry and fusion.","Gianni T, Menotti L, Campadelli-Fiume G.",J Virol. 2005
AVP1715,EVVLFLLNVF,10,Enterovirus 71,EV 71,Picornaviridae,vFLIP,Anti- FLICE-like inhibitory protein (FLIP) peptides,F5HEZ4,MRC-5,5.9±0.2,log10 TCID50/ml,Replication,Light microscopy,22960766,Antiviral protection against enterovirus 71 mediated by autophagy induction following FLICE-inhibitory protein inactivation.,"Won M, Jun EJ, Khim M, Hong SH, Park NH, Kim YK, Lee H.",Virus Res. 2012
AVP1716,TLKPIFKLPLGINITNFR,18,SARS coronavirus,SARS-CoV,Coronaviridae,peptide 9626,SARS-CoV spike protein,P59594,293T,11,μM,Virus entry,Luciferase assay,19853613,Identification of a new region of SARS-CoV S protein critical for viral entry.,"Guo Y, Tisoncik J, McReynolds S, Farzan M, Prabhakar BS, Gallagher T, Rong L, Caffrey M.",J Mol Biol. 2009
AVP1717,ISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL,35,SARS coronavirus,SARS-CoV,Coronaviridae,HR2,SARS-CoV spike protein,P59594,Vero E3,0.34,μM(EC50),Virus entry,Luciferase assay,18442051,Fusion core structure of the severe acute respiratory syndrome coronavirus (SARS-CoV): in search of potent SARS-CoV entry inhibitors.,"Chu LH, Chan SH, Tsai SN, Wang Y, Cheng CH, Wong KB, Waye MM, Ngai SM.",J Cell Biochem. 2008
AVP1718,YENQKQIANQFNKAISQIQESLTTTSTA,28,SARS coronavirus,SARS-CoV,Coronaviridae,HR1-a,SARS-CoV spike protein,P59594,Vero E3,1.16,μM(EC50),Virus entry,Luciferase assay,18442051,Fusion core structure of the severe acute respiratory syndrome coronavirus (SARS-CoV): in search of potent SARS-CoV entry inhibitors.,"Chu LH, Chan SH, Tsai SN, Wang Y, Cheng CH, Wong KB, Waye MM, Ngai SM.",J Cell Biochem. 2008
AVP1719,DVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYI,48,SARS coronavirus,SARS-CoV,Coronaviridae,GST-removed HR2,SARS-CoV spike protein,P59594,Vero E3,2.15,μM(EC50),Virus entry,Luciferase assay,18442051,Fusion core structure of the severe acute respiratory syndrome coronavirus (SARS-CoV): in search of potent SARS-CoV entry inhibitors.,"Chu LH, Chan SH, Tsai SN, Wang Y, Cheng CH, Wong KB, Waye MM, Ngai SM.",J Cell Biochem. 2008
AVP1720,IQESLTTTSTALGKLQDVVNQNAQALNTLVKQLSS,35,SARS coronavirus,SARS-CoV,Coronaviridae,HR1-b,SARS-CoV spike protein,P59594,Vero E3,ND,μM(EC50),Virus entry,Luciferase assay,18442051,Fusion core structure of the severe acute respiratory syndrome coronavirus (SARS-CoV): in search of potent SARS-CoV entry inhibitors.,"Chu LH, Chan SH, Tsai SN, Wang Y, Cheng CH, Wong KB, Waye MM, Ngai SM.",J Cell Biochem. 2008
AVP1721,YENQKQIANQFNKAISQIQESLTTTSTALGKLQDVVNQNAQALNTLVKQLSSNFGAISSV,60,SARS coronavirus,SARS-CoV,Coronaviridae,His6-HR1,SARS-CoV spike protein,P59594,Vero E3,ND,μM(EC50),Virus entry,Luciferase assay,18442051,Fusion core structure of the severe acute respiratory syndrome coronavirus (SARS-CoV): in search of potent SARS-CoV entry inhibitors.,"Chu LH, Chan SH, Tsai SN, Wang Y, Cheng CH, Wong KB, Waye MM, Ngai SM.",J Cell Biochem. 2008
AVP1722,FGGASCCLYCRCHIDHPNPKGFCDLKGKY,29,SARS coronavirus,SARS-CoV,Coronaviridae,K29,SARS-CoV non- structural protein 10,P0C6U8,E. coli,160,μM,Replication,MTase Activity assay,22659295,Short peptides derived from the interaction domain of SARS coronavirus nonstructural protein nsp10 can suppress the 2'-O-methyltransferase activity of nsp10/nsp16 complex.,"Ke M, Chen Y, Wu A, Sun Y, Su C, Wu H, Jin X, Tao J, Wang Y, Ma X, Pan JA, Guo D.",Virus Res. 2012
AVP1723,GGASCCLYCRCH,12,SARS coronavirus,SARS-CoV,Coronaviridae,K12,SARS-CoV non- structural protein 10,P0C6U8,E. coli,160,μM,Replication,MTase Activity assay,22659295,Short peptides derived from the interaction domain of SARS coronavirus nonstructural protein nsp10 can suppress the 2'-O-methyltransferase activity of nsp10/nsp16 complex.,"Ke M, Chen Y, Wu A, Sun Y, Su C, Wu H, Jin X, Tao J, Wang Y, Ma X, Pan JA, Guo D.",Virus Res. 2012
AVP1724,DLKGKYVQIP,10,SARS coronavirus,SARS-CoV,Coronaviridae,K10,SARS-CoV non- structural protein 10,P0C6U8,E. coli,Low,μM,Replication,MTase Activity assay,22659295,Short peptides derived from the interaction domain of SARS coronavirus nonstructural protein nsp10 can suppress the 2'-O-methyltransferase activity of nsp10/nsp16 complex.,"Ke M, Chen Y, Wu A, Sun Y, Su C, Wu H, Jin X, Tao J, Wang Y, Ma X, Pan JA, Guo D.",Virus Res. 2012
AVP1725,NCVKMLCTHTGTGQAITVTP,20,SARS coronavirus,SARS-CoV,Coronaviridae,K20,SARS-CoV non- structural protein 10,P0C6U8,E. coli,Low,μM,Replication,MTase Activity assay,22659295,Short peptides derived from the interaction domain of SARS coronavirus nonstructural protein nsp10 can suppress the 2'-O-methyltransferase activity of nsp10/nsp16 complex.,"Ke M, Chen Y, Wu A, Sun Y, Su C, Wu H, Jin X, Tao J, Wang Y, Ma X, Pan JA, Guo D.",Virus Res. 2012
AVP1726,PTTCANDP,8,SARS coronavirus,SARS-CoV,Coronaviridae,K8,SARS-CoV non- structural protein 10,P0C6U8,E. coli,Low,μM,Replication,MTase Activity assay,22659295,Short peptides derived from the interaction domain of SARS coronavirus nonstructural protein nsp10 can suppress the 2'-O-methyltransferase activity of nsp10/nsp16 complex.,"Ke M, Chen Y, Wu A, Sun Y, Su C, Wu H, Jin X, Tao J, Wang Y, Ma X, Pan JA, Guo D.",Virus Res. 2012
AVP1727,HRILMRIRAMMT,12,Porcine reproductive and respiratory syndrome Virus,PRRSV,Arteriviridae,9-P9,Phage display,,MARC-145,34.13563,μM,Replication,MTT assay,22743126,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,"Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P.",Virology. 2012
AVP1728,HRALMRIRQMMT,12,Porcine reproductive and respiratory syndrome Virus,PRRSV,Arteriviridae,3-P9,Phage display,,MARC-145,34.18095,μM,Replication,MTT assay,22743126,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,"Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P.",Virology. 2012
AVP1729,HRILMRIR,8,Porcine reproductive and respiratory syndrome Virus,PRRSV,Arteriviridae,b-p9,Phage display,,MARC-145,43.50202,μM,Replication,MTT assay,22743126,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,"Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P.",Virology. 2012
AVP1730,HRIAMRIRQMMT,12,Porcine reproductive and respiratory syndrome Virus,PRRSV,Arteriviridae,4-P9,Phage display,,MARC-145,54.5872,μM,Replication,MTT assay,22743126,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,"Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P.",Virology. 2012
AVP1731,HRILMRIRQMMT,12,Porcine reproductive and respiratory syndrome Virus,PRRSV,Arteriviridae,p9,Phage display,,MARC-145,56,μM,Replication,MTT assay,22743126,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,"Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P.",Virology. 2012
AVP1732,ARILMRIRQMMT,12,Porcine reproductive and respiratory syndrome Virus,PRRSV,Arteriviridae,1-P9,Phage display,,MARC-145,56.12263,μM,Replication,MTT assay,22743126,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,"Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P.",Virology. 2012
AVP1733,HRILMRIRQAMT,12,Porcine reproductive and respiratory syndrome Virus,PRRSV,Arteriviridae,10-P9,Phage display,,MARC-145,57.98146,μM,Replication,MTT assay,22743126,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,"Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P.",Virology. 2012
AVP1734,HRILMRIAQMMT,12,Porcine reproductive and respiratory syndrome Virus,PRRSV,Arteriviridae,8-P9,Phage display,,MARC-145,60.60846,μM,Replication,MTT assay,22743126,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,"Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P.",Virology. 2012
AVP1735,RLNNRARIILRA,12,Mink enteritis virus,MEV,Parvoviridae,Pr,Phage display,,F81,High,-,Virus entry,MTT assay,23238955,Selection of antiviral peptides against mink enteritis virus using a phage display Peptide library.,"Zhang Q, Wang Y, Ji Q, Gu J, Liu S, Feng X, Sun C, Li Y, Lei L.",Curr Microbiol. 2013
AVP1736,LAHKSRLYERHM,12,Mink enteritis virus,MEV,Parvoviridae,Pl,Phage display,,F81,High,-,Virus entry,MTT assay,23238955,Selection of antiviral peptides against mink enteritis virus using a phage display Peptide library.,"Zhang Q, Wang Y, Ji Q, Gu J, Liu S, Feng X, Sun C, Li Y, Lei L.",Curr Microbiol. 2013
AVP1737,HRILMRIRQMMA,12,Porcine reproductive and respiratory syndrome Virus,PRRSV,Arteriviridae,12-P9,Phage display,,MARC-145,89.41235,μM,Replication,MTT assay,22743126,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,"Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P.",Virology. 2012
AVP1738,HRILMRIRQMAT,12,Porcine reproductive and respiratory syndrome Virus,PRRSV,Arteriviridae,11-P9,Phage display,,MARC-145,120.5239,μM,Replication,MTT assay,22743126,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,"Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P.",Virology. 2012
AVP1739,HRILMRARQMMT,12,Porcine reproductive and respiratory syndrome Virus,PRRSV,Arteriviridae,7-P9,Phage display,,MARC-145,150.1405,μM,Replication,MTT assay,22743126,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,"Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P.",Virology. 2012
AVP1740,LMRIRQMMT,9,Porcine reproductive and respiratory syndrome Virus,PRRSV,Arteriviridae,a-p9,Phage display,,MARC-145,263.8101,μM,Replication,MTT assay,22743126,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,"Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P.",Virology. 2012
AVP1741,HRILARIRQMMT,12,Porcine reproductive and respiratory syndrome Virus,PRRSV,Arteriviridae,5-P9,Phage display,,MARC-145,435.4996,μM,Replication,MTT assay,22743126,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,"Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P.",Virology. 2012
AVP1742,LMRIR,5,Porcine reproductive and respiratory syndrome Virus,PRRSV,Arteriviridae,c-p9,Phage display,,MARC-145,716.4193,μM,Replication,MTT assay,22743126,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,"Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P.",Virology. 2012
AVP1743,HAILMRIRQMMT,12,Porcine reproductive and respiratory syndrome Virus,PRRSV,Arteriviridae,2-P9,Phage display,,MARC-145,ND,μM,Replication,MTT assay,22743126,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,"Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P.",Virology. 2012
AVP1744,HRILMAIRQMMT,12,Porcine reproductive and respiratory syndrome Virus,PRRSV,Arteriviridae,6-P9,Phage display,,MARC-145,ND,μM,Replication,MTT assay,22743126,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,"Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P.",Virology. 2012
AVP1745,EVSHPKVG,8,Newcastle disease virus,NDV,Paramyxoviridae,-,Phage display,,CEF,Medium,-,Neutralization sites,NDV neutralization assay,16397382,Identification and characterization of peptides binding to newcastle disease virus by phage display.,"Ozawa M, Ohashi K, Onuma M.",J Vet Med Sci. 2005
AVP1746,SGGSNRSP,8,Newcastle disease virus,NDV,Paramyxoviridae,-,Phage display,,CEF,Medium,-,Neutralization sites,NDV neutralization assay,16397382,Identification and characterization of peptides binding to newcastle disease virus by phage display.,"Ozawa M, Ohashi K, Onuma M.",J Vet Med Sci. 2005
AVP1747,WVTTSNQW,8,Newcastle disease virus,NDV,Paramyxoviridae,-,Phage display,,CEF,Medium,-,Neutralization sites,NDV neutralization assay,16397382,Identification and characterization of peptides binding to newcastle disease virus by phage display.,"Ozawa M, Ohashi K, Onuma M.",J Vet Med Sci. 2005
AVP1748,FFLLFLQGAAGNSVLCRIRGGRCHVGSCHFPERHIGRCSGFQACCIRTWG,50,Duck hepaptitis virus,DHV,Picornaviridae,AvBD16,Duck beta defensin,Q9DG58,Duck embryo,High,-,Replication,Neutralization assay,23112840,"Identification, expression and activity analyses of five novel duck beta-defensins.","Ma D, Zhang K, Zhang M, Xin S, Liu X, Han Z, Shao Y, Liu S.",PLoS One. 2012
AVP1749,MQILPLLFAVLLLMLQAEPGLSLARGLPQDCERRGGFCSHKSCPPGIGRIGLCSKEDFCCRSRWYS,66,Duck hepaptitis virus,DHV,Picornaviridae,AvBD5,Duck beta defensin,Q6IV26,Duck embryo,High,-,Replication,Neutralization assay,23112840,"Identification, expression and activity analyses of five novel duck beta-defensins.","Ma D, Zhang K, Zhang M, Xin S, Liu X, Han Z, Shao Y, Liu S.",PLoS One. 2012
AVP1750,MRILYLLLSVLFVVLQGVAGQPYFSSPIHACRYQRGVCIPGPCRWPYYRVGSCGSGLKSCCVRNRWA,67,Duck hepaptitis virus,DHV,Picornaviridae,AvBD6,Duck beta defensin,Q6QLR3,Duck embryo,High,-,Replication,Neutralization assay,23112840,"Identification, expression and activity analyses of five novel duck beta-defensins.","Ma D, Zhang K, Zhang M, Xin S, Liu X, Han Z, Shao Y, Liu S.",PLoS One. 2012
AVP1751,MRIVYLLFPFILLLVQGAAGSSLAPRNKEKCHREKGFCGFLKCFPFIISGKCSRFFFCCKKIFG,64,Duck hepaptitis virus,DHV,Picornaviridae,AvBD1,Duck beta defensin,P46157,Duck embryo,High,-,Replication,Neutralization assay,23112840,"Identification, expression and activity analyses of five novel duck beta-defensins.","Ma D, Zhang K, Zhang M, Xin S, Liu X, Han Z, Shao Y, Liu S.",PLoS One. 2012
AVP1752,TATQCRIRGGFCRVGSCRFPHIAIGKCATFISCCGRAYEVDALNSVRTSPWLLAPGNNPH,60,Duck hepaptitis virus,DHV,Picornaviridae,AvBD3,Duck beta defensin,Q9DG58,Duck embryo,High,-,Replication,Neutralization assay,23112840,"Identification, expression and activity analyses of five novel duck beta-defensins.","Ma D, Zhang K, Zhang M, Xin S, Liu X, Han Z, Shao Y, Liu S.",PLoS One. 2012
AVP1753,WLVFFVIFYFFRRRKK,16,Influenza A virus,INFV A,Orthomyxoviridae,FP3,Mimetic for the SOCS protein,Q8WXH5,MDCK,0.00003,μM,Virus entry,Plaque assay,22258859,A novel family of peptides with potent activity against influenza A viruses.,"Nicol MQ, Ligertwood Y, Bacon MN, Dutia BM, Nash AA.",J Gen Virol. 2012
AVP1754,RRKKWLVFFVIFYFFR,16,Influenza A virus,INFV A,Orthomyxoviridae,FP4,Mimetic for the SOCS protein,Q8WXH5,MDCK,0.00004,μM,Virus entry,Plaque assay,22258859,A novel family of peptides with potent activity against influenza A viruses.,"Nicol MQ, Ligertwood Y, Bacon MN, Dutia BM, Nash AA.",J Gen Virol. 2012
AVP1755,WLVFFVIAYFAR,12,Influenza A virus,INFV A,Orthomyxoviridae,FP2,Mimetic for the SOCS protein,Q8WXH5,MDCK,0.00087,μM,Virus entry,Plaque assay,22258859,A novel family of peptides with potent activity against influenza A viruses.,"Nicol MQ, Ligertwood Y, Bacon MN, Dutia BM, Nash AA.",J Gen Virol. 2012
AVP1756,WLVFFVIFYFFR,12,Influenza A virus,INFV A,Orthomyxoviridae,FP1 (Tkip),Mimetic for the SOCS protein,Q8WXH5,MDCK,0.0936,μM,Virus entry,Plaque assay,22258859,A novel family of peptides with potent activity against influenza A viruses.,"Nicol MQ, Ligertwood Y, Bacon MN, Dutia BM, Nash AA.",J Gen Virol. 2012
AVP1757,AWDFGSLGGVFTSIGKALHQVFGAIYGAA,29,Dengue 1 virus,DENV 1,Flaviviridae,DV2,DENV2 envelope protein (Stem peptide),P29984,BHK-21,0.1,μM(IC90),Virus entry,Plaque assay,20881042,Peptide inhibitors of flavivirus entry derived from the E protein stem.,"Schmidt AG, Yang PL, Harrison SC.",J Virol. 2010
AVP1758,AWDFGSVGGVLNSLGKMVHQIFGSAYTAL,29,Dengue 1 virus,DENV 1,Flaviviridae,DV3,DENV3 envelope protein (Stem peptide),Q99D35,BHK-21,0.1,μM(IC90),Virus entry,Plaque assay,20881042,Peptide inhibitors of flavivirus entry derived from the E protein stem.,"Schmidt AG, Yang PL, Harrison SC.",J Virol. 2010
AVP1759,RRKKIFYFFR,10,Influenza A virus,INFV A,Orthomyxoviridae,FP7,Mimetic for the SOCS protein,Q8WXH5,MDCK,0.15483,μM,Virus entry,Plaque assay,22258859,A novel family of peptides with potent activity against influenza A viruses.,"Nicol MQ, Ligertwood Y, Bacon MN, Dutia BM, Nash AA.",J Gen Virol. 2012
AVP1760,AWDFGSLGGVFTSIGKALHQVFGAIYGAA,29,Dengue 2 virus,DENV 2,Flaviviridae,DV2,DENV2 envelope protein (Stem peptide),P29984,BHK-21,0.3,μM(IC90),Virus entry,Plaque assay,20881042,Peptide inhibitors of flavivirus entry derived from the E protein stem.,"Schmidt AG, Yang PL, Harrison SC.",J Virol. 2010
AVP1761,AKTIRLESEVTAIKNALKKTNEAVSTLGNGVRVLATAVRELKDFVSKN,48,Human metapneumovirus,hMPV,Paramyxoviridae,HRA2,hMPV fusion (F) protein,Q6WB98,LLC-MK2,1.6,nM,Virus entry,Plaque assay,17967906,Identification and evaluation of a highly effective fusion inhibitor for human metapneumovirus.,"Deffrasnes C, Hamelin ME, Prince GA, Boivin G.",Antimicrob Agents Chemother. 2008
AVP1762,HVTTTFAPPPPR,12,Transmissible gastroenteritis virus,TGEV,Coronaviridae,H peptide,Random peptide library,,ST,10,μg/ml,Virus entry,Plaque assay,21176936,Phage displayed peptides recognizing porcine aminopeptidase N inhibit transmissible gastroenteritis coronavirus infection in vitro.,"Ren X, Liu B, Yin J, Zhang H, Li G.",Virology. 2011
AVP1763,SVVPSKATWGFA,12,Transmissible gastroenteritis virus,TGEV,Coronaviridae,S peptide,Random peptide library,,ST,15,μg/ml,Virus entry,Plaque assay,21176936,Phage displayed peptides recognizing porcine aminopeptidase N inhibit transmissible gastroenteritis coronavirus infection in vitro.,"Ren X, Liu B, Yin J, Zhang H, Li G.",Virology. 2011
AVP1764,FKPSSPPSITLW,12,Transmissible gastroenteritis virus,TGEV,Coronaviridae,F peptide,Random peptide library,,ST,20,μg/ml,Virus entry,Plaque assay,21176936,Phage displayed peptides recognizing porcine aminopeptidase N inhibit transmissible gastroenteritis coronavirus infection in vitro.,"Ren X, Liu B, Yin J, Zhang H, Li G.",Virology. 2011
AVP1765,ATCYCRTGRCATRESLSGVCRISGRLYRLCCR,32,Herpes simplex virus 2,HSV 2,Herpesviridae,E21R-HD5,Human alpha defensin,Q01523,CaSki,25,μg/ml,Virus entry,Plaque assay,23269800,Enhancement of antiviral activity of human alpha-defensin 5 against herpes simplex virus 2 by arginine mutagenesis at adaptive evolution sites.,"Wang A, Chen F, Wang Y, Shen M, Xu Y, Hu J, Wang S, Geng F, Wang C, Ran X, Su Y, Cheng T, Wang J.",J Virol. 2013
AVP1766,ATCYCRTGRCATRESLSGVCEISGRLYRLCCR,32,Herpes simplex virus 2,HSV 2,Herpesviridae,HD5,Human alpha defensin,Q01523,CaSki,35,μg/ml,Virus entry,Plaque assay,23269800,Enhancement of antiviral activity of human alpha-defensin 5 against herpes simplex virus 2 by arginine mutagenesis at adaptive evolution sites.,"Wang A, Chen F, Wang Y, Shen M, Xu Y, Hu J, Wang S, Geng F, Wang C, Ran X, Su Y, Cheng T, Wang J.",J Virol. 2013
AVP1767,ATCYCRTGRCATRESLSGVCEIRGRLYRLCCR,32,Herpes simplex virus 2,HSV 2,Herpesviridae,S23R-HD5,Human alpha defensin,Q01523,CaSki,36,μg/ml,Virus entry,Plaque assay,23269800,Enhancement of antiviral activity of human alpha-defensin 5 against herpes simplex virus 2 by arginine mutagenesis at adaptive evolution sites.,"Wang A, Chen F, Wang Y, Shen M, Xu Y, Hu J, Wang S, Geng F, Wang C, Ran X, Su Y, Cheng T, Wang J.",J Virol. 2013
AVP1768,ATCYCRRGRCATRESLSGVCEISGRLYRLCCR,32,Herpes simplex virus 2,HSV 2,Herpesviridae,T7R-HD5,Human alpha defensin,Q01523,CaSki,40,μg/ml,Virus entry,Plaque assay,23269800,Enhancement of antiviral activity of human alpha-defensin 5 against herpes simplex virus 2 by arginine mutagenesis at adaptive evolution sites.,"Wang A, Chen F, Wang Y, Shen M, Xu Y, Hu J, Wang S, Geng F, Wang C, Ran X, Su Y, Cheng T, Wang J.",J Virol. 2013
AVP1769,RARRSLLIASALCTSDVAAATNADLRTALARADHQKTLFWL,41,Herpes simplex virus 1,HSV 1,Herpesviridae,H-HR2,HSV-1 H glycoprotein (gH),Q9DHD5,Vero,40,%,Virus entry,Plaque assay,16603508,Analysis of synthetic peptides from heptad-repeat domains of herpes simplex virus type 1 glycoproteins H and B.,"Galdiero S, Vitiello M, D'Isanto M, Falanga A, Collins C, Raieta K, Pedone C, Browne H, Galdiero M.",J Gen Virol. 2006
AVP1770,ALNCYWPLNDYGFYTTTGIGYQPYRVVVLSFEL,33,SARS coronavirus,SARS-CoV,Coronaviridae,S471-503,SARS-CoV rceptor binding domin (RBD),P59594,Vero,41.6,μM,Virus entry,Plaque assay,16153058,Screening and identification of linear B-cell epitopes and entry-blocking peptide of severe acute respiratory syndrome (SARS)-associated coronavirus using synthetic overlapping peptide library.,"Hu H, Li L, Kao RY, Kou B, Wang Z, Zhang L, Zhang H, Hao Z, Tsui WH, Ni A, Cui L, Fan B, Guo F, Rao S, Jiang C, Li Q, Sun M, He W, Liu G.",J Comb Chem. 2005
AVP1771,TARLQLEARLQHLVAEILEREQSLALHALGYQLAFV,36,Herpes simplex virus 1,HSV 1,Herpesviridae,H-HR1,HSV-1 H glycoprotein (gH),Q9DHD5,Vero,65,%,Virus entry,Plaque assay,16603508,Analysis of synthetic peptides from heptad-repeat domains of herpes simplex virus type 1 glycoproteins H and B.,"Galdiero S, Vitiello M, D'Isanto M, Falanga A, Collins C, Raieta K, Pedone C, Browne H, Galdiero M.",J Gen Virol. 2006
AVP1772,ATCYCRTGRCATRESRSGVCEISGRLYRLCCR,32,Herpes simplex virus 2,HSV 2,Herpesviridae,L16R-HD5,Human alpha defensin,Q01523,CaSki,67,μg/ml,Virus entry,Plaque assay,23269800,Enhancement of antiviral activity of human alpha-defensin 5 against herpes simplex virus 2 by arginine mutagenesis at adaptive evolution sites.,"Wang A, Chen F, Wang Y, Shen M, Xu Y, Hu J, Wang S, Geng F, Wang C, Ran X, Su Y, Cheng T, Wang J.",J Virol. 2013
AVP1773,NASDMEIKKVNKKIEEYIKKIEEVEKKLEEVNKK,34,Newcastle disease virus,NDV,Paramyxoviridae,NOVEL-1,NDV fusion (F) glycoprotein,,CEF,90,%,Virus entry,Plaque assay,21601229,Characterisation and evaluation of antiviral recombinant peptides based on the heptad repeat regions of NDV and IBV fusion glycoproteins.,"Wang XJ, Li CG, Chi XJ, Wang M.",Virology. 2011
AVP1774,VNKKIEEIDKKIEELNKKLEELEKKLEEVNKK,32,Newcastle disease virus,NDV,Paramyxoviridae,NOVEL-2,NDV fusion (F) glycoprotein,,CEF,90,%,Virus entry,Plaque assay,21601229,Characterisation and evaluation of antiviral recombinant peptides based on the heptad repeat regions of NDV and IBV fusion glycoproteins.,"Wang XJ, Li CG, Chi XJ, Wang M.",Virology. 2011
AVP1775,ALHALGYQLAFVLDSPSAY,19,Herpes simplex virus 1,HSV 1,Herpesviridae,H-HR1-SC,HSV-1 H glycoprotein (gH),Q9DHD5,Vero,25-30,%,Virus entry,Plaque assay,16603508,Analysis of synthetic peptides from heptad-repeat domains of herpes simplex virus type 1 glycoproteins H and B.,"Galdiero S, Vitiello M, D'Isanto M, Falanga A, Collins C, Raieta K, Pedone C, Browne H, Galdiero M.",J Gen Virol. 2006
AVP1776,AKFEVNNPQVQRQAFNELIRVVHQLLPESSLRKRKRSRC,39,Encephalomyocarditis virus,ECMV,Picornaviridae,IFN gamma (95-133),Gamma interferon (IFN-gamma),P01580,L929,High,-,Immunostimulaton,Plaque assay,16893996,The gamma interferon (IFN-gamma) mimetic peptide IFN-gamma (95-133) prevents encephalomyocarditis virus infection both in tissue culture and in mice.,"Mujtaba MG, Patel CB, Patel RA, Flowers LO, Burkhart MA, Waiboci LW, Martin J, Haider MI, Ahmed CM, Johnson HM.",Clin Vaccine Immunol. 2006
AVP1777,TKKNSFKRKSIMLPKSLLSVVKSATLETKPESKYS,35,Encephalomyocarditis virus,ECMV,Picornaviridae,IFNGR,Gamma interferon (IFN-gamma),P15261,L929,Low,-,Immunostimulaton,Plaque assay,16893996,The gamma interferon (IFN-gamma) mimetic peptide IFN-gamma (95-133) prevents encephalomyocarditis virus infection both in tissue culture and in mice.,"Mujtaba MG, Patel CB, Patel RA, Flowers LO, Burkhart MA, Waiboci LW, Martin J, Haider MI, Ahmed CM, Johnson HM.",Clin Vaccine Immunol. 2006
AVP1778,AGDNATVAAGHATLREHLRDIKAENTDAN,29,Herpes simplex virus 1,HSV 1,Herpesviridae,B-HR1,HSV B glycoprotein (gB),P06436,Vero,Low,-,Virus entry,Plaque assay,16603508,Analysis of synthetic peptides from heptad-repeat domains of herpes simplex virus type 1 glycoproteins H and B.,"Galdiero S, Vitiello M, D'Isanto M, Falanga A, Collins C, Raieta K, Pedone C, Browne H, Galdiero M.",J Gen Virol. 2006
AVP1779,AGHATLREHLRDIKAENTDAN,21,Herpes simplex virus 1,HSV 1,Herpesviridae,B-HR1-S,HSV B glycoprotein (gB),P06436,Vero,Low,-,Virus entry,Plaque assay,16603508,Analysis of synthetic peptides from heptad-repeat domains of herpes simplex virus type 1 glycoproteins H and B.,"Galdiero S, Vitiello M, D'Isanto M, Falanga A, Collins C, Raieta K, Pedone C, Browne H, Galdiero M.",J Gen Virol. 2006
AVP1780,DVREEEQLGERATGLNLNI,19,Herpes simplex virus 1,HSV 1,Herpesviridae,B-HR2-scrambled,HSV B glycoprotein (gB),P06436,Vero,Nil,-,Virus entry,Plaque assay,16603508,Analysis of synthetic peptides from heptad-repeat domains of herpes simplex virus type 1 glycoproteins H and B.,"Galdiero S, Vitiello M, D'Isanto M, Falanga A, Collins C, Raieta K, Pedone C, Browne H, Galdiero M.",J Gen Virol. 2006
AVP1781,GENNELRLTRDAI,13,Herpes simplex virus 1,HSV 1,Herpesviridae,B-HR2-S,HSV B glycoprotein (gB),P06436,Vero,Nil,-,Virus entry,Plaque assay,16603508,Analysis of synthetic peptides from heptad-repeat domains of herpes simplex virus type 1 glycoproteins H and B.,"Galdiero S, Vitiello M, D'Isanto M, Falanga A, Collins C, Raieta K, Pedone C, Browne H, Galdiero M.",J Gen Virol. 2006
AVP1782,TAAGDARANAVAKAGLHDLNIETDTERNH,29,Herpes simplex virus 1,HSV 1,Herpesviridae,B-HR1-scrambled,HSV B glycoprotein (gB),P06436,Vero,Nil,-,Virus entry,Plaque assay,16603508,Analysis of synthetic peptides from heptad-repeat domains of herpes simplex virus type 1 glycoproteins H and B.,"Galdiero S, Vitiello M, D'Isanto M, Falanga A, Collins C, Raieta K, Pedone C, Browne H, Galdiero M.",J Gen Virol. 2006
AVP1783,VEGQLGENNELRLTRDAIE,19,Herpes simplex virus 1,HSV 1,Herpesviridae,B-HR2,HSV B glycoprotein (gB),P06436,Vero,Nil,-,Virus entry,Plaque assay,16603508,Analysis of synthetic peptides from heptad-repeat domains of herpes simplex virus type 1 glycoproteins H and B.,"Galdiero S, Vitiello M, D'Isanto M, Falanga A, Collins C, Raieta K, Pedone C, Browne H, Galdiero M.",J Gen Virol. 2006
AVP1784,HATCSLAFALATSVALATRNDLLLRWAAARDAQTILSKRDR,41,Herpes simplex virus 1,HSV 1,Herpesviridae,H-HR2-scrambled,HSV-1 H glycoprotein (gH),Q9DHD5,Vero,Nil,-,Virus entry,Plaque assay,16603508,Analysis of synthetic peptides from heptad-repeat domains of herpes simplex virus type 1 glycoproteins H and B.,"Galdiero S, Vitiello M, D'Isanto M, Falanga A, Collins C, Raieta K, Pedone C, Browne H, Galdiero M.",J Gen Virol. 2006
AVP1785,LQLEARLQHLVAEILER,17,Herpes simplex virus 1,HSV 1,Herpesviridae,H-HR1-SN,HSV-1 H glycoprotein (gH),Q9DHD5,Vero,Nil,-,Virus entry,Plaque assay,16603508,Analysis of synthetic peptides from heptad-repeat domains of herpes simplex virus type 1 glycoproteins H and B.,"Galdiero S, Vitiello M, D'Isanto M, Falanga A, Collins C, Raieta K, Pedone C, Browne H, Galdiero M.",J Gen Virol. 2006
AVP1786,TSDVAAATNADLRTALARADHQKTLFWL,28,Herpes simplex virus 1,HSV 1,Herpesviridae,H-HR2-S,HSV-1 H glycoprotein (gH),Q9DHD5,Vero,Nil,-,Virus entry,Plaque assay,16603508,Analysis of synthetic peptides from heptad-repeat domains of herpes simplex virus type 1 glycoproteins H and B.,"Galdiero S, Vitiello M, D'Isanto M, Falanga A, Collins C, Raieta K, Pedone C, Browne H, Galdiero M.",J Gen Virol. 2006
AVP1787,YQFHLVLHEALRAQALSRQLILGRELAQELVAELAT,36,Herpes simplex virus 1,HSV 1,Herpesviridae,H-HR1-scrambled,HSV-1 H glycoprotein (gH),Q9DHD5,Vero,Nil,-,Virus entry,Plaque assay,16603508,Analysis of synthetic peptides from heptad-repeat domains of herpes simplex virus type 1 glycoproteins H and B.,"Galdiero S, Vitiello M, D'Isanto M, Falanga A, Collins C, Raieta K, Pedone C, Browne H, Galdiero M.",J Gen Virol. 2006
AVP1788,AWDFGSLGGVFTSIGKALHQVFGAIYGAA,29,Dengue 4 virus,DENV 4,Flaviviridae,DV2,DENV2 envelope protein (Stem peptide),P29984,BHK-21,0.7,μM(IC90),Virus entry,Plaque assay,20881042,Peptide inhibitors of flavivirus entry derived from the E protein stem.,"Schmidt AG, Yang PL, Harrison SC.",J Virol. 2010
AVP1789,AWDFGSVGGVLNSLGKMVHQIFGSAYTAL,29,Dengue 4 virus,DENV 4,Flaviviridae,DV3,DENV3 envelope protein (Stem peptide),Q99D35,BHK-21,1.5,μM(IC90),Virus entry,Plaque assay,20881042,Peptide inhibitors of flavivirus entry derived from the E protein stem.,"Schmidt AG, Yang PL, Harrison SC.",J Virol. 2010
AVP1790,AWDFGSIGGVFTSVGKLVHQVFGTAYGVL,29,Dengue 1 virus,DENV 1,Flaviviridae,DV1,DENV1 envelope protein (Stem peptide),P27909,BHK-21,1.5,μM(IC90),Virus entry,Plaque assay,20881042,Peptide inhibitors of flavivirus entry derived from the E protein stem.,"Schmidt AG, Yang PL, Harrison SC.",J Virol. 2010
AVP1791,AWDFGSLGGVFTSIGKALHQVFGAIYGAA,29,Dengue 3 virus,DENV 3,Flaviviridae,DV2,DENV2 envelope protein (Stem peptide),P29984,BHK-21,2,μM(IC90),Virus entry,Plaque assay,20881042,Peptide inhibitors of flavivirus entry derived from the E protein stem.,"Schmidt AG, Yang PL, Harrison SC.",J Virol. 2010
AVP1792,AWDFGSVGGVLNSLGKMVHQIFGSAYTAL,29,Dengue 2 virus,DENV 2,Flaviviridae,DV3,DENV3 envelope protein (Stem peptide),Q99D35,BHK-21,2,μM(IC90),Virus entry,Plaque assay,20881042,Peptide inhibitors of flavivirus entry derived from the E protein stem.,"Schmidt AG, Yang PL, Harrison SC.",J Virol. 2010
AVP1793,AWDFGSIGGVFTSVGKLVHQVFGTAYGVL,29,Dengue 2 virus,DENV 2,Flaviviridae,DV1,DENV1 envelope protein (Stem peptide),P27909,BHK-21,2,μM(IC90),Virus entry,Plaque assay,20881042,Peptide inhibitors of flavivirus entry derived from the E protein stem.,"Schmidt AG, Yang PL, Harrison SC.",J Virol. 2010
AVP1794,AWDFGSVGGVLNSLGKMVHQIFGSAYTAL,29,Dengue 3 virus,DENV 3,Flaviviridae,DV3,DENV3 envelope protein (Stem peptide),Q99D35,BHK-21,4,μM(IC90),Virus entry,Plaque assay,20881042,Peptide inhibitors of flavivirus entry derived from the E protein stem.,"Schmidt AG, Yang PL, Harrison SC.",J Virol. 2010
AVP1795,AWDFGSIGGVFTSVGKLVHQVFGTAYGVL,29,Dengue 1 virus,DENV 1,Flaviviridae,DV4,DENV4 envelope protein (Stem peptide),P27909,BHK-21,5,μM(IC90),Virus entry,Plaque assay,20881042,Peptide inhibitors of flavivirus entry derived from the E protein stem.,"Schmidt AG, Yang PL, Harrison SC.",J Virol. 2010
AVP1796,AWDFGSIGGVFTSVGKLVHQVFGTAYGVL,29,Dengue 2 virus,DENV 2,Flaviviridae,DV4,DENV4 envelope protein (Stem peptide),P27909,BHK-21,6,μM(IC90),Virus entry,Plaque assay,20881042,Peptide inhibitors of flavivirus entry derived from the E protein stem.,"Schmidt AG, Yang PL, Harrison SC.",J Virol. 2010
AVP1797,AWDFGSVGGLFTSLGKAVHQVFGSVYTIM,29,Dengue 4 virus,DENV 4,Flaviviridae,DV4,DENV4 envelope protein (Stem peptide),P27909,BHK-21,6,μM(IC90),Virus entry,Plaque assay,20881042,Peptide inhibitors of flavivirus entry derived from the E protein stem.,"Schmidt AG, Yang PL, Harrison SC.",J Virol. 2010
AVP1798,AWDFGSIGGVFTSVGKLVHQVFGTAYGVL,29,Dengue 3 virus,DENV 3,Flaviviridae,DV4,DENV4 envelope protein (Stem peptide),P27909,BHK-21,>6,μM(IC90),Virus entry,Plaque assay,20881042,Peptide inhibitors of flavivirus entry derived from the E protein stem.,"Schmidt AG, Yang PL, Harrison SC.",J Virol. 2010
AVP1799,AWDFGSIGGVFTSVGKLVHQVFGTAYGVL,29,Dengue 3 virus,DENV 3,Flaviviridae,DV1,DENV1 envelope protein (Stem peptide),P27909,BHK-21,>6,μM(IC90),Virus entry,Plaque assay,20881042,Peptide inhibitors of flavivirus entry derived from the E protein stem.,"Schmidt AG, Yang PL, Harrison SC.",J Virol. 2010
AVP1800,AWDFGSIGGVFTSVGKLVHQVFGTAYGVL,29,Dengue 4 virus,DENV 4,Flaviviridae,DV1,DENV1 envelope protein (Stem peptide),P27909,BHK-21,>6,μM(IC90),Virus entry,Plaque assay,20881042,Peptide inhibitors of flavivirus entry derived from the E protein stem.,"Schmidt AG, Yang PL, Harrison SC.",J Virol. 2010
AVP1801,NADIIKSLIRKTIINASKNTASLSILQHLYVLRS,34,Marek's disease virus,MDV,Herpesviridae,gHH3,MDV H glycoprotein (gH),Q9E6P6,CEF,12±0.8,μM,Virus entry,Plaque assay,21518442,Structural characteristics and antiviral activity of multiple peptides derived from MDV glycoproteins B and H.,"Wang X, Chi X, Wang M.",Virol J. 2011
AVP1802,HMNASDMEIKSYINMIESVEESSNYDF,27,Marek's disease virus,MDV,Herpesviridae,gHH1,MDV H glycoprotein (gH),Q9E6P6,CEF,4±0.26,μM,Virus entry,Plaque assay,21518442,Structural characteristics and antiviral activity of multiple peptides derived from MDV glycoproteins B and H.,"Wang X, Chi X, Wang M.",Virol J. 2011
AVP1803,VVTTRLFMSLVASVRNAFQSGYISFDEIIKTE,32,Marek's disease virus,MDV,Herpesviridae,gHH2,MDV H glycoprotein (gH),Q9E6P6,CEF,8±0.24,μM,Virus entry,Plaque assay,21518442,Structural characteristics and antiviral activity of multiple peptides derived from MDV glycoproteins B and H.,"Wang X, Chi X, Wang M.",Virol J. 2011
AVP1804,CTEEHIVATELVIQEMYIKINVKNSP,26,Marek's disease virus,MDV,Herpesviridae,gHH5,MDV H glycoprotein (gH),Q9E6P6,CEF,8±0.48,μM,Virus entry,Plaque assay,21518442,Structural characteristics and antiviral activity of multiple peptides derived from MDV glycoproteins B and H.,"Wang X, Chi X, Wang M.",Virol J. 2011
AVP1805,RIILGQCIKREAEAAIEQIFRTKYNDSH,28,Marek's disease virus,MDV,Herpesviridae,gBH1,MDV B glycoprotein (gB),P18538,CEF,9±0.27,μM,Virus entry,Plaque assay,21518442,Structural characteristics and antiviral activity of multiple peptides derived from MDV glycoproteins B and H.,"Wang X, Chi X, Wang M.",Virol J. 2011
AVP1806,WLVFFVRRKK,10,Influenza A virus,INFV A,Orthomyxoviridae,FP8,Mimetic for the SOCS protein,Q8WXH5,MDCK,0.63806,μM,Virus entry,Plaque assay,22258859,A novel family of peptides with potent activity against influenza A viruses.,"Nicol MQ, Ligertwood Y, Bacon MN, Dutia BM, Nash AA.",J Gen Virol. 2012
AVP1807,MPRRRRIRRRQK,12,Herpes simplex virus 2,HSV 2,Herpesviridae,G2,Phage display,,Vero,1,mg/ml,Virus entry,Plaque assay,22491462,A 3-O-sulfated heparan sulfate binding peptide preferentially targets herpes simplex virus 2-infected cells.,"Ali MM, Karasneh GA, Jarding MJ, Tiwari V, Shukla D.",J Virol. 2012
AVP1808,FFVIFYRRKK,10,Influenza A virus,INFV A,Orthomyxoviridae,FP9,Mimetic for the SOCS protein,Q8WXH5,MDCK,1.48175,μM,Virus entry,Plaque assay,22258859,A novel family of peptides with potent activity against influenza A viruses.,"Nicol MQ, Ligertwood Y, Bacon MN, Dutia BM, Nash AA.",J Gen Virol. 2012
AVP1809,RRKKAAVALLPAVLLALLAP,20,Cowpox virus,CPXV,Poxviridae,EB,Human FGF4 protein,P08620,BSC-1,26.3,μM(EC50),Virus entry,Plaque assay,22225618,Antiviral activity of the EB peptide against zoonotic poxviruses.,"Altmann SE, Brandt CR, Jahrling PB, Blaney JE.",Virol J. 2012
AVP1810,RRKKAAVALLPAVLLALLAP,20,Monkeypox virus,MPV,Poxviridae,EB,Human FGF4 Protein,P08620,BSC-1,48.6,μM(EC50),Virus entry,Plaque assay,22225618,Antiviral activity of the EB peptide against zoonotic poxviruses.,"Altmann SE, Brandt CR, Jahrling PB, Blaney JE.",Virol J. 2012
AVP1811,GICRCICGRGICRCICGRIGGRVPGVGVPGVGHHHHHH,38,Dengue 2 virus,DENV 2,Flaviviridae,RC-1,Synthetic,,Vero,21.4±1.6,μM,Replication,Plaque assay,23171075,Inhibition of dengue NS2B-NS3 protease and viral replication in Vero cells by recombinant retrocyclin-1.,"Rothan HA, Han HC, Ramasamy TS, Othman S, Rahman NA, Yusof R.",BMC Infect Dis. 2012
AVP1812,TIRLESEVTAIKNALKKTNEAVSTLGNGVRVLATAVRELKDFV,43,Human metapneumovirus,hMPV,Paramyxoviridae,HRA1,hMPV fusion (F) protein,Q6WB98,LLC-MK2,177,nM,Virus entry,RT PCR,17967906,Identification and evaluation of a highly effective fusion inhibitor for human metapneumovirus.,"Deffrasnes C, Hamelin ME, Prince GA, Boivin G.",Antimicrob Agents Chemother. 2008
AVP1813,FNVALDQVFESIENSQALVDQSNRILSSAEKGNTG,35,Human metapneumovirus,hMPV,Paramyxoviridae,HRB5,hMPV fusion (F) protein,Q6WB98,LLC-MK2,1520,nM,Virus entry,RT PCR,17967906,Identification and evaluation of a highly effective fusion inhibitor for human metapneumovirus.,"Deffrasnes C, Hamelin ME, Prince GA, Boivin G.",Antimicrob Agents Chemother. 2008
AVP1814,LESEVTAIKNALKKTNEAVSTLGNGVRVLATAVRE,35,Human metapneumovirus,hMPV,Paramyxoviridae,HRA3,hMPV fusion (F) protein,Q6WB98,LLC-MK2,3240,nM,Virus entry,RT PCR,17967906,Identification and evaluation of a highly effective fusion inhibitor for human metapneumovirus.,"Deffrasnes C, Hamelin ME, Prince GA, Boivin G.",Antimicrob Agents Chemother. 2008
AVP1815,PEDQFNVALDQVFESIENSQALVDQSNRILSSAEKGNTG,39,Human metapneumovirus,hMPV,Paramyxoviridae,HRB6,hMPV fusion (F) protein,Q6WB98,LLC-MK2,3310,nM,Virus entry,RT PCR,17967906,Identification and evaluation of a highly effective fusion inhibitor for human metapneumovirus.,"Deffrasnes C, Hamelin ME, Prince GA, Boivin G.",Antimicrob Agents Chemother. 2008
AVP1816,FNVALDQVFESIENSQALVDQSNRILSSAE,30,Human metapneumovirus,hMPV,Paramyxoviridae,HRB2,hMPV fusion (F) protein,Q6WB98,LLC-MK2,">9,000",nM,Virus entry,RT PCR,17967906,Identification and evaluation of a highly effective fusion inhibitor for human metapneumovirus.,"Deffrasnes C, Hamelin ME, Prince GA, Boivin G.",Antimicrob Agents Chemother. 2008
AVP1817,FNVALDQVFESIENSQALVDQSNRILSSAEKGN,33,Human metapneumovirus,hMPV,Paramyxoviridae,HRB3,hMPV fusion (F) protein,Q6WB98,LLC-MK2,">9,000",nM,Virus entry,RT PCR,17967906,Identification and evaluation of a highly effective fusion inhibitor for human metapneumovirus.,"Deffrasnes C, Hamelin ME, Prince GA, Boivin G.",Antimicrob Agents Chemother. 2008
AVP1818,NVALDQVFESIENSQALVDQSNRILSSA,28,Human metapneumovirus,hMPV,Paramyxoviridae,HRB1,hMPV fusion (F) protein,Q6WB98,LLC-MK2,">9,000",nM,Virus entry,RT PCR,17967906,Identification and evaluation of a highly effective fusion inhibitor for human metapneumovirus.,"Deffrasnes C, Hamelin ME, Prince GA, Boivin G.",Antimicrob Agents Chemother. 2008
AVP1819,SSFDPVKFPEDQFNVALDQVFESIENSQALVDQSNRILSSAEK,43,Human metapneumovirus,hMPV,Paramyxoviridae,HRB4,hMPV fusion (F) protein,Q6WB98,LLC-MK2,">9,000",nM,Virus entry,RT PCR,17967906,Identification and evaluation of a highly effective fusion inhibitor for human metapneumovirus.,"Deffrasnes C, Hamelin ME, Prince GA, Boivin G.",Antimicrob Agents Chemother. 2008
AVP1820,LFRLIKSLIKRLVSAFK,17,Hepatitis B virus,HBV,Hepadnaviridae,Mucroporin-M1,Scorpion venom,B9UIY3,HepG2.2.15,11,μM,Replication,RT PCR,22791717,Mucroporin-M1 inhibits hepatitis B virus replication by activating the mitogen-activated protein kinase (MAPK) pathway and down-regulating HNF4α in vitro and in vivo.,"Zhao Z, Hong W, Zeng Z, Wu Y, Hu K, Tian X, Li W, Cao Z.",J Biol Chem. 2012
AVP1821,RGGRLCYCRRRFCVCVGR,18,Dengue 2 virus,DENV 2,Flaviviridae,PG-1,Porcine white blood cells (Protegrin-1),P32194,MK2,11.7,μM,Replication,RT PCR,23093838,Protegrin-1 inhibits dengue NS2B-NS3 serine protease and viral replication in MK2 cells.,"Rothan HA, Abdulrahman AY, Sasikumer PG, Othman S, Rahman NA, Yusof R.",J Biomed Biotechnol. 2012
AVP1822,YKYRYL,6,SARS coronavirus,SARS-CoV,Coronaviridae,-,Receptor-binding domain of SARS-CoV,P59594,Vero E6,High,-,Virus entry,RT PCR,22265858,A hexapeptide of the receptor-binding domain of SARS corona virus spike protein blocks viral entry into host cells via the human receptor ACE2.,"Struck AW, Axmann M, Pfefferle S, Drosten C, Meyer B.",Antiviral Res. 2012
AVP1823,CFQWQRNMRKVRGPPVSCIKRDSPIQ,26,Hepatitis B virus,HBV,Hepadnaviridae,HLP20-45,Human lactoferrin,P02788,HepaRG,50,%,Virus entry,RT PCR,23508903,"Characterization of the anti-HBV activity of HLP1-23, a human lactoferrin-derived peptide.","Florian PE, Macovei A, Lazar C, Milac AL, Sokolowska I, Darie CC, Evans RW, Roseanu A, Branza-Nichita N.",J Med Virol. 2013
AVP1824,GRRRRSVQWCAVSQPEATKCFQWQRNMRKVRGPPVSCIKRDSPIQCI,47,Hepatitis B virus,HBV,Hepadnaviridae,Hlf(1-47),Human lactoferrin,P02788,HepaRG,55,%,Virus entry,RT PCR,23508903,"Characterization of the anti-HBV activity of HLP1-23, a human lactoferrin-derived peptide.","Florian PE, Macovei A, Lazar C, Milac AL, Sokolowska I, Darie CC, Evans RW, Roseanu A, Branza-Nichita N.",J Med Virol. 2013
AVP1825,GRRRRSVQWCAVSQPEATKCFQW,23,Hepatitis B virus,HBV,Hepadnaviridae,HLP1-23,Human lactoferrin,P02788,HepaRG,80,%,Virus entry,RT PCR,23508903,"Characterization of the anti-HBV activity of HLP1-23, a human lactoferrin-derived peptide.","Florian PE, Macovei A, Lazar C, Milac AL, Sokolowska I, Darie CC, Evans RW, Roseanu A, Branza-Nichita N.",J Med Virol. 2013
AVP1826,LEEWYKKTEELQKKFEEIIKKIEENNKKVEEGLKK,35,Feline immunodeficiency virus,FIV,Retroviridae,FIV-C35EK1,FIV envelope glycoprotein (gp40),Q04995,HeLa,High,-,Virus entry,Syncitia assay,19036536,Antiviral activity of membrane fusion inhibitors that target gp40 of the feline immunodeficiency virus envelope protein.,"Mizukoshi F, Baba K, Goto Y, Setoguchi A, Fujino Y, Ohno K, Oishi S, Kodera Y, Fujii N, Tsujimoto H.",Vet Microbiol. 2009
AVP1827,LGEWYNQTKELQQKFYEIIMNIEQNNVQVKKGLQQ,35,Feline immunodeficiency virus,FIV,Retroviridae,FIV-C35,FIV envelope glycoprotein (gp40),Q04995,HeLa,High,-,Virus entry,Syncitia assay,19036536,Antiviral activity of membrane fusion inhibitors that target gp40 of the feline immunodeficiency virus envelope protein.,"Mizukoshi F, Baba K, Goto Y, Setoguchi A, Fujino Y, Ohno K, Oishi S, Kodera Y, Fujii N, Tsujimoto H.",Vet Microbiol. 2009
AVP1828,GEETLKKWEEQTKKLEEKFKKIEENIKKNEEQVKKGEEQLKK,42,Feline immunodeficiency virus,FIV,Retroviridae,FIV-C35EK3,FIV envelope glycoprotein (gp40),Q04995,HeLa,Nil,-,Virus entry,Syncitia assay,19036536,Antiviral activity of membrane fusion inhibitors that target gp40 of the feline immunodeficiency virus envelope protein.,"Mizukoshi F, Baba K, Goto Y, Setoguchi A, Fujino Y, Ohno K, Oishi S, Kodera Y, Fujii N, Tsujimoto H.",Vet Microbiol. 2009
AVP1829,NEELGKKYEETKKKQEEFYKKIEEIEKKNEEVKKKLEELQKK,42,Feline immunodeficiency virus,FIV,Retroviridae,FIV-C35EK2,FIV envelope glycoprotein (gp40),Q04995,HeLa,Nil,-,Virus entry,Syncitia assay,19036536,Antiviral activity of membrane fusion inhibitors that target gp40 of the feline immunodeficiency virus envelope protein.,"Mizukoshi F, Baba K, Goto Y, Setoguchi A, Fujino Y, Ohno K, Oishi S, Kodera Y, Fujii N, Tsujimoto H.",Vet Microbiol. 2009
AVP1830,ATHQETIEKVTEALKINNLRLVTLEHQVLVIGLKVE,36,Feline immunodeficiency virus,FIV,Retroviridae,FIV-N36,FIV envelope glycoprotein (gp40),Q04995,HeLa,Nil,-,Virus entry,Syncitia assay,19036536,Antiviral activity of membrane fusion inhibitors that target gp40 of the feline immunodeficiency virus envelope protein.,"Mizukoshi F, Baba K, Goto Y, Setoguchi A, Fujino Y, Ohno K, Oishi S, Kodera Y, Fujii N, Tsujimoto H.",Vet Microbiol. 2009
AVP1831,SISNALNKLEESNRNLDKVNVKLT,24,Newcastle disease virus,NDV,Paramyxoviridae,C24,NDV fusion protein (HR2),P12571,Cos-7,3.27,μM,Fusion,Syncitia assay,12127571,Mode of action of two inhibitory peptides from heptad repeat domains of the fusion protein of Newcastle disease virus.,"San Roman K, Villar E, Munoz-Barroso I.",Int J Biochem Cell Biol. 2002
AVP1832,KQNAANILRLKESIAATNEAVHEV,24,Newcastle disease virus,NDV,Paramyxoviridae,N24,NDV fusion protein (HR1),P12571,Cos-7,22.5,nM,Fusion,Syncitia assay,12127571,Mode of action of two inhibitory peptides from heptad repeat domains of the fusion protein of Newcastle disease virus.,"San Roman K, Villar E, Munoz-Barroso I.",Int J Biochem Cell Biol. 2002
AVP1833,CANLLLQYGSFCTQLNRALSGIA,23,SARS coronavirus,SARS-CoV,Coronaviridae,P9,SARS-CoV spike protein,P59594,HEK293T,50,%,Virus entry,Syncitia assay,15811330,Synthetic peptides derived from SARS coronavirus S protein with diagnostic and therapeutic potential.,"Lu W, Wu XD, Shi MD, Yang RF, He YY, Bian C, Shi TL, Yang S, Zhu XL, Jiang WH, Li YX, Yan LC, Ji YY, Lin Y, Lin GM, Tian L, Wang J, Wang HX, Xie YH, Pei G, Wu JR, Sun B.",FEBS Lett. 2005
AVP1834,PSSKRFQPFQQFGRDVSDFT,20,SARS coronavirus,SARS-CoV,Coronaviridae,P8,SARS-CoV spike protein,P59594,HEK293T,50,%,Virus entry,Syncitia assay,15811330,Synthetic peptides derived from SARS coronavirus S protein with diagnostic and therapeutic potential.,"Lu W, Wu XD, Shi MD, Yang RF, He YY, Bian C, Shi TL, Yang S, Zhu XL, Jiang WH, Li YX, Yan LC, Ji YY, Lin Y, Lin GM, Tian L, Wang J, Wang HX, Xie YH, Pei G, Wu JR, Sun B.",FEBS Lett. 2005
AVP1835,RNTREVFAQVKQMYKTPTLKYFG,23,SARS coronavirus,SARS-CoV,Coronaviridae,P10,SARS-CoV spike protein,P59594,HEK293T,Low,-,Virus entry,Syncitia assay,15811330,Synthetic peptides derived from SARS coronavirus S protein with diagnostic and therapeutic potential.,"Lu W, Wu XD, Shi MD, Yang RF, He YY, Bian C, Shi TL, Yang S, Zhu XL, Jiang WH, Li YX, Yan LC, Ji YY, Lin Y, Lin GM, Tian L, Wang J, Wang HX, Xie YH, Pei G, Wu JR, Sun B.",FEBS Lett. 2005
AVP1836,TKFPSVYAWERKKISNCVAD,20,SARS coronavirus,SARS-CoV,Coronaviridae,P6,SARS-CoV spike protein,P59594,HEK293T,Low,-,Virus entry,Syncitia assay,15811330,Synthetic peptides derived from SARS coronavirus S protein with diagnostic and therapeutic potential.,"Lu W, Wu XD, Shi MD, Yang RF, He YY, Bian C, Shi TL, Yang S, Zhu XL, Jiang WH, Li YX, Yan LC, Ji YY, Lin Y, Lin GM, Tian L, Wang J, Wang HX, Xie YH, Pei G, Wu JR, Sun B.",FEBS Lett. 2005
AVP1837,KGIYQTSNFRVVPSGDVVRF,20,SARS coronavirus,SARS-CoV,Coronaviridae,P5,SARS-CoV spike protein,P59594,HEK293T,Nil,-,Virus entry,Syncitia assay,15811330,Synthetic peptides derived from SARS coronavirus S protein with diagnostic and therapeutic potential.,"Lu W, Wu XD, Shi MD, Yang RF, He YY, Bian C, Shi TL, Yang S, Zhu XL, Jiang WH, Li YX, Yan LC, Ji YY, Lin Y, Lin GM, Tian L, Wang J, Wang HX, Xie YH, Pei G, Wu JR, Sun B.",FEBS Lett. 2005
AVP1838,KSNVVRGWVFGSTMNNKSQS,20,SARS coronavirus,SARS-CoV,Coronaviridae,P2,SARS-CoV spike protein,P59594,HEK293T,Nil,-,Virus entry,Syncitia assay,15811330,Synthetic peptides derived from SARS coronavirus S protein with diagnostic and therapeutic potential.,"Lu W, Wu XD, Shi MD, Yang RF, He YY, Bian C, Shi TL, Yang S, Zhu XL, Jiang WH, Li YX, Yan LC, Ji YY, Lin Y, Lin GM, Tian L, Wang J, Wang HX, Xie YH, Pei G, Wu JR, Sun B.",FEBS Lett. 2005
AVP1839,TDAVDCSQNPLAELKCSVKSF,21,SARS coronavirus,SARS-CoV,Coronaviridae,P4,SARS-CoV spike protein,P59594,HEK293T,Nil,-,Virus entry,Syncitia assay,15811330,Synthetic peptides derived from SARS coronavirus S protein with diagnostic and therapeutic potential.,"Lu W, Wu XD, Shi MD, Yang RF, He YY, Bian C, Shi TL, Yang S, Zhu XL, Jiang WH, Li YX, Yan LC, Ji YY, Lin Y, Lin GM, Tian L, Wang J, Wang HX, Xie YH, Pei G, Wu JR, Sun B.",FEBS Lett. 2005
AVP1840,TSSMRGVYYPDEIFRSDTLYL,21,SARS coronavirus,SARS-CoV,Coronaviridae,P1,SARS-CoV spike protein,P59594,HEK293T,Nil,-,Virus entry,Syncitia assay,15811330,Synthetic peptides derived from SARS coronavirus S protein with diagnostic and therapeutic potential.,"Lu W, Wu XD, Shi MD, Yang RF, He YY, Bian C, Shi TL, Yang S, Zhu XL, Jiang WH, Li YX, Yan LC, Ji YY, Lin Y, Lin GM, Tian L, Wang J, Wang HX, Xie YH, Pei G, Wu JR, Sun B.",FEBS Lett. 2005
AVP1841,YKGYQPIDVVRDLPSGFNTL,20,SARS coronavirus,SARS-CoV,Coronaviridae,P3,SARS-CoV spike protein,P59594,HEK293T,Nil,-,Virus entry,Syncitia assay,15811330,Synthetic peptides derived from SARS coronavirus S protein with diagnostic and therapeutic potential.,"Lu W, Wu XD, Shi MD, Yang RF, He YY, Bian C, Shi TL, Yang S, Zhu XL, Jiang WH, Li YX, Yan LC, Ji YY, Lin Y, Lin GM, Tian L, Wang J, Wang HX, Xie YH, Pei G, Wu JR, Sun B.",FEBS Lett. 2005
AVP1842,YNYKYRYLRHGKLRPFERDI,20,SARS coronavirus,SARS-CoV,Coronaviridae,P7,SARS-CoV spike protein,P59594,HEK293T,Nil,-,Virus entry,Syncitia assay,15811330,Synthetic peptides derived from SARS coronavirus S protein with diagnostic and therapeutic potential.,"Lu W, Wu XD, Shi MD, Yang RF, He YY, Bian C, Shi TL, Yang S, Zhu XL, Jiang WH, Li YX, Yan LC, Ji YY, Lin Y, Lin GM, Tian L, Wang J, Wang HX, Xie YH, Pei G, Wu JR, Sun B.",FEBS Lett. 2005
AVP1843,HGVSGHGQHGVHG,13,Kaposi's sarcoma-associated herpesvirus,KSHV,Herpesviridae,Alloferon,Calliphora vicina,,BCBL-1,High,-,Reactivation,Thymidine incorporation assay,21311105,Inhibition of lytic reactivation of Kaposi's sarcoma-associated herpesvirus by alloferon.,"Lee N, Bae S, Kim H, Kong JM, Kim HR, Cho BJ, Kim SJ, Seok SH, Hwang YI, Kim S, Kang JS, Lee WJ.",Antivir Ther. 2011
AVP1844,WEIHHINKFAQAYSSYSRVIGGTVFVA,27,Human cytomegalovirus,HCMV,Herpesviridae,174-200,HCMV B glycoprotein (gB),P06473,HFF,80,%,Virus entry,Flow cytometry,21342525,Peptide inhibition of human cytomegalovirus infection.,"Melnik LI, Garry RF, Morris CA.",Virol J. 2011
AVP1845,WHSRGSTWLYRETANLNAMLTITTARSKYPY,31,Human cytomegalovirus,HCMV,Herpesviridae,233-263,HCMV B glycoprotein (gB),P06473,HFF,97,%,Virus entry,Flow cytometry,21342525,Peptide inhibition of human cytomegalovirus infection.,"Melnik LI, Garry RF, Morris CA.",Virol J. 2011
AVP1846,FFIFPNYTIVSDFGRPNAA,19,Human cytomegalovirus,HCMV,Herpesviridae,297-315,HCMV B glycoprotein (gB),P06473,HFF,Nil,-,Virus entry,Flow cytometry,21342525,Peptide inhibition of human cytomegalovirus infection.,"Melnik LI, Garry RF, Morris CA.",Virol J. 2011
AVP1847,HFFATSTGDVVYISPFYNGTNRNASYFG,28,Human cytomegalovirus,HCMV,Herpesviridae,264-291,HCMV B glycoprotein (gB),P06473,HFF,Nil,-,Virus entry,Flow cytometry,21342525,Peptide inhibition of human cytomegalovirus infection.,"Melnik LI, Garry RF, Morris CA.",Virol J. 2011
AVP1848,GRRRRSVQWCAVSQPEATKCFQWQRNMRKVRGPPVSCIKRDSPIQCIQA,49,Human papillomavirus,HPV,Papillomaviridae,HLFcin 1-49,Human lactoferrin,P02788,HaCaT,16±7.4,μM,Virus entry,Western blotting,17481742,The anti-papillomavirus activity of human and bovine lactoferricin.,"Mistry N, Drobni P, Naslund J, Sunkari VG, Jenssen H, Evander M.",Antiviral Res. 2007
AVP1849,FKCRRWQWRMKKLGAPSITCVRRAFA,26,Human papillomavirus,HPV,Papillomaviridae,BLfcinB 17-42,Bovine lactoferrin,P24627,HaCaT,9.7±5.0,μM,Virus entry,Western blotting,17481742,The anti-papillomavirus activity of human and bovine lactoferricin.,"Mistry N, Drobni P, Naslund J, Sunkari VG, Jenssen H, Evander M.",Antiviral Res. 2007
AVP1850,GIKCRFCCGCCTPGICGVCCRF,22,Nervous necrosis nirus,NNV,Nodaviridae,TH 1-5,Human tilapia hepcidin 1-5,P81172,GF-1,High,-,Virus entry,Western blotting,20004246,Antimicrobial peptides (AMP) with antiviral activity against fish nodavirus.,"Chia TJ, Wu YC, Chen JY, Chi SC.",Fish Shellfish Immunol. 2010
AVP1851,ECKFTVKPYLKRFQVYYKGRMWCP,24,Nervous necrosis nirus,NNV,Nodaviridae,cSALF,Shrimp anti-lipopolysaccharide factor,A5A3I5,GF-1,High,-,Virus entry,Western blotting,20004246,Antimicrobial peptides (AMP) with antiviral activity against fish nodavirus.,"Chia TJ, Wu YC, Chen JY, Chi SC.",Fish Shellfish Immunol. 2010
AVP1852,GRTTLSTRGPPRGGPG,16,Coxsackievirus,CV,Picornaviridae,-,Synthetic,,HeLa,High,-,Replication,Western blotting,20096913,Targeting enteroviral 2A protease by a 16-mer synthetic peptide: inhibition of 2Apro-induced apoptosis in a stable Tet-on HeLa cell line.,"Maghsoudi N, Tafreshi NKh, Khodagholi F, Zakeri Z, Esfandiarei M, Hadi-Alijanvand H, Sabbaghian M, Maghsoudi AH, Sajadi M, Zohri M, Moosavi M, Zeinoddini M.",Virology. 2010
AVP1853,FKCRRWQWRMKKLGA,15,Human papillomavirus,HPV,Papillomaviridae,BLfcin 17-31,Bovine lactoferrin,P24627,HaCaT,Nil,-,Virus entry,Western blotting,17481742,The anti-papillomavirus activity of human and bovine lactoferricin.,"Mistry N, Drobni P, Naslund J, Sunkari VG, Jenssen H, Evander M.",Antiviral Res. 2007
AVP1854,TKCFQWQRNMRKVRGPPVSCIKRDS,25,Human papillomavirus,HPV,Papillomaviridae,HLfcin 18-42,Human lactoferrin,P02788,HaCaT,Nil,-,Virus entry,Western blotting,17481742,The anti-papillomavirus activity of human and bovine lactoferricin.,"Mistry N, Drobni P, Naslund J, Sunkari VG, Jenssen H, Evander M.",Antiviral Res. 2007
AVP1855,CNDFRSKTC,9,Avian influenza virus,AIV,Orthomyxoviridae,C-P1(Cyclic),Phage display,,MDCK,48,μM,Virus entry,Yeast two-hybrid assay,19497129,Identification and characterisation of a novel anti-viral peptide against avian influenza virus H9N2.,"Rajik M, Jahanshiri F, Omar AR, Ideris A, Hassan SS, Yusoff K.",Virol J. 2009
AVP1856,NDFRSKT,7,Avian influenza virus,AIV,Orthomyxoviridae,L-P1(Linear),Phage display,,MDCK,71,μM,Virus entry,Yeast two-hybrid assay,19497129,Identification and characterisation of a novel anti-viral peptide against avian influenza virus H9N2.,"Rajik M, Jahanshiri F, Omar AR, Ideris A, Hassan SS, Yusoff K.",Virol J. 2009
AVP1857,NGIGVTQNVLYENQKQIANQFNKAISQIQESLTTTSTA,38,SARS coronavirus,SARS-CoV,Coronaviridae,HR1-1,SARS-CoV spike protein,P59594,293T,0.14,μM(EC50),Virus entry,Luciferase assay,15184046,Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein.,"Yuan K, Yi L, Chen J, Qu X, Qing T, Rao X, Jiang P, Hu J, Xiong Z, Nie Y, Shi X, Wang W, Ling C, Yin X, Fan K, Lai L, Ding M, Deng H.",Biochem Biophys Res Commun.  2004
AVP1858,IQKEIDRLNEVAKNLNESLIDLQELGK,27,SARS coronavirus,SARS-CoV,Coronaviridae,HR2-18,SARS-CoV spike protein,P59594,293T,1.19,μM(EC50),Virus entry,Luciferase assay,15184046,Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein.,"Yuan K, Yi L, Chen J, Qu X, Qing T, Rao X, Jiang P, Hu J, Xiong Z, Nie Y, Shi X, Wang W, Ling C, Yin X, Fan K, Lai L, Ding M, Deng H.",Biochem Biophys Res Commun.  2004
AVP1859,FNKAISQIQESLTTTSTALGKLQDVVNQNAQALNTLVKQL,40,SARS coronavirus,SARS-CoV,Coronaviridae,HR1-2,SARS-CoV spike protein,P59594,293T,Low,NA,Virus entry,Luciferase assay,15184046,Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein.,"Yuan K, Yi L, Chen J, Qu X, Qing T, Rao X, Jiang P, Hu J, Xiong Z, Nie Y, Shi X, Wang W, Ling C, Yin X, Fan K, Lai L, Ding M, Deng H.",Biochem Biophys Res Commun.  2004
AVP1860,ALNTLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRL,39,SARS coronavirus,SARS-CoV,Coronaviridae,HR1-3,SARS-CoV spike protein,P59594,293T,Low,NA,Virus entry,Luciferase assay,15184046,Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein.,"Yuan K, Yi L, Chen J, Qu X, Qing T, Rao X, Jiang P, Hu J, Xiong Z, Nie Y, Shi X, Wang W, Ling C, Yin X, Fan K, Lai L, Ding M, Deng H.",Biochem Biophys Res Commun.  2004
AVP1861,IDRLITGRLQSLQTYVTQQLIRAAEIRASANLAATK,36,SARS coronavirus,SARS-CoV,Coronaviridae,HR1-4,SARS-CoV spike protein,P59594,293T,Low,NA,Virus entry,Luciferase assay,15184046,Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein.,"Yuan K, Yi L, Chen J, Qu X, Qing T, Rao X, Jiang P, Hu J, Xiong Z, Nie Y, Shi X, Wang W, Ling C, Yin X, Fan K, Lai L, Ding M, Deng H.",Biochem Biophys Res Commun.  2004
AVP1862,YVTQQLIRAAEIRASANLAATKMSECVLGQSKRVDFCGKG,40,SARS coronavirus,SARS-CoV,Coronaviridae,HR1-5,SARS-CoV spike protein,P59594,293T,Low,NA,Virus entry,Luciferase assay,15184046,Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein.,"Yuan K, Yi L, Chen J, Qu X, Qing T, Rao X, Jiang P, Hu J, Xiong Z, Nie Y, Shi X, Wang W, Ling C, Yin X, Fan K, Lai L, Ding M, Deng H.",Biochem Biophys Res Commun.  2004
AVP1863,VYDPLQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVV,41,SARS coronavirus,SARS-CoV,Coronaviridae,HR2-1,SARS-CoV spike protein,P59594,293T,Low,NA,Virus entry,Luciferase assay,15184046,Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein.,"Yuan K, Yi L, Chen J, Qu X, Qing T, Rao X, Jiang P, Hu J, Xiong Z, Nie Y, Shi X, Wang W, Ling C, Yin X, Fan K, Lai L, Ding M, Deng H.",Biochem Biophys Res Commun.  2004
AVP1864,QPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQ,39,SARS coronavirus,SARS-CoV,Coronaviridae,HR2-2,SARS-CoV spike protein,P59594,293T,Low,NA,Virus entry,Luciferase assay,15184046,Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein.,"Yuan K, Yi L, Chen J, Qu X, Qing T, Rao X, Jiang P, Hu J, Xiong Z, Nie Y, Shi X, Wang W, Ling C, Yin X, Fan K, Lai L, Ding M, Deng H.",Biochem Biophys Res Commun.  2004
AVP1865,SFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNE,42,SARS coronavirus,SARS-CoV,Coronaviridae,HR2-3,SARS-CoV spike protein,P59594,293T,Low,NA,Virus entry,Luciferase assay,15184046,Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein.,"Yuan K, Yi L, Chen J, Qu X, Qing T, Rao X, Jiang P, Hu J, Xiong Z, Nie Y, Shi X, Wang W, Ling C, Yin X, Fan K, Lai L, Ding M, Deng H.",Biochem Biophys Res Commun.  2004
AVP1866,LDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAK,40,SARS coronavirus,SARS-CoV,Coronaviridae,HR2-4,SARS-CoV spike protein,P59594,293T,Low,NA,Virus entry,Luciferase assay,15184046,Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein.,"Yuan K, Yi L, Chen J, Qu X, Qing T, Rao X, Jiang P, Hu J, Xiong Z, Nie Y, Shi X, Wang W, Ling C, Yin X, Fan K, Lai L, Ding M, Deng H.",Biochem Biophys Res Commun.  2004
AVP1867,FKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNES,41,SARS coronavirus,SARS-CoV,Coronaviridae,HR2-5,SARS-CoV spike protein,P59594,293T,Low,NA,Virus entry,Luciferase assay,15184046,Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein.,"Yuan K, Yi L, Chen J, Qu X, Qing T, Rao X, Jiang P, Hu J, Xiong Z, Nie Y, Shi X, Wang W, Ling C, Yin X, Fan K, Lai L, Ding M, Deng H.",Biochem Biophys Res Commun.  2004
AVP1868,PDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQ,40,SARS coronavirus,SARS-CoV,Coronaviridae,HR2-6,SARS-CoV spike protein,P59594,293T,Low,NA,Virus entry,Luciferase assay,15184046,Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein.,"Yuan K, Yi L, Chen J, Qu X, Qing T, Rao X, Jiang P, Hu J, Xiong Z, Nie Y, Shi X, Wang W, Ling C, Yin X, Fan K, Lai L, Ding M, Deng H.",Biochem Biophys Res Commun.  2004
AVP1869,GDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKY,40,SARS coronavirus,SARS-CoV,Coronaviridae,HR2-7,SARS-CoV spike protein,P59594,293T,Low,NA,Virus entry,Luciferase assay,15184046,Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein.,"Yuan K, Yi L, Chen J, Qu X, Qing T, Rao X, Jiang P, Hu J, Xiong Z, Nie Y, Shi X, Wang W, Ling C, Yin X, Fan K, Lai L, Ding M, Deng H.",Biochem Biophys Res Commun.  2004
AVP1870,ISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYI KWPW,47,SARS coronavirus,SARS-CoV,Coronaviridae,HR2-8,SARS-CoV spike protein,P59594,293T,Low,NA,Virus entry,Luciferase assay,15184046,Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein.,"Yuan K, Yi L, Chen J, Qu X, Qing T, Rao X, Jiang P, Hu J, Xiong Z, Nie Y, Shi X, Wang W, Ling C, Yin X, Fan K, Lai L, Ding M, Deng H.",Biochem Biophys Res Commun.  2004
AVP1871,ISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGK,37,SARS coronavirus,SARS-CoV,Coronaviridae,HR2-9,SARS-CoV spike protein,P59594,293T,Low,NA,Virus entry,Luciferase assay,15184046,Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein.,"Yuan K, Yi L, Chen J, Qu X, Qing T, Rao X, Jiang P, Hu J, Xiong Z, Nie Y, Shi X, Wang W, Ling C, Yin X, Fan K, Lai L, Ding M, Deng H.",Biochem Biophys Res Commun.  2004
AVP1872,ISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL,35,SARS coronavirus,SARS-CoV,Coronaviridae,HR2-10,SARS-CoV spike protein,P59594,293T,Low,NA,Virus entry,Luciferase assay,15184046,Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein.,"Yuan K, Yi L, Chen J, Qu X, Qing T, Rao X, Jiang P, Hu J, Xiong Z, Nie Y, Shi X, Wang W, Ling C, Yin X, Fan K, Lai L, Ding M, Deng H.",Biochem Biophys Res Commun.  2004
AVP1873,GINASVVNIQKEIDRLNEVAKNLNESLIDLQELGK,35,SARS coronavirus,SARS-CoV,Coronaviridae,HR2-11,SARS-CoV spike protein,P59594,293T,Low,NA,Virus entry,Luciferase assay,15184046,Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein.,"Yuan K, Yi L, Chen J, Qu X, Qing T, Rao X, Jiang P, Hu J, Xiong Z, Nie Y, Shi X, Wang W, Ling C, Yin X, Fan K, Lai L, Ding M, Deng H.",Biochem Biophys Res Commun.  2004
AVP1874,INASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIKWPW,43,SARS coronavirus,SARS-CoV,Coronaviridae,HR2-12,SARS-CoV spike protein,P59594,293T,Low,NA,Virus entry,Luciferase assay,15184046,Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein.,"Yuan K, Yi L, Chen J, Qu X, Qing T, Rao X, Jiang P, Hu J, Xiong Z, Nie Y, Shi X, Wang W, Ling C, Yin X, Fan K, Lai L, Ding M, Deng H.",Biochem Biophys Res Commun.  2004
AVP1875,INASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYI,39,SARS coronavirus,SARS-CoV,Coronaviridae,HR2-13,SARS-CoV spike protein,P59594,293T,Low,NA,Virus entry,Luciferase assay,15184046,Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein.,"Yuan K, Yi L, Chen J, Qu X, Qing T, Rao X, Jiang P, Hu J, Xiong Z, Nie Y, Shi X, Wang W, Ling C, Yin X, Fan K, Lai L, Ding M, Deng H.",Biochem Biophys Res Commun.  2004
AVP1876,INASVVNIQKEIDRLNEVAKNLNESLIDLQELGK,34,SARS coronavirus,SARS-CoV,Coronaviridae,HR2-14,SARS-CoV spike protein,P59594,293T,Low,NA,Virus entry,Luciferase assay,15184046,Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein.,"Yuan K, Yi L, Chen J, Qu X, Qing T, Rao X, Jiang P, Hu J, Xiong Z, Nie Y, Shi X, Wang W, Ling C, Yin X, Fan K, Lai L, Ding M, Deng H.",Biochem Biophys Res Commun.  2004
AVP1877,INASVVNIQKEIDRLNEVAKNLNESLIDL,29,SARS coronavirus,SARS-CoV,Coronaviridae,HR2-15,SARS-CoV spike protein,P59594,293T,Low,NA,Virus entry,Luciferase assay,15184046,Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein.,"Yuan K, Yi L, Chen J, Qu X, Qing T, Rao X, Jiang P, Hu J, Xiong Z, Nie Y, Shi X, Wang W, Ling C, Yin X, Fan K, Lai L, Ding M, Deng H.",Biochem Biophys Res Commun.  2004
AVP1878,VVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIKWPW,39,SARS coronavirus,SARS-CoV,Coronaviridae,HR2-16,SARS-CoV spike protein,P59594,293T,Low,NA,Virus entry,Luciferase assay,15184046,Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein.,"Yuan K, Yi L, Chen J, Qu X, Qing T, Rao X, Jiang P, Hu J, Xiong Z, Nie Y, Shi X, Wang W, Ling C, Yin X, Fan K, Lai L, Ding M, Deng H.",Biochem Biophys Res Commun.  2004
AVP1879,VVNIQKEIDRLNEVAKNLNESLIDLQELGK,30,SARS coronavirus,SARS-CoV,Coronaviridae,HR2-17,SARS-CoV spike protein,P59594,293T,Low,NA,Virus entry,Luciferase assay,15184046,Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein.,"Yuan K, Yi L, Chen J, Qu X, Qing T, Rao X, Jiang P, Hu J, Xiong Z, Nie Y, Shi X, Wang W, Ling C, Yin X, Fan K, Lai L, Ding M, Deng H.",Biochem Biophys Res Commun.  2004
AVP1880,IQKEIDRLNEVAKNLNESLIDLQELGKYEQYIKWPW,36,SARS coronavirus,SARS-CoV,Coronaviridae,HR2-19,SARS-CoV spike protein,P59594,293T,Low,NA,Virus entry,Luciferase assay,15184046,Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein.,"Yuan K, Yi L, Chen J, Qu X, Qing T, Rao X, Jiang P, Hu J, Xiong Z, Nie Y, Shi X, Wang W, Ling C, Yin X, Fan K, Lai L, Ding M, Deng H.",Biochem Biophys Res Commun.  2004
AVP1881,IDRLNEVAKNLNESLIDLQELGKYEQYIKWPW,32,SARS coronavirus,SARS-CoV,Coronaviridae,HR2-20,SARS-CoV spike protein,P59594,293T,Low,NA,Virus entry,Luciferase assay,15184046,Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein.,"Yuan K, Yi L, Chen J, Qu X, Qing T, Rao X, Jiang P, Hu J, Xiong Z, Nie Y, Shi X, Wang W, Ling C, Yin X, Fan K, Lai L, Ding M, Deng H.",Biochem Biophys Res Commun.  2004
AVP1882,GYRARPKFKAGKR,13,Human Papillomavirus,HPV,Papillomaviridae,HPV-31 L1 Cta,HPV capsid protein,P17388,Cos-7,91±4,%,Virus entry,Luciferase assay,15170645,Positively charged synthetic peptides from structural proteins of papillomaviruses abrogate human papillomavirus infectivity.,"Bousarghin L, Touze A, Yvonnet B, Coursaget P.",J Med Virol.  2004
AVP1883,TTTPAKRKKTKK,12,Human Papillomavirus,HPV,Papillomaviridae,HPV-31 L1 Ctb,HPV capsid protein,P17388,Cos-7,15±8,%,Virus entry,Luciferase assay,15170645,Positively charged synthetic peptides from structural proteins of papillomaviruses abrogate human papillomavirus infectivity.,"Bousarghin L, Touze A, Yvonnet B, Coursaget P.",J Med Virol.  2004
AVP1884,MLRKRRKRL,9,Human Papillomavirus,HPV,Papillomaviridae,HPV-16 L2 Ct,HPV capsid protein,P03107,Cos-7,96±20,%,Virus entry,Luciferase assay,15170645,Positively charged synthetic peptides from structural proteins of papillomaviruses abrogate human papillomavirus infectivity.,"Bousarghin L, Touze A, Yvonnet B, Coursaget P.",J Med Virol.  2004
AVP1885,PLETLMAKAIDAGFIR,16,Kaposi's sarcoma-associated herpesvirus,KSHV,Herpesviridae,alpha5,Synthetic,,NA,No,NA,Assembly,CD spectroscopy,15163756,Herpesvirus protease inhibition by dimer disruption.,"Shimba N, Nomura AM, Marnett AB, Craik CS.",J Virol.  2004
AVP1886,PSQPTYPGDDAPLEDLMAFAIDLSFYLGVV,30,Kaposi's sarcoma-associated herpesvirus,KSHV,Herpesviridae,KSDD,Synthetic,,NA,300,μM(Kd),Assembly,CD spectroscopy,15163756,Herpesvirus protease inhibition by dimer disruption.,"Shimba N, Nomura AM, Marnett AB, Craik CS.",J Virol.  2004
AVP1887,LDSPKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE,63,SARS coronavirus,SARS-CoV,Coronaviridae,sHR2-1,SARS-CoV spike protein,P59594,Vero,43±6.4,μM(EC50),Fusion,Immunofluorescence,15150417,Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.,"Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ.",Proc Natl Acad Sci U S A.  2004
AVP1888,PKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE,60,SARS coronavirus,SARS-CoV,Coronaviridae,sHR2-2,SARS-CoV spike protein,P59594,Vero,24±2.8,μM(EC50),Fusion,Immunofluorescence,15150417,Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.,"Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ.",Proc Natl Acad Sci U S A.  2004
AVP1889,LDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE,56,SARS coronavirus,SARS-CoV,Coronaviridae,sHR2-3,SARS-CoV spike protein,P59594,Vero,>50,μM(EC50),Fusion,Immunofluorescence,15150417,Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.,"Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ.",Proc Natl Acad Sci U S A.  2004
AVP1890,FKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE,52,SARS coronavirus,SARS-CoV,Coronaviridae,sHR2-4,SARS-CoV spike protein,P59594,Vero,>50,μM(EC50),Fusion,Immunofluorescence,15150417,Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.,"Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ.",Proc Natl Acad Sci U S A.  2004
AVP1891,TSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE,48,SARS coronavirus,SARS-CoV,Coronaviridae,sHR2-5,SARS-CoV spike protein,P59594,Vero,>50,μM(EC50),Fusion,Immunofluorescence,15150417,Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.,"Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ.",Proc Natl Acad Sci U S A.  2004
AVP1892,VDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE,44,SARS coronavirus,SARS-CoV,Coronaviridae,sHR2-6,SARS-CoV spike protein,P59594,Vero,>50,μM(EC50),Fusion,Immunofluorescence,15150417,Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.,"Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ.",Proc Natl Acad Sci U S A.  2004
AVP1893,DISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE,40,SARS coronavirus,SARS-CoV,Coronaviridae,sHR2-7,SARS-CoV spike protein,P59594,Vero,>50,μM(EC50),Fusion,Immunofluorescence,15150417,Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.,"Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ.",Proc Natl Acad Sci U S A.  2004
AVP1894,ELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIK,68,SARS coronavirus,SARS-CoV,Coronaviridae,sHR2-8,SARS-CoV spike protein,P59594,Vero,17±3.0,μM(EC50),Fusion,Immunofluorescence,15150417,Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.,"Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ.",Proc Natl Acad Sci U S A.  2004
AVP1895,ELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL,60,SARS coronavirus,SARS-CoV,Coronaviridae,sHR2-9,SARS-CoV spike protein,P59594,Vero,34±4.0,μM(EC50),Fusion,Immunofluorescence,15150417,Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.,"Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ.",Proc Natl Acad Sci U S A.  2004
AVP1896,ELDSPKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLID,56,SARS coronavirus,SARS-CoV,Coronaviridae,sHR2-10,SARS-CoV spike protein,P59594,Vero,>50,μM(EC50),Fusion,Immunofluorescence,15150417,Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.,"Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ.",Proc Natl Acad Sci U S A.  2004
AVP1897,DLSLDFEKLNVTLLDLTYEMNRIQDAIKKLNESYINLKE,39,SARS coronavirus,SARS-CoV,Coronaviridae,mHR2,SARS-CoV spike protein,P11224,Vero,>50,μM(EC50),Fusion,Immunofluorescence,15150417,Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.,"Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ.",Proc Natl Acad Sci U S A.  2004
AVP1898,AYRFNGIQVTQNVLYENQKQIANQFNKAISQIQESLTTTSTALGKLQDVVNQNAQALNTLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLIT,96,SARS coronavirus,SARS-CoV,Coronaviridae,sHR1,SARS-CoV spike protein,P59594,Vero,>50,μM(EC50),Fusion,Immunofluorescence,15150417,Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.,"Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ.",Proc Natl Acad Sci U S A.  2004
AVP1899,NQKQIANQFNKAISQIQESLTTTSTALGKLQDVVNQNAQALNTLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLIT,80,SARS coronavirus,SARS-CoV,Coronaviridae,sHR1a,SARS-CoV spike protein,P59594,Vero,>50,μM(EC50),Fusion,Immunofluorescence,15150417,Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.,"Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ.",Proc Natl Acad Sci U S A.  2004
AVP1900,NQKQIANQFNKAISQIQESLTTTSTALGKLQDVVNQNAQALNTLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLIT,80,SARS coronavirus,SARS-CoV,Coronaviridae,sHR1b,SARS-CoV spike protein,P59594,Vero,>50,μM(EC50),Fusion,Immunofluorescence,15150417,Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.,"Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ.",Proc Natl Acad Sci U S A.  2004
AVP1901,NQNAQALNTLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLIT,46,SARS coronavirus,SARS-CoV,Coronaviridae,sHR1c,SARS-CoV spike protein,P59594,Vero,>50,μM(EC50),Fusion,Immunofluorescence,15150417,Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.,"Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ.",Proc Natl Acad Sci U S A.  2004
AVP1902,GFCRCLCRRGVCRCICTR,18,Herpes simplex virus 1,HSV 1,Herpesviridae,RTD1,Rhesus theta-defensin,P82271,ME-180,No,NA,Virus entry,MTT assay,15113897,Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry.,"Yasin B, Wang W, Pang M, Cheshenko N, Hong T, Waring AJ, Herold BC, Wagar EA, Lehrer RI.",J Virol.  2004
AVP1903,GVCRCLCRRGVCRCICRR,18,Herpes simplex virus 1,HSV 1,Herpesviridae,RTD2,Rhesus theta-defensin,P82271,ME-180,No,NA,Virus entry,MTT assay,15113897,Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry.,"Yasin B, Wang W, Pang M, Cheshenko N, Hong T, Waring AJ, Herold BC, Wagar EA, Lehrer RI.",J Virol.  2004
AVP1904,GFCRCICTRGFCRCICTR,18,Herpes simplex virus 1,HSV 1,Herpesviridae,RTD3,Rhesus theta-defensin,P82270,ME-180,High,NA,Virus entry,MTT assay,15113897,Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry.,"Yasin B, Wang W, Pang M, Cheshenko N, Hong T, Waring AJ, Herold BC, Wagar EA, Lehrer RI.",J Virol.  2004
AVP1905,GICRCICGRGICRCICGR,18,Herpes simplex virus 1,HSV 1,Herpesviridae,Retrocyclin 1 ,Theta-defensin,P86722,ME-180,High,NA,Virus entry,MTT assay,15113897,Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry.,"Yasin B, Wang W, Pang M, Cheshenko N, Hong T, Waring AJ, Herold BC, Wagar EA, Lehrer RI.",J Virol.  2004
AVP1906,GICRCICGRRICRCICGR,18,Herpes simplex virus 1,HSV 1,Herpesviridae,Retrocyclin 2 ,Theta-defensin,P86722,ME-180,High,NA,Virus entry,MTT assay,15113897,Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry.,"Yasin B, Wang W, Pang M, Cheshenko N, Hong T, Waring AJ, Herold BC, Wagar EA, Lehrer RI.",J Virol.  2004
AVP1907,RICRCICGRRICRCICGR,18,Herpes simplex virus 1,HSV 1,Herpesviridae,Retrocyclin 3 ,Theta-defensin,P86722,ME-180,No,NA,Virus entry,MTT assay,15113897,Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry.,"Yasin B, Wang W, Pang M, Cheshenko N, Hong T, Waring AJ, Herold BC, Wagar EA, Lehrer RI.",J Virol.  2004
AVP1908,GFCRCLCRRGVCRCICTR,18,Herpes simplex virus 2,HSV 2,Herpesviridae,RTD1,Rhesus theta-defensin,P82271,ME-180,No,NA,Virus entry,MTT assay,15113897,Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry.,"Yasin B, Wang W, Pang M, Cheshenko N, Hong T, Waring AJ, Herold BC, Wagar EA, Lehrer RI.",J Virol.  2004
AVP1909,GVCRCLCRRGVCRCICRR,18,Herpes simplex virus 2,HSV 2,Herpesviridae,RTD2,Rhesus theta-defensin,P82271,ME-180,Moderate ,NA,Virus entry,MTT assay,15113897,Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry.,"Yasin B, Wang W, Pang M, Cheshenko N, Hong T, Waring AJ, Herold BC, Wagar EA, Lehrer RI.",J Virol.  2004
AVP1910,GFCRCICTRGFCRCICTR,18,Herpes simplex virus 2,HSV 2,Herpesviridae,RTD3,Rhesus theta-defensin,P82270,ME-180,High ,NA,Virus entry,MTT assay,15113897,Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry.,"Yasin B, Wang W, Pang M, Cheshenko N, Hong T, Waring AJ, Herold BC, Wagar EA, Lehrer RI.",J Virol.  2004
AVP1911,GICRCICGRGICRCICGR,18,Herpes simplex virus 2,HSV 2,Herpesviridae,Retrocyclin 1 ,Theta-defensin,P86722,ME-180,Moderate ,NA,Virus entry,MTT assay,15113897,Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry.,"Yasin B, Wang W, Pang M, Cheshenko N, Hong T, Waring AJ, Herold BC, Wagar EA, Lehrer RI.",J Virol.  2004
AVP1912,GICRCICGRRICRCICGR,18,Herpes simplex virus 2,HSV 2,Herpesviridae,Retrocyclin 2 ,Theta-defensin,P86722,ME-180,High ,NA,Virus entry,MTT assay,15113897,Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry.,"Yasin B, Wang W, Pang M, Cheshenko N, Hong T, Waring AJ, Herold BC, Wagar EA, Lehrer RI.",J Virol.  2004
AVP1913,RICRCICGRRICRCICGR,18,Herpes simplex virus 2,HSV 2,Herpesviridae,Retrocyclin 3 ,Theta-defensin,P86722,ME-180,No,NA,Virus entry,MTT assay,15113897,Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry.,"Yasin B, Wang W, Pang M, Cheshenko N, Hong T, Waring AJ, Herold BC, Wagar EA, Lehrer RI.",J Virol.  2004
AVP1914,GVTQNVLYENQKQIANQFNKAISQIQESLTTTSTALGKLQ,40,SARS coronavirus,SARS-CoV,Coronaviridae,NP-1,SARS-CoV spike protein,P59594,Vero E6,Low,NA,Fusion,Cytopathic effect,15043961,Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors.,"Liu S, Xiao G, Chen Y, He Y, Niu J, Escalante CR, Xiong H, Farmar J, Debnath AK, Tien P, Jiang S.",Lancet.  2004
AVP1915,LTTTSTALGKLQDVVNQNAQALNTLVKQLSSNFG,34,SARS coronavirus,SARS-CoV,Coronaviridae,NP-2,SARS-CoV spike protein,P59594,Vero E6,No,NA,Fusion,Cytopathic effect,15043961,Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors.,"Liu S, Xiao G, Chen Y, He Y, Niu J, Escalante CR, Xiong H, Farmar J, Debnath AK, Tien P, Jiang S.",Lancet.  2004
AVP1916,KQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITG,36,SARS coronavirus,SARS-CoV,Coronaviridae,NP-3,SARS-CoV spike protein,P59594,Vero E6,No,NA,Fusion,Cytopathic effect,15043961,Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors.,"Liu S, Xiao G, Chen Y, He Y, Niu J, Escalante CR, Xiong H, Farmar J, Debnath AK, Tien P, Jiang S.",Lancet.  2004
AVP1917,GRLQSLQTYVTQQLIRAAEIRASANLAATKMSEC,34,SARS coronavirus,SARS-CoV,Coronaviridae,NP-4,SARS-CoV spike protein,P59594,Vero E6,No,NA,Fusion,Cytopathic effect,15043961,Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors.,"Liu S, Xiao G, Chen Y, He Y, Niu J, Escalante CR, Xiong H, Farmar J, Debnath AK, Tien P, Jiang S.",Lancet.  2004
AVP1918,GINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE,37,SARS coronavirus,SARS-CoV,Coronaviridae,CP-1,SARS-CoV spike protein,P59594,Vero E6,19,μmol/l,Fusion,Cytopathic effect,15043961,Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors.,"Liu S, Xiao G, Chen Y, He Y, Niu J, Escalante CR, Xiong H, Farmar J, Debnath AK, Tien P, Jiang S.",Lancet.  2004
AVP1919,KEIDRLNEVAKNLNESLIDLQELGKYEQYIKWPWYVW,37,SARS coronavirus,SARS-CoV,Coronaviridae,CP-2,SARS-CoV spike protein,P59594,Vero E6,No,NA,Fusion,Cytopathic effect,15043961,Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors.,"Liu S, Xiao G, Chen Y, He Y, Niu J, Escalante CR, Xiong H, Farmar J, Debnath AK, Tien P, Jiang S.",Lancet.  2004
AVP1920,SGFDPLITHA,10,Measles virus,MV,Paramyxoviridae,-,Phage Display,,CHO,High,NA,Virus entry,ELISA,15033456,Characterization of a region involved in binding of measles virus H protein and its receptor SLAM (CD150).,"Hu C, Zhang P, Liu X, Qi Y, Zou T, Xu Q.",Biochem Biophys Res Commun.  2004
AVP1921,SDWDPLFTHK,10,Measles virus,MV,Paramyxoviridae,-,Phage Display,,CHO,High,NA,Virus entry,ELISA,15033456,Characterization of a region involved in binding of measles virus H protein and its receptor SLAM (CD150).,"Hu C, Zhang P, Liu X, Qi Y, Zou T, Xu Q.",Biochem Biophys Res Commun.  2004
AVP1922,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,37,Vaccinia,VACV,Poxviridae,LL-37,Human cathelicidin,P49913,BSC-1,High,NA,Replication,Plaque assay,14734759,Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum.,"Howell MD, Jones JF, Kisich KO, Streib JE, Gallo RL, Leung DY.",J Immunol.  2004
AVP1923,SPQYWTGPA,9,Hepatitis C virus,HCV,Flaviviridae,C25,Phage Display,,MOLT-4,81,%,Virus entry,ELISA,14728804,Phage display selection on whole cells yields a small peptide specific for HCV receptor human CD81.,"Cao J, Zhao P, Miao XH, Zhao LJ, Xue LJ, Qi Zt Zt.",Cell Res.  2003
AVP1924,TDVILMCFSIDSPDSLENI,19,Respiratory syncytial virus,RSV,Paramyxoviridae,77-95,Rho-A protein,P08134,HEp-2,7.6,μM,Replication,Viral antigen reduction assay,14576104,Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,"Budge PJ, Lebowitz J, Graham BS.",Antimicrob Agents Chemother.  2003
AVP1925,CSIELSDIPLSVDFNTMID,19,Respiratory syncytial virus,RSV,Paramyxoviridae,77-95,Rho-A protein,P08134,HEp-2,>50,μM,Replication,Viral antigen reduction assay,14576104,Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,"Budge PJ, Lebowitz J, Graham BS.",Antimicrob Agents Chemother.  2003
AVP1926,ADVILMCFSIDSPDSLENI,19,Respiratory syncytial virus,RSV,Paramyxoviridae,77-95-77A,Rho-A protein,P08134,HEp-2,2.56,μM,Replication,Viral antigen reduction assay,14576104,Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,"Budge PJ, Lebowitz J, Graham BS.",Antimicrob Agents Chemother.  2003
AVP1927,TAVILMCFSIDSPDSLENI,19,Respiratory syncytial virus,RSV,Paramyxoviridae,77-95-78A,Rho-A protein,P08134,HEp-2,1.37,μM,Replication,Viral antigen reduction assay,14576104,Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,"Budge PJ, Lebowitz J, Graham BS.",Antimicrob Agents Chemother.  2003
AVP1928,TDAILMCFSIDSPDSLENI,19,Respiratory syncytial virus,RSV,Paramyxoviridae,77-95-79A,Rho-A protein,P08134,HEp-2,6.6,μM,Replication,Viral antigen reduction assay,14576104,Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,"Budge PJ, Lebowitz J, Graham BS.",Antimicrob Agents Chemother.  2003
AVP1929,TDVALMCFSIDSPDSLENI,19,Respiratory syncytial virus,RSV,Paramyxoviridae,77-95-80A,Rho-A protein,P08134,HEp-2,11.6,μM,Replication,Viral antigen reduction assay,14576104,Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,"Budge PJ, Lebowitz J, Graham BS.",Antimicrob Agents Chemother.  2003
AVP1930,TDVIAMCFSIDSPDSLENI,19,Respiratory syncytial virus,RSV,Paramyxoviridae,77-95-81A,Rho-A protein,P08134,HEp-2,5.42,μM,Replication,Viral antigen reduction assay,14576104,Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,"Budge PJ, Lebowitz J, Graham BS.",Antimicrob Agents Chemother.  2003
AVP1931,TDVILACFSIDSPDSLENI,19,Respiratory syncytial virus,RSV,Paramyxoviridae,77-95-82A,Rho-A protein,P08134,HEp-2,1.43,μM,Replication,Viral antigen reduction assay,14576104,Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,"Budge PJ, Lebowitz J, Graham BS.",Antimicrob Agents Chemother.  2003
AVP1932,TDVILMAFSIDSPDSLENI,19,Respiratory syncytial virus,RSV,Paramyxoviridae,77-95-83A,Rho-A protein,P08134,HEp-2,>50,μM,Replication,Viral antigen reduction assay,14576104,Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,"Budge PJ, Lebowitz J, Graham BS.",Antimicrob Agents Chemother.  2003
AVP1933,TDVILMCASIDSPDSLENI,19,Respiratory syncytial virus,RSV,Paramyxoviridae,77-95-84A,Rho-A protein,P08134,HEp-2,6.29,μM,Replication,Viral antigen reduction assay,14576104,Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,"Budge PJ, Lebowitz J, Graham BS.",Antimicrob Agents Chemother.  2003
AVP1934,TDVILMCFAIDSPDSLENI,19,Respiratory syncytial virus,RSV,Paramyxoviridae,77-95-85A,Rho-A protein,P08134,HEp-2,6.82,μM,Replication,Viral antigen reduction assay,14576104,Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,"Budge PJ, Lebowitz J, Graham BS.",Antimicrob Agents Chemother.  2003
AVP1935,TDVILMCFSADSPDSLENI,19,Respiratory syncytial virus,RSV,Paramyxoviridae,77-95-86A,Rho-A protein,P08134,HEp-2,3.52,μM,Replication,Viral antigen reduction assay,14576104,Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,"Budge PJ, Lebowitz J, Graham BS.",Antimicrob Agents Chemother.  2003
AVP1936,TDVILMCFSIASPDSLENI,19,Respiratory syncytial virus,RSV,Paramyxoviridae,77-95-87A,Rho-A protein,P08134,HEp-2,4.36,μM,Replication,Viral antigen reduction assay,14576104,Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,"Budge PJ, Lebowitz J, Graham BS.",Antimicrob Agents Chemother.  2003
AVP1937,TDVILMCFSIDAPDSLENI,19,Respiratory syncytial virus,RSV,Paramyxoviridae,77-95-88A,Rho-A protein,P08134,HEp-2,2.26,μM,Replication,Viral antigen reduction assay,14576104,Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,"Budge PJ, Lebowitz J, Graham BS.",Antimicrob Agents Chemother.  2003
AVP1938,TDVILMCFSIDSADSLENI,19,Respiratory syncytial virus,RSV,Paramyxoviridae,77-95-89A,Rho-A protein,P08134,HEp-2,15.32,μM,Replication,Viral antigen reduction assay,14576104,Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,"Budge PJ, Lebowitz J, Graham BS.",Antimicrob Agents Chemother.  2003
AVP1939,TDVILMCFSIDSPASLENI,19,Respiratory syncytial virus,RSV,Paramyxoviridae,77-95-90A,Rho-A protein,P08134,HEp-2,2.61,μM,Replication,Viral antigen reduction assay,14576104,Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,"Budge PJ, Lebowitz J, Graham BS.",Antimicrob Agents Chemother.  2003
AVP1940,TDVILMCFSIDSPDALENI,19,Respiratory syncytial virus,RSV,Paramyxoviridae,77-95-91A,Rho-A protein,P08134,HEp-2,1.19,μM,Replication,Viral antigen reduction assay,14576104,Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,"Budge PJ, Lebowitz J, Graham BS.",Antimicrob Agents Chemother.  2003
AVP1941,TDVILMCFSIDSPDSAENI,19,Respiratory syncytial virus,RSV,Paramyxoviridae,77-95-92A,Rho-A protein,P08134,HEp-2,2.27,μM,Replication,Viral antigen reduction assay,14576104,Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,"Budge PJ, Lebowitz J, Graham BS.",Antimicrob Agents Chemother.  2003
AVP1942,TDVILMCFSIDSPDSLANI,19,Respiratory syncytial virus,RSV,Paramyxoviridae,77-95-93A,Rho-A protein,P08134,HEp-2,9.83,μM,Replication,Viral antigen reduction assay,14576104,Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,"Budge PJ, Lebowitz J, Graham BS.",Antimicrob Agents Chemother.  2003
AVP1943,TDVILMCFSIDSPDSLEAI,19,Respiratory syncytial virus,RSV,Paramyxoviridae,77-95-94A,Rho-A protein,P08134,HEp-2,18.47,μM,Replication,Viral antigen reduction assay,14576104,Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,"Budge PJ, Lebowitz J, Graham BS.",Antimicrob Agents Chemother.  2003
AVP1944,TDVILMCFSIDSPDSLENA,19,Respiratory syncytial virus,RSV,Paramyxoviridae,77-95-95A,Rho-A protein,P08134,HEp-2,4.89,μM,Replication,Viral antigen reduction assay,14576104,Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,"Budge PJ, Lebowitz J, Graham BS.",Antimicrob Agents Chemother.  2003
AVP1945,TDVILMCFSI,10,Respiratory syncytial virus,RSV,Paramyxoviridae,77-86,Rho-A protein,P08134,HEp-2,>50,μM,Replication,Viral antigen reduction assay,14576104,Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,"Budge PJ, Lebowitz J, Graham BS.",Antimicrob Agents Chemother.  2003
AVP1946,TDVILMCFSIDSP,13,Respiratory syncytial virus,RSV,Paramyxoviridae,77–89,Rho-A protein,P08134,HEp-2,>50,μM,Replication,Viral antigen reduction assay,14576104,Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,"Budge PJ, Lebowitz J, Graham BS.",Antimicrob Agents Chemother.  2003
AVP1947,TDVILMCFSIDSPDSL,16,Respiratory syncytial virus,RSV,Paramyxoviridae,77-92,Rho-A protein,P08134,HEp-2,10.86,μM,Replication,Viral antigen reduction assay,14576104,Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,"Budge PJ, Lebowitz J, Graham BS.",Antimicrob Agents Chemother.  2003
AVP1948,DVILMCFSIDSPDSLENI,18,Respiratory syncytial virus,RSV,Paramyxoviridae,78-95,Rho-A protein,P08134,HEp-2,1.23,μM,Replication,Viral antigen reduction assay,14576104,Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,"Budge PJ, Lebowitz J, Graham BS.",Antimicrob Agents Chemother.  2003
AVP1949,VILMCFSIDSPDSLENI,17,Respiratory syncytial virus,RSV,Paramyxoviridae,79-95,Rho-A protein,P08134,HEp-2,16.95,μM,Replication,Viral antigen reduction assay,14576104,Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,"Budge PJ, Lebowitz J, Graham BS.",Antimicrob Agents Chemother.  2003
AVP1950,ILMCFSIDSPDSLENI,16,Respiratory syncytial virus,RSV,Paramyxoviridae,80-95,Rho-A protein,P08134,HEp-2,7.17,μM,Replication,Viral antigen reduction assay,14576104,Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,"Budge PJ, Lebowitz J, Graham BS.",Antimicrob Agents Chemother.  2003
AVP1951,CFSIDSPDSLENI,13,Respiratory syncytial virus,RSV,Paramyxoviridae,83-95,Rho-A protein,P08134,HEp-2,>50,μM,Replication,Viral antigen reduction assay,14576104,Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,"Budge PJ, Lebowitz J, Graham BS.",Antimicrob Agents Chemother.  2003
AVP1952,ILMCFSIDSPDSLEN,15,Respiratory syncytial virus,RSV,Paramyxoviridae,80-94,Rho-A protein,P08134,HEp-2,1.75,μM,Replication,Viral antigen reduction assay,14576104,Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,"Budge PJ, Lebowitz J, Graham BS.",Antimicrob Agents Chemother.  2003
AVP1953,ILMCFSIDSPDSLE,14,Respiratory syncytial virus,RSV,Paramyxoviridae,80-93,Rho-A protein,P08134,HEp-2,3.5,μM,Replication,Viral antigen reduction assay,14576104,Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,"Budge PJ, Lebowitz J, Graham BS.",Antimicrob Agents Chemother.  2003
AVP1954,ILMCFSIDSPDSL,13,Respiratory syncytial virus,RSV,Paramyxoviridae,80-92,Rho-A protein,P08134,HEp-2,12.4,μM,Replication,Viral antigen reduction assay,14576104,Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,"Budge PJ, Lebowitz J, Graham BS.",Antimicrob Agents Chemother.  2003
AVP1955,ILMCFSIDSPDS,12,Respiratory syncytial virus,RSV,Paramyxoviridae,80-91,Rho-A protein,P08134,HEp-2,6.36,μM,Replication,Viral antigen reduction assay,14576104,Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,"Budge PJ, Lebowitz J, Graham BS.",Antimicrob Agents Chemother.  2003
AVP1956,ILMCFSIDSPD,11,Respiratory syncytial virus,RSV,Paramyxoviridae,80-90,Rho-A protein,P08134,HEp-2,4.61,μM,Replication,Viral antigen reduction assay,14576104,Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,"Budge PJ, Lebowitz J, Graham BS.",Antimicrob Agents Chemother.  2003
AVP1957,ILMCFSIDSP,10,Respiratory syncytial virus,RSV,Paramyxoviridae,80-89,Rho-A protein,P08134,HEp-2,35.77,μM,Replication,Viral antigen reduction assay,14576104,Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,"Budge PJ, Lebowitz J, Graham BS.",Antimicrob Agents Chemother.  2003
AVP1958,ILMCFSIDS,9,Respiratory syncytial virus,RSV,Paramyxoviridae,80-88,Rho-A protein,P08134,HEp-2,>50,μM,Replication,Viral antigen reduction assay,14576104,Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,"Budge PJ, Lebowitz J, Graham BS.",Antimicrob Agents Chemother.  2003
AVP1959,ILMCFSID,8,Respiratory syncytial virus,RSV,Paramyxoviridae,80-87,Rho-A protein,P08134,HEp-2,>50,μM,Replication,Viral antigen reduction assay,14576104,Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,"Budge PJ, Lebowitz J, Graham BS.",Antimicrob Agents Chemother.  2003
AVP1960,ILMCFSI,7,Respiratory syncytial virus,RSV,Paramyxoviridae,80-86,Rho-A protein,P08134,HEp-2,>50,μM,Replication,Viral antigen reduction assay,14576104,Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,"Budge PJ, Lebowitz J, Graham BS.",Antimicrob Agents Chemother.  2003
AVP1961,ILMCFS,6,Respiratory syncytial virus,RSV,Paramyxoviridae,80-85,Rho-A protein,P08134,HEp-2,>50,μM,Replication,Viral antigen reduction assay,14576104,Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,"Budge PJ, Lebowitz J, Graham BS.",Antimicrob Agents Chemother.  2003
AVP1962,LYIRPRPPDNDDGDDNDDGGGENNGGDGDNYATDDMMMVMIMMMVVVRIMVVMVIIMLLMT,61,Rhinovirus,RV,Picornaviridae,I421,cDNA library,,HeLa,High,NA,Replication,Plaque assay,12951031,Isolation of a peptide inhibitor of human rhinovirus.,"Poritz MA, Malmstrom S, Schmitt A, Kim MK, Zharkikh L, Kamb A, Teng DH.",Virology.  2003
AVP1963,MSTNPKPQRKTKRNTNRRPQ,20,Hepatitis C virus,HCV,Flaviviridae,HCV core aa 1-20,HCV core protein,P26662,Huh7,80,%,Translation,Luciferase assay,12655082,"Amino acids 1-20 of the hepatitis C virus (HCV) core protein specifically inhibit HCV IRES-dependent translation in HepG2 cells, and inhibit both HCV IRES- and cap-dependent translation in HuH7 and CV-1 cells.","Li D, Takyar ST, Lott WB, Gowans EJ.",J Gen Virol.  2003
AVP1964,DTHTTGGVAGRDTLRFTGFFSFGPKQK,27,Hepatitis C virus,HCV,Flaviviridae,HCV E2 HVR1 aa 384-419,HCV core protein,P26662,Huh7,No,NA,Translation,Luciferase assay,12655082,"Amino acids 1-20 of the hepatitis C virus (HCV) core protein specifically inhibit HCV IRES-dependent translation in HepG2 cells, and inhibit both HCV IRES- and cap-dependent translation in HuH7 and CV-1 cells.","Li D, Takyar ST, Lott WB, Gowans EJ.",J Gen Virol.  2003
AVP1965,STLPETTVVRRRGRSPRRRT,20,Hepatitis C virus,HCV,Flaviviridae,HBV core aa141-160,HBV core protein,Q9QAB9,Huh7,No,NA,Translation,Luciferase assay,12655082,"Amino acids 1-20 of the hepatitis C virus (HCV) core protein specifically inhibit HCV IRES-dependent translation in HepG2 cells, and inhibit both HCV IRES- and cap-dependent translation in HuH7 and CV-1 cells.","Li D, Takyar ST, Lott WB, Gowans EJ.",J Gen Virol.  2003
AVP1966,IPQSLDSWWTSL,12,Hepatitis C virus,HCV,Flaviviridae,HBsAg aa 202-213,HBV long surface antigen (L-HBsAg)  ,Q9QAB7,Huh7,No,NA,Translation,Luciferase assay,12655082,"Amino acids 1-20 of the hepatitis C virus (HCV) core protein specifically inhibit HCV IRES-dependent translation in HepG2 cells, and inhibit both HCV IRES- and cap-dependent translation in HuH7 and CV-1 cells.","Li D, Takyar ST, Lott WB, Gowans EJ.",J Gen Virol.  2003
AVP1967,NKSLLTEVETPIRNEWGCRCNDSSD,25,Influenza A virus,INFV A,Orthomyxoviridae,P1,INFV A  matrix protein 2,P63231,MDCK,High,NA,Replication,ELISA,12628550,N-terminus of M2 protein could induce antibodies with inhibitory activity against influenza virus replication.,"Liu W, Li H, Chen YH.",FEMS Immunol Med Microbiol.  2003
AVP1968,KSLLTEVETPIRGSLLTEVETPIR,24,Influenza A virus,INFV A,Orthomyxoviridae,P2,INFV A  matrix protein 2,P63231,MDCK,High,NA,Replication,ELISA,12628550,N-terminus of M2 protein could induce antibodies with inhibitory activity against influenza virus replication.,"Liu W, Li H, Chen YH.",FEMS Immunol Med Microbiol.  2003
AVP1969,KETPIRNEWGCRGETPIRNEWGCR,24,Influenza A virus,INFV A,Orthomyxoviridae,P3,INFV A  matrix protein 2,P63231,MDCK,Low,NA,Replication,ELISA,12628550,N-terminus of M2 protein could induce antibodies with inhibitory activity against influenza virus replication.,"Liu W, Li H, Chen YH.",FEMS Immunol Med Microbiol.  2003
AVP1970,KNEWGCRCNDSSDGNEWGCRCNDSSD,26,Influenza A virus,INFV A,Orthomyxoviridae,P4,INFV A  matrix protein 2,P63231,MDCK,Low,NA,Replication,ELISA,12628550,N-terminus of M2 protein could induce antibodies with inhibitory activity against influenza virus replication.,"Liu W, Li H, Chen YH.",FEMS Immunol Med Microbiol.  2003
AVP1971,AVSKVLHLEGEVNKISALLSTNKAVVSLSNGVSVLTSKVLDLDNYIDKQLLPIVNK,56,Respiratory syncytial virus,RSV,Paramyxoviridae,HR1-30a,RSV fusion (F) protein,P03420,Hep2,1.68,μM,Fusion,Cell-fusion assay,12615056,Both heptad repeats of human respiratory syncytial virus fusion protein are potent inhibitors of viral fusion.,"Wang E, Sun X, Qian Y, Zhao L, Tien P, Gao GF.",Biochem Biophys Res Commun.  2003
AVP1972,NFYDPLVFPSDEFDASISQVNEKINQSLASIRKSDELLHNVNAGK,45,Respiratory syncytial virus,RSV,Paramyxoviridae,HR2-30a,RSV fusion (F) protein,P03420,Hep2,2.93,μM,Fusion,Cell-fusion assay,12615056,Both heptad repeats of human respiratory syncytial virus fusion protein are potent inhibitors of viral fusion.,"Wang E, Sun X, Qian Y, Zhao L, Tien P, Gao GF.",Biochem Biophys Res Commun.  2003
AVP1973,QLQKWEDWVRWIGNIPQYLKG,21,Feline immunodeficiency virus,FIV,Retroviridae,Peptide 59,FIV ectodomain,P16090,MBM,0.03,μg/ml,Replication,ELISA,12610147,Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.,"Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M.",J Virol.  2003
AVP1974,QKWEDWVRWIGN,12,Feline immunodeficiency virus,FIV,Retroviridae,C12a,FIV ectodomain,P16090,MBM,0.25,μg/ml,Replication,ELISA,12610147,Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.,"Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M.",J Virol.  2003
AVP1975,WEDWVRWIGNIP,12,Feline immunodeficiency virus,FIV,Retroviridae,C12b,FIV ectodomain,P16090,MBM,0.04,μg/ml,Replication,ELISA,12610147,Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.,"Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M.",J Virol.  2003
AVP1976,QLQKWEDWVRWI,12,Feline immunodeficiency virus,FIV,Retroviridae,C12c,FIV ectodomain,P16090,MBM,0.03,μg/ml,Replication,ELISA,12610147,Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.,"Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M.",J Virol.  2003
AVP1977,WEDWVRWI,8,Feline immunodeficiency virus,FIV,Retroviridae,C8,FIV ectodomain,P16090,MBM,0.06,μg/ml,Replication,ELISA,12610147,Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.,"Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M.",J Virol.  2003
AVP1978,DWVRWI,6,Feline immunodeficiency virus,FIV,Retroviridae,C6a,FIV ectodomain,P16090,MBM,0.15,μg/ml,Replication,ELISA,12610147,Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.,"Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M.",J Virol.  2003
AVP1979,WEDWVR,6,Feline immunodeficiency virus,FIV,Retroviridae,C6b,FIV ectodomain,P16090,MBM,>50,μg/ml,Replication,ELISA,12610147,Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.,"Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M.",J Virol.  2003
AVP1980,WVRWI,5,Feline immunodeficiency virus,FIV,Retroviridae,C5,FIV ectodomain,P16090,MBM,0.2,μg/ml,Replication,ELISA,12610147,Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.,"Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M.",J Virol.  2003
AVP1981,WVRW,4,Feline immunodeficiency virus,FIV,Retroviridae,C4a,FIV ectodomain,P16090,MBM,36,μg/ml,Replication,ELISA,12610147,Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.,"Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M.",J Virol.  2003
AVP1982,VRWI,4,Feline immunodeficiency virus,FIV,Retroviridae,C4b,FIV ectodomain,P16090,MBM,7.8,μg/ml,Replication,ELISA,12610147,Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.,"Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M.",J Virol.  2003
AVP1983,AEDWVRWI,8,Feline immunodeficiency virus,FIV,Retroviridae,C8W->A770,FIV ectodomain,P16090,MBM,4.30±0.70,μg/ml,Replication,ELISA,12610147,Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.,"Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M.",J Virol.  2003
AVP1984,WADWVRWI,8,Feline immunodeficiency virus,FIV,Retroviridae,C8E->A771,FIV ectodomain,P16090,MBM,0.16±0.03,μg/ml,Replication,ELISA,12610147,Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.,"Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M.",J Virol.  2003
AVP1985,WEAWVRWI,8,Feline immunodeficiency virus,FIV,Retroviridae,C8D->A772,FIV ectodomain,P16090,MBM,0.10±0.02,μg/ml,Replication,ELISA,12610147,Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.,"Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M.",J Virol.  2003
AVP1986,WEDAVRWI,8,Feline immunodeficiency virus,FIV,Retroviridae,C8W->A773,FIV ectodomain,P16090,MBM,>50,μg/ml,Replication,ELISA,12610147,Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.,"Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M.",J Virol.  2003
AVP1987,WEDWARWI,8,Feline immunodeficiency virus,FIV,Retroviridae,C8V->A774,FIV ectodomain,P16090,MBM,0.07±0.03,μg/ml,Replication,ELISA,12610147,Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.,"Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M.",J Virol.  2003
AVP1988,WEDWVAWI,8,Feline immunodeficiency virus,FIV,Retroviridae,C8G->A775,FIV ectodomain,P16090,MBM,0.09±0.03,μg/ml,Replication,ELISA,12610147,Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.,"Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M.",J Virol.  2003
AVP1989,WEDWVRAI,8,Feline immunodeficiency virus,FIV,Retroviridae,C8W->A776,FIV ectodomain,P16090,MBM,>50,μg/ml,Replication,ELISA,12610147,Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.,"Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M.",J Virol.  2003
AVP1990,WEDWVRWA,8,Feline immunodeficiency virus,FIV,Retroviridae,C8I->A777,FIV ectodomain,P16090,MBM,0.15±0.01,μg/ml,Replication,ELISA,12610147,Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.,"Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M.",J Virol.  2003
AVP1991,CRFPNITNSHVPILQERPPLENRVLTGWGL,30,Human T-cell leukaemia virus 1,HTLV 1,Retroviridae,P-400,HTLV-1 envelope glycoprotein (gp21),P03381,MT2,3.9,μM,Virus entry,Syncitia assay,12584351,An antiviral peptide targets a coiled-coil domain of the human T-cell leukemia virus envelope glycoprotein.,"Pinon JD, Kelly SM, Price NC, Flanagan JU, Brighty DW.",J Virol.  2003
AVP1992,CCFLNITNSHVSILQERPPLENRVLTGWGL,30,Human T-cell leukaemia virus 1,HTLV 1,Retroviridae,Pcr-400,HTLV-1 envelope glycoprotein (gp21),P03381,MT2,0.28,μM,Virus entry,Syncitia assay,12584351,An antiviral peptide targets a coiled-coil domain of the human T-cell leukemia virus envelope glycoprotein.,"Pinon JD, Kelly SM, Price NC, Flanagan JU, Brighty DW.",J Virol.  2003
AVP1993,PPATHTIADRNHTPFSDV,18,Measles virus,MV,Paramyxoviridae,CPMV-CD46,Human measles virus (MV) receptor CD46 ,P15529,HeLa,0.33,μM(EC50),Virus entry,Fluorescence assay,11932408,Novel strategy for inhibiting viral entry by use of a cellular receptor-plant virus chimera.,"Khor IW, Lin T, Langedijk JP, Johnson JE, Manchester M.",J Virol.  2002
AVP1994,ATHTICDRNHTW,12,Measles virus,MV,Paramyxoviridae,CD46 12.2,Human measles virus (MV) receptor CD47,P15529,HeLa,60,μM(EC50),Virus entry,Fluorescence assay,11932408,Novel strategy for inhibiting viral entry by use of a cellular receptor-plant virus chimera.,"Khor IW, Lin T, Langedijk JP, Johnson JE, Manchester M.",J Virol.  2002
AVP1995,SFYSVLFLWGTCGGFSHSWY,20,Hepatitis B Virus,HBV,Flaviviridae,C1-1,Peptide aptamer expression library,,Huh7,High,NA,Replication,Western blotting,11641783,Peptide aptamers targeting the hepatitis B virus core protein: a new class of molecules with antiviral activity.,"Butz K, Denk C, Fitscher B, Crnkovic-Mertens I, Ullmann A, Schroder CH, Hoppe-Seyler F.",Oncogene.  2001
AVP1996,GFSSIFRGVAKFASKGLGKDLARLGVNLVACKISKQC,37,Frog virus 3,FV3,Iridoviridae,Esculentin-2P,Esculentin,P82846,FHM,80,%,Virucidal,Plaque assay,11601906,"Inactivation of frog virus 3 and channel catfish virus by esculentin-2P and ranatuerin-2P, two antimicrobial peptides isolated from frog skin.","Chinchar VG, Wang J, Murti G, Carey C, Rollins-Smith L.",Virology.  2001
AVP1997,GLMDTVKNVAKNLAGHMLDKLKCKITGC,28,Frog virus 3,FV3,Iridoviridae,Ranatuerin-2P,Ranatuerin,Q8QFQ4,FHM,80,%,Virucidal,Plaque assay,11601906,"Inactivation of frog virus 3 and channel catfish virus by esculentin-2P and ranatuerin-2P, two antimicrobial peptides isolated from frog skin.","Chinchar VG, Wang J, Murti G, Carey C, Rollins-Smith L.",Virology.  2001
AVP1998,GFSSIFRGVAKFASKGLGKDLARLGVNLVACKISKQC,37,Channel catfish virus ,CCV,Herpesviridae,Esculentin-2P,Esculentin,P82846,CCO,90,%,Virucidal,Plaque assay,11601906,"Inactivation of frog virus 3 and channel catfish virus by esculentin-2P and ranatuerin-2P, two antimicrobial peptides isolated from frog skin.","Chinchar VG, Wang J, Murti G, Carey C, Rollins-Smith L.",Virology.  2001
AVP1999,GLMDTVKNVAKNLAGHMLDKLKCKITGC,28,Channel catfish virus ,CCV,Herpesviridae,Ranatuerin-2P,Ranatuerin,Q8QFQ4,CCO,40,%,Virucidal,Plaque assay,11601906,"Inactivation of frog virus 3 and channel catfish virus by esculentin-2P and ranatuerin-2P, two antimicrobial peptides isolated from frog skin.","Chinchar VG, Wang J, Murti G, Carey C, Rollins-Smith L.",Virology.  2001
AVP2000,KQRQNKPPSKPNNDFHFEVFNFVPCSICSNNPTCWAICKRIPNKKPGKK,49,Respiratory syncytial virus,RSV,Paramyxoviridae,G149-197,RSV attachment glycoprotein,P03423,HEp-2,80,μM,Cytopathic effect,NMR,11487583,Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.,"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.",J Biol Chem.  2001
AVP2001,FHFEVFNFVPCSICSNNPTCWAICKRIPNKKPGKK,35,Respiratory syncytial virus,RSV,Paramyxoviridae,G163-197,RSV attachment glycoprotein,P03423,HEp-2,80,μM,Cytopathic effect,NMR,11487583,Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.,"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.",J Biol Chem.  2001
AVP2002,VPCSICSNNPTCWAICKRIPNKKPGKK,27,Respiratory syncytial virus,RSV,Paramyxoviridae,G171-197,RSV attachment glycoprotein,P03423,HEp-2,>165,μM,Cytopathic effect,NMR,11487583,Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.,"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.",J Biol Chem.  2001
AVP2003,CSICSNNPTCWAICKRIPNKKPGKK,25,Respiratory syncytial virus,RSV,Paramyxoviridae,G173-197,RSV attachment glycoprotein,P03423,HEp-2,>177,μM,Cytopathic effect,NMR,11487583,Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.,"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.",J Biol Chem.  2001
AVP2004,KQRQNKPPSKPNNDFHFEVFNFVPCSICSNNPTCWAICKRI,41,Respiratory syncytial virus,RSV,Paramyxoviridae,G149-189,RSV attachment glycoprotein,P03423,HEp-2,12,μM,Cytopathic effect,NMR,11487583,Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.,"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.",J Biol Chem.  2001
AVP2005,KPPSKPNNDFHFEVFNFVPCSICSNNPTCWAICKRI,36,Respiratory syncytial virus,RSV,Paramyxoviridae,G154-189,RSV attachment glycoprotein,P03423,HEp-2,12,μM,Cytopathic effect,NMR,11487583,Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.,"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.",J Biol Chem.  2001
AVP2006,KPNNDFHFEVFNFVPCSICSNNPTCWAICKRI,32,Respiratory syncytial virus,RSV,Paramyxoviridae,G158-189,RSV attachment glycoprotein,P03423,HEp-2,25,μM,Cytopathic effect,NMR,11487583,Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.,"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.",J Biol Chem.  2001
AVP2007,KQRQNKPPSKPNNDFHFEVFN,21,Respiratory syncytial virus,RSV,Paramyxoviridae,G149-169,RSV attachment glycoprotein,P03423,HEp-2,>190,μM,Cytopathic effect,NMR,11487583,Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.,"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.",J Biol Chem.  2001
AVP2008,KQRQNKPPSKPNNDFHF,17,Respiratory syncytial virus,RSV,Paramyxoviridae,G149-165,RSV attachment glycoprotein,P03423,HEp-2,>240,μM,Cytopathic effect,NMR,11487583,Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.,"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.",J Biol Chem.  2001
AVP2009,KPPSKPNNDFHFEVFNFVP,19,Respiratory syncytial virus,RSV,Paramyxoviridae,G154-172,RSV attachment glycoprotein,P03423,HEp-2,220,μM,Cytopathic effect,NMR,11487583,Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.,"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.",J Biol Chem.  2001
AVP2010,KPPSKPNNDFHFEVFNFV,18,Respiratory syncytial virus,RSV,Paramyxoviridae,G154-171,RSV attachment glycoprotein,P03423,HEp-2,14,μM,Cytopathic effect,NMR,11487583,Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.,"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.",J Biol Chem.  2001
AVP2011,KPPSKPNNDFHFEVFNF,17,Respiratory syncytial virus,RSV,Paramyxoviridae,G154-170,RSV attachment glycoprotein,P03423,HEp-2,7,μM,Cytopathic effect,NMR,11487583,Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.,"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.",J Biol Chem.  2001
AVP2012,KPPSKPNNDFHFEVFN,16,Respiratory syncytial virus,RSV,Paramyxoviridae,G154-169,RSV attachment glycoprotein,P03423,HEp-2,>510,μM,Cytopathic effect,NMR,11487583,Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.,"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.",J Biol Chem.  2001
AVP2013,LLRVKR,6,Human cytomegalovirus,HCMV,Herpesviridae,-,Synthetic,,CHO,0.42±0.02,μM(Ki),Furin,Flouroscence spectrtophotometery,10958789,Polyarginines are potent furin inhibitors.,"Cameron A, Appel J, Houghten RA, Lindberg I.",J Biol Chem.  2000
AVP2014,RRRR,4,Human cytomegalovirus,HCMV,Herpesviridae,-,Synthetic,,CHO,6.4±0.9,μM(Ki),Furin,Flouroscence spectrtophotometery,10958789,Polyarginines are potent furin inhibitors.,"Cameron A, Appel J, Houghten RA, Lindberg I.",J Biol Chem.  2000
AVP2015,RRRRR,5,Human cytomegalovirus,HCMV,Herpesviridae,-,Synthetic,,CHO,0.99±0.08,μM(Ki),Furin,Flouroscence spectrtophotometery,10958789,Polyarginines are potent furin inhibitors.,"Cameron A, Appel J, Houghten RA, Lindberg I.",J Biol Chem.  2000
AVP2016,RRRRRR,6,Human cytomegalovirus,HCMV,Herpesviridae,-,Synthetic,,CHO,0.114±0.006,μM(Ki),Furin,Flouroscence spectrtophotometery,10958789,Polyarginines are potent furin inhibitors.,"Cameron A, Appel J, Houghten RA, Lindberg I.",J Biol Chem.  2000
AVP2017,RRRRRRR,7,Human cytomegalovirus,HCMV,Herpesviridae,-,Synthetic,,CHO,0.068±0.001,μM(Ki),Furin,Flouroscence spectrtophotometery,10958789,Polyarginines are potent furin inhibitors.,"Cameron A, Appel J, Houghten RA, Lindberg I.",J Biol Chem.  2000
AVP2018,RRRRRRRR,8,Human cytomegalovirus,HCMV,Herpesviridae,-,Synthetic,,CHO,0.061±0.001,μM(Ki),Furin,Flouroscence spectrtophotometery,10958789,Polyarginines are potent furin inhibitors.,"Cameron A, Appel J, Houghten RA, Lindberg I.",J Biol Chem.  2000
AVP2019,RRRRRRRRR,9,Human cytomegalovirus,HCMV,Herpesviridae,-,Synthetic,,CHO,0.042±0.003,μM(Ki),Furin,Flouroscence spectrtophotometery,10958789,Polyarginines are potent furin inhibitors.,"Cameron A, Appel J, Houghten RA, Lindberg I.",J Biol Chem.  2000
AVP2020,NILRLKESITATIEAVHEVTDGLS,24,Newcastle disease virus,NDV,Paramyxoviridae,NDVFhr24 peptide,NDV fusion protein (HR1),P12572,Cos-7,2,μM,Fusion,Fusion assay,10364347,Interaction of peptides with sequences from the Newcastle disease virus fusion protein heptad repeat regions.,"Young JK, Li D, Abramowitz MC, Morrison TG.",J Virol.  1999
AVP2021,SMEKLAGFGAVGAGATAEETRRMLHRAFDTLA,32,Herpes simplex virus 1,HSV 1,Herpesviridae,EtxB-Pol chimera,HSV DNA polymerase,P07917,Vero,15,μM,Replication,Plaque assay,10220447,Intranuclear delivery of an antiviral peptide mediated by the B subunit of Escherichia coli heat-labile enterotoxin.,"Loregian A, Papini E, Satin B, Marsden HS, Hirst TR, Palu G.",Proc Natl Acad Sci U S A.  1999
AVP2022,LNLADATNFLQDSKAELEKARKILSEVGRWY,31,Sendai virus,SeV,Paramyxoviridae,SV-465,SeV fusion protein,P04855,RBCs,80,%,Fusion,Hemolysis assay,9765238,Structure-function study of a heptad repeat positioned near the transmembrane domain of Sendai virus fusion protein which blocks virus-cell fusion.,"Ghosh JK, Peisajovich SG, Ovadia M, Shai Y.",J Biol Chem.  1998
AVP2023,ALDKLEESNSKLDKVNVKLT,20,Newcastle disease virus,NDV,Paramyxoviridae,NDVFz20 peptide,NDV fusion protein (HR2),P12572,Cos,2,μM,Fusion,Fusion assay,9527912,The role of leucine residues in the structure and function of a leucine zipper peptide inhibitor of paramyxovirus (NDV) fusion.,"Young JK, Hicks RP, Wright GE, Morrison TG.",Virology.  1998
AVP2024,ALDKAEESNSKLDKVNVKLT,20,Newcastle disease virus,NDV,Paramyxoviridae,NDVFz20-L5A peptide,NDV fusion protein (HR2),P12572,Cos,6,μM,Fusion,Fusion assay,9527912,The role of leucine residues in the structure and function of a leucine zipper peptide inhibitor of paramyxovirus (NDV) fusion.,"Young JK, Hicks RP, Wright GE, Morrison TG.",Virology.  1998
AVP2025,ALDKAEESNSKADKVNVKLT,20,Newcastle disease virus,NDV,Paramyxoviridae,"NDVFz20-L5,12A peptide",NDV fusion protein (HR2),P12572,Cos,35,μM,Fusion,Fusion assay,9527912,The role of leucine residues in the structure and function of a leucine zipper peptide inhibitor of paramyxovirus (NDV) fusion.,"Young JK, Hicks RP, Wright GE, Morrison TG.",Virology.  1998
AVP2026,ALDKAEESNSKADKVNVKAT,20,Newcastle disease virus,NDV,Paramyxoviridae,"NDVFz20-L5,12,19A peptide",NDV fusion protein (HR2),P12572,Cos,No,NA,Fusion,Fusion assay,9527912,The role of leucine residues in the structure and function of a leucine zipper peptide inhibitor of paramyxovirus (NDV) fusion.,"Young JK, Hicks RP, Wright GE, Morrison TG.",Virology.  1998
AVP2027,CHWMFSPWC,9,Puumala virus,PuV,Bunyaviridae,-,Phage Display,,Vero E6,High,NA,Virucidal,Fluorescence assay,9094664,Phage-displayed peptide targeting on the Puumala hantavirus neutralization site.,"Heiskanen T, Lundkvist A, Vaheri A, Lankinen H.",J Virol.  1997
AVP2028,CATCEQIADSQHRSHRQMV,19,Influenza A virus,INFV A,Orthomyxoviridae,Peptide 6,INFV A  matrix protein 1,P03485,MDCK,0.7,nM,Replication,Viral titer,9056014,In vivo anti-influenza virus activity of a zinc finger peptide.,"Judd AK, Sanchez A, Bucher DJ, Huffman JH, Bailey K, Sidwell RW.",Antimicrob Agents Chemother.  1997
AVP2029,ACYCRIPACIAGERRYGTCIYQGRLWAFCC,30,Herpes simplex virus 1,HSV 1,Herpesviridae,HNP-1,Human granulocute defensin,P59665,Vero,High,NA,Virucidal,Plaque assay,3023659,Direct inactivation of viruses by human granulocyte defensins.,"Daher KA, Selsted ME, Lehrer RI.",J Virol.  1986
AVP2030,YAGAVVNDL,9,Herpes simplex virus 1,HSV 1,Herpesviridae,HSV H2-(7-15),HSV ribonucleotide reductase subunit 2,P10224,BHK-21/C13,52,μM,Replication,Ribonucleotide reductase assay,2846533,"Mechanism of inhibition of herpes simplex virus (HSV) ribonucleotide reductase by a nonapeptide corresponding to the carboxyl terminus of its subunit 2. Specific binding of a photoaffinity analog, [4'- azido-Phe6] HSV H2-6(6-15), to subunit 1.","Paradis H, Gaudreau P, Brazeau P, Langelier Y.",J Biol Chem.  1988
AVP2031,YAGAVVNDLL,10,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV ribonucleotide reductase subunit 2,P10224,BHK-21/C13,28,μM,Replication,Ribonucleotide reductase assay,2161904,Inhibition of equine herpesvirus type 1 subtype 1-induced ribonucleotide reductase by the nonapeptide YAGAVVNDL.,"Telford E, Lankinen H, Marsden H.",J Gen Virol.  1990
AVP2032,YGAVVNDL,8,Herpes simplex virus 1,HSV 1,Herpesviridae,Peptide 1,HSV ribonucleotide reductase subunit 2,P10224,BHK,21,μg,Replication,Ribonucleotide reductase assay,3012359,Specific inhibition of herpesvirus ribonucleotide reductase by synthetic peptides.,"Dutia BM, Frame MC, Subak-Sharpe JH, Clark WN, Marsden HS.",Nature.  1986
AVP2033,YAGAVVNDL,9,Herpes simplex virus 1,HSV 1,Herpesviridae,Peptide 3,HSV ribonucleotide reductase subunit 2,P10224,BHK,4.5,μg,Replication,Ribonucleotide reductase assay,3012359,Specific inhibition of herpesvirus ribonucleotide reductase by synthetic peptides.,"Dutia BM, Frame MC, Subak-Sharpe JH, Clark WN, Marsden HS.",Nature.  1986
AVP2034,YAGAVVNDLL,10,Herpes simplex virus 1,HSV 1,Herpesviridae,-,HSV ribonucleotide reductase subunit 2,P10224,BHK-21/C13,22,μM,Replication,Ribonucleotide reductase assay,3012360,Specific inhibition of herpesvirus ribonucleotide reductase by a nonapeptide derived from the carboxy terminus of subunit 2.,"Cohen EA, Gaudreau P, Brazeau P, Langelier Y.",Nature.  1986
AVP2035,LGNWAREIWATL,12,Feline immunodeficiency virus,FIV,Retroviridae,-,SU glycoprotein of FIV,P16090,CrFK,High,NA,Replication,Syncitia assay,9600086,The antiviral activity of a synthetic peptide derived from the envelope SU glycoprotein of feline immunodeficiency virus maps in correspondence of an amphipathic helical segment.,"Massi C, Indino E, Lami C, Fissi A, Pieroni O, La Rosa C, Esposito F, Galoppini C, Rovero P, Bandecchi P, Bendinelli M, Garzelli C.",Biochem Biophys Res Commun.  1998
AVP2036,CNIAPASIVSRNIVYTRAQPNQDIA,25,Bovine rotavirus,BRV,Reoviridae,VP4-peptide,BRV capsid protein-VP4 ,P08713,MA-104,200,μg/ml,Virus entry,Plaque assay,9682337,Inhibition of rotavirus infection in vitro and in vivo by a synthetic peptide from VP4.,"Ijaz MK, Nur-E-Kamal MS, Dar FK, Uduman S, Redmond MJ, Attah-Poku SK, Dent D, Babiuk LA.",Vaccine.  1998
AVP2037,ANVVATYPAHS,11,Herpes simplex virus 1,HSV 1,Herpesviridae,RC-183,RC 138 (Rozites caperata),,Buffalo Green,5,μM,Replication,Plaque assay,10517309,"Isolation and partial characterization of an antiviral, RC-183, from the edible mushroom Rozites caperata.","Piraino F, Brandt CR.",Antiviral Res.  1999
AVP2038,YLTTLK,6,Simian rotavirus,SRV,Reoviridae,Fragment 324-329,Bovine Lactoferrin,P24627,HT-29,1000±25,μg/ml(EC50),Replication,Cytopathic effect,11687297,"Involvement of bovine lactoferrin metal saturation, sialic acid and protein fragments in the inhibition of rotavirus infection.","Superti F, Siciliano R, Rega B, Giansanti F, Valenti P, Antonini G.",Biochim Biophys Acta.  2001
AVP2039,FLQDSKAELEKARKILSEVG,20,Sendai virus,SeV,Paramyxoviridae,Residues 473-492,SeV fusion protein,P04855,RBCs,17,μM,Hemolysis,Hemolysis assay,12586338,Peptides derived from the heptad repeat region near the C-terminal of Sendai virus F protein bind the hemagglutinin-neuraminidase ectodomain.,"Tomasi M, Pasti C, Manfrinato C, Dallocchio F, Bellini T.",FEBS Lett.  2003
AVP2040,KAAKKAAKAAKKAAKWAKKAA,21,Herpes simplex virus 1,HSV 1,Herpesviridae,RJ3,Synthetic,,MRC-5,117,μM,Replication,Plaque assay,15498607,"A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus.","Jenssen H, Andersen JH, Mantzilas D, Gutteberg TJ.",Antiviral Res.  2004
AVP2041,AKKAAKKAKKAAKKAKKAAKK,21,Herpes simplex virus 1,HSV 1,Herpesviridae,RJ5,Synthetic,,MRC-5,41,μM,Replication,Plaque assay,15498607,"A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus.","Jenssen H, Andersen JH, Mantzilas D, Gutteberg TJ.",Antiviral Res.  2004
AVP2042,AKKAAKKAKKAAKKAKKWAKK,21,Herpes simplex virus 1,HSV 1,Herpesviridae,RJ6,Synthetic,,MRC-5,47.3,μM,Replication,Plaque assay,15498607,"A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus.","Jenssen H, Andersen JH, Mantzilas D, Gutteberg TJ.",Antiviral Res.  2004
AVP2043,AKKAWKKAKKAAKKAKKWAKK,21,Herpes simplex virus 1,HSV 1,Herpesviridae,RJ7,Synthetic,,MRC-5,40.8,μM,Replication,Plaque assay,15498607,"A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus.","Jenssen H, Andersen JH, Mantzilas D, Gutteberg TJ.",Antiviral Res.  2004
AVP2044,ARRAWRRARRAARRARRAARR,21,Herpes simplex virus 1,HSV 1,Herpesviridae,RJ8,Synthetic,,MRC-5,18.2,μM,Replication,Plaque assay,15498607,"A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus.","Jenssen H, Andersen JH, Mantzilas D, Gutteberg TJ.",Antiviral Res.  2004
AVP2045,ARRAKRRARRAARRARRKARR,21,Herpes simplex virus 1,HSV 1,Herpesviridae,RJ9,Synthetic,,MRC-5,13,μM,Replication,Plaque assay,15498607,"A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus.","Jenssen H, Andersen JH, Mantzilas D, Gutteberg TJ.",Antiviral Res.  2004
AVP2046,ARRAKRRARRAKRRARRKKRR,21,Herpes simplex virus 1,HSV 1,Herpesviridae,RJ10,Synthetic,,MRC-5,24.6,μM,Replication,Plaque assay,15498607,"A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus.","Jenssen H, Andersen JH, Mantzilas D, Gutteberg TJ.",Antiviral Res.  2004
AVP2047,IFKAIWSGIKSLF,13,Hepatitis C virus,HCV,Flaviviridae,Hp1090,Scorpion venom,P0DJ02,Huh7.5.1,5,μM,Virucidal,RT PCR,20950663,A new natural Î±-helical peptide from the venom of the scorpion Heterometrus petersii kills HCV.,"Yan R, Zhao Z, He Y, Wu L, Cai D, Hong W, Wu Y, Cao Z, Zheng C, Li W.",Peptides.  2011
AVP2048,IFSAIGGFLKSIF,13,Hepatitis C virus,HCV,Flaviviridae,Hp1035,Scorpion venom,P0DJ03,Huh7.5.1,No,NA,Virucidal,RT PCR,20950663,A new natural Î±-helical peptide from the venom of the scorpion Heterometrus petersii kills HCV.,"Yan R, Zhao Z, He Y, Wu L, Cai D, Hong W, Wu Y, Cao Z, Zheng C, Li W.",Peptides.  2011
AVP2049,LFGLIPSLIGGLVSAFK,17,Measles virus,MV,Paramyxoviridae,Mucroporin,Scorpion venom,B9UIY3,Vero,3.52,μM(EC50),Replication,Plaque assay,21620914,"Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses.","Li Q, Zhao Z, Zhou D, Chen Y, Hong W, Cao L, Yang J, Zhang Y, Shi W, Cao Z, Wu Y, Yan H, Li W.",Peptides.  2011
AVP2050,LFRLIKSLIKRLVSAFK,17,Measles virus,MV,Paramyxoviridae,Mucroporin-M1,Scorpion venom,B9UIY3,Vero,No,NA,Replication,Plaque assay,21620914,"Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses.","Li Q, Zhao Z, Zhou D, Chen Y, Hong W, Cao L, Yang J, Zhang Y, Shi W, Cao Z, Wu Y, Yan H, Li W.",Peptides.  2011
AVP2051,SLIGGLVSAFK,11,Measles virus,MV,Paramyxoviridae,Mucroporin-S1,Scorpion venom,B9UIY3,Vero,No,NA,Replication,Plaque assay,21620914,"Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses.","Li Q, Zhao Z, Zhou D, Chen Y, Hong W, Cao L, Yang J, Zhang Y, Shi W, Cao Z, Wu Y, Yan H, Li W.",Peptides.  2011
AVP2052,VSAFK,5,Measles virus,MV,Paramyxoviridae,Mucroporin-S2,Scorpion venom,B9UIY3,Vero,No,NA,Replication,Plaque assay,21620914,"Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses.","Li Q, Zhao Z, Zhou D, Chen Y, Hong W, Cao L, Yang J, Zhang Y, Shi W, Cao Z, Wu Y, Yan H, Li W.",Peptides.  2011
AVP2053,LFGLIPSLIGGLVSAFK,17,SARS coronavirus,SARS-CoV,Coronaviridae,Mucroporin,Scorpion venom,B9UIY3,MDCK,7.12,μM(EC50),Replication,Plaque assay,21620914,"Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses.","Li Q, Zhao Z, Zhou D, Chen Y, Hong W, Cao L, Yang J, Zhang Y, Shi W, Cao Z, Wu Y, Yan H, Li W.",Peptides.  2011
AVP2054,LFRLIKSLIKRLVSAFK,17,SARS coronavirus,SARS-CoV,Coronaviridae,Mucroporin-M1,Scorpion venom,B9UIY3,MDCK,No,NA,Replication,Plaque assay,21620914,"Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses.","Li Q, Zhao Z, Zhou D, Chen Y, Hong W, Cao L, Yang J, Zhang Y, Shi W, Cao Z, Wu Y, Yan H, Li W.",Peptides.  2011
AVP2055,SLIGGLVSAFK,11,SARS coronavirus,SARS-CoV,Coronaviridae,Mucroporin-S1,Scorpion venom,B9UIY3,MDCK,No,NA,Replication,Plaque assay,21620914,"Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses.","Li Q, Zhao Z, Zhou D, Chen Y, Hong W, Cao L, Yang J, Zhang Y, Shi W, Cao Z, Wu Y, Yan H, Li W.",Peptides.  2011
AVP2056,VSAFK,5,SARS coronavirus,SARS-CoV,Coronaviridae,Mucroporin-S2,Scorpion venom,B9UIY3,MDCK,No,NA,Replication,Plaque assay,21620914,"Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses.","Li Q, Zhao Z, Zhou D, Chen Y, Hong W, Cao L, Yang J, Zhang Y, Shi W, Cao Z, Wu Y, Yan H, Li W.",Peptides.  2011
AVP2057,LFGLIPSLIGGLVSAFK,17,Influenza A virus,INFV A,Orthomyxoviridae,Mucroporin-S2,Scorpion venom,B9UIY3,MDCK,1.03,μM(EC50),Replication,Plaque assay,21620914,"Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses.","Li Q, Zhao Z, Zhou D, Chen Y, Hong W, Cao L, Yang J, Zhang Y, Shi W, Cao Z, Wu Y, Yan H, Li W.",Peptides.  2011
AVP2058,LFRLIKSLIKRLVSAFK,17,Influenza A virus,INFV A,Orthomyxoviridae,Mucroporin-S2,Scorpion venom,B9UIY3,MDCK,No,NA,Replication,Plaque assay,21620914,"Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses.","Li Q, Zhao Z, Zhou D, Chen Y, Hong W, Cao L, Yang J, Zhang Y, Shi W, Cao Z, Wu Y, Yan H, Li W.",Peptides.  2011
AVP2059,SLIGGLVSAFK,11,Influenza A virus,INFV A,Orthomyxoviridae,Mucroporin-S2,Scorpion venom,B9UIY3,MDCK,No,NA,Replication,Plaque assay,21620914,"Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses.","Li Q, Zhao Z, Zhou D, Chen Y, Hong W, Cao L, Yang J, Zhang Y, Shi W, Cao Z, Wu Y, Yan H, Li W.",Peptides.  2011
AVP2060,VSAFK,5,Influenza A virus,INFV A,Orthomyxoviridae,Mucroporin-S2,Scorpion venom,B9UIY3,MDCK,No,NA,Replication,Plaque assay,21620914,"Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses.","Li Q, Zhao Z, Zhou D, Chen Y, Hong W, Cao L, Yang J, Zhang Y, Shi W, Cao Z, Wu Y, Yan H, Li W.",Peptides.  2011
AVP2061,KHMHWHPPALNT,12,Hepatitis B virus,HBV,Hepadnaviridae,P7,Phage Display,,-,High,NA,Virus entry,ELISA,21856287,Blocking peptides against HBV: preS1 protein selected from a phage display library.,"Wang W, Liu Y, Zu X, Jin R, Xiao G.",Biochem Biophys Res Commun.  2011
AVP2062,SLIGRL,6,Influenza A virus,INFV A,Orthomyxoviridae,-,PAR2-activating peptide,P55086,Mouse,40,μg/mouse,Virucidal,ELISA,22988062,Inhibitory influence of the hexapeptidic sequence SLIGRL on influenza A virus infection in mice.,"Betts RJ, Mann TS, Henry PJ.",J Pharmacol Exp Ther.  2012
